WO2016036980A1 - Compounds, compositions, and methods for modulating sweet taste - Google Patents
Compounds, compositions, and methods for modulating sweet taste Download PDFInfo
- Publication number
- WO2016036980A1 WO2016036980A1 PCT/US2015/048400 US2015048400W WO2016036980A1 WO 2016036980 A1 WO2016036980 A1 WO 2016036980A1 US 2015048400 W US2015048400 W US 2015048400W WO 2016036980 A1 WO2016036980 A1 WO 2016036980A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ppm
- compound
- sweetener
- present
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 339
- 235000019605 sweet taste sensations Nutrition 0.000 title claims abstract description 167
- 238000000034 method Methods 0.000 title claims abstract description 144
- 150000001875 compounds Chemical class 0.000 title claims description 595
- 235000000346 sugar Nutrition 0.000 claims abstract description 40
- 230000002708 enhancing effect Effects 0.000 claims abstract description 21
- 235000019658 bitter taste Nutrition 0.000 claims abstract description 19
- 239000003765 sweetening agent Substances 0.000 claims description 251
- 235000003599 food sweetener Nutrition 0.000 claims description 250
- 150000003839 salts Chemical class 0.000 claims description 180
- -1 isomogroside Natural products 0.000 claims description 62
- 150000001413 amino acids Chemical class 0.000 claims description 52
- 239000000796 flavoring agent Substances 0.000 claims description 50
- 235000019634 flavors Nutrition 0.000 claims description 46
- 230000008447 perception Effects 0.000 claims description 46
- 239000000654 additive Substances 0.000 claims description 45
- 235000001014 amino acid Nutrition 0.000 claims description 42
- 229930188195 rebaudioside Natural products 0.000 claims description 42
- 239000000284 extract Substances 0.000 claims description 40
- 150000001720 carbohydrates Chemical group 0.000 claims description 38
- 235000014633 carbohydrates Nutrition 0.000 claims description 38
- 239000004615 ingredient Substances 0.000 claims description 35
- 235000019533 nutritive sweetener Nutrition 0.000 claims description 35
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 29
- 229930006000 Sucrose Natural products 0.000 claims description 28
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 26
- 235000009508 confectionery Nutrition 0.000 claims description 26
- 239000005720 sucrose Substances 0.000 claims description 26
- 239000005715 Fructose Substances 0.000 claims description 25
- 229930091371 Fructose Natural products 0.000 claims description 25
- 229930003935 flavonoid Natural products 0.000 claims description 25
- 235000017173 flavonoids Nutrition 0.000 claims description 25
- 229920005862 polyol Polymers 0.000 claims description 25
- 150000003077 polyols Chemical class 0.000 claims description 25
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 23
- 235000019202 steviosides Nutrition 0.000 claims description 23
- 239000004386 Erythritol Substances 0.000 claims description 22
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 22
- 229940009714 erythritol Drugs 0.000 claims description 22
- 235000019414 erythritol Nutrition 0.000 claims description 22
- 230000000996 additive effect Effects 0.000 claims description 20
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 19
- 235000013399 edible fruits Nutrition 0.000 claims description 19
- 239000008103 glucose Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 18
- 235000020357 syrup Nutrition 0.000 claims description 18
- 239000006188 syrup Substances 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 16
- 239000004383 Steviol glycoside Substances 0.000 claims description 16
- 229910052708 sodium Inorganic materials 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 16
- 235000019411 steviol glycoside Nutrition 0.000 claims description 16
- 229930182488 steviol glycoside Natural products 0.000 claims description 16
- 150000008144 steviol glycosides Chemical group 0.000 claims description 16
- 150000005846 sugar alcohols Chemical class 0.000 claims description 16
- 229920000858 Cyclodextrin Polymers 0.000 claims description 15
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 14
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 14
- PBILBHLAPJTJOT-CQSZACIVSA-N Phyllodulcin Chemical compound C1=C(O)C(OC)=CC=C1[C@@H]1OC(=O)C2=C(O)C=CC=C2C1 PBILBHLAPJTJOT-CQSZACIVSA-N 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 14
- 150000002215 flavonoids Chemical class 0.000 claims description 14
- 150000007524 organic acids Chemical class 0.000 claims description 14
- XNLFIERPGXTDDP-UHFFFAOYSA-N periandrin i Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O XNLFIERPGXTDDP-UHFFFAOYSA-N 0.000 claims description 14
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 14
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 claims description 14
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 claims description 14
- 229920002472 Starch Polymers 0.000 claims description 13
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 240000008042 Zea mays Species 0.000 claims description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 12
- 235000005822 corn Nutrition 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 11
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 10
- LKDRXBCSQODPBY-NSHGFSBMSA-N L-fructose Chemical compound OCC1(O)OC[C@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-NSHGFSBMSA-N 0.000 claims description 10
- 150000007513 acids Chemical class 0.000 claims description 10
- 150000001298 alcohols Chemical class 0.000 claims description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 10
- 239000004094 surface-active agent Substances 0.000 claims description 10
- 108010011485 Aspartame Proteins 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000004376 Sucralose Substances 0.000 claims description 9
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 9
- 229960004998 acesulfame potassium Drugs 0.000 claims description 9
- 239000000619 acesulfame-K Substances 0.000 claims description 9
- 239000008122 artificial sweetener Substances 0.000 claims description 9
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 9
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 9
- 235000010357 aspartame Nutrition 0.000 claims description 9
- 239000000605 aspartame Substances 0.000 claims description 9
- 229960003438 aspartame Drugs 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 235000019408 sucralose Nutrition 0.000 claims description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 9
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 8
- 239000004377 Alitame Substances 0.000 claims description 8
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 239000004384 Neotame Substances 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- 235000019409 alitame Nutrition 0.000 claims description 8
- 108010009985 alitame Proteins 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- 229960001855 mannitol Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 235000019412 neotame Nutrition 0.000 claims description 8
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 8
- 108010070257 neotame Proteins 0.000 claims description 8
- 235000019204 saccharin Nutrition 0.000 claims description 8
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 8
- 229940081974 saccharin Drugs 0.000 claims description 8
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 8
- 235000010356 sorbitol Nutrition 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 229960002920 sorbitol Drugs 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 7
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims description 7
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 claims description 7
- YTKBWWKAVMSYHE-OALUTQOASA-N (3s)-3-[3-(3-hydroxy-4-methoxyphenyl)propylamino]-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H](CC(O)=O)NCCCC=1C=C(O)C(OC)=CC=1)C1=CC=CC=C1 YTKBWWKAVMSYHE-OALUTQOASA-N 0.000 claims description 7
- NNXQSUSEFPRCRS-YCKMUKMSSA-N 3-[(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-3-[(E,2S)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1[C@@H]2[C@@H]([C@@](C)(O)C\C=C\C(C)(C)O)CC[C@@]2(C)[C@]2(C)CC[C@@H](C(C)=C)[C@](C)(CCC(O)=O)[C@H]2C1 NNXQSUSEFPRCRS-YCKMUKMSSA-N 0.000 claims description 7
- PBILBHLAPJTJOT-UHFFFAOYSA-N 3S-phyllodulcin Natural products C1=C(O)C(OC)=CC=C1C1OC(=O)C2=C(O)C=CC=C2C1 PBILBHLAPJTJOT-UHFFFAOYSA-N 0.000 claims description 7
- CJHYXUPCGHKJOO-GUESNGNRSA-N Abrusoside A Natural products O=C(O)[C@]1(C)[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]23[C@H]1CC[C@H]1[C@@]4(C)[C@@](C)([C@H]([C@@H](C)[C@H]5OC(=O)C(C)=CC5)CC4)CC[C@@]21C3 CJHYXUPCGHKJOO-GUESNGNRSA-N 0.000 claims description 7
- 239000004394 Advantame Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 7
- 229930186291 Dulcoside Natural products 0.000 claims description 7
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 claims description 7
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 claims description 7
- 239000001329 FEMA 3811 Substances 0.000 claims description 7
- 239000001512 FEMA 4601 Substances 0.000 claims description 7
- 239000001689 FEMA 4674 Substances 0.000 claims description 7
- 239000001776 FEMA 4720 Substances 0.000 claims description 7
- GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 claims description 7
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 claims description 7
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 claims description 7
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 7
- 108050004114 Monellin Proteins 0.000 claims description 7
- 108010093901 N-(N-(3-(3-hydroxy-4-methoxyphenyl) propyl)-alpha-aspartyl)-L-phenylalanine 1-methyl ester Proteins 0.000 claims description 7
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 claims description 7
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 claims description 7
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 claims description 7
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 claims description 7
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims description 7
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 claims description 7
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 7
- 229930182647 Trilobatin Natural products 0.000 claims description 7
- HINSNOJRHFIMKB-DJDMUFINSA-N [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound [H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC(=O)[C@]2(C)CCC[C@@]3(C)[C@]4([H])CC[C@@]5(C[C@]4(CC5=C)CC[C@]23[H])O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@]2([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O HINSNOJRHFIMKB-DJDMUFINSA-N 0.000 claims description 7
- CJHYXUPCGHKJOO-AYOTXDKCSA-N abrusoside A Chemical compound O([C@H]1CC[C@@]23[C@H]([C@]1(C)C(O)=O)CC[C@H]1[C@]4(C)CC[C@@H]([C@]4(CC[C@]12C3)C)[C@H](C)[C@H]1OC(=O)C(C)=CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CJHYXUPCGHKJOO-AYOTXDKCSA-N 0.000 claims description 7
- 235000019453 advantame Nutrition 0.000 claims description 7
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 claims description 7
- 108010010165 curculin Proteins 0.000 claims description 7
- 229930193831 cyclocarioside Natural products 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims description 7
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims description 7
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 7
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 7
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 229930191869 mogroside IV Natural products 0.000 claims description 7
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 claims description 7
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 claims description 7
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims description 7
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims description 7
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 claims description 7
- 235000010434 neohesperidine DC Nutrition 0.000 claims description 7
- 235000005985 organic acids Nutrition 0.000 claims description 7
- FAASKPMBDMDYGK-UHFFFAOYSA-N phlomisoside I Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1C(C)(C)C(CCC(C)=C2CCC3=COC=C3)C2(C)CC1 FAASKPMBDMDYGK-UHFFFAOYSA-N 0.000 claims description 7
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 claims description 7
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 claims description 7
- 235000019139 phlorizin Nutrition 0.000 claims description 7
- 150000003085 polypodoside A derivatives Polymers 0.000 claims description 7
- NNXQSUSEFPRCRS-UHFFFAOYSA-N pterocaryoside A Natural products OC1C(O)C(O)C(C)OC1OC1C2C(C(C)(O)CC=CC(C)(C)O)CCC2(C)C2(C)CCC(C(C)=C)C(C)(CCC(O)=O)C2C1 NNXQSUSEFPRCRS-UHFFFAOYSA-N 0.000 claims description 7
- SODWWCZKQRRZTG-UHFFFAOYSA-N pterocaryoside B Natural products OC(=O)CCC1(C)C(C(=C)C)CCC(C2(CCC(C22)C(C)(O)CC=CC(C)(C)O)C)(C)C1CC2OC1OCC(O)C(O)C1O SODWWCZKQRRZTG-UHFFFAOYSA-N 0.000 claims description 7
- 235000019203 rebaudioside A Nutrition 0.000 claims description 7
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 claims description 7
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 claims description 7
- GSGVXNMGMKBGQU-PHESRWQRSA-N rebaudioside M Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GSGVXNMGMKBGQU-PHESRWQRSA-N 0.000 claims description 7
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 claims description 7
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 7
- 229930190082 siamenoside Natural products 0.000 claims description 7
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 7
- 229940013618 stevioside Drugs 0.000 claims description 7
- 235000010436 thaumatin Nutrition 0.000 claims description 7
- 239000000892 thaumatin Substances 0.000 claims description 7
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims description 7
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 claims description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 6
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- 235000004279 alanine Nutrition 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 claims description 6
- 239000003531 protein hydrolysate Substances 0.000 claims description 6
- 235000004400 serine Nutrition 0.000 claims description 6
- 229960001462 sodium cyclamate Drugs 0.000 claims description 6
- 229960003080 taurine Drugs 0.000 claims description 6
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose group Chemical group OCC(=O)[C@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 claims description 5
- LKDRXBCSQODPBY-IANNHFEVSA-N D-sorbose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-IANNHFEVSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- PYMYPHUHKUWMLA-MROZADKFSA-N aldehydo-L-ribose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-MROZADKFSA-N 0.000 claims description 5
- GZCGUPFRVQAUEE-OMMKOOBNSA-N aldehydo-L-talose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-OMMKOOBNSA-N 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 229930189775 mogroside Natural products 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- BJHIKXHVCXFQLS-PYWDMBMJSA-N keto-D-sorbose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PYWDMBMJSA-N 0.000 claims description 4
- 150000002895 organic esters Chemical class 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 claims description 4
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 3
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000018977 lysine Nutrition 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000004067 bulking agent Substances 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000013043 chemical agent Substances 0.000 claims description 2
- 238000010668 complexation reaction Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 238000000265 homogenisation Methods 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000005063 solubilization Methods 0.000 claims description 2
- 230000007928 solubilization Effects 0.000 claims description 2
- 230000003381 solubilizing effect Effects 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims 3
- 241000544066 Stevia Species 0.000 claims 3
- 235000013305 food Nutrition 0.000 abstract description 50
- 235000005911 diet Nutrition 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 4
- 230000000903 blocking effect Effects 0.000 abstract description 3
- 235000019577 caloric intake Nutrition 0.000 abstract description 3
- 235000002639 sodium chloride Nutrition 0.000 description 143
- 229940024606 amino acid Drugs 0.000 description 50
- 235000013361 beverage Nutrition 0.000 description 47
- 239000003963 antioxidant agent Substances 0.000 description 30
- 235000006708 antioxidants Nutrition 0.000 description 30
- 239000000047 product Substances 0.000 description 28
- 235000019640 taste Nutrition 0.000 description 27
- 239000006041 probiotic Substances 0.000 description 26
- 235000018291 probiotics Nutrition 0.000 description 26
- 229910052500 inorganic mineral Inorganic materials 0.000 description 25
- 235000010755 mineral Nutrition 0.000 description 25
- 239000011707 mineral Substances 0.000 description 25
- 229930182490 saponin Natural products 0.000 description 25
- 235000017709 saponins Nutrition 0.000 description 25
- 229960004793 sucrose Drugs 0.000 description 25
- 229940088594 vitamin Drugs 0.000 description 25
- 239000011782 vitamin Substances 0.000 description 25
- 235000013351 cheese Nutrition 0.000 description 23
- 229930003231 vitamin Natural products 0.000 description 23
- 235000013343 vitamin Nutrition 0.000 description 23
- 150000007949 saponins Chemical class 0.000 description 22
- 229920001542 oligosaccharide Polymers 0.000 description 20
- 235000013406 prebiotics Nutrition 0.000 description 20
- 239000003755 preservative agent Substances 0.000 description 20
- 230000003078 antioxidant effect Effects 0.000 description 19
- 235000013325 dietary fiber Nutrition 0.000 description 17
- 241000196324 Embryophyta Species 0.000 description 16
- 125000001931 aliphatic group Chemical group 0.000 description 16
- 230000036541 health Effects 0.000 description 16
- 230000000670 limiting effect Effects 0.000 description 16
- 235000001727 glucose Nutrition 0.000 description 15
- 230000036571 hydration Effects 0.000 description 15
- 238000006703 hydration reaction Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 13
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 13
- 230000002335 preservative effect Effects 0.000 description 13
- 229940083542 sodium Drugs 0.000 description 13
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 12
- 244000269722 Thea sinensis Species 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000003623 enhancer Substances 0.000 description 12
- 239000000835 fiber Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 150000008163 sugars Chemical class 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 244000078534 Vaccinium myrtillus Species 0.000 description 11
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 11
- 229960002442 glucosamine Drugs 0.000 description 11
- 150000002482 oligosaccharides Chemical class 0.000 description 11
- 230000003389 potentiating effect Effects 0.000 description 11
- 230000000529 probiotic effect Effects 0.000 description 11
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 10
- 229940012843 omega-3 fatty acid Drugs 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 235000015067 sauces Nutrition 0.000 description 10
- 150000003722 vitamin derivatives Chemical class 0.000 description 10
- 230000037221 weight management Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 244000299461 Theobroma cacao Species 0.000 description 9
- 235000013339 cereals Nutrition 0.000 description 9
- 235000012149 noodles Nutrition 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 150000004804 polysaccharides Chemical class 0.000 description 9
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 241000220225 Malus Species 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229920002770 condensed tannin Polymers 0.000 description 8
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 235000013311 vegetables Nutrition 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 7
- 244000046052 Phaseolus vulgaris Species 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 7
- 229960005069 calcium Drugs 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000006014 omega-3 oil Substances 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 6
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 235000011430 Malus pumila Nutrition 0.000 description 6
- 235000015103 Malus silvestris Nutrition 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 235000021014 blueberries Nutrition 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- 229940125898 compound 5 Drugs 0.000 description 6
- 230000007407 health benefit Effects 0.000 description 6
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 229940068065 phytosterols Drugs 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 229960003975 potassium Drugs 0.000 description 6
- 235000020095 red wine Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 5
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000294611 Punica granatum Species 0.000 description 5
- 235000014360 Punica granatum Nutrition 0.000 description 5
- 244000235659 Rubus idaeus Species 0.000 description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 5
- 241001593968 Vitis palmata Species 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000021028 berry Nutrition 0.000 description 5
- 235000014171 carbonated beverage Nutrition 0.000 description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 5
- 229940074393 chlorogenic acid Drugs 0.000 description 5
- 235000001368 chlorogenic acid Nutrition 0.000 description 5
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 5
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 5
- 230000000112 colonic effect Effects 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- 235000004634 cranberry Nutrition 0.000 description 5
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 235000011987 flavanols Nutrition 0.000 description 5
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical group OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 5
- 108091005708 gustatory receptors Proteins 0.000 description 5
- 229940093915 gynecological organic acid Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 159000000003 magnesium salts Chemical class 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 5
- 229940033080 omega-6 fatty acid Drugs 0.000 description 5
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 5
- 235000010987 pectin Nutrition 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 239000001814 pectin Substances 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 239000003075 phytoestrogen Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- 241001444063 Aronia Species 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 4
- 241000207199 Citrus Species 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 4
- 240000007154 Coffea arabica Species 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 235000016623 Fragaria vesca Nutrition 0.000 description 4
- 240000009088 Fragaria x ananassa Species 0.000 description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 240000002129 Malva sylvestris Species 0.000 description 4
- 235000006770 Malva sylvestris Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- SXPRUELMHUBWQX-UHFFFAOYSA-N OC=1C=C(C=CC=1OC)C1OC2=CC(=C(C=C2CC1)C)O Chemical compound OC=1C=C(C=CC=1OC)C1OC2=CC(=C(C=C2CC1)C)O SXPRUELMHUBWQX-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 240000001890 Ribes hudsonianum Species 0.000 description 4
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 4
- 235000001466 Ribes nigrum Nutrition 0.000 description 4
- 235000011034 Rubus glaucus Nutrition 0.000 description 4
- 235000009122 Rubus idaeus Nutrition 0.000 description 4
- 244000228451 Stevia rebaudiana Species 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 235000009470 Theobroma cacao Nutrition 0.000 description 4
- 241000219095 Vitis Species 0.000 description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 description 4
- 235000014787 Vitis vinifera Nutrition 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 235000016213 coffee Nutrition 0.000 description 4
- 235000013353 coffee beverage Nutrition 0.000 description 4
- 235000012754 curcumin Nutrition 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 229920001968 ellagitannin Polymers 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 150000002206 flavan-3-ols Chemical class 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 235000019534 high fructose corn syrup Nutrition 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 235000021374 legumes Nutrition 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 244000005706 microflora Species 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 4
- 229940052490 naringin Drugs 0.000 description 4
- 229930019673 naringin Natural products 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000018192 pine bark supplement Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229940106796 pycnogenol Drugs 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 235000003351 Brassica cretica Nutrition 0.000 description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 235000003343 Brassica rupestris Nutrition 0.000 description 3
- 244000045195 Cicer arietinum Species 0.000 description 3
- 235000010523 Cicer arietinum Nutrition 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920000241 Punicalagin Polymers 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 239000002830 appetite depressant Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 235000021029 blackberry Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 229960002737 fructose Drugs 0.000 description 3
- 235000011087 fumaric acid Nutrition 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 229940087559 grape seed Drugs 0.000 description 3
- 235000021384 green leafy vegetables Nutrition 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 229940025878 hesperidin Drugs 0.000 description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 3
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- 150000002453 idose derivatives Chemical class 0.000 description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 description 3
- 235000008960 ketchup Nutrition 0.000 description 3
- 239000004310 lactic acid Chemical class 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 235000010460 mustard Nutrition 0.000 description 3
- 235000021096 natural sweeteners Nutrition 0.000 description 3
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 3
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229920002414 procyanidin Polymers 0.000 description 3
- ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 description 3
- LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 description 3
- ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 description 3
- 235000021391 short chain fatty acids Nutrition 0.000 description 3
- 150000004666 short chain fatty acids Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical class OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- UIAFKZKHHVMJGS-UHFFFAOYSA-N 2,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- 240000006914 Aspalathus linearis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 241000273930 Brevoortia tyrannus Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 2
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010056474 Erythrosis Diseases 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 235000017048 Garcinia mangostana Nutrition 0.000 description 2
- 240000006053 Garcinia mangostana Species 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 2
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- GPLOTACQBREROW-UHFFFAOYSA-N Phlegmanol A-acetat Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC1=2)C=C(O)C(=O)C1=C(O)C(O)=CC=2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GPLOTACQBREROW-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000151637 Sambucus canadensis Species 0.000 description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- KMJPKUVSXFVQGZ-UHFFFAOYSA-N TF2B Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-UHFFFAOYSA-N 0.000 description 2
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical group C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000001361 adipic acid Chemical class 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 244000193174 agave Species 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Chemical class OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 235000007123 blue elder Nutrition 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 125000004452 carbocyclyl group Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012846 chilled/fresh pasta Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical class C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 235000020965 cold beverage Nutrition 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940109275 cyclamate Drugs 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 235000010300 dimethyl dicarbonate Nutrition 0.000 description 2
- 239000004316 dimethyl dicarbonate Substances 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 244000013123 dwarf bean Species 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000007124 elderberry Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 2
- 235000021554 flavoured beverage Nutrition 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013569 fruit product Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229960003681 gluconolactone Drugs 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 235000014168 granola/muesli bars Nutrition 0.000 description 2
- 235000019674 grape juice Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229940096427 hawthorn berry extract Drugs 0.000 description 2
- 235000010209 hesperetin Nutrition 0.000 description 2
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 2
- 229960001587 hesperetin Drugs 0.000 description 2
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 2
- 125000004475 heteroaralkyl group Chemical group 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 235000013902 inosinic acid Nutrition 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 2
- 229960000511 lactulose Drugs 0.000 description 2
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 235000019223 lemon-lime Nutrition 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000001630 malic acid Chemical class 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 150000002826 nitrites Chemical class 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 229940109529 pomegranate extract Drugs 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 235000013324 preserved food Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000019675 red grape juice Nutrition 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000000185 sucrose group Chemical group 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 2
- 235000014620 theaflavin Nutrition 0.000 description 2
- 229940026509 theaflavin Drugs 0.000 description 2
- 235000008118 thearubigins Nutrition 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000015113 tomato pastes and purées Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- CDDWAYFUFNQLRZ-KJVHGCRFSA-N (3beta,21beta,22beta)-olean-12-ene-3,21,22,24-tetrol Chemical compound C([C@@]12C)C[C@H](O)[C@](C)(CO)[C@@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)[C@@H](O)[C@@H](O)[C@]3(C)CC[C@]21C CDDWAYFUFNQLRZ-KJVHGCRFSA-N 0.000 description 1
- YOQAQNKGFOLRGT-UXXABWCISA-N (3beta,22beta)-olean-12-ene-3,22,24-triol Chemical compound C1C[C@H](O)[C@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)[C@H](O)CC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C YOQAQNKGFOLRGT-UXXABWCISA-N 0.000 description 1
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- TWSWSIQAPQLDBP-CGRWFSSPSA-N (7e,10e,13e,16e)-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O TWSWSIQAPQLDBP-CGRWFSSPSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- HVGRZDASOHMCSK-UHFFFAOYSA-N (Z,Z)-13,16-docosadienoic acid Natural products CCCCCC=CCC=CCCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Chemical class OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- JCSJTDYCNQHPRJ-UHFFFAOYSA-N 20-hydroxyecdysone 2,3-acetonide Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(OC2C(C(O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 description 1
- XVHKLOFEZNFSRF-HNNXBMFYSA-N 7,3'-dihydroxy-4'-methoxy-8-methylflavan Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=C(C)C(O)=CC=C2CC1 XVHKLOFEZNFSRF-HNNXBMFYSA-N 0.000 description 1
- ZEASWHWETFMWCV-UHFFFAOYSA-N 7-O-(2-O-Acetyl-6-O-Methyl-beta-D-glucuronoside)-4',5,7-Trihydroxyflavone Natural products C=1C(O)=C(O)C2=C(O)C(=O)C=C(C3C(CC4=C(O)C=C(O)C=C4O3)OC(=O)C=3C=C(O)C(O)=C(O)C=3)C=C2C=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 ZEASWHWETFMWCV-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 241001499808 Allium atrorubens Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001041927 Alloscardovia omnicolens Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000442425 Aristeomorpha foliacea Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000093727 Berzelia alopecuroides Species 0.000 description 1
- 241000186014 Bifidobacterium angulatum Species 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 241000186013 Bifidobacterium asteroides Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186011 Bifidobacterium catenulatum Species 0.000 description 1
- 241001495388 Bifidobacterium choerinum Species 0.000 description 1
- 241000186022 Bifidobacterium coryneforme Species 0.000 description 1
- 241000186021 Bifidobacterium cuniculi Species 0.000 description 1
- 241000186020 Bifidobacterium dentium Species 0.000 description 1
- 241001312346 Bifidobacterium gallicum Species 0.000 description 1
- 241001312342 Bifidobacterium gallinarum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241001312344 Bifidobacterium merycicum Species 0.000 description 1
- 241000186150 Bifidobacterium minimum Species 0.000 description 1
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 241001626537 Bifidobacterium psychraerophilum Species 0.000 description 1
- 241001312954 Bifidobacterium pullorum Species 0.000 description 1
- 241001312356 Bifidobacterium ruminantium Species 0.000 description 1
- 241001311520 Bifidobacterium saeculare Species 0.000 description 1
- 241000042873 Bifidobacterium scardovii Species 0.000 description 1
- 241001051647 Bifidobacterium simiae Species 0.000 description 1
- 241001302264 Bifidobacterium subtile Species 0.000 description 1
- 241001034431 Bifidobacterium thermacidophilum Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 235000008744 Brassica perviridis Nutrition 0.000 description 1
- 244000233513 Brassica perviridis Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical class CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 241001153023 Capicola Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- HSNZZMHEPUFJNZ-QMTIVRBISA-N D-keto-manno-heptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-QMTIVRBISA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- 101710119265 DNA topoisomerase 1 Proteins 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000275449 Diplectrum formosum Species 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 235000021292 Docosatetraenoic acid Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920000025 Emblicanin Polymers 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Chemical class 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- QGWNDRXFNXRZMB-UUOKFMHZSA-N GDP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O QGWNDRXFNXRZMB-UUOKFMHZSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 244000148687 Glycosmis pentaphylla Species 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical class OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- JPXZQMKKFWMMGK-KQYNXXCUSA-N IDP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 JPXZQMKKFWMMGK-KQYNXXCUSA-N 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- HAEJPQIATWHALX-KQYNXXCUSA-N ITP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 HAEJPQIATWHALX-KQYNXXCUSA-N 0.000 description 1
- 235000003368 Ilex paraguariensis Nutrition 0.000 description 1
- 244000188472 Ilex paraguariensis Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- URRZRRQMNMZIAP-UHFFFAOYSA-N Kudzusapogenol C Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C)CCC21C URRZRRQMNMZIAP-UHFFFAOYSA-N 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241001134654 Lactobacillus leichmannii Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 108700035965 MEG3 Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 240000000571 Nopalea cochenillifera Species 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- XVHKLOFEZNFSRF-OAHLLOKOSA-N OC=1C=C(C=CC=1OC)[C@@H]1OC2=C(C(=CC=C2CC1)O)C Chemical compound OC=1C=C(C=CC=1OC)[C@@H]1OC2=C(C(=CC=C2CC1)O)C XVHKLOFEZNFSRF-OAHLLOKOSA-N 0.000 description 1
- FSJSODMMIYGSTK-AGJIYOFVSA-N OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC[C@H]3O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O Chemical compound OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC[C@H]3O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O FSJSODMMIYGSTK-AGJIYOFVSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- RVSTWRHIGKXTLG-WCXIOVBPSA-N Pangamic acid Chemical compound CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RVSTWRHIGKXTLG-WCXIOVBPSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Chemical class OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- XSEQBUVOXWTHGU-UHFFFAOYSA-N Pieristoxin G Natural products CC1(O)CC2(C(C(O)C3(O)C4(C)C)O)C(O)C1CCC2(O)C(C)(O)C3C1C4O1 XSEQBUVOXWTHGU-UHFFFAOYSA-N 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 241000819847 Pomella Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102100023075 Protein Niban 2 Human genes 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000011552 Rhamnus crocea Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000016911 Ribes sativum Nutrition 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 235000016897 Ribes triste Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-O S-methyl-L-methionine Chemical compound C[S+](C)CC[C@H]([NH3+])C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-O 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 241000219287 Saponaria Species 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 241001253754 Scolopia mundii Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 206010040550 Shigella infections Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- BVMDSEFJGKQBKJ-UHFFFAOYSA-N Theaflavin 3'-gallate Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O BVMDSEFJGKQBKJ-UHFFFAOYSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 235000011720 Vaccinium uliginosum Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000166315 Vulcaniibacterium thermophilum Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 240000005780 Yucca gloriosa Species 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- GNTQICZXQYZQNE-HSUXUTPPSA-N abequose Chemical compound C[C@@H](O)[C@H](O)C[C@@H](O)C=O GNTQICZXQYZQNE-HSUXUTPPSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 229940124332 anorexigenic agent Drugs 0.000 description 1
- 230000002891 anorexigenic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 229930002878 anthoxanthin Natural products 0.000 description 1
- 150000004637 anthoxanthins Chemical class 0.000 description 1
- 235000004458 antinutrient Nutrition 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229940029830 benefiber Drugs 0.000 description 1
- 230000009704 beneficial physiological effect Effects 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-VQEHIDDOSA-N benzoic acid Chemical compound OC(=O)C1=CC=C[13CH]=C1 WPYMKLBDIGXBTP-VQEHIDDOSA-N 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- FBJQEBRMDXPWNX-CFCQXFMMSA-N beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](O)O2)O)O1 FBJQEBRMDXPWNX-CFCQXFMMSA-N 0.000 description 1
- JCSJTDYCNQHPRJ-FDVJSPBESA-N beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-D-Xylp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)C(O)OC2)O)OC1 JCSJTDYCNQHPRJ-FDVJSPBESA-N 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 229940114055 beta-resorcylic acid Drugs 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000019611 bitter taste sensations Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 235000014448 bouillon/stock cubes Nutrition 0.000 description 1
- 235000012186 breakfast bars Nutrition 0.000 description 1
- 239000008376 breath freshener Substances 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000004403 catechin group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- 235000014696 chilled pizza Nutrition 0.000 description 1
- 235000010675 chips/crisps Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940081970 citrucel Drugs 0.000 description 1
- 229940070404 citrus bioflavonoids Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229940119429 cocoa extract Drugs 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical class OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 235000008936 dinner mixes Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- MKZUDFZKTZOCRS-UHFFFAOYSA-N diphosphono hydrogen phosphate;1h-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.OP(O)(=O)OP(O)(=O)OP(O)(O)=O MKZUDFZKTZOCRS-UHFFFAOYSA-N 0.000 description 1
- 235000014505 dips Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 235000015432 dried pasta Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 235000021112 essential micronutrients Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004674 formic acids Chemical class 0.000 description 1
- 235000012020 french fries Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000021456 frozen pasta Nutrition 0.000 description 1
- 235000012396 frozen pizza Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000008410 fruit bars Nutrition 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 235000011494 fruit snacks Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 125000005611 glucoheptonic acid group Chemical class 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- XHMJOUIAFHJHBW-VFUOTHLCSA-N glucosamine 6-phosphate Chemical compound N[C@H]1[C@H](O)O[C@H](COP(O)(O)=O)[C@H](O)[C@@H]1O XHMJOUIAFHJHBW-VFUOTHLCSA-N 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000013761 grape skin extract Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 235000015810 grayleaf red raspberry Nutrition 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- QGWNDRXFNXRZMB-UHFFFAOYSA-N guanidine diphosphate Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O QGWNDRXFNXRZMB-UHFFFAOYSA-N 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 150000002386 heptoses Chemical class 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 229940089491 hydroxycitric acid Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 235000008416 impulse ice cream Nutrition 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002630 limonoids Chemical class 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- 229940099262 marinol Drugs 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000021486 meal replacement product Nutrition 0.000 description 1
- 235000015255 meat loaf Nutrition 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960005173 methiosulfonium chloride Drugs 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- LPUQAYUQRXPFSQ-UHFFFAOYSA-M monosodium glutamate Chemical compound [Na+].[O-]C(=O)C(N)CCC(O)=O LPUQAYUQRXPFSQ-UHFFFAOYSA-M 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000015253 mortadella Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000021278 navy bean Nutrition 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000008519 pasta sauces Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical class C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- 125000000394 phosphonato group Chemical group [O-]P([O-])(*)=O 0.000 description 1
- RAYIFMWTQKNDNK-UHFFFAOYSA-N phosphono dihydrogen phosphate;1h-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.OP(O)(=O)OP(O)(O)=O RAYIFMWTQKNDNK-UHFFFAOYSA-N 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- KPYHRMNYOUGKKI-UHFFFAOYSA-N phosphoric acid;1h-pyrimidine-2,4-dione Chemical compound OP(O)(O)=O.O=C1C=CNC(=O)N1 KPYHRMNYOUGKKI-UHFFFAOYSA-N 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000020741 pine bark extract Nutrition 0.000 description 1
- 229940106587 pine bark extract Drugs 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000010604 prepared salads Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000012434 pretzels Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000014059 processed cheese Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical group CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001007 puffing effect Effects 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 235000011835 quiches Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000015504 ready meals Nutrition 0.000 description 1
- 235000013526 red clover Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 235000021572 root beer Nutrition 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229940119224 salmon oil Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 235000019553 satiation Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000021108 sauerkraut Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000021484 savory snack Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000019613 sensory perceptions of taste Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000020994 smoked meat Nutrition 0.000 description 1
- 235000009561 snack bars Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000011497 sour milk drink Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- CDDWAYFUFNQLRZ-UHFFFAOYSA-N soyasapogenol A Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)C(O)C3(C)CCC21C CDDWAYFUFNQLRZ-UHFFFAOYSA-N 0.000 description 1
- MADZMXIFUWFDJK-AEARDBQCSA-N soyasapogenol B Natural products CC1(C)C[C@@H](O)[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@H]2C1 MADZMXIFUWFDJK-AEARDBQCSA-N 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000011476 stock cubes Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 235000016045 table sauces Nutrition 0.000 description 1
- 235000015273 take-home ice cream Nutrition 0.000 description 1
- 235000008603 tangeritin Nutrition 0.000 description 1
- 229920002258 tannic acid Chemical class 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical class OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000035923 taste sensation Effects 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- IKLDTEFDTLKDRK-UHFFFAOYSA-N theaflavin 3'-gallate Natural products OC1Cc2c(O)cc(O)cc2OC1c3cc4C=C(C=C(O)C(=O)c4c(O)c3O)C5Oc6cc(O)cc(O)c6CC5OC(=O)c7cc(O)c(O)c(O)c7 IKLDTEFDTLKDRK-UHFFFAOYSA-N 0.000 description 1
- AATSUYYYTHJRJO-UHFFFAOYSA-N theaflavin 3-gallate Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC(=O)C(O)=C1C(O)=C2O)C=C1C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-UHFFFAOYSA-N 0.000 description 1
- 235000002365 theaflavin-3'-gallate Nutrition 0.000 description 1
- AATSUYYYTHJRJO-RZYARBFNSA-N theaflavin-3-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=C(O)C(O)=C2C(=O)C(O)=CC(=CC2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-RZYARBFNSA-N 0.000 description 1
- 235000007900 theaflavin-3-gallate Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 239000008377 tooth whitener Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 235000008371 tortilla/corn chips Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003641 trioses Chemical class 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000014348 vinaigrettes Nutrition 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- ABKNGTPZXRUSOI-UHFFFAOYSA-N xylotriose Natural products OCC(OC1OCC(OC2OCC(O)C(O)C2O)C(O)C1O)C(O)C(O)C=O ABKNGTPZXRUSOI-UHFFFAOYSA-N 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/86—Addition of bitterness inhibitors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2052—Heterocyclic compounds having oxygen or sulfur as the only hetero atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to flavor in edible compositions.
- the present disclosure provides compounds that enhance sweet taste, edible compositions comprising such compounds, and methods of preparing such edible compositions.
- the present disclosure also provides methods of reducing the amount of a sweetener in an edible composition.
- the present disclosure further provides a method of enhancing, modulating or potentiating the sweet taste of an edible composition, such as a food, consumer or pharmaceutical product, in a subject.
- the present disclosure also provides a method of modulating, particularly enhancing or
- a further aspect of the present disclosure provides compounds, or mixtures thereof for masking or reducing unpleasant taste sensations, in particular for masking or reducing the bitter taste sensation of a bitter-tastant.
- One aspect of the present disclosure provides compounds for modulating sweet taste (e.g., enhancing sweet taste) of a sweet tastant.
- the compound is a flavonoid compound.
- the flavonoid is a flavan.
- the flavonoid is a flavan.
- flavonoid compound has a molecular weight less than about 1000, 500, or 300 Daltons. In certain embodiments, the flavonoid compound is a
- the flavonoid compound is any one of Compounds 1-6 or combinations thereof, or comestibly or biologically acceptable salts or derivatives thereof.
- the present disclosure also includes edible
- compositions comprising sweet taste modulating compounds such as the compounds of Formula (I).
- present disclosure also includes edible compositions comprising sweet taste modulating compounds such as any one of Compounds 1-6, or combinations thereof.
- Such taste modulators may be combined with any suitable sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener including a synthetic high-potency sweetener, sugar alcohols, rare sugars, sweetener enhancers or combinations thereof, to provide a composition having enhanced sweetness.
- a suitable sweetener such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener including a synthetic high-potency sweetener, sugar alcohols, rare sugars, sweetener enhancers or combinations thereof.
- the compound of Formula (I) comestibly or biologically acceptable salts or derivatives thereof, or enantiomers thereof, or combinations thereof is present in the composition in an amount at or below its inherent sweetness threshold.
- compositions may further comprise at least one sweet taste improving composition.
- the present disclosure provides a method of enhancing the sweetness of a sweetener comprising combining (i) at least one sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener including a synthetic high-potency sweetener, sugar alcohols, rare sugars, sweetener enhancers or combinations thereof, and (ii) a flavonoid sweet taste modulator of the present invention, such as a compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, or enantiomers thereof, or combinations thereof.
- the flavonoid sweet taste modulator of the present invention is any one of Compounds 1-6, or combinations thereof.
- the method may further comprise combining (iii) at least one sweet taste improving composition.
- the compounds may be added in an amount at or below their sweetness threshold.
- compositions such as beverage compositions, concentrates (for use in, e.g., beverage compositions), food products, pharmaceutical preparations and table-top sweeteners comprising the compositions of the present disclosure; methods for preparing an edible composition; methods for reducing the amount of a sweetener in an edible composition; methods for reducing caloric intake; methods of enhancing activation of a sweet taste receptor and methods of synthesizing the sweet taste modulators of the present invention.
- Particular embodiments of the invention are set forth in the following numbered paragraphs:
- composition wherein said method comprises adding an effective amount of a compound of Formula (I) any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, to said edible composition, such that the perception of sweetness intensity of said sweetener is enhanced.
- the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
- the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
- the method of Paragraph 12 wherein the caloric sweetener is sucrose.
- the sugar alcohol is a polyol selected from erythritol, sorbitol, mannitol and xylitol.
- the artificial high-potency sweetener is sucralose or a salt thereof, acesulfame potassium or anther salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
- the natural high-potency sweetener is a steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, a mogroside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin,
- the rare sugar is a D-psicose, D- turanose, D-allose, D-tagatose, D-sorbose, L-fructose, L-glucose, D- sorbose, L-fructose, L-talose, L-ribose, L-arabinose or a mixture thereof.
- the method of Paragraph 34 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-35%.
- the method of Paragraph 35 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-25%.
- the edible composition further comprises one or more antioxidants, vitamins, glucosamine, dietary fibers, hydration agents, probiotics, prebiotics, phytosterols, omega-3 oils, fatty acids, saponins, natural or synthetic preservatives, minerals, weight management agents, osteoporosis management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, or phytosterols.
- said one of more sweet taste improving additives is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
- the method of Paragraph 45 wherein the ratio of erythritol to the compound of Formula (I), any one of Compounds 1-6, or a combination thereof, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about (30-200): 1 or about (50-100): 1 by weight.
- a composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener.
- composition of Paragraph 57 wherein the compound of Formula (I), or any one of Compounds 1-3, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in one or more natural extracts.
- composition of Paragraph 57 or 58 wherein the composition further comprises a sweetener.
- composition of Paragraph 57-59 wherein the composition further comprises a solubilizing agent.
- composition of Paragraph 61 wherein the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
- composition of Paragraph 62 wherein the caloric sweetener is high fructose corn or starch syrup.
- composition of Paragraph 62 wherein the caloric sweetener is sucrose.
- composition of Paragraph 61 wherein the caloric sweetener is a polyol selected from erythritol, sorbitol, mannitol and xylitol.
- composition of Paragraph 61 wherein the artificial sweetener is sucralose, acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
- the natural high-potency sweetener is steviol glycoside, rebaudioside A, rebaudioside B,
- rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, Rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin
- composition comprises Compound 1 , or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition comprises Compound 2, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition comprises Compound 3, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition comprises Compound 4, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition comprises Compound 5, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition comprises Compound 6, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 0.1 ppm-100 ppm.
- composition of Paragraph 74 wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 5 ppm-60 ppm.
- composition of Paragraph 75 wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 10 ppm-50 ppm.
- composition of Paragraph 77 wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm- 1,000 ppm.
- composition of Paragraph 78 wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivatives thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm-300 ppm.
- an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof is present in the edible composition at a concentration of about 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 ppm.
- composition of Paragraph 81 wherein the edible composition is at a pH of about 2.0 to about 4.0, about 3.0 to about 7.0, or about 6.0 to about 8.0.
- composition of Paragraph 82, wherein the edible composition is at a pH of about 3.0 or about 7.0.
- perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-100%.
- composition of Paragraph 84 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-60%.
- composition of Paragraph 85 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-50%.
- composition of Paragraph 85 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-40%.
- composition of Paragraph 85 wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-25%.
- perception of sweetness intensity of said sweetener is enhanced by about 5- 50% in an edible composition at a pH of about 6.5-7.5.
- perception of sweetness intensity of said sweetener is enhanced by about 5- 40% in an edible composition at a pH of about 2.5-3.5.
- composition of Paragraph 92, wherein the beverage is a nonalcoholic beverage.
- composition of Paragraph 95 wherein said sweet taste improving additive is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
- sweet taste improving additive is a polyol.
- composition of Paragraph 96 wherein the ratio of erythritol to the compound of Formula (I), or any one of Compounds 1-6, a or combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about 1 : 1 to about 800: 1 by weight.
- composition of Paragraph 96 wherein the ratio of erythritol to the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about (30-200): 1 or about (50-100): 1 by weight.
- composition of Paragraph 101 wherein the amino acid is glycine, alanine, taurine, serine or proline.
- a method of preparing an edible composition comprising:
- acceptable carrier further comprises a solubilizing agent.
- any one of Paragraphs 107-108 wherein the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
- the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
- carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
- sucralose or a salt thereof acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
- sweetener is steviol glycoside, rebaudioside A, rebaudioside B,
- rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilob
- composition of Paragraph 92 wherein said composition is a
- beverage selected from the group consisting of a non-carbonated beverage, carbonated beverage, cola, root beer, fruit flavored beverage, citrus- flavored beverage, fruit juice, fruit-containing beverage, vegetable juice, vegetable containing beverage, tea, coffee, dairy beverage, sports drinks, energy drinks, enhanced and flavored water.
- composition of Paragraph 57 wherein the composition is used in food, beverage products, pharmaceutical compositions, nutritional products, functional products, a dietary supplement, over-the-counter medications, or oral care products.
- a tabletop sweetener composition comprising a sweetener and a sweet taste modulator according to Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- product is selected from the group consisting of soup, powdered soft drinks, bakery products, chewing gums, confections, cereals, edible gels, jams and jellys, spreads, ketchup, dairy products, frozen dairy products,
- gelatins/puddings gelatins/puddings, and ice-creams.
- a method of preparing a complex comprising:
- a delivery system selected from the group consisting of a co- crystallized flavor composition with a sugar or a polyol, an agglomerated flavor composition, a compacted flavor composition, a dried flavor composition, a particle flavor composition, a spheronized flavor
- composition a granular flavor composition or a liquid flavor composition, wherein the flavor composition comprises a compound of Formula (I), or any one of Compounds 1-6 or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- the flavor composition comprises a compound of Formula (I), or any one of Compounds 1-6 or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
- composition wherein said method comprises adding an effective amount of a compound of Formula (I) or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, to said edible composition, such that the perception of bitter taste of said bitter tastant is reduced.
- a composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of reducing the bitter taste of a bitter tastant.
- a composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener and reducing the bitter taste of a bitter tastant.
- Figure 1 depicts descriptive analysis assessment of 7 taste attributes for Compound 2 in a lemon-lime matrix sweetened with high fructose corn syrup solution at pH 7.
- Compound 2 is compared in spider plot format to a control sweetener solution.
- For Compound 2 in addition to significant increase in perceived sweetness (indicated by ** on the attribute descriptor), other attributes including astringent, licorice and bitter are observed to be significant, for high fructose corn syrup.
- Figure 2 depicts descriptive analysis assessment of 7 taste attributes for Compound 5 in a lemon- lime matrix sweetened with high fructose corn syrup solution at pH 7.
- Compound 5 is compared in spider plot format to a control sweetener solution.
- aliphatic refers to straight chain or branched hydrocarbons that are completely saturated or that contain one or more units of unsaturation.
- aliphatic groups include substituted or unsubstituted linear or branched alkyl, alkenyl and alkynyl groups. Unless indicated otherwise, the term “aliphatic” encompasses both substituted and unsubstituted hydrocarbons.
- alkoxy refers to O-alkyl substituent, wherein the alkyl portion may be optionally substituted.
- alkoxy substituents include, but are not limited to, methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy. Also explicitly included within the scope of the term “alkoxy” are O-alkenyl or
- alkyl, alkene and alkyne portions may be optionally substituted.
- alkyl refers to both straight and branched saturated chains containing, for example, 1-3, 1-6, 1-9, or 1-12 carbon atoms. An alkyl group may be optionally substituted.
- alkenyl refers to both straight and branched saturated chains containing, for example, 2-3, 2-6, 2-9, or 2-12 carbon atoms, and at least one carbon-carbon double bond.
- An alkenyl group may be optionally substituted.
- alkynyl refers to both straight and branched saturated chains containing, for example, 2-3, 2-6, 2-9, or 2-12 carbon atoms, and at least one carbon-carbon triple bond.
- An alkynyl group may be optionally substituted.
- bitter or “bitter taste” as used herein refers to the perception or gustatory sensation resulting following the detection of a bitter tastant.
- the following flavor attributes may contribute to bitter taste: astringent, bitter- astringent, metallic, bitter-metallic, as well as off-tastes aftertastes and undesirable tastes including but not limited to freezer-burn and card-board taste or a combination of these. It is noted that, in the art, the term “off-taste” is often synonymous with “bitter taste.”
- bitter tastant refers to a compound that activates or that can be detected by a bitter taste receptor and/or confers the perception of a bitter taste in a subject.
- bitter tastant also refers to a multiplicity of compounds that combine to activate or be detected by a bitter taste receptor and/or confer the perception of a bitter taste in a subject.
- bitter tastants may include substances which also possess or primarily possess a sweet taste. Examples of such substances include steviol glycosides and acesulfame potassium.
- the term "combination” refers to a compound of Formula (I), or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, in combination with one or more compounds of Formula (I), or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, or one of Compounds 1-6, or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, in combination with one or more of Compounds 1-6, or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof.
- diet collectively refers to the food products and/or beverages consumed by a subject.
- a subject's “diet” also includes any consumer products or pharmaceutical compositions the subject ingests.
- flavor modifier refers to a compound or a mixture of compounds that, when added to an edible composition, such as a food product, changes the individual characteristics of a food flavor (odor and/or taste). Flavor modification effects can include increasing, decreasing, masking, eliminating, reducing, enhancing or changing the perception of relevant sensorial characteristics of flavor in the edible composition. The ability of flavor modifiers to modify flavor may be independent of their aromatic or taste characteristics.
- pharmaceutically active ingredient refers to a compound in a pharmaceutical composition which is biologically active.
- replace refers to substituting one compound for another compound in or in the preparation of, for example, an edible composition, such as food product. It includes complete and partial replacements or
- An aliphatic group may contain one or more substituents.
- suitable substituents on a saturated or unsaturated carbon of an aliphatic group include, but are not limited to, halogen, -CF 3 , -R', -OR', -OH, -SH, -SR', protected -OH (such as acyloxy), -N0 2 , -CN, -NH 2 , -NHR', -N(R') 2 , -NHCOR',
- the compounds of the invention are intended to include all stereochemical forms of the compound, including geometric isomers (i.e., E, Z) and optical isomers (i.e., R, S, (+), (-)). Single stereochemical isomers as well as enantiomeric mixtures of the present compounds are within the scope of the invention and are specifically contemplated.
- formulas depicted herein are also meant to include compounds which differ only in the presence of one or more isotopically enriched atoms. For example, compounds having the present formulas except for the replacement of a hydrogen by a deuterium or tritium, or the replacement of a carbon by a 13 C- or 14 C-enriched carbon are within the scope of this invention.
- One aspect of present invention provides edible compositions comprising a sweet taste modulator of the present invention, including food products, consumer products, and pharmaceutical compositions comprising said compounds, and methods of preparing a such compositions.
- the present invention also provides methods of reducing the amount of a sweetener in an edible composition, methods for reducing caloric intake, methods of enhancing or potentiating sweet taste of a sweetener, methods of blocking a bitter taste, methods of enhancing or potentiating the activity of a sweet taste receptor, and methods of synthesizing sweet taste modulators.
- the present invention also includes reducing the amount of a sweetener in an edible composition or diet by replacing an amount of sugar or the other sweetener with an amount of one or more compounds or one or more extracts containing compounds of the present invention.
- the invention provides compounds for modulating sweet taste (e.g., enhancing or potentiating the sweet taste of a sweetener).
- sweet flavor or “sweet taste” refers to the taste elicited by, for example, sugars.
- compositions eliciting a sweet flavor include glucose, sucrose, fructose, saccharin, cyclamate, aspartame, acesulfame potassium, sucralose, alitame, and neotame.
- the amount of sweet flavor or the sweetness of a composition can be determined by, e.g., taste testing.
- sweet taste modulators refers to flavor substances with taste modifying properties.
- Sweetness enhancers are understood to be a type of “sweet taste modulator” where perception of sweetness is increased in a manner not solely attributable to the inherent sweetness of the sweetness enhancer alone.
- sweetness enhancer is understood to include at least compositions capable of enhancing or intensifying the perception of sweet taste of sweetener compositions or sweetened compositions.
- sweetness enhancer is synonymous with the terms “sweet taste potentiator,” “sweetness potentiator,” “sweetness amplifier,” and “sweetness intensifier.”
- the sweet taste modulating compounds provided herein may enhance or potentiate the sweet taste of sweeteners without providing any noticeable sweet taste by themselves at acceptable use levels; however, the sweetness enhancers may themselves provide sweet taste at concentrations above a sweetness threshold level. It is noted that the sweetness enhancers may be effective as enhancers even if present at concentrations above their sweetness threshold level. In such embodiments, there is major contribution of the sweetness enhancer to the sweetness of the composition via enhancement of the inherently sweet taste attributed to a sweetener, where the sweetener is also present in the composition.
- sweetness threshold level is understood to include at least the concentration at which the sweetness is perceptible as sweet in the edible compositions.
- the sweetness threshold level varies for different edible compositions (e.g., in different matrices), and may be varied with respect to the individual perceiving the sweetness.
- the sweet taste modulator(s) of the present invention is a different compound from any sweetener. Accordingly, although an ingredient may be characterized as both a sweet taste modulator and a sweetener, in all embodiments of the disclosure, the sweet taste modulator and the sweetener are different ingredients, i.e., the sweet taste modulator and the sweetener are not the same compound.
- the present invention provides flavonoid compounds for modulating or potentiating the sweet taste of a sweetener.
- the flavonoid compounds of this invention are capable of modulating or potentiating the sweet taste of a sweetener.
- the flavonoid compound may have a molecular weight less than about 1000, 500, or 300 Daltons.
- the flavonoid compound may have a molecular weight less than 1000, 500, or 300 Daltons.
- the flavonoid is a flavan.
- the flavonoid compound is a compound of Formula (I):
- Ri to R 6 are each independently H, OH, Ci-C 6 alkyl, or Ci-C 6 alkoxy, provided that at least one of R 4 and R 6 is not H.
- Ri and R 2 are each independently OH or OMe
- R3-R 6 are each independently H, OH, Ci-C 6 alkyl, or Ci-C 6 alkoxy, provided that at least one of R 4 and R 6 is not H.
- Ri,R 2 , and R 5 are each independently OH or OMe;
- R 3 ,R 4 , and R 6 are each independently H, OH, Ci-C 6 alkyl, or Ci-C 6 alkoxy, provided that at least one of R 4 and R 6 is not H.
- Ri and R 2 are each independently OH or OMe
- R 3 , R 4 , and R 6 are each independently H, OH, Ci-C 6 alkyl, or Ci-C 6 alkoxy, provided that at least one of R 4 and R 6 is not H;
- R 5 is OH.
- Ri and R 2 are each independently OH or OMe
- R 3 is H, OH, Ci-C 6 alkyl, or Ci-C 6 alkoxy
- R 5 is OH
- R 4 and R 6 are Me.
- the compound according to Formula (I) has the f llowing structure:
- “comestibly or biologically acceptable salt” refer to any comestibly or biologically acceptable derivative or salt of a sweet taste modulator of the present invention, which, upon ingestion, is capable of providing (directly or indirectly) a sweet taste modulator or bitter blocker of the present invention, or a polymorph, metabolite, residue or portion thereof, characterized by the ability to enhance the perception of a sweet taste attributed to a sweetener or block the perception of bitter taste attributed to a bitter tastant.
- a “comestible product” is a product suitable for oral use, such as eating or drinking. Therefore, a comestibly acceptable compound is an edible compound.
- a comestibly or biologically acceptable salt of a compound of the present invention is used, such salt is preferably derived from inorganic or organic bases.
- Salts derived from appropriate bases include alkali metal (e.g., sodium and potassium), alkaline earth metal (e.g., magnesium), ammonium and N + (Ci_ 4 alkyl) 4 salts.
- the compounds of the present invention are present as sodium or potassium salts.
- Sweet taste modulators synergize with sweeteners to enhance or potentiate the perception of sweet taste due to the sweetener.
- sweet taste modulators When sweet taste modulators are used above their sweetness threshold level, they synergize with sweeteners to enhance or potentiate the perception of sweet taste due to the sweetener.
- the overall sweetness of a composition comprising a sweet taste modulator and a sweet compound is higher than the mere addition of inherent sweetness due to each of the sweet taste modulators and a sweet compound.
- the perceived sweetness of the resulting composition would be greater than that of a 6% sucrose solution -with any perceived sweetness greater than a 6% sucrose solution being attributable to the sweetness enhancing properties of the sweet taste modulators.
- Such an increase in perceived sweetness may be referred to as synergistic, not additive.
- sweetness threshold and “sweetness recognition threshold,” are used interchangeably, herein, and refer to the level at which the lowest known concentration of a certain sweet compound is perceivable as sweet by the human sense of taste.
- This sweetness recognition threshold also encompasses the sweetness detection threshold, referring to the level at which the lowest known concentration of a certain sweet compound is perceivable by the human sense of taste.
- the sweetness threshold can vary from person to person.
- the sweetness threshold can also vary from matrix to matrix (e.g. , different sweetness thresholds in water and a carbonated beverage). For example, a sweetness threshold level for sucrose in water could be around 1% or 1.5%.
- the sweetness enhancers of Formula (I), any one of Compounds 1-6, or combinations thereof are used at concentrations below their sweetness threshold.
- concentration and “effective amount” are used interchangeably herein and refer to an amount sufficient to produce a desired property or result.
- an effective amount of a sweet taste modulator of the present invention is an amount capable of modulating (e.g., enhancing) the perception of sweet taste associated with a sweetener.
- effective amount of a sweet taste modulator of the invention also refers to an amount which, when added to an edible composition, enhances the sweet taste of, e.g. , a sugar, thereby allowing for the maintenance of the perception of a desired sweet flavor of the edible composition.
- the term "effective amount” also refers to the amount of a sweet taste modulator of the present invention capable of modulating (e.g. , enhancing) the perception of a sweet taste associated with either a sweetener in a food product or an inherently sweet food product.
- the sweet taste modulators of the present invention may impart a sweetness or taste at certain concentrations and no perceptible sweetness or taste at other concentrations.
- the sweet taste modulator may be present in an amount such that the taste, such as sweetness, of the sweet taste modulator is imperceptible.
- the compositions discussed herein include an effective amount of the sweet taste modulator.
- An effective amount of the sweet taste modulator includes an amount sufficient to enhance the perception of sweetness intensity of a sweetener.
- a sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration between about 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 ppm; 10 to 20 ppm; 10 to 25 ppm; 10 to 30 ppm; 1 to 50 ppm; 5 to 50 ppm; 10 to 50 ppm; 30 to 50 ppm; 1 to 60 ppm; 100 to 300 ppm; 100 to 1000 ppm; or 30 to 3000 ppm.
- a concentration between about 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 pp
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration between about 50 to 100 ppm; 100 to 200 ppm; 200 to 300 ppm; 300 to 400 ppm; 400 to 500 ppm; 500 to 600 ppm; 600 to 700 ppm; 700 to 800 ppm; 800 to 900 ppm; 900 to 1000 ppm; 1000 to 1 100 ppm; 1 100 to 1200 ppm; 1200 to 1300 ppm; 1300 to 1400 ppm; 1400 to 1500 ppm; 1500 to 1600 ppm; 1600 to 1700 ppm; 1700 to 1800 ppm; 1800 to 1900 ppm; 1900 to 2000 ppm; 2000 to 2100 ppm; 2100 to 2200 ppm; 2200 to 2300 ppm; 2300 to 2400 ppm; 2400 to 2500
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of about 0.1 to 30 ppm; 1 to 30 ppm; or 1 to 50 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- a sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration between 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 ppm; 10 to 20 ppm; 10 to 25 ppm; 10 to 30 ppm; 1 to 50 ppm; 5 to 50 ppm; 10 to 50 ppm; 30 to 50 ppm; 1 to 60 ppm; 100 to 300 ppm; 100 to 1000 ppm; or 30 to 3000 ppm.
- a concentration between 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 ppm;
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration between 50 to 100 ppm; 100 to 200 ppm; 200 to 300 ppm; 300 to 400 ppm; 400 to 500 ppm; 500 to 600 ppm; 600 to 700 ppm; 700 to 800 ppm; 800 to 900 ppm; 900 to 1000 ppm; 1000 to 1 100 ppm; 1 100 to 1200 ppm; 1200 to 1300 ppm; 1300 to 1400 ppm; 1400 to 1500 ppm; 1500 to 1600 ppm; 1600 to 1700 ppm; 1700 to 1800 ppm; 1800 to 1900 ppm; 1900 to 2000 ppm; 2000 to 2100 ppm; 2100 to 2200 ppm; 2200 to 2300 ppm; 2300 to 2400 ppm; 2400 to 2500
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of 0.1 to 30 ppm; 1 to 30 ppm; or 1 to 50 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of about 0.1 ppm, about 0.5 ppm, about 1 ppm, about 2 ppm, about 3 ppm, about 4 ppm, about 5 ppm, about 6 ppm, about 7 ppm, about 8 ppm, about 9 ppm, about 10 ppm, about 1 1 ppm, about 12 ppm, about 13 ppm, about 14 ppm, about 15 ppm, about 16 ppm, about 17 ppm, about 18 ppm, about 19 ppm, about 20 ppm, about 21 ppm, about 22 ppm, about 23 ppm, about 24 ppm, about 25 ppm, about 26 ppm, about 27 ppm, about 28 ppm, about 29 ppm
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of about 100 ppm, about 200 ppm, about 300 ppm, about 400 ppm, about 500 ppm, about 600 ppm, about 700 ppm, about 800 ppm, about 900 ppm, about 1000 ppm, about 1 100 ppm, about 1200 ppm, about 1300 ppm, about 1400 ppm, about 1500 ppm, about 1600 ppm, about 1700 ppm, about 1800 ppm, about 1900 ppm, about 2000 ppm, about 2100 ppm, about 2200 ppm, about 2300 ppm, about 2400 ppm, about 2500 ppm, about 2600 ppm, about 2700 ppm, about 2800 ppm, about 2900 ppm, or about 3
- the compound is present at a concentration of about 0.1 ppm. In some embodiments, the compound is present at a concentration of about 0.5 ppm. In some embodiments, the compound is present at a concentration of about 1 ppm. In some embodiments, the compound is present at a concentration of about 2 ppm. In some embodiments, the compound is present at a concentration of about 3 ppm. In some embodiments, the compound is present at a concentration of about 4 ppm. In some embodiments, the compound is present at a concentration of about 5 ppm. In some embodiments, the compound is present at a concentration of about 6 ppm. In some embodiments, the compound is present at a concentration of about 7 ppm.
- the compound is present at a concentration of about 8 ppm. In some embodiments, the compound is present at a concentration of about 9 ppm. In some embodiments, the compound is present at a concentration of about 10 ppm. In some embodiments, the compound is present at a concentration of about 11 ppm. In some embodiments, the compound is present at a concentration of about 12 ppm. In some embodiments, the compound is present at a concentration of about 13 ppm. In some embodiments, the compound is present at a concentration of about 14 ppm. In some
- the compound is present at a concentration of about 15 ppm. In some embodiments, the compound is present at a concentration of about 16 ppm. In some embodiments, the compound is present at a concentration of about 17 ppm. In some embodiments, the compound is present at a concentration of about 18 ppm. In some embodiments, the compound is present at a concentration of about 19 ppm. In some embodiments, the compound is present at a concentration of about 20 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 21 ppm. In some embodiments, the compound is present at a concentration of about 22 ppm. In some embodiments, the compound is present at a concentration of about 23 ppm. In some embodiments, the compound is present at a concentration of about 24 ppm. In some embodiments, the compound is present at a concentration of about 25 ppm. In some embodiments, the compound is present at a concentration of about 26 ppm. In some embodiments, the compound is present at a concentration of about 27 ppm. In some
- the compound is present at a concentration of about 28 ppm. In some embodiments, the compound is present at a concentration of about 29 ppm. In some embodiments, the compound is present at a concentration of about 30 ppm. In some embodiments, the compound is present at a concentration of about 31 ppm. In some embodiments, the compound is present at a concentration of about 32 ppm. In some embodiments, the compound is present at a concentration of about 33 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 34 ppm. In some embodiments, the compound is present at a concentration of about 35 ppm. In some embodiments, the compound is present at a concentration of about 36 ppm. In some embodiments, the compound is present at a concentration of about 37 ppm. In some embodiments, the compound is present at a concentration of about 38 ppm. In some embodiments, the compound is present at a concentration of about 39 ppm. In some embodiments, the compound is present at a concentration of about 40 ppm. In some embodiments,
- the compound is present at a concentration of about 41 ppm. In some embodiments, the compound is present at a concentration of about 42 ppm. In some embodiments, the compound is present at a concentration of about 43 ppm. In some embodiments, the compound is present at a concentration of about 44 ppm. In some embodiments, the compound is present at a concentration of about 45 ppm. In some embodiments, the compound is present at a concentration of about 46 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 47 ppm. In some embodiments, the compound is present at a concentration of about 48 ppm. In some embodiments, the compound is present at a concentration of about 49 ppm. In some embodiments, the compound is present at a concentration of about 50 ppm. In some embodiments, the compound is present at a concentration of about 51 ppm. In some embodiments, the compound is present at a concentration of about 52 ppm. In some embodiments, the compound is present at a concentration of about 53 ppm. In some
- the compound is present at a concentration of about 54 ppm. In some embodiments, the compound is present at a concentration of about 55 ppm. In some embodiments, the compound is present at a concentration of about 56 ppm. In some embodiments, the compound is present at a concentration of about 57 ppm. In some embodiments, the compound is present at a concentration of about 58 ppm. In some embodiments, the compound is present at a concentration of about 59 ppm. In some embodiments, the compound is present at a concentration of about 60 ppm. In some embodiments, the compound is present at a concentration of about 61 ppm. In some embodiments, the compound is present at a concentration of about 62 ppm.
- the compound is present at a concentration of about 63 ppm. In some embodiments, the compound is present at a concentration of about 64 ppm. In some embodiments, the compound is present at a concentration of about 65 ppm. In some embodiments, the compound is present at a concentration of about 66 ppm. In some
- the compound is present at a concentration of about 67 ppm. In some embodiments, the compound is present at a concentration of about 68 ppm. In some embodiments, the compound is present at a concentration of about 69 ppm. In some embodiments, the compound is present at a concentration of about 70 ppm. In some embodiments, the compound is present at a concentration of about 71 ppm. In some embodiments, the compound is present at a concentration of about 72 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 73 ppm. In some embodiments, the compound is present at a concentration of about 74 ppm. In some embodiments, the compound is present at a concentration of about 75 ppm. In some embodiments, the compound is present at a concentration of about 76 ppm. In some embodiments, the compound is present at a concentration of about 77 ppm. In some embodiments, the compound is present at a concentration of about 78 ppm. In some embodiments, the compound is present at a concentration of about 79 ppm. In some embodiments,
- the compound is present at a concentration of about 80 ppm. In some embodiments, the compound is present at a concentration of about 81 ppm. In some embodiments, the compound is present at a concentration of about 82 ppm. In some embodiments, the compound is present at a concentration of about 83 ppm. In some embodiments, the compound is present at a concentration of about 84 ppm. In some embodiments, the compound is present at a concentration of about 85 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 86 ppm. In some embodiments, the compound is present at a concentration of about 87 ppm. In some embodiments, the compound is present at a concentration of about 88 ppm. In some embodiments, the compound is present at a concentration of about 89 ppm. In some embodiments, the compound is present at a concentration of about 90 ppm. In some embodiments, the compound is present at a concentration of about 91 ppm. In some embodiments, the compound is present at a concentration of about 92 ppm. In some
- the compound is present at a concentration of about 93 ppm. In some embodiments, the compound is present at a concentration of about 94 ppm. In some embodiments, the compound is present at a concentration of about 95 ppm. In some embodiments, the compound is present at a concentration of about 96 ppm. In some embodiments, the compound is present at a concentration of about 97 ppm. In some embodiments, the compound is present at a concentration of about 98 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 99 ppm. In some embodiments, the compound is present at a concentration of about 100 ppm. In some embodiments, the compound is present at a concentration of about 101 ppm. In some embodiments, the compound is present at a concentration of about 102 ppm. In some embodiments, the compound is present at a concentration of about 103 ppm. In some embodiments, the compound is present at a concentration of about 104 ppm. In some embodiments, the compound is present at a concentration of about 105 ppm. In some
- the compound is present at a concentration of about 106 ppm. In some embodiments, the compound is present at a concentration of about 107 ppm. In some embodiments, the compound is present at a concentration of about 108 ppm. In some embodiments, the compound is present at a concentration of about 109 ppm. In some embodiments, the compound is present at a concentration of about 110 ppm. In some embodiments, the compound is present at a concentration of about 111 ppm. In some embodiments, the compound is present at a
- the compound is present at a concentration of about 112 ppm. In some embodiments, the compound is present at a concentration of about 113 ppm. In some embodiments, the compound is present at a concentration of about 114 ppm. In some embodiments, the compound is present at a concentration of about 115 ppm. In some embodiments, the compound is present at a concentration of about 116 ppm. In some embodiments, the compound is present at a concentration of about 117 ppm. In some
- the compound is present at a concentration of about 118 ppm. In some embodiments, the compound is present at a concentration of about 119 ppm. In some embodiments, the compound is present at a concentration of about 120 ppm. In some embodiments, the compound is present at a concentration of about 121 ppm. In some embodiments, the compound is present at a concentration of about 122 ppm. In some embodiments, the compound is present at a concentration of about 123 ppm. In some embodiments, the compound is present at a concentration of about 124 ppm. In some embodiments, the compound is present at a concentration of about 125 ppm. In some embodiments, the compound is present at a concentration of about 126 ppm.
- the compound is present at a concentration of about 127 ppm. In some embodiments, the compound is present at a concentration of about 128 ppm. In some embodiments, the compound is present at a concentration of about 129 ppm. In some
- the compound is present at a concentration of about 130 ppm. In some embodiments, the compound is present at a concentration of about 131 ppm. In some embodiments, the compound is present at a concentration of about 132 ppm. In some embodiments, the compound is present at a concentration of about 133 ppm. In some embodiments, the compound is present at a concentration of about 134 ppm. In some embodiments, the compound is present at a concentration of about 135 ppm. In some embodiments, the compound is present at a concentration of about 136 ppm. In some embodiments, the compound is present at a concentration of about 137 ppm. In some embodiments, the compound is present at a concentration of about 138 ppm.
- the compound is present at a concentration of about 139 ppm. In some embodiments, the compound is present at a concentration of about 140 ppm. In some embodiments, the compound is present at a concentration of about 141 ppm. In some
- the compound is present at a concentration of about 142 ppm. In some embodiments, the compound is present at a concentration of about 143 ppm. In some embodiments, the compound is present at a concentration of about 144 ppm. In some embodiments, the compound is present at a concentration of about 145 ppm. In some embodiments, the compound is present at a concentration of about 146 ppm. In some embodiments, the compound is present at a concentration of about 147 ppm. In some embodiments, the compound is present at a concentration of about 148 ppm. In some embodiments, the compound is present at a concentration of about 149 ppm. In some embodiments, the compound is present at a concentration of about 150 ppm.
- the sweet taste modulator of the present invention may enhance the sweetness of a sweetener when the compound is present at a concentration of 0.1 ppm, 0.5 ppm, 1 ppm, 2 ppm, 3 ppm, 4 ppm, 5 ppm, 6 ppm, 7 ppm, 8 ppm, 9 ppm, 10 ppm, 1 1 ppm, 12 ppm, 13 ppm, 14 ppm, 15 ppm, 16 ppm, 17 ppm, 18 ppm, 19 ppm, 20 ppm, 21 ppm, 22 ppm, 23 ppm, 24 ppm, 25 ppm, 26 ppm, 27 ppm, 28 ppm, 29 ppm, 30 ppm, 31 ppm, 32 ppm, 33 ppm, 34 ppm, 35 ppm, 36 ppm,
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of 100 ppm, 200 ppm, 300 ppm, 400 ppm, 500 ppm, 600 ppm, 700 ppm, 800 ppm, 900 ppm, 1000 ppm, 1 100 ppm, 1200 ppm, 1300 ppm, 1400 ppm, 1500 ppm, 1600 ppm, 1700 ppm, 1800 ppm, 1900 ppm, 2000 ppm, 2100 ppm, 2200 ppm, 2300 ppm, 2400 ppm, 2500 ppm, 2600 ppm, 2700 ppm, 2800 ppm, 2900 ppm, or 3000 ppm.
- the compound present at a concentration of 0.1 ppm. In some embodiments, the compound is present at a concentration of 0.5 ppm. In some embodiments, the compound is present at a concentration of 1 ppm. In some embodiments, the compound is present at a concentration of 2 ppm. In some embodiments, the compound is present at a concentration of 3 ppm. In some embodiments, the compound is present at a concentration of 4 ppm. In some embodiments, the compound is present at a concentration of 5 ppm. In some embodiments, the compound is present at a concentration of 6 ppm. In some embodiments, the compound is present at a concentration of 7 ppm. In some embodiments, the compound is present at a concentration of 8 ppm.
- the compound is present at a concentration of 9 ppm. In some embodiments, the compound is present at a concentration of 10 ppm. In some embodiments, the compound is present at a concentration of 11 ppm. In some embodiments, the compound is present at a concentration of 12 ppm. In some embodiments, the compound is present at a concentration of 13 ppm. In some embodiments, the compound is present at a concentration of 14 ppm. In some embodiments, the compound is present at a concentration of 15 ppm. In some embodiments, the compound is present at a concentration of 16 ppm. In some embodiments, the compound is present at a concentration of 17 ppm. In some embodiments, the compound is present at a concentration of 18 ppm.
- the compound is present at a concentration of 19 ppm. In some embodiments, the compound is present at a concentration of 20 ppm. In some embodiments, the compound is present at a concentration of 21 ppm. In some embodiments, the compound is present at a concentration of 22 ppm. In some embodiments, the compound is present at a concentration of 23 ppm. In some embodiments, the compound is present at a concentration of 24 ppm. In some embodiments, the compound is present at a concentration of 25 ppm. In some embodiments, the compound is present at a concentration of 26 ppm. In some embodiments, the compound is present at a concentration of 27 ppm. In some embodiments, the compound is present at a concentration of 28 ppm.
- the compound is present at a concentration of 29 ppm. In some embodiments, the compound is present at a concentration of 30 ppm. In some embodiments, the compound is present at a concentration of 31 ppm. In some embodiments, the compound is present at a concentration of 32 ppm. In some embodiments, the compound is present at a concentration of 33 ppm. In some embodiments, the compound is present at a concentration of 34 ppm. In some embodiments, the compound is present at a concentration of 35 ppm. In some embodiments, the compound is present at a concentration of 36 ppm. In some embodiments, the compound is present at a concentration of 37 ppm. In some embodiments, the compound is present at a concentration of 38 ppm.
- the compound is present at a concentration of 39 ppm. In some embodiments, the compound is present at a concentration of 40 ppm. In some embodiments, the compound is present at a concentration of 41 ppm. In some embodiments, the compound is present at a concentration of 42 ppm. In some embodiments, the compound is present at a concentration of 43 ppm. In some embodiments, the compound is present at a concentration of 44 ppm. In some embodiments, the compound is present at a concentration of 45 ppm. In some embodiments, the compound is present at a concentration of 46 ppm. In some embodiments, the compound is present at a concentration of 47 ppm. In some embodiments, the compound is present at a concentration of 48 ppm.
- the compound is present at a concentration of 49 ppm. In some embodiments, the compound is present at a concentration of 50 ppm. In some embodiments, the compound is present at a concentration of 51 ppm. In some embodiments, the compound is present at a concentration of 52 ppm. In some embodiments, the compound is present at a concentration of 53 ppm. In some embodiments, the compound is present at a concentration of 54 ppm. In some embodiments, the compound is present at a concentration of 55 ppm. In some embodiments, the compound is present at a concentration of 56 ppm. In some embodiments, the compound is present at a concentration of 57 ppm. In some embodiments, the compound is present at a concentration of 58 ppm.
- the compound is present at a concentration of 59 ppm. In some embodiments, the compound is present at a concentration of 60 ppm. In some embodiments, the compound is present at a concentration of 61 ppm. In some embodiments, the compound is present at a concentration of 62 ppm. In some embodiments, the compound is present at a concentration of 63 ppm. In some embodiments, the compound is present at a concentration of 64 ppm. In some embodiments, the compound is present at a concentration of 65 ppm. In some embodiments, the compound is present at a concentration of 66 ppm. In some embodiments, the compound is present at a concentration of 67 ppm.
- the compound is present at a concentration of 68 ppm. In some embodiments, the compound is present at a concentration of 69 ppm. In some embodiments, the compound is present at a concentration of 70 ppm. In some embodiments, the compound is present at a concentration of 71 ppm. In some embodiments, the compound is present at a concentration of 72 ppm. In some embodiments, the compound is present at a concentration of 73 ppm. In some embodiments, the compound is present at a concentration of 74 ppm. In some embodiments, the compound is present at a concentration of 75 ppm. In some embodiments, the compound is present at a concentration of 76 ppm.
- the compound is present at a concentration of 77 ppm. In some embodiments, the compound is present at a concentration of 78 ppm. In some embodiments, the compound is present at a concentration of 79 ppm. In some embodiments, the compound is present at a concentration of 80 ppm. In some embodiments, the compound is present at a concentration of 81 ppm. In some embodiments, the compound is present at a concentration of 82 ppm. In some embodiments, the compound is present at a concentration of 83 ppm. In some embodiments, the compound is present at a concentration of 84 ppm. In some embodiments, the compound is present at a concentration of 85 ppm.
- the compound is present at a concentration of 86 ppm. In some embodiments, the compound is present at a concentration of 87 ppm. In some embodiments, the compound is present at a concentration of 88 ppm. In some embodiments, the compound is present at a concentration of 89 ppm. In some embodiments, the compound is present at a concentration of 90 ppm. In some embodiments, the compound is present at a concentration of 91 ppm. In some embodiments, the compound is present at a concentration of 92 ppm. In some embodiments, the compound is present at a concentration of 93 ppm. In some embodiments, the compound is present at a concentration of 94 ppm.
- the compound is present at a concentration of 95 ppm. In some embodiments, the compound is present at a concentration of 96 ppm. In some embodiments, the compound is present at a concentration of 97 ppm. In some embodiments, the compound is present at a concentration of 98 ppm. In some embodiments, the compound is present at a concentration of 99 ppm.
- the compound is present at a concentration of 00 ppm In some embodiments, the compound is present at a concentration of 01 ppm In some embodiments, the compound is present at a concentration of 02 ppm In some embodiments, the compound is present at a concentration of 03 ppm In some embodiments, the compound is present at a concentration of 04 ppm In some embodiments, the compound is present at a concentration of 05 ppm In some embodiments, the compound is present at a concentration of 06 ppm In some embodiments, the compound is present at a concentration of 07 ppm In some embodiments, the compound is present at a concentration of 08 ppm In some embodiments, the compound is present at a concentration of 09 ppm In some embodiments, the compound is present at a concentration of 10 ppm In some embodiments, the compound is present at a concentration of 11 ppm In some embodiments, the compound is present at a concentration of 12 ppm In some embodiments, the compound is present at a concentration of 13 ppm In
- the compound is present at a concentration of 126 ppm. In some embodiments, the compound is present at a concentration of 127 ppm. In some embodiments, the compound is present at a concentration of 128 ppm. In some embodiments, the compound is present at a concentration of 129 ppm. In some embodiments, the compound is present at a concentration of 130 ppm. In some embodiments, the compound is present at a concentration of 131 ppm. In some embodiments, the compound is present at a concentration of 132 ppm. In some embodiments, the compound is present at a concentration of 133 ppm. In some embodiments, the compound is present at a concentration of 134 ppm.
- the compound is present at a concentration of 135 ppm. In some embodiments, the compound is present at a concentration of 136 ppm. In some embodiments, the compound is present at a concentration of 137 ppm. In some embodiments, the compound is present at a concentration of 138 ppm. In some embodiments, the compound is present at a concentration of 139 ppm. In some embodiments, the compound is present at a concentration of 140 ppm. In some embodiments, the compound is present at a concentration of 141 ppm. In some embodiments, the compound is present at a concentration of 142 ppm. In some embodiments, the compound is present at a concentration of 143 ppm.
- the compound is present at a concentration of 144 ppm. In some embodiments, the compound is present at a concentration of 145 ppm. In some embodiments, the compound is present at a concentration of 146 ppm. In some embodiments, the compound is present at a concentration of 147 ppm. In some embodiments, the compound is present at a concentration of 148 ppm. In some embodiments, the compound is present at a concentration of 149 ppm. In some embodiments, the compound is present at a concentration of 150 ppm.
- the sweet taste modulator of the present invention e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of more than 0.5 ppm, 1 ppm, 5 ppm, 10 ppm, 15 ppm, 20 ppm, 25 ppm, 30 ppm, or 35 ppm, up to, for example, 35 ppm or 50 ppm.
- the compound is present at a concentration of more than 0.5 ppm.
- the compound is present at a concentration of more than 1 ppm.
- the compound is present at a concentration of more than 5 ppm.
- the compound is present at a concentration of more than 10 ppm. In some embodiments, the compound is present at a concentration of more than 15 ppm. In some embodiments, the compound is present at a concentration of more than 20 ppm. In some embodiments, the compound is present at a concentration of more than 25 ppm. In some
- the compound is present at a concentration of more than 30 ppm. In some embodiments, the compound is present at a concentration of more than 35 ppm. In some embodiments, the compound is present at a concentration of more than 50 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration less than 50 ppm, 35ppm, 30 ppm, 25 ppm, 20 ppm, 15 ppm, 10 ppm, 5 ppm, 1 ppm, or 0.5 ppm.
- the compound is present at a concentration less than 50 ppm.
- the compound is present at a concentration less than 35ppm.
- the compound is present at a concentration less than 30 ppm.
- the compound is present at a concentration less than 25 ppm.
- the compound is present at a
- the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration less than about 35 ppm, 10 ppm, or 1 ppm. In some embodiments, the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration less than 35 ppm, 10 ppm, or 1 ppm.
- ppm parts per million
- ppm parts per million
- one gram of solute in 1000 ml of solvent has a concentration of 1000 ppm and one thousandth of a gram (0.00 lg) of solute in 1000 ml of solvent has a concentration of one ppm.
- a concentration of one milligram per liter i.e., 1 mg/L
- a concentration of 1 mg% is 1 mg/lOOmL.
- a concentration of 1 mg% is equal to 10 ppm.
- sweet taste modulators of the invention may be combined with known naturally occurring and/or synthetic sweet taste modulators when used in embodiments (e.g. , edible compositions and methods) described herein.
- compositions and methods of the invention that comprise a sweetener can be of any type, for example a natural, non-natural, or synthetic sweetener.
- sweeteners include caloric
- carbohydrate sweeteners natural carbohydrate sweeteners, non-natural
- the at least one sweetener is chosen from caloric sweeteners. In another embodiment, the at least one sweetener is chosen from synthetic sweeteners. In another embodiment, the at least one sweetener is chosen from non- natural sweeteners.
- Non-limiting examples of rare sugars include D-Psicose, D- Turanose, D-allose, D-Tagatose, D-Sorbose, L-fructose, L-glucose, L-fructose, L- talose, L-ribose, L-arabinose.
- the sweetener is a natural or inherent component of an edible composition.
- the sweetener may be an inherent component of a food product or of a food stuff, such as fruit or a fruit product (e.g., fruit sauce). Accordingly, the compounds of the present invention may be used in edible compositions to which no sweetener is added.
- caloric sweeteners and “caloric carbohydrate sweeteners,” are used interchangeably herein, and refer to nutritive sweeteners that provide calories and include all caloric carbohydrate sweeteners, such as sugars and polyols.
- suitable caloric carbohydrate sweeteners include sucrose, fructose, glucose, erythritol, maltitol, lactitol, sorbitol, mannitol, xylitol, D-tagatose, trehalose, galactose, rhamnose, cyclodextrin (e.g.
- fructooligosaccharides kestose, nystose and the like
- maltotetraol maltotriol
- malto-oligosaccharides maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose and the like
- lactulose melibiose
- raffinose rhamnose
- ribose isomerized liquid sugars such as high fructose corn/starch syrup (e.g., HFCS55, HFCS42, or HFCS90), honey, maple syrup, coupling sugars, soybean
- the sweetener is a natural sweetener chosen from glucose, fructose, sucrose, and mixtures thereof.
- polyol refers to a molecule that contains more than one hydroxyl group.
- a polyol may be a diol, triol, or a tetraol, which contain 2, 3, and 4 hydroxyl groups, respectively.
- a polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively.
- a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group.
- Non-limiting examples of polyols in some embodiments include erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, isomalt, propylene glycol, glycerol (glycerin), threitol, galactitol, palatinose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, and sugar alcohols or any other carbohydrates capable of being reduced which do not adversely affect the taste of the edible composition.
- the sweetener is a carbohydrate sweetener.
- the sweetener is chosen from sucrose, fructose, glucose, erythritol, high fructose corn or starch syrup, and mixtures thereof.
- synthetic high potency sweetener and “artificial high potency sweetener” are used interchangeably herein and refer to any composition which is not found in nature and characteristically has a sweetness potency greater than sucrose, fructose, or glucose, yet have fewer or no calories.
- synthetic sweeteners suitable for embodiments of this invention include sucralose, acesulfame potassium or other salts, aspartame, alitame, saccharin, neohesperidin dihydrochalcone, cyclamate, neotame, advantame, and salts thereof.
- sweetener and “artificial sweetener” are used interchangeably herein and refer to any composition which is not found in nature and characteristically confers a sweet taste, yet have fewer or no calories.
- the sweetener is a synthetic sweetener.
- the synthetic sweetener is a synthetic high potency sweetener, such as sucralose, aspartame, potassium acesulfame, and mixtures thereof.
- sweeteners suitable for use in embodiments provided herein include natural sweeteners.
- natural high-potency sweetener NHPS
- NHPS composition NHPS composition
- natural high-potency sweetener composition refers to any sweetener found in nature which may be in raw, extracted, purified, or any other form, singularly or in combination thereof and characteristically have a sweetness potency greater than sucrose, fructose, or glucose, yet have fewer or no calories.
- Non-limiting examples of NHPSs suitable for embodiments of this disclosure include steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, glycosylated steviol glycosides, mogrosides, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin and its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid and its salts, thaumatin, monellin, mabinlin
- the glycosylated steviol glycoside is 13-[(2-0-P-D-glucopyranosyl- 3-0-(4-0-a-D-glucopyranosyl)-P-D-glucopyranosyl-P-D-glucopyranosyl)oxy] ent- kaur-16-en-19-oic acid-[(4-0-a-D-glucopyranosyl-P-D-glucopyranosyl) ester], 13- [(2-0-P-D-glucopyranosyl-P-D-glucopyranosyl)oxy] e/?t-kaur-16-en-19-oic acid- [(4-0-(4-0-(4-0-a-D-glucopyranosyl)-a-D-glucopyranosyl)-a-D-glucopyranosyl)- ⁇ -D-glucopyranosyl ester], 13-[(2-0-P-D-glucopyranosyl
- NHPS also includes modified NHPSs.
- Modified NHPSs include NHPSs which have been altered naturally.
- a modified NHPS includes, but is not limited to, NHPSs which have been fermented, contacted with enzyme, or derivatized or substituted on the NHPS.
- at least one modified NHPS may be used in combination with at least one NHPS.
- at least one modified NHPS may be used without a NHPS.
- modified NHPSs may be substituted for a NHPS or may be used in combination with NHPSs for any of the embodiments described herein.
- a modified NHPS is not expressly described as an alternative to an unmodified NHPS, but it should be understood that modified NHPSs can be substituted for NHPSs in any embodiment disclosed herein.
- the sweetener may be used individually or in combination with other sweeteners.
- the sweetener composition may comprise a single caloric sweetener, a single NHPS or a single synthetic sweetener; a single caloric sweetener with a single NHPS; a single caloric sweetener with a single synthetic sweetener; one or more caloric sweetener with a single NHPS; one or more caloric sweetener with a single synthetic sweetener; a single caloric sweetener with one or more NHPS; a single caloric sweetener with one or more synthetic sweeteners; a single NHPS in combination with a single synthetic sweetener; one or more NHPSs in combination with a single synthetic sweetener; a single NHPS in combination with one or more synthetic sweeteners; one or more NHPSs in combination with one or more synthetic sweeteners; or one or more caloric sweetener with one or more NHPS and one
- the sweetener composition can be customized to obtain a desired calorie content.
- a low-caloric or non-caloric synthetic sweetener may be combined with a caloric sweetener and/or other caloric additives to produce a sweetener composition with a preferred calorie content.
- the sweetener is present in the composition in an amount greater than its sweetness threshold level.
- the sweetener may be present in an amount ranging from 0.01% to 99.9% by weight, relative to the total weight of the composition.
- the at least one sweetener may be present in an amount ranging from 2% to 50%, or for example from 4% to 50% by weight, relative to the total weight of the composition.
- the at least one sweetener may be present in about 5% to 20% by weight.
- the at least one sweetener may be present in about 5% to 15% by weight.
- the at least one sweetener may be present in about 5%> to 12%) by weight in beverages, for example, in non-alcoholic beverages.
- the at least one sweetener may be present in 5% to 20% by weight. In further embodiments, the at least one sweetener may be present in 5% to 15% by weight. In yet further embodiments, the at least one sweetener may be present in 5% to 12% by weight in beverages, for example, in non-alcoholic beverages.
- the sweet taste modulator of the present invention potentiates or enhances the sweetness of the sweetener.
- the composition comprising the sweetener and the sweet taste modulator of the present invention has more sweetness intensity than a composition comprising the at least one sweetener without the sweet taste modulator.
- sweetness intensity is understood to mean any perceptible sweetness.
- the composition comprising the sweetener and the sweet taste modulator of the present invention is perceptibly sweeter than a composition comprising the sweetener without the sweet taste modulator.
- a composition comprising the sweetener and the sweet taste modulator of the present invention may be slightly sweeter, moderately sweeter, or significantly sweeter than a composition comprising the sweetener without the sweet taste modulator.
- the sweet taste modulators of Formula (I) any one of Compounds 1-6, or combinations thereof are used above their sweetness threshold, the increase in sweetness intensity is synergistic, not additive.
- the sweetness of a composition may be based on (i.e. , relative to) a known sweet standard.
- Sweet compounds based on such sweet standards include, but are not limited to, for example natural, non-natural, or synthetic sweeteners.
- Non-limiting examples of such sweeteners include caloric carbohydrate sweeteners, natural carbohydrate sweeteners, non-natural carbohydrate sweeteners, natural high-potency sweeteners, non-natural high-potency sweeteners, synthetic high potency sweeteners, synthetic carbohydrate sweeteners, and combinations thereof.
- the sweetness of a composition may be based on to a 5% sucrose solution.
- a composition comprising the sweetener and a sweet taste modulator of the present invention may be perceived as having a sweetness equivalent to a 5.5 % sucrose solution.
- the composition comprising the sweetener and a sweet taste modulator of the present invention may be perceived as having a sweetness equivalent to a 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, or 10% sucrose solution.
- Suitable sweet standards include, but are not limited to, sucrose standards, fructose standards and glucose standards.
- the sweetness intensity of the composition comprising the sweetener and a sweet taste modulator of the present invention increases the perceived sweetness based on a sweet standard by greater than 10%>, by greater than 20%, by greater than 30%, by greater than 40%, greater than by 50% or greater than by 60% compared to a composition comprising the sweetener without the sweet taste modulator.
- the perception of sweetness intensity of the sweetener is enhanced by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%,
- the perception of sweetness intensity of the sweetener is enhanced beyond 100%, for example, by 125%, 150%, 175%, 200%, 225%, 250%, 275%, 300%, 325%, 350%, 375%, 400%, 425%, 450%, 475%, 500% or increments in between those recited.
- the perception of sweetness intensity is enhanced by up to 25%.
- the perception of sweetness intensity is enhanced by up to 50%).
- the perception of sweetness intensity is enhanced by up to 75%).
- the sweetness intensity is enhanced by up to 100%).
- the perception of sweetness intensity is enhanced by about 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10- 25%. 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25- 60%, 25-50%), 25-40%), or 25-30%). In some embodiments, the perception of sweetness intensity is enhanced by 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%.
- the combination of at least one sweetness enhancer and at least one sweetener may be carried out in any pH range that does not materially or adversely affect the taste of the sweetener composition or the sweetened composition.
- a non- limiting example of the pH range may be from about 1.5 to about 9.0.
- Further examples include a pH range from about 2.0 to about 8.5, from about 2.0 to about 8.0, from about 2.0 to about 7.5, from about 2.0 to about 7.0, from about 2.5 to about 7.0, and from about 3.0 to about 7.0.
- pH ranges include from about 2.0 to about 4.0, from about 2.5 to about 3.5, from about 2.5 to about 4.5, from about 3.5 to about 5.5, from about 4.0 to about 5.5, from about 5.0 to about 6.0, from about 6.5 to about 7.5, and from about 6.0 to about 8.0.
- the pH is about 3.0 or about 7.0.
- the pH is about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, about 2.0, about 2.1, about 2.2, about 2.3, about 2.4, about 2.5, about 2.6, about 2.7, about 2.8, about 2.9, about 3.0, about 3.1, about 3.2, about 3.3, about 3.4, about 3.5, about 3.6, about 3.7, about 3.8, about 3.9, about 4.0, about 4.1, about 4.2, about 4.3, about 4.4, about 4.5, about 4.6, about 4.7, about 4.8, about 4.9, about 5.0, about 5.1, about 5.2, about 5.3, about 5.4, about 5.5, about 5.6, about 5.7, about 5.8, about 5.9, about 6.0, about 6.1, about 6.2, about 6.3, about 6.4, about 6.5, about 6.6, about 6.7, about 6.8, about 6.9, about 7.0, about 7.1, about 7.2, about 7.3, about 7.4, about 7.5, about 7.6, about 7.7, about 7.
- the pH range may be from 1.5 to 9.0. Further examples include a pH range from 2.0 to 8.5, from 2.0 to 8.0, from 2.0 to 7.5, from 2.0 to 7.0, from 2.5 to 7.0, and from 3.0 to 7.0. Additional examples of pH ranges include from 2.0 to 4.0, from 2.5 to 3.5, from 2.5 to 4.5, from 3.5 to 5.5, from 4.0 to 5.5, from 5.0 to 6.0, from 6.5 to 7.5, and from 6.0 to 8.0. In some embodiments, the pH is 3.0 or 7.0.
- the pH is 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6.0, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7.0, 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9, 8.0, 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9, or 9.0.
- the temperature of the composition may, for example, range from about -4 °C to about 90 °C. In some embodiments, the temperature of
- the pH is about 1.5. In some embodiments, the pH is about 1.6. In some embodiments, the pH is about 1.7. In some embodiments, the pH is about 1.8. In some embodiments, the pH is about 1.9. In some embodiments, the pH is about 2.0. In some embodiments, the pH is about 2.1. In some embodiments, the pH is about 2.2. In some embodiments, the pH is about 2.3. In some embodiments, the pH is about 2.4. In some embodiments, the pH is about 2.5. In some embodiments, the pH is about 2.6. In some embodiments, the pH is about 2.7. In some embodiments, the pH is about 2.8. In some
- the pH is about 2.9. In some embodiments, the pH is about 3.0. In some embodiments, the pH is about 3.1. In some embodiments, the pH is about 3.2. In some embodiments, the pH is about 3.3. In some embodiments, the pH is about 3.4. In some embodiments, the pH is about 3.5. In some embodiments, the pH is about 3.6. In some embodiments, the pH is about 3.7. In some
- the pH is about 3.8. In some embodiments, the pH is about 3.9. In some embodiments, the pH is about 4.0. In some embodiments, the pH is about 4.1. In some embodiments, the pH is about 4.2. In some embodiments, the pH is about 4.3. In some embodiments, the pH is about 4.4. In some embodiments, the pH is about 4.5. In some embodiments, the pH is about 4.6. In some embodiments,
- the pH is about 4.7. In some embodiments, the pH is about 4.8. In some embodiments, the pH is about 4.9. In some embodiments, the pH is about 5.0. In some embodiments, the pH is about 5.1. In some embodiments, the pH is about 5.2. In some embodiments, the pH is about 5.3. In some embodiments, the pH is about 5.4. In some embodiments, the pH is about 5.5. In some
- the pH is about 5.6. In some embodiments, the pH is about 5.7. In some embodiments, the pH is about 5.8. In some embodiments, the pH is about 5.9. In some embodiments, the pH is about 6.0. In some embodiments, the pH is about 6.1. In some embodiments, the pH is about 6.2. In some embodiments, the pH is about 6.3. In some embodiments, the pH is about 6.4. In some
- the pH is about 6.5. In some embodiments, the pH is about 6.6. In some embodiments, the pH is about 6.7. In some embodiments, the pH is about 6.8. In some embodiments, the pH is about 6.9. In some embodiments, the pH is about 7.0. In some embodiments, the pH is about 7.1. In some embodiments, the pH is about 7.2. In some embodiments, the pH is about 7.3. In some
- the pH is about 7.4. In some embodiments, the pH is about 7.5. In some embodiments, the pH is about 7.6. In some embodiments, the pH is about 7.7. In some embodiments, the pH is about 7.8. In some embodiments, the pH is about 7.9. In some embodiments, the pH is about 8.0. In some embodiments, the pH is about 8.1. In some embodiments, the pH is about 8.2. In some
- the pH is about 8.3. In some embodiments, the pH is about 8.4. In some embodiments, the pH is about 8.5. In some embodiments, the pH is about 8.6. In some embodiments, the pH is about 8.7. In some embodiments, the pH is about 8.8. In some embodiments, the pH is about 8.9. In some embodiments, the pH is about 8.8. In some embodiments, the pH is about 9.0.
- the pH is 1.5. In some embodiments, the pH is 1.6. In some embodiments, the pH is 1.7. In some embodiments, the pH is 1.8. In some embodiments, the pH is 1.9. In some embodiments, the pH is 2.0. In some embodiments, the pH is 2, .1. In some embodiments, the pH is 2, .2. In some embodiments, the pH is 2, .3. In some embodiments, the pH is 2, .4. In some embodiments, the pH is 2, .5. In some embodiments, the pH is 2, .6. In some embodiments, the pH is 2, .7. In some embodiments, the pH is 2, .8. In some embodiments, the pH is 2, .9. In some embodiments, the pH is 3, .0.
- the pH is 3, .1. In some embodiments, the pH is 3, .2. In some embodiments, the pH is 3, .3. In some embodiments, the pH is 3, .4. In some embodiments, the pH is 3, .5. In some embodiments, the pH is 3, .6. In some embodiments, the pH is 3, .7. In some embodiments, the pH is 3, .8. In some embodiments, the pH is 3, .9. In some embodiments, the pH is 4, .0. In some embodiments, the pH is 4 1. In some embodiments, the pH is 4 2. In some embodiments, the pH is 4 3. In some embodiments, the pH is 4 4. In some embodiments, the pH is 4 5. In some embodiments, the pH is 4 6.
- the pH is 4 7. In some embodiments, the pH is 4 8. In some embodiments, the pH is 4 9. In some embodiments, the pH is 5 0. In some embodiments, the pH is 5 1. In some embodiments, the pH is 5 2. In some embodiments, the pH is 5 3. In some embodiments, the pH is 5 4. In some embodiments, the pH is 5 5. In some embodiments, the pH is 5 6. In some embodiments, the pH is 5 7. In some embodiments, the pH is 5 8. In some embodiments, the pH is 5 9. In some embodiments, the pH is 6 0. In some embodiments, the pH is 6 1. In some embodiments, the pH is 6 2. In some embodiments, the pH is 6 3. In some embodiments, the pH is 6 4. In some embodiments, the pH is 6 5.
- the pH is 6 6. In some embodiments, the pH is 6 7. In some embodiments, the pH is 6 8. In some embodiments, the pH is 6 9. In some embodiments, the pH is 7 0. In some embodiments, the pH is 7 1. In some embodiments, the pH is 7 2. In some embodiments, the pH is 7 3. In some embodiments, the pH is 7 4. In some embodiments, the pH is 7 5. In some embodiments, the pH is 7 6. In some embodiments, the pH is 7 7. In some embodiments, the pH is 7 8. In some embodiments, the pH is 7 9. In some embodiments, the pH is 8 0. In some embodiments, the pH is 8 1. In some embodiments, the pH is 8 2. In some embodiments, the pH is 8 3. In some embodiments, the pH is 8 4.
- the pH is 8 5. In some embodiments, the pH is 8 6. In some embodiments, the pH is 8 7. In some embodiments, the pH is 8 8. In some embodiments, the pH is 8 9. In some embodiments, the pH is 8 8. In some embodiments, the pH is 9 0.
- sweet taste improving composition and “sweet taste improving additive” are used interchangeably herein and refer to any material that imparts a more sugar-like temporal profile or sugar-like flavor profile or both to a synthetic sweetener. Suitable sweet taste improving additives useful in
- embodiments of this disclosure include amino acids and salts thereof, poly-amino acids and salts thereof, peptides, sugar acids and salts thereof, nucleotides and salts thereof, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic acid salts (e.g., sodium chloride, potassium chloride, magnesium chloride), acid salts (e.g., sodium citrate), bitter compounds, flavorants and flavoring ingredients, astringent compounds, polymers, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, and natural high-potency sweeteners.
- organic acids inorganic acids, organic salts including organic acid salts and organic base salts
- inorganic acid salts e.g., sodium chloride, potassium chloride, magnesium chloride
- acid salts e.g., sodium citrate
- bitter compounds e.g., sodium citrate
- bitter compounds e.g., sodium citrate
- sucrose-like characteristic “sugar-like taste,” “sugar-like sweet,” “sugary,” and “sugar-like” are used interchangeably, herein, and include any characteristic similar to that of sucrose and include, but are not limited to, maximal response, flavor profile, temporal profile, adaptation behavior, mouth feel, concentration/response function behavior, tastant and flavor/sweet taste interactions, spatial pattern selectivity, and temperature effects.
- characteristics are dimensions in which the taste of sucrose is different from the tastes of sweetness enhanced sweetener compositions. Suitable procedures for determining whether a composition has a more sugar-like taste are well known in the art.
- compositions of the present invention may also further comprise at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
- a sweet taste improving composition such as a sweet taste improving composition, and/or a sweet taste improving additive.
- the composition of the disclosure may comprise at least one sweet taste improving composition for balancing the temporal and/or flavor profile of the sweetness enhanced sweetener composition.
- sweet taste improving compositions to improve the temporal and/or flavor profile of sweetener compositions are described in detail in U.S. Patent Application Publication Nos. 2007/012831 1 , 2007/0275147, 2008/0292765, 201 1/016031 1 , and US 201 1/0318464 the disclosures of which are incorporated herein by reference in their entirety.
- Exemplary suitable sweet-taste improving compounds include, but are not limited to, carbohydrates, polyols, amino acids and their corresponding salts, poly- amino acids and their corresponding salts, sugar acids and their corresponding salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, flavorants and flavoring ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, other sweet taste improving taste additives imparting such sugar-like characteristics, and
- the sweet-taste improving compound is erythritol.
- the ratio of erythritol to any one of Compounds 1-6, or mixtures thereof is about 1 : 1 to about 800: 1 by weight.
- the ratio of erythritol to any one of compounds of Formula (I) or Compounds 1-6, or mixtures thereof is about (30-200): l or about (50-100): l by weight.
- the ratio of erythritol to any one of Compounds 1- 6, or mixtures thereof is 1 : 1 to 800: 1 by weight.
- the ratio of erythritol to any one of Compounds 1-6, or mixtures thereof is (30-200): 1 or (50-100): 1 by weight.
- embodiments of this disclosure include, but are not limited to, aspartic acid, arginine, glycine, glutamic acid, proline, threonine, theanine, cysteine, cystine, alanine, valine, tyrosine, leucine, isoleucine, asparagine, serine, lysine, histidine, ornithine, methionine, carnitine, aminobutyric acid ( ⁇ -, ⁇ -, or ⁇ -isomers), glutamine, hydroxyproline, taurine, norvaline, sarcosine, and their salt forms such as sodium or potassium salts or acid salts.
- the sweet taste improving amino acid additives also may be in the D- or L-configuration and in the mono-, di-, or triform of the same or different amino acids. Additionally, the amino acids may be ⁇ -, ⁇ -, ⁇ -, ⁇ -, and ⁇ -isomers if appropriate. Combinations of the foregoing amino acids and their corresponding salts (e.g. , sodium, potassium, calcium, magnesium salts or other alkali or alkaline earth metal salts thereof, or acid salts) also are suitable sweet taste improving additives in some embodiments.
- the amino acids may be natural or synthetic.
- the amino acids also may be modified.
- Modified amino acids refers to any amino acid wherein at least one atom has been added, removed, substituted, or combinations thereof (e.g., N-alkyl amino acid, N-acyl amino acid, or N-methyl amino acid).
- modified amino acids include amino acid derivatives such as trimethyl glycine, N-methyl-glycine, and N-methyl-alanine.
- modified amino acids encompass both modified and unmodified amino acids.
- amino acids also
- polypeptides encompass both peptides and polypeptides (e.g., dipeptides, tripeptides,
- Suitable sweet taste improving polyamino acid additives include poly-L-aspartic acid, poly-L-lysine (e.g., poly-L-a-lysine or poly-L-8-lysine), poly-L-ornithine (e.g., poly-L-a-ornithine or poly-L-8-ornithine), poly-L-arginine, other polymeric forms of amino acids, and salt forms thereof (e.g., calcium, potassium, sodium, or magnesium salts such as L-glutamic acid mono sodium salt).
- poly-L-lysine e.g., poly-L-a-lysine or poly-L-8-lysine
- poly-L-ornithine e.g., poly-L-a-ornithine or poly-L-8-ornithine
- poly-L-arginine e.g., calcium, potassium, sodium, or magnesium salts such as L-glutamic acid mono sodium salt.
- the sweet taste improving poly-amino acid additives also may be in the D- or L-configuration. Additionally, the poly-amino acids may be ⁇ -, ⁇ -, ⁇ -, ⁇ -, and ⁇ -isomers if appropriate. Combinations of the foregoing poly-amino acids and their
- poly-amino acids described herein also may comprise co-polymers of different amino acids.
- the poly-amino acids may be natural or synthetic.
- the poly-amino acids also may be modified, such that at least one atom has been added, removed, substituted, or combinations thereof (e.g., N-alkyl poly-amino acid or N-acyl poly-amino acid).
- poly- amino acids encompass both modified and unmodified poly-amino acids.
- modified poly-amino acids include, but are not limited to poly-amino acids of various molecular weights (MW), such as poly-L-a-lysine with a MW of 1,500, MW of 6,000, MW of 25,200, MW of 63,000, MW of 83,000, or MW of 300,000.
- the taste improving amino acid additive is glycine, alanine, taurine, serine or proline.
- the taste improving amino acid additive is present in a concentration of about 10 ppm to about 25,000 ppm, about 100 ppm to about 1000 ppm, or about 100 to 5000 ppm.
- the taste improving amino acid additive is present in a concentration of 10 ppm to 25,000 ppm, 100 ppm to 1000 ppm, or about 100 to 5000 ppm.
- Suitable sweet taste improving sugar acid additives include, for example, but are not limited to aldonic, uronic, aldaric, alginic, gluconic, glucuronic, glucaric, galactaric, galacturonic, and salts thereof (e.g., sodium, potassium, calcium, magnesium salts or other physiologically acceptable salts), and combinations thereof.
- suitable sweet taste improving nucleotide additives include, but are not limited to, inosine monophosphate ("IMP”), guanosine monophosphate (“GMP”), adenosine monophosphate (“AMP”), cytosine monophosphate (“CMP”), uracil monophosphate (“UMP”), inosine diphosphate, guanosine diphosphate, adenosine diphosphate, cytosine diphosphate, uracil diphosphate, inosine triphosphate, guanosine triphosphate, adenosine triphosphate, cytosine cytosine cytosine IMP
- IMP inosine monophosphate
- GMP guanosine monophosphate
- AMP adenosine monophosphate
- CMP cytosine monophosphate
- UMP uracil monophosphate
- inosine diphosphate guanosine diphosphate
- adenosine diphosphate adenos
- nucleotides described herein also may comprise nucleotide-related additives, such as nucleosides or nucleic acid bases (e.g. , guanine, cytosine, adenine, thymine, uracil).
- nucleosides or nucleic acid bases e.g. , guanine, cytosine, adenine, thymine, uracil.
- Suitable sweet taste improving organic acid additives include any compound which comprises a -COOH moiety.
- Suitable sweet taste improving organic acid additives include but are not limited to C 2 -C30 carboxylic acids, substituted hydroxyl C 2 -C30 carboxylic acids, benzoic acid, substituted benzoic acids (e.g., 2,4-dihydroxybenzoic acid), substituted cinnamic acids, hydroxyacids, substituted hydroxybenzoic acids, substituted cyclohexyl carboxylic acids, tannic acid, lactic acid, tartaric acid, citric acid, gluconic acid, glucoheptonic acids, adipic acid, hydroxycitric acid, malic acid, fruitaric acid (a blend of malic, fumaric, and tartaric acids), fumaric acid, maleic acid, succinic acid, chlorogenic acid, salicylic acid, creatine, caffeic acid, bile acids, acetic acid, ascorbic
- suitable sweet taste improving organic acid additive salts include, but are not limited to, sodium, calcium, potassium, and magnesium salts of all organic acids, such as salts of citric acid, malic acid, tartaric acid, fumaric acid, lactic acid (e.g., sodium lactate), alginic acid (e.g., sodium alginate), ascorbic acid (e.g. , sodium ascorbate), benzoic acid (e.g. , sodium benzoate or potassium benzoate), and adipic acid.
- organic acids such as salts of citric acid, malic acid, tartaric acid, fumaric acid, lactic acid (e.g., sodium lactate), alginic acid (e.g., sodium alginate), ascorbic acid (e.g. , sodium ascorbate), benzoic acid (e.g. , sodium benzoate or potassium benzoate), and adipic acid.
- sweet taste improving organic acid additives described optionally may be substituted with at least one group chosen from hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, thiol, imine, sulfonyl, sulfenyl, sulfmyl, sulfamyl, carboxalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, anhydride, oximino, hydrazino, carbamyl, phospho, phosphonato, and any other viable functional group provided the substituted organic acid additives function to improve the sweet taste of a synthetic
- suitable sweet taste improving inorganic acid additives include but are not limited to phosphoric acid, phosphorous acid, polyphosphoric acid, hydrochloric acid, sulfuric acid, carbonic acid, sodium dihydrogen phosphate, and alkali or alkaline earth metal salts thereof (e.g. , inositol hexaphosphate Mg/Ca).
- Suitable sweet taste improving bitter compound additives include but are not limited to caffeine, quinine, urea, bitter orange oil, naringin, quassia, and salts thereof.
- the invention provides an edible composition comprising a sweet taste modulator of the invention for enhancing or potentiating the sweet taste of a sweetener or for masking or blocking a bitter or unpleasant taste.
- a sweet taste modulator of the invention for enhancing or potentiating the sweet taste of a sweetener or for masking or blocking a bitter or unpleasant taste.
- such edible compositions may comprise a compound of Formula (I), any one of Compounds 1-6, or combinations thereof.
- the edible composition comprises a (i) sweetener; and (ii) a compound of Formula (I), any one of Compounds 1-6, or combinations thereof.
- Edible composition orally ingestible composition
- sweetenable composition refers to a composition suitable for consumption, typically via the oral cavity (although consumption may occur via non-oral means such as inhalation).
- compositions may be present in any form including, but not limited to, liquids, solids, semi-solids, tablets, lozenges, powders, gels, gums, pastes, slurries, syrups, aerosols and sprays.
- edible compositions include food products, pharmaceutical compositions, and consumer products.
- composition also refers to, for example, dietary and nutritional supplements.
- edible compositions also include compositions that are placed within the oral cavity but not swallowed, including professional dental products, such as dental treatments, fillings, packing materials, molds and polishes.
- professional dental products such as dental treatments, fillings, packing materials, molds and polishes.
- the term “comestible” refers to similar compositions and is generally used as a synonym to the term "edible.”
- Food product refers to any composition comprising one or more processed foodstuffs.
- Food products include, but are not limited to, confectionaries, bakery products (including, but not limited to, doughs, breads, biscuits, crackers, cakes, pastries, pies, tarts, quiches, and cookies), ice creams (including but not limited to impulse ice cream, take -home ice cream, frozen yogurt, gelato, sorbet, sherbet and soy, oat, bean and rice-based ice cream), dairy products (including, but not limited to, drinking milk, cheese, yogurt, and sour milk drinks), cheeses (including, but not limited to, natural cheeses and processed cheeses), butter, margarine, sweet and savory snacks (including but not limited to fruit snacks, chips/crisps, tortilla/corn chips, popcorn, pretzels, chocolates, and nuts), hot and cold beverages (including, but not limited to, beverages, beverage mixes, concentrates, juices, carbonated beverages, non-carbonated beverages, alcoholic
- the food product is animal feed.
- the food product may be a pet food product, i.e. a food product for consumption by a household pet.
- the food product is a livestock food product, i.e. a food product for consumption by livestock.
- foodstuff refers to an unprocessed ingredient or a basic nutrient or flavor containing element used to prepare a food product.
- foodstuffs include: fruits, vegetables, meats, fishes, grains, milks, eggs, tubers, sugars, sweeteners, oils, herbs, snacks, sauces, spices and salts.
- processed foodstuff refers to a foodstuff has been subjected to any process which alters its original state (excluding, e.g. , harvesting, slaughtering, and cleaning).
- methods of processing foods include, but are not limited to, removal of unwanted outer layers, such as potato peeling or the skinning of peaches; chopping or slicing; mincing or macerating; liquefaction, such as to produce fruit juice; fermentation ⁇ e.g.
- beer beer
- emulsification cooking, such as boiling, broiling, frying, heating, steaming or grilling; deep frying; baking; mixing; addition of gas such as air entrainment for bread or gasification of soft drinks; proofing; seasoning (with, e.g., herbs, spices, salts); spray drying; pasteurization; packaging ⁇ e.g., canning or boxing); extrusion; puffing; blending; and preservation ⁇ e.g., adding salt, sugar, potassium lactate or other preservatives).
- consumer product refers to health and beauty products for the personal use and/or consumption by a subject.
- Consumer products may be present in any form including, but not limited to, liquids, solids, semi-solids, tablets, capsules, lozenges, strips, powders, gels, gums, pastes, slurries, syrups, aerosols and sprays.
- Non-limiting examples of consumer products include nutriceuticals, nutritional supplements, lipsticks, lip balms, soaps, shampoos, gums, adhesives ⁇ e.g., dental adhesives), toothpastes, oral analgesics, breath fresheners,
- the edible composition may comprise (i) a sweet taste modulator of the invention, or combinations thereof; and (ii) a sweetener.
- the sweet taste modulating compound is a flavonoid compound having a molecular weight less than about 1000, 500, or 300 Daltons. In some embodiments, the sweet taste modulating compound is a flavonoid compound having a molecular weight less than 1000, 500, or 300 Daltons.
- the sweet taste modulating compound is a compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, enantiomers or diastereomers thereof, or combinations thereof. In other embodiments, the sweet taste modulating compound is a compound of any one of Compounds 1-6, or combinations thereof, or comestibly or biologically acceptable salts or derivatives thereof.
- the edible composition naturally or inherently comprises a sweetener.
- the sweetener may be an inherent component of a food product or of a food stuff, such as fruit or a fruit product (e.g. , fruit sauce).
- the compounds of the present invention may be added to edible compositions to which no sweetener is added.
- the edible composition is a sweetened composition
- a sweet taste modulator of the invention e.g., a compound of Formula (I), any one of Compounds 1-6, or combinations thereof
- a sweetener e.g., a compound of Formula (I), any one of Compounds 1-6, or combinations thereof.
- the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may be used to enhance the sweet taste or perception of any suitable natural or synthetic sweetener, such as any suitable caloric, low-caloric or non-caloric sweetener.
- the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may have an inherent sweet taste and, in some embodiments, it is present at or above its sweetness threshold, but is not the primary sweetener in the composition. Rather, the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof serves to enhance the sweet taste of the sweetener.
- the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may be present at or below its sweetness threshold.
- the compound serves only to enhance the sweet taste of the sweetener.
- a person of skill in the art will be able to select the concentration of the sweet taste modulator so that it may impart the perception of enhanced sweetness to a composition comprising a sweetener.
- a skilled artisan may select a concentration for the sweet taste modulator so that it does not impart any perceptible sweetness to a composition that does not comprise a sweetener.
- Non-limiting examples of such sweeteners include caloric carbohydrate sweeteners, natural carbohydrate sweeteners, non-natural
- the edible composition further comprises functional ingredients.
- functional ingredient refers to compound which provide a real or perceived heath benefit to the composition.
- Functional ingredients include, but are not limited to, saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydration agents, probiotics, prebiotics, weight management agents, osteoporosis
- phytoestrogens long chain primary aliphatic saturated alcohols
- phytosterols and combinations thereof.
- the edible compositions are beverages.
- the beverage can also contain one or more functional ingredients, which provide a real or perceived heath benefit to the composition.
- Functional ingredients include, but are not limited to, saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydration agents, probiotics, prebiotics, weight management agents, osteoporosis
- phytoestrogens long chain primary aliphatic saturated alcohols
- phytosterols and combinations thereof.
- the functional ingredient is at least one saponin.
- the at least one saponin may comprise a single saponin or a plurality of saponins as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one saponin is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Saponins are glycosidic natural plant products comprising an aglycone ring structure and one or more sugar moieties.
- the combination of the nonpolar aglycone and the water soluble sugar moiety gives saponins surfactant properties, which allow them to form a foam when shaken in an aqueous solution.
- the saponins are grouped together based on several common properties.
- saponins are surfactants which display hemolytic activity and form complexes with cholesterol. Although saponins share these properties, they are structurally diverse.
- the types of aglycone ring structures forming the ring structure in saponins can vary greatly.
- Non-limiting examples of the types of aglycone ring structures in saponin for use in particular embodiments of the invention include steroids, triterpenoids, and steroidal alkaloids.
- Non-limiting examples of specific aglycone ring structures for use in particular embodiments of the invention include soyasapogenol A, soyasapogenol B and soyasopogenol E.
- sugar moieties attached to the aglycone ring structure can also vary greatly.
- sugar moieties for use in particular embodiments of the invention include glucose, galactose, glucuronic acid, xylose, rhamnose, and methylpentose moieties.
- Non- limiting examples of specific saponins for use in particular embodiments of the invention include group A acetyl saponin, group B acetyl saponin, and group E acetyl saponin.
- Saponins can be found in a large variety of plants and plant products, and are especially prevalent in plant skins and barks where they form a waxy protective coating.
- Several common sources of saponins include soybeans, which have approximately 5% saponin content by dry weight, soapwort plants ⁇ Saponaria), the root of which was used historically as soap, as well as alfalfa, aloe, asparagus, grapes, chickpeas, yucca, and various other beans and weeds.
- Saponins may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. A description of conventional extraction techniques can be found in U.S. Pat. Appl. No. 2005/0123662, the disclosure of which is expressly incorporated by reference.
- the functional ingredient is at least one antioxidant.
- the at least one antioxidant may comprise a single antioxidant or a plurality of antioxidants as a functional ingredient for the edible compositions ⁇ e.g., beverages) provided herein.
- the at least one antioxidant is present in the edible composition ⁇ e.g. , beverage) in a concentration sufficient to promote health and wellness.
- antioxidant refers to any substance which inhibits, suppresses, or reduces oxidative damage to cells and biomolecules. Without being bound by theory, it is believed that antioxidants inhibit, suppress, or reduce oxidative damage to cells or biomolecules by stabilizing free radicals before they can cause harmful reactions. As such, antioxidants may prevent or postpone the onset of some degenerative diseases.
- antioxidants for embodiments of this invention include, but are not limited to, vitamins, vitamin cofactors, minerals, hormones, carotenoids, carotenoid terpenoids, non-carotenoid terpenoids, flavonoids, flavonoid polyphenolics (e.g., bioflavonoids), flavonols, flavones, phenols, polyphenols, esters of phenols, esters of polyphenols, nonflavonoid phenolics, isothiocyanates, and combinations thereof.
- bioflavonoids bioflavonoids
- flavonols flavones
- phenols polyphenols
- esters of phenols esters of polyphenols
- nonflavonoid phenolics isothiocyanates
- the antioxidant is vitamin A, vitamin C, vitamin E, ubiquinone, mineral selenium, manganese, melatonin, a-carotene, ⁇ -carotene, lycopene, lutein, zeanthin, crypoxanthin, reservatol, eugenol, quercetin, catechin, gossypol, hesperetin, curcumin, ferulic acid, thymol, hydroxytyrosol, tumeric, thyme, olive oil, lipoic acid, glutathinone, gutamine, oxalic acid, tocopherol-derived compounds, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), ethylenediaminetetraacetic acid (EDTA), tert-butylhydroquinone, acetic acid, pectin, tocotrienol, tocopherol, coenzyme
- phytoestrogens genistein, daidzein, glycitein, anythocyanins, cyaniding, delphinidin, malvidin, pelargonidin, peonidin, petunidin, ellagic acid, gallic acid, salicylic acid, rosmarinic acid, cinnamic acid and its derivatives (e.g., ferulic acid), chlorogenic acid, chicoric acid, gallotannins, ellagitannins, anthoxanthins, betacyanins and other plant pigments, silymarin, citric acid, lignan, antinutrients, bilirubin, uric acid, R-a-lipoic acid, N-acetylcysteine, emblicanin, apple extract, apple skin extract (applephenon), rooibos extract red, rooibos extract, green, hawthorn berry extract, red raspberry extract, green coffee antioxidant (GCA), ar
- the antioxidant is a synthetic antioxidant such as butylated hydroxytolune or butylated hydroxyanisole, for example.
- suitable antioxidants for embodiments of this invention include, but are not limited to, fruits, vegetables, tea, cocoa, chocolate, spices, herbs, rice, organ meats from livestock, yeast, whole grains, or cereal grains.
- polyphenols also known as “polyphenolics”
- a variety of health benefits may be derived from
- polyphenols including prevention of cancer, heart disease, and chronic
- Suitable polyphenols for embodiments of this invention include catechins, proanthocyanidins, procyanidins, anthocyanins, quercerin, rutin, reservatrol, isoflavones, curcumin, punicalagin, ellagitannin, hesperidin, naringin, citrus flavonoids, chlorogenic acid, other similar materials, and combinations thereof.
- the antioxidant is a catechin such as, for example, epigallocatechin gallate (EGCG).
- EGCG epigallocatechin gallate
- Suitable sources of catechins for embodiments of this invention include, but are not limited to, green tea, white tea, black tea, oolong tea, chocolate, cocoa, red wine, grape seed, red grape skin, purple grape skin, red grape juice, purple grape juice, berries, pycnogenol, and red apple peel.
- the antioxidant is chosen from proanthocyanidins, procyanidins or combinations thereof. Suitable sources of proanthocyanidins and procyanidins for embodiments of this invention include, but are not limited to, red grapes, purple grapes, cocoa, chocolate, grape seeds, red wine, cacao beans, cranberry, apple peel, plum, blueberry, black currants, choke berry, green tea, sorghum, cinnamon, barley, red kidney bean, pinto bean, hops, almonds, hazelnuts, pecans, pistachio, pycnogenol, and colorful berries. [0102] In particular embodiments, the antioxidant is an anthocyanin.
- Suitable sources of anthocyanins for embodiments of this invention include, but are not limited to, red berries, blueberries, bilberry, cranberry, raspberry, cherry, pomegranate, strawberry, elderberry, choke berry, red grape skin, purple grape skin, grape seed, red wine, black currant, red currant, cocoa, plum, apple peel, peach, red pear, red cabbage, red onion, red orange, and blackberries.
- the antioxidant is chosen from quercetin, rutin or combinations thereof.
- Suitable sources of quercetin and rutin for embodiments of this invention include, but are not limited to, red apples, onions, kale, bog whortleberry, lingonberrys, chokeberry, cranberry, blackberry, blueberry, strawberry, raspberry, black currant, green tea, black tea, plum, apricot, parsley, leek, broccoli, chili pepper, berry wine, and ginkgo.
- the antioxidant is resveratrol.
- Suitable sources of resveratrol for embodiments of this invention include, but are not limited to, red grapes, peanuts, cranberry, blueberry, bilberry, mulberry, Japanese Itadori tea, and red wine.
- the antioxidant is an isoflavone.
- Suitable sources of isoflavones for embodiments of this invention include, but are not limited to, soy beans, soy products, legumes, alfalfa spouts, chickpeas, peanuts, and red clover.
- the antioxidant is curcumin.
- Suitable sources of curcumin for embodiments of this invention include, but are not limited to, turmeric and mustard.
- the antioxidant is chosen from punicalagin, ellagitannin or combinations thereof.
- Suitable sources of punicalagin and ellagitannin for embodiments of this invention include, but are not limited to, pomegranate, raspberry, strawberry, walnut, and oak-aged red wine.
- the antioxidant is a citrus flavonoid, such as hesperidin or naringin.
- Suitable sources of citrus flavonids, such as hesperidin or naringin, for embodiments of this invention include, but are not limited to, oranges, grapefruits, and citrus juices.
- the antioxidant is chlorogenic acid.
- Suitable sources of chlorogenic acid for embodiments of this invention include, but are not limited to, green coffee, yerba mate, red wine, grape seed, red grape skin, purple grape skin, red grape juice, purple grape juice, apple juice, cranberry, pomegranate, blueberry, strawberry, sunflower, Echinacea, pycnogenol, and apple peel.
- the functional ingredient is at least one dietary fiber source.
- the at least one dietary fiber source may comprise a single dietary fiber source or a plurality of dietary fiber sources as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one dietary fiber source is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- polymeric carbohydrates having significantly different structures in both composition and linkages fall within the definition of dietary fiber.
- Such compounds are well known to those skilled in the art, non-limiting examples of which include non-starch polysaccharides, lignin, cellulose, methylcellulose, the hemicelluloses, ⁇ -glucans, pectins, gums, mucilage, waxes, inulins, oligosaccharides, fructooligosaccharides, cyclodextrins, chitins, and combinations thereof.
- Polysaccharides are complex carbohydrates composed of
- Non-starch polysaccharides are bonded with ⁇ -linkages, which humans are unable to digest due to a lack of an enzyme to break the ⁇ -linkages.
- digestable starch polysaccharides generally comprise a(l-4) linkages.
- Lignin is a large, highly branched and cross-linked polymer based on oxygenated phenylpropane units.
- Cellulose is a linear polymer of glucose molecules joined by a ⁇ (1-4) linkage, which mammalian amylases are unable to hydrolyze.
- Methylcellulose is a methyl esther of cellulose that is often used in foodstuffs as a thickener, and emulsifier. It is commercially available (e.g., Citrucel by GlaxoSmithKline, Celevac by Shire Pharmaceuticals).
- Hemicelluloses are highly branched polymers consisting mainly of glucurono- and 4-0- methylglucuroxylans.
- ⁇ -Glucans are mixed-linkage (1-3), (1-4) ⁇ -D-glucose polymers found primarily in cereals, such as oats and barley.
- Pectins such as beta pectin, are a group of polysaccharides composed primarily of D-galacturonic acid, which is methoxylated to variable degrees.
- Gums and mucilages represent a broad array of different branched structures.
- Guar gum derived from the ground endosperm of the guar seed, is a galactomannan. Guar gum is commercially available (e.g., Benefiber by Novartis AG). Other gums, such as gum arabic and pectins, have still different structures. Still other gums include xanthan gum, gellan gum, tara gum, psylium seed husk gum, and locust been gum.
- Waxes are esters of ethylene glycol and two fatty acids, generally occurring as a hydrophobic liquid that is insoluble in water.
- Inulins comprise naturally occurring oligosaccharides belonging to a class of carbohydrates known as fructans. They generally are comprised of fructose units joined by ⁇ (2-1) glycosidic linkages with a terminal glucose unit.
- Oligosaccharides are saccharide polymers containing typically three to six component sugars. They are generally found either O- or N-linked to compatible amino acid side chains in proteins or to lipid molecules. Fructooligosaccharides are oligosaccharides consisting of short chains of fructose molecules.
- Food sources of dietary fiber include, but are not limited to, grains, legumes, fruits, and vegetables.
- Grains providing dietary fiber include, but are not limited to, oats, rye, barley, wheat,.
- Legumes providing fiber include, but are not limited to, peas and beans such as soybeans.
- Fruits and vegetables providing a source of fiber include, but are not limited to, apples, oranges, pears, bananas, berries, tomatoes, green beans, broccoli, cauliflower, carrots, potatoes, celery.
- Plant foods such as bran, nuts, and seeds (such as flax seeds) are also sources of dietary fiber.
- Parts of plants providing dietary fiber include, but are not limited to, the stems, roots, leaves, seeds, pulp, and skin.
- dietary fiber generally is derived from plant sources, indigestible animal products such as chitins are also classified as dietary fiber.
- Chitin is a polysaccharide composed of units of acetylglucosamine joined by ⁇ (1- 4) linkages, similar to the linkages of cellulose.
- Sources of dietary fiber often are divided into categories of soluble and insoluble fiber based on their solubility in water. Both soluble and insoluble fibers are found in plant foods to varying degrees depending upon the characteristics of the plant. Although insoluble in water, insoluble fiber has passive hydrophilic properties that help increase bulk, soften stools, and shorten transit time of fecal solids through the intestinal tract.
- soluble fiber Unlike insoluble fiber, soluble fiber readily dissolves in water. Soluble fiber undergoes active metabolic processing via fermentation in the colon, increasing the colonic microflora and thereby increasing the mass of fecal solids. Fermentation of fibers by colonic bacteria also yields end-products with significant health benefits. For example, fermentation of the food masses produces gases and short-chain fatty acids. Acids produced during fermentation include butyric, acetic, propionic, and valeric acids that have various beneficial properties such as stabilizing blood glucose levels by acting on pancreatic insulin release and providing liver control by glycogen breakdown. In addition, fiber fermentation may reduce atherosclerosis by lowering cholesterol synthesis by the liver and reducing blood levels of LDL and triglycerides.
- the acids produced during fermentation lower colonic pH, thereby protecting the colon lining from cancer polyp formation.
- the lower colonic pH also increases mineral absorption, improves the barrier properties of the colonic mucosal layer, and inhibits inflammatory and adhesion irritants. Fermentation of fibers also may benefit the immune system by stimulating production of T-helper cells, antibodies, leukocytes, splenocytes, cytokinins and lymphocytes.
- the functional ingredient is at least one fatty acid.
- the at least one fatty acid may be single fatty acid or a plurality of fatty acids as a functional ingredient for the sweetener edible compositions (e.g., beverages) provided herein.
- the at least one fatty acid is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
- fatty acid refers to any straight chain monocarboxylic acid and includes saturated fatty acids, unsaturated fatty acids, long chain fatty acids, medium chain fatty acids, short chain fatty acids, fatty acid precursors (including omega-9 fatty acid precursors), and esterified fatty acids.
- long chain polyunsaturated fatty acid refers to any polyunsaturated carboxylic acid or organic acid with a long aliphatic tail.
- omega-9 fatty acid precursors including omega-9 fatty acid precursors
- the omega-3 fatty acid may comprise a long chain omega- 3 fatty acid.
- omega-6 fatty acid any polyunsaturated fatty acid having a first double bond as the sixth carbon-carbon bond from the terminal methyl end of its carbon chain.
- Suitable omega-3 fatty acids for use in embodiments of the present invention can be derived from algae, fish, animals, plants, or combinations thereof, for example.
- suitable omega-3 fatty acids include, but are not limited to, linolenic acid, alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, stearidonic acid, eicosatetraenoic acid and combinations thereof.
- suitable omega-3 fatty acids can be provided in fish oils, (e.g. , menhaden oil, tuna oil, salmon oil, bonito oil, and cod oil), microalgae omega-3 oils or combinations thereof.
- suitable omega-3 fatty acids may be derived from commercially available omega-3 fatty acid oils such as Microalgae DHA oil (from Martek, Columbia, MD), OmegaPure (from Omega Protein, Houston, TX), Marinol C-38 (from Lipid Nutrition, Channahon, IL), Bonito oil and MEG-3 (from Ocean Nutrition, Dartmouth, NS), Evogel (from Symrise, Holzminden, Germany), Marine Oil, from tuna or salmon (from Arista Wilton, CT), OmegaSource 2000, Marine Oil, from menhaden and Marine Oil, from cod (from OmegaSource, RTP, NC).
- omega-3 fatty acid oils such as Microalgae DHA oil (from Martek, Columbia, MD), OmegaPure (from Omega Protein, Houston, TX), Marinol C-38 (from Lipid Nutrition, Channahon, IL), Bonito oil and MEG-3 (from Ocean Nutrition, Dartmouth, NS), Evogel (from Symrise, Holzminden, Germany), Marine Oil, from tuna or salmon (
- Suitable omega-6 fatty acids include, but are not limited to, linoleic acid, gamma-linolenic acid, dihommo-gamma-linolenic acid, arachidonic acid, eicosadienoic acid, docosadienoic acid, adrenic acid, docosapentaenoic acid and combinations thereof.
- Suitable esterified fatty acids for embodiments of the present invention may include, but are not limited to, monoacylgycerols containing omega-3 and/or omega-6 fatty acids, diacylgycerols containing omega-3 and/or omega-6 fatty acids, or triacylgycerols containing omega-3 and/or omega-6 fatty acids and combinations thereof.
- the functional ingredient is at least one vitamin.
- the at least one vitamin may be single vitamin or a plurality of vitamins as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one vitamin is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
- Vitamins are organic compounds that the human body needs in small quantities for normal functioning. The body uses vitamins without breaking them down, unlike other nutrients such as carbohydrates and proteins. To date, thirteen vitamins have been recognized, and one or more can be used in the functional sweetener and sweetened compositions herein. Suitable vitamins include, vitamin A, vitamin D, vitamin E, vitamin K, vitamin Bl , vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B9, vitamin B12, and vitamin C. Many of vitamins also have alternative chemical names, non-limiting examples of which are provided below.
- vitamin includes pseudo-vitamins.
- the vitamin is a fat-soluble vitamin chosen from vitamin A, D, E, K and combinations thereof.
- the vitamin is a water-soluble vitamin chosen from vitamin Bl , vitamin B2, vitamin B3, vitamin B6, vitamin B12, folic acid, biotin, pantothenic acid, vitamin C and combinations thereof.
- the functional ingredient is glucosamine.
- glucosamine is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Glucosamine also called chitosamine, is an amino sugar that is believed to be an important precursor in the biochemical synthesis of glycosylated proteins and lipids. D-glucosamine occurs naturally in the cartilage in the form of glucosamine-6-phosphate, which is synthesized from fructose-6-phosphate and glutamine. However, glucosamine also is available in other forms, non-limiting examples of which include glucosamine hydrochloride, glucosamine sulfate, N- acetyl-glucosamine, or any other salt forms or combinations thereof.
- Glucosamine may be obtained by acid hydrolysis of the shells of lobsters, crabs, shrimps, or prawns using methods well known to those of ordinary skill in the art.
- glucosamine may be derived from fungal biomass containing chitin, as described in U.S. Patent Publication No. 2006/0172392.
- the edible composition e.g., beverage
- the functional ingredient is at least one mineral.
- the at least one mineral may be single mineral or a plurality of minerals as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one mineral is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
- Minerals in accordance with the teachings of this invention, comprise inorganic chemical elements required by living organisms. Minerals are comprised of a broad range of compositions (e.g., elements, simple salts, and complex silicates) and also vary broadly in crystalline structure. They may naturally occur in foods and beverages, may be added as a supplement, or may be consumed or administered separately from foods or beverages.
- compositions e.g., elements, simple salts, and complex silicates
- Minerals may be categorized as either bulk minerals, which are required in relatively large amounts, or trace minerals, which are required in relatively small amounts.
- Bulk minerals generally are required in amounts greater than or equal to about 100 mg per day and trace minerals are those that are required in amounts less than about 100 mg per day.
- the mineral is chosen from bulk minerals, trace minerals or combinations thereof.
- bulk minerals include calcium, chlorine, magnesium, phosphorous, potassium, sodium, and sulfur.
- trace minerals include chromium, cobalt, copper, fluorine, iron, manganese, molybdenum, selenium, zinc, and iodine. Although iodine generally is classified as a trace mineral, it is required in larger quantities than other trace minerals and often is categorized as a bulk mineral.
- the mineral is a trace mineral, believed to be necessary for human nutrition, non-limiting examples of which include bismuth, boron, lithium, nickel, rubidium, silicon, strontium, tellurium, tin, titanium, tungsten, and vanadium.
- the minerals embodied herein may be in any form known to those of ordinary skill in the art.
- the minerals may be in their ionic form, having either a positive or negative charge.
- the minerals may be in their molecular form.
- sulfur and phosphorous often are found naturally as sulfates, sulfides, and phosphates.
- the functional ingredient is at least one preservative.
- the at least one preservative may be single preservative or a plurality of preservatives as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one preservative is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
- the preservative is chosen from antimicrobials, antioxidants, antienzymatics or combinations thereof.
- antimicrobials include sulfites, propionates, benzoates, sorbates, nitrates, nitrites, bacteriocins, salts, sugars, acetic acid, dimethyl dicarbonate (DMDC), ethanol, and ozone.
- the preservative is a sulfite.
- Sulfites include, but are not limited to, sulfur dioxide, sodium bisulfite, and potassium hydrogen sulfite.
- the preservative is a propionate.
- Propionates include, but are not limited to, propionic acid, calcium propionate, and sodium propionate.
- the preservative is a benzoate.
- Benzoates include, but are not limited to, sodium benzoate and benzoic acid.
- the preservative is a sorbate. Sorbates include, but are not limited to, potassium sorbate, sodium sorbate, calcium sorbate, and sorbic acid. [0148] In still another particular embodiment, the preservative is a nitrate and/or a nitrite. Nitrates and nitrites include, but are not limited to, sodium nitrate and sodium nitrite.
- the at least one preservative is a bacteriocin, such as, for example, nisin.
- the preservative is ethanol.
- the preservative is ozone.
- Non-limiting examples of antienzymatics suitable for use as preservatives in particular embodiments of the invention include ascorbic acid, citric acid, and metal chelating agents such as ethylenediaminetetraacetic acid (EDTA).
- ascorbic acid citric acid
- metal chelating agents such as ethylenediaminetetraacetic acid (EDTA).
- the functional ingredient is at least one hydration agent.
- the at least one hydration agent may be single hydration agent or a plurality of hydration agents as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one hydration agent is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Hydration products help the body to replace fluids that are lost through excretion. For example, fluid is lost as sweat in order to regulate body
- Fluid loss can also occur due to a wide range of external causes, non-limiting examples of which include physical activity, exposure to dry air, diarrhea, vomiting, hyperthermia, shock, blood loss, and hypotension.
- Diseases causing fluid loss include diabetes, cholera, gastroenteritis, shigellosis, and yellow fever.
- Forms of malnutrition that cause fluid loss include the excessive consumption of alcohol, electrolyte imbalance, fasting, and rapid weight loss.
- the hydration product is a composition that helps the body replace fluids that are lost during exercise.
- the hydration product is an electrolyte, non-limiting examples of which include sodium, potassium, calcium, magnesium, chloride, phosphate, bicarbonate, and combinations thereof.
- Suitable electrolytes for use in particular embodiments of this invention are also described in U.S. Patent No. 5,681,569, the disclosure of which is expressly incorporated herein by reference.
- the electrolytes are obtained from their corresponding water-soluble salts.
- embodiments include chlorides, carbonates, sulfates, acetates, bicarbonates, citrates, phosphates, hydrogen phosphates, tartates, sorbates, citrates, benzoates, or combinations thereof.
- the electrolytes are provided by juice, fruit extracts, vegetable extracts, tea, or teas extracts.
- the hydration product is a carbohydrate to supplement energy stores burned by muscles.
- glyceraldehyde dihydroxyacetone, erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose, tagatose, mannoheptulose, sedoheltulose, octolose, and sialose.
- suitable amino acids erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose
- disaccharides include sucrose, lactose, and maltose.
- suitable oligosaccharides include saccharose, maltotriose, and maltodextrin.
- the carbohydrates are provided by a corn syrup, a beet sugar, a cane sugar, a juice, or a tea.
- the hydration is a flavanol that provides cellular rehydration.
- Flavanols are a class of natural substances present in plants, and generally comprise a 2-phenylbenzopyrone molecular skeleton attached to one or more chemical moieties.
- suitable flavanols for use in particular embodiments of this invention include catechin, epicatechin, gallocatechin, epigallocatechin, epicatechin gallate, epigallocatechin 3-gallate, theaflavin, theaflavin 3-gallate, theaflavin 3'-gallate, theaflavin 3,3' gallate, thearubigin or combinations thereof.
- Several common sources of flavanols include tea plants, fruits, vegetables, and flowers. In preferred embodiments, the flavanol is extracted from green tea.
- the hydration product is a glycerol solution to enhance exercise endurance.
- the ingestion of a glycerol containing solution has been shown to provide beneficial physiological effects, such as expanded blood volume, lower heart rate, and lower rectal temperature.
- the functional ingredient is chosen from at least one probiotic, prebiotic and combination thereof.
- the at least one probiotic or prebiotic may be single probiotic or prebiotic or a plurality of probiotics or prebiotics as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one probiotic, prebiotic or combination thereof is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Probiotics in accordance with the teachings of this invention, comprise microorganisms that benefit health when consumed in an effective amount.
- probiotics beneficially affect the human body's naturally-occurring gastrointestinal microflora and impart health benefits apart from nutrition.
- Probiotics may include, without limitation, bacteria, yeasts, and fungi.
- the probiotic is a beneficial microorganisms that beneficially affects the human body's naturally-occurring gastrointestinal microflora and imparts health benefits apart from nutrition.
- probiotics include, but are not limited to, bacteria of the genus Lactobacilli, Bifidobacteria, Streptococci, or combinations thereof, that confer beneficial effects to humans.
- the at least one probiotic is chosen from the genus Lactobacilli.
- Lactobacilli i.e., bacteria of the genus Lactobacillus, hereinafter "L." have been used for several hundred years as a food preservative and for promoting human health.
- Non-limiting examples of species of Lactobacilli found in the human intestinal tract include L. acidophilus, L. casei, L. fermentum, L. saliva roes, L. brevis, L. leichmannii, L. plantarum, L. cellobiosus, L. reuteri, L. rhamnosus, L. GG, L. bulgaricus, and L. thermophilus, .
- the probiotic is chosen from the genus Bifidobacteria.
- Bifidobacteria also are known to exert a beneficial influence on human health by producing short chain fatty acids (e.g. , acetic, propionic, and butyric acids), lactic, and formic acids as a result of carbohydrate metabolism.
- Non-limiting species of Bifidobacteria found in the human gastrointestinal tract include B. angulatum, B. animalis, B. asteroides, B. bifidum, B. bourn, B. breve, B. catenulatum, B. choerinum, B. coryneforme, B. cuniculi, B. dentium, B. gallicum, B. gallinarum, B indicum, B. longum, B.
- magnum B. merycicum, B. minimum, B. pseudocatenulatum, B. pseudolongum, B. psychraerophilum, B. pullorum, B. ruminantium, B. saeculare, B. scardovii, B. simiae, B. subtile, B. thermacidophilum, B. thermophilum, B. urinalis, and B. sp.
- the probiotic is chosen from the genus Streptococcus.
- Streptococcus thermophilus is a gram- positive facultative anaerobe. It is classified as lactic acid bacteria, commonly found in milk and milk products, and is used in the production of yogurt.
- Other non-limiting probiotic species of this bacteria include Streptococcus salivarus and Streptococcus cremoris.
- Probiotics that may be used in accordance with this invention are well- known to those of skill in the art.
- foodstuffs comprising probiotics include yogurt, sauerkraut, kefir, kimchi, fermented vegetables, and other foodstuffs containing a microbial element that beneficially affects the host animal by improving the intestinal microbalance.
- Prebiotics in accordance with the teachings of this invention, are compositions that promote the growth of beneficial bacteria in the intestines.
- Prebiotic substances can be consumed by a relevant probiotic, or otherwise assist in keeping the relevant probiotic alive or stimulate its growth.
- prebiotics When consumed in an effective amount, prebiotics also beneficially affect the human body's naturally- occurring gastrointestinal microflora and thereby impart health benefits apart from just nutrition.
- Prebiotic foods enter the colon and serve as substrate for the endogenous bacteria, thereby indirectly providing the host with energy, metabolic substrates, and essential micronutrients. The body's digestion and absorption of prebiotic foods is dependent upon bacterial metabolic activity, which salvages energy for the host from nutrients that escaped digestion and absorption in the small intestine.
- Prebiotics include, without limitation, mucopolysaccharides, oligosaccharides, polysaccharides, amino acids, vitamins, nutrient precursors, proteins and combinations thereof.
- the prebiotic is chosen from dietary fibers, including, without limitation, polysaccharides and oligosaccharides. These compounds have the ability to increase the number of probiotics, which leads to the benefits conferred by the probiotics.
- oligosaccharides that are categorized as prebiotics in accordance with particular embodiments of this invention include fructooligosaccharides, inulins, isomalto-oligosaccharides, lactilol, lactosucrose, lactulose, pyrodextrins, soy oligosaccharides, transgalacto-oligosaccharides, and xylo-oligosaccharides.
- the prebiotic is an amino acid.
- some probiotics also require amino acids for nourishment.
- Prebiotics are found naturally in a variety of foods including, without limitation, bananas, berries, asparagus, garlic, wheat, oats, barley (and other whole grains), flaxseed, tomatoes, Jerusalem artichoke, onions and chicory, greens (e.g., dandelion greens, spinach, collard greens, chard, kale, mustard greens, turnip greens), and legumes (e.g., lentils, kidney beans, chickpeas, navy beans, white beans, black beans).
- the functional ingredient is at least one weight management agent.
- the at least one weight management agent may be single weight management agent or a plurality of weight management agents as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one weight management agent is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
- a weight management agent includes an appetite suppressant and/or a thermogenesis agent.
- appetite suppressant As used herein, the phrases “appetite suppressant”, “appetite satiation compositions", “satiety agents", and “satiety ingredients” are synonymous.
- appetite suppressant describes macronutrients, herbal extracts, exogenous hormones, anorectics, anorexigenics, pharmaceutical drugs, and combinations thereof, that when delivered in an effective amount, suppress, inhibit, reduce, or otherwise curtail a person's appetite.
- thermogenesis agent describes macronutrients, herbal extracts, exogenous hormones, anorectics, anorexigenics, pharmaceutical drugs, and combinations thereof, that when delivered in an effective amount, activate or otherwise enhance a person's thermogenesis or metabolism.
- Suitable weight management agents include macronutrient selected from the group consisting of proteins, carbohydrates, dietary fats, and combinations thereof. Consumption of proteins, carbohydrates, and dietary fats stimulates the release of peptides with appetite-suppressing effects. For example, consumption of proteins and dietary fats stimulates the release of the gut hormone cholecytokinin (CCK), while consumption of carbohydrates and dietary fats stimulates release of Glucagon- like peptide 1 (GLP-1).
- CCK gut hormone cholecytokinin
- GLP-1 Glucagon- like peptide 1
- Suitable macronutrient weight management agents also include carbohydrates.
- Carbohydrates generally comprise sugars, starches, cellulose and gums that the body converts into glucose for energy. Carbohydrates often are classified into two categories, digestible carbohydrates (e.g., monosaccharides, disaccharides, and starch) and non-digestible carbohydrates (e.g., dietary fiber). Studies have shown that non-digestible carbohydrates and complex polymeric carbohydrates having reduced absorption and digestibility in the small intestine stimulate physiologic responses that inhibit food intake. Accordingly, the carbohydrates embodied herein desirably comprise non-digestible carbohydrates or carbohydrates with reduced digestibility.
- Non-limiting examples of such carbohydrates include polydextrose; inulin; monosaccharide-derived polyols such as erythritol, mannitol, xylitol, and sorbitol; disaccharide-derived alcohols such as isomalt, lactitol, and maltitol; and hydrogenated starch hydrolysates.
- weight management agent is a dietary fat.
- Dietary fats are lipids comprising combinations of saturated and unsaturated fatty acids. Polyunsaturated fatty acids have been shown to have a greater satiating power than mono-unsaturated fatty acids. Accordingly, the dietary fats embodied herein desirably comprise poly-unsaturated fatty acids, non-limiting examples of which include triacylglycerols.
- the weight management agents is an herbal extract. Extracts from numerous types of plants have been identified as possessing appetite suppressant properties. Non-limiting examples of plants whose extracts have appetite suppressant properties include plants of the genus Hoodia,
- Trichocaulon Caralluma, Stapelia, Orbea, Asclepias, and Camelia.
- Other embodiments include extracts derived from Gymnema Sylvestre, Kola Nut, Citrus Auran tium, Yerba Mate, Griffonia Simplicifolia, Guarana, myrrh, guggul Lipid, and black current seed oil.
- the herbal extracts may be prepared from any type of plant material or plant biomass.
- plant material and biomass include the stems, roots, leaves, dried powder obtained from the plant material, and sap or dried sap.
- the herbal extracts generally are prepared by extracting sap from the plant and then spray-drying the sap. Alternatively, solvent extraction procedures may be employed. Following the initial extraction, it may be desirable to further fractionate the initial extract (e.g., by column chromatography) in order to obtain an herbal extract with enhanced activity. Such techniques are well known to those of ordinary skill in the art.
- the herbal extract is derived from a plant of the genus Hoodia, species of which include H. alstonii, H. currorii, H. dregei, H. flava, H. gordonii, H.juicidee, H. mossamedensis, H. officinalis, H. parviflorai, H. pedicellata, H. pilifera, H. ruschii, and H. triebneri.
- Hoodia plants are stem succulents native to southern Africa.
- a sterol glycoside of Hoodia, known as P57 is believed to be responsible for the appetite-suppressant effect of the Hoodia species.
- the herbal extract is derived from a plant of the genus Caralluma, species of which include C. indica, C.fimbriata, C. attenuate, C. tuberculata, C. edulis, C. adscendens, C. stalagmifera, C. umbellate, C. penicillata, C. russeliana, C. retrospicens, C. Arabica, and C. lasiantha.
- Carralluma plants belong to the same Subfamily as Hoodia, Asclepiadaceae.
- Caralluma are small, erect and fleshy plants native to India having medicinal properties, such as appetite suppression, that generally are attributed to glycosides belonging to the pregnane group of glycosides, non-limiting examples of which include caratuberside A, caratuberside B, bouceroside I, bouceroside II, bouceroside III, bouceroside IV, bouceroside V, bouceroside VI, bouceroside VII, bouceroside VIII, bouceroside IX, and bouceroside X.
- the at least one herbal extract is derived from a plant of the genus Trichocaulon.
- Trichocaulon plants are succulents that generally are native to southern Africa, similar to Hoodia, and include the species T. piliferum and T. officinale.
- the herbal extract is derived from a plant of the genus Stapelia or Orbea, species of which include S. gigantean and O. variegate, respectively. Both Stapelia and Orbea plants belong to the same Subfamily as Hoodia, Asclepiadaceae.
- saponins such as pregnane glycosides, which include stavarosides A, B, C, D, E, F, G, H, I, J, and K.
- the herbal extract is derived from a plant of the genus Asclepias.
- Asclepias plants also belong to the Asclepiadaceae family of plants.
- Non- limiting examples of Asclepias plants include A. incarnate, A. curassayica, A. syriaca, and A. tuberose.
- the extracts comprise steroidal compounds, such as pregnane glycosides and pregnane aglycone, having appetite suppressant effects.
- the weight management agent is an exogenous hormone having a weight management effect.
- hormones include CCK, peptide YY, ghrelin, bombesin and gastrin- releasing peptide (GRP), enterostatin, apolipoprotein A-IV, GLP-1, amylin, somastatin, and leptin.
- GRP gastrin- releasing peptide
- Non-limiting examples include phentenime, diethylpropion, phendimetrazine, sibutramine, rimonabant, oxyntomodulin, floxetine
- hydrochloride hydrochloride, ephedrine, phenethylamine, or other stimulants.
- the at least one weight management agent may be utilized individually or in combination as a functional ingredient for the edible compositions (e.g., beverages) provided in this invention.
- the functional ingredient is at least one osteoporosis management agent.
- the at least one osteoporosis management agent may be single osteoporosis management agent or a plurality of osteoporosis management agent as a functional ingredient for the edible
- compositions e.g., beverages
- the at least one osteoporosis management agent is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Osteoporosis is a skeletal disorder of compromised bone strength, resulting in an increased risk of bone fracture. Generally, osteoporosis is characterized by reduction of the bone mineral density (BMD), disruption of bone micro-architecture, and changes to the amount and variety of non-collagenous proteins in the bone.
- BMD bone mineral density
- the osteoporosis management agent is at least one calcium source.
- the calcium source is any compound containing calcium, including salt complexes, solubilized species, and other forms of calcium.
- Non-limiting examples of calcium sources include amino acid chelated calcium, calcium carbonate, calcium oxide, calcium
- hydroxide calcium sulfate, calcium chloride, calcium phosphate, calcium hydrogen phosphate, calcium dihydrogen phosphate, calcium citrate, calcium malate, calcium citrate malate, calcium gluconate, calcium tartrate, calcium lactate, solubilized species thereof, and combinations thereof.
- the osteoporosis management agent is a magnesium source.
- the magnesium source is any compound containing magnesium, including salt complexes, solubilized species, and other forms of magnesium.
- Non-limiting examples of magnesium sources include magnesium chloride, magnesium citrate, magnesium gluceptate, magnesium gluconate, magnesium lactate, magnesium hydroxide, magnesium picolate, magnesium sulfate, solubilized species thereof, and mixtures thereof.
- the magnesium source comprises an amino acid chelated or creatine chelated magnesium.
- the osteoporosis agent is chosen from vitamins D, C, K, their precursors and/or beta-carotene and combinations thereof.
- 2005/0106215 species of the genus Lindera, Artemisia, Acorus, Carthamus, Carum, Cnidium, Curcuma, Cyperus, Juniperus, Prunus, Iris, Cichorium, Dodonaea, Epimedium, Erigonoum, Soya, Mentha, Ocimum, thymus, Tanacetum, Plantago, Spearmint, Bixa, Vitis, Rosemarinus, Rhus, and Anethum, as disclosed in U.S. Patent Publication No. 2005/0079232.
- the functional ingredient is at least one phytoestrogen.
- the at least one phytoestrogen may be single phytoestrogen or a plurality of phytoestrogens as a functional ingredient for the edible compositions ⁇ e.g., beverages) provided herein.
- the at least one phytoestrogen is present in the edible compositions ⁇ e.g. , beverages) in a concentration sufficient to promote health and wellness.
- Phytoestrogens are compounds found in plants which can typically be delivered into human bodies by ingestion of the plants or the plant parts having the phytoestrogens.
- phytoestrogen refers to any substance which, when introduced into a body causes an estrogen-like effect of any degree.
- a phytoestrogen may bind to estrogen receptors within the body and have a small estrogen-like effect.
- phytoestrogens for embodiments of this invention include, but are not limited to, isoflavones, stilbenes, lignans, resorcyclic acid lactones, coumestans, coumestrol, equol, and combinations thereof.
- Sources of suitable phytoestrogens include, but are not limited to, whole grains, cereals, fibers, fruits, vegetables, black cohosh, agave root, black currant, black haw, chasteberries, cramp bark, dong quai root, devil's club root, false unicorn root, ginseng root, groundsel herb, licorice, liferoot herb, motherwort herb, peony root, raspberry leaves, rose family plants, sage leaves, sarsaparilla root, saw palmetto berried, wild yam root, yarrow blossoms, legumes, soybeans, soy products (e.g., miso, soy flour, soymilk, soy nuts, soy protein isolate, tempen, or tofu) chick peas, nuts, lentils, seeds, clover, red clover, dandelion leaves, dandelion roots, fenugreek seeds, green tea, hops, red wine, flaxseed, garlic, onions, linseed, bo
- Isoflavones belong to the group of phytonutrients called polyphenols.
- polyphenols also known as “polyphenolics”
- polyphenolics are a group of chemical substances found in plants, characterized by the presence of more than one phenol group per molecule.
- Suitable phytoestrogen isoflavones in accordance with embodiments of this invention include genistein, daidzein, glycitein, biochanin A, formononetin, their respective naturally occurring glycosides and glycoside conjugates, matairesinol, secoisolariciresinol, enterolactone, enterodiol, textured vegetable protein, and combinations thereof.
- Suitable sources of isoflavones for embodiments of this invention include, but are not limited to, soy beans, soy products, legumes, alfalfa spouts, chickpeas, peanuts, and red clover.
- the functional ingredient is at least one long chain primary aliphatic saturated alcohol.
- the at least one long chain primary aliphatic saturated alcohol may be single long chain primary aliphatic saturated alcohol or a plurality of long chain primary aliphatic saturated alcohols as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
- the at least one long chain primary aliphatic saturated alcohol is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
- Long-chain primary aliphatic saturated alcohols are a diverse group of organic compounds.
- alcohol refers to the fact these compounds feature a hydroxyl group (-OH) bound to a carbon atom.
- the term primary refers to the fact that in these compounds the carbon atom which is bound to the hydroxyl group is bound to only one other carbon atom.
- the term saturated refers to the fact that these compounds feature no carbon to carbon pi bonds.
- the term aliphatic refers to the fact that the carbon atoms in these compounds are joined together in straight or branched chains rather than in rings.
- long-chain refers to the fact that the number of carbon atoms in these compounds is at least 8 carbons).
- Non-limiting examples of particular long-chain primary aliphatic saturated alcohols for use in particular embodiments of the invention include the 8 carbon atom 1-octanol, the 9 carbon 1-nonanol, the 10 carbon atom 1-decanol, the 12 carbon atom 1-dodecanol, the 14 carbon atom 1-tetradecanol, the 16 carbon atom 1-hexadecanol, the 18 carbon atom 1-octadecanol, the 20 carbon atom 1- eicosanol, the 22 carbon 1-docosanol, the 24 carbon 1-tetracosanol, the 26 carbon 1-hexacosanol, the 27 carbon 1-heptacosanol, the 28 carbon 1-octanosol, the 29 carbon 1-nonacosanol, the 30 carbon 1-triacontanol, the 32 carbon 1- dotriacontanol, and the 34 carbon 1-tetracontanol.
- the long-chain primary aliphatic saturated alcohols are policosanol.
- Policosanol is the term for a mixture of long-chain primary aliphatic saturated alcohols composed primarily of 28 carbon 1-octanosol and 30 carbon 1-triacontanol, as well as other alcohols in lower concentrations such as 22 carbon 1-docosanol, 24 carbon 1-tetracosanol, 26 carbon 1-hexacosanol, 27 carbon 1-heptacosanol, 29 carbon 1-nonacosanol, 32 carbon 1-dotriacontanol, and 34 carbon 1-tetracontanol.
- Long-chain primary aliphatic saturated alcohols are derived from natural fats and oils. They may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. Policosanols can be isolated from a variety of plants and materials including sugar cane (Saccharum officinarium), yams (e.g. Dioscorea opposite), bran from rice (e.g. Oryza sativa), and beeswax. Policosanols may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. A description of such extraction techniques can be found in U.S. Pat. Appl. No. 2005/0220868, the disclosure of which is expressly incorporated by reference.
- the functional ingredient is at least one phytosterol, phytostanol or combination thereof.
- the at least one phytosterol, phytostanol or combination thereof is present in the edible composition ⁇ e.g., beverage) in a concentration sufficient to promote health and wellness.
- stanol As used herein, the phrases “stanol”, “plant stanol” and “phytostanol” are synonymous.
- Plant sterols and stanols are present naturally in small quantities in many fruits, vegetables, nuts, seeds, cereals, legumes, vegetable oils, bark of the trees and other plant sources. Although people normally consume plant sterols and stanols every day, the amounts consumed are insufficient to have significant cholesterol-lowering effects or other health benefits. Accordingly, it would be desirable to supplement food and beverages with plant sterols and stanols.
- Sterols are a subgroup of steroids with a hydroxyl group at C-3.
- phytosterols have a double bond within the steroid nucleus, like cholesterol; however, phytosterols also may comprise a substituted sidechain (R) at C-24, such as an ethyl or methyl group, or an additional double bond.
- R sidechain
- phytosterols At least 44 naturally-occurring phytosterols have been discovered, and generally are derived from plants, such as corn, soy, wheat, and wood oils;
- phytosterols well known to those or ordinary skill in the art include 4- desmethylsterols (e.g., ⁇ -sitosterol, campesterol, stigmasterol, brassicasterol, 22- dehydrobrassicasterol, and A5-avenasterol), 4-monomethyl sterols, and 4,4- dimethyl sterols (triterpene alcohols) (e.g. , cycloartol, 24-methylenecycloartanol, and cyclobranol).
- 4- desmethylsterols e.g., ⁇ -sitosterol, campesterol, stigmasterol, brassicasterol, 22- dehydrobrassicasterol, and A5-avenasterol
- 4-monomethyl sterols e.g., cycloartol, 24-methylenecycloartanol, and cyclobranol
- triterpene alcohols e.g. , cycloartol, 24-methylenecyclo
- stanol As used herein, the phrases “stanol”, “plant stanol” and “phytostanol” are synonymous. Phytostanols are saturated sterol alcohols present in only trace amounts in nature and also may be synthetically produced, such as by
- phytostanols include ⁇ -sitostanol
- campestanol cycloartanol, and saturated forms of other triterpene alcohols.
- Both phytosterols and phytostanols include the various isomers such as the a and ⁇ isomers (e.g., a-sitosterol and ⁇ -sitostanol, which comprise one of the most effective phytosterols and phytostanols, respectively, for lowering serum cholesterol in mammals).
- a-sitosterol and ⁇ -sitostanol which comprise one of the most effective phytosterols and phytostanols, respectively, for lowering serum cholesterol in mammals.
- the phytosterols and phytostanols of the present invention also may be in their ester form. Suitable methods for deriving the esters of phytosterols and phytostanols are well known to those of ordinary skill in the art, and are disclosed in U.S. Patent Numbers 6,589,588, 6,635,774, 6,800,317, and U.S. Patent
- phytosterol and phytostanol esters include sitosterol acetate, sitosterol oleate, stigmasterol oleate, and their corresponding phytostanol esters.
- the phytosterols and phytostanols of the present invention also may include their derivatives.
- the amount of functional ingredient in the edible composition varies widely depending on the particular edible composition (e.g. , beverage) and the desired functional ingredient. Those of ordinary skill in the art will readily ascertain the appropriate amount of functional ingredient for each beverage.
- the edible composition further comprises a solubilizing agent, as discussed herein.
- a solubilizing agent such as sweet taste modulators - have a particular solubility in aqueous solutions.
- the solubility of a compound depends on a number of factors including, but not limited to, the chemical structure of the compound, the solvent, the pH of the solvent, etc. Solubilizing agents may be used to increase the amount of a compound, such as a sweet taste modulator, that may be dissolved in a particular amount of solvent.
- a compound according to Formula (I) or Compounds 1-6, as defined herein is solubilized by converting the compound into one or more crystalline forms, amorphous forms, one or more alcohol solvate forms, one or more hydrate forms, or mixtures thereof.
- the edible composition further comprises a surfactant to increase or decrease the effectiveness of the compounds of the present invention as sweet taste modulators.
- Suitable surfactants include, but are not limited to, non-ionic surfactants (e.g., mono and diglycerides, fatty acid esters, sorbitan esters, propylene glycol esters, and lactylate esters) anionic surfactants (e.g., sulfosuccinates and lecithin) and cationic surfactants (e.g., quaternary ammonium salts).
- the rate of release of the sweet taste modulator of the present invention may be regulated.
- the release rate of the sweet taste modulator of the present invention can be altered by, for example, varying its solubility in water. Rapid release can be achieved by encapsulating the sweet taste modulator of the present invention with a material with high water solubility. Delayed release of the sweet taste modulator of the present invention can be achieved by encapsulating the sweet taste modulator of the present invention with a material with low water solubility.
- the sweet taste modulator of the present invention can be
- the rate of release of the sweet taste modulator of the present invention can also be regulated by the degree of encapsulation. In some embodiments, the sweet taste modulator of the present invention is fully encapsulated. In other embodiments, the compounds of the present invention are partially encapsulated. In some embodiments, the rate of release may be regulated so as to release with the sweet taste modulator. In some embodiments, the rate of release may be regulated in a manner that is dependent on the structure of the sweetener and sweet taste modulator. [0215]
- the edible compositions of this invention are prepared according to techniques well-known in the art.
- an edible composition of the invention is prepared by mixing a component or ingredient of the edible composition, such as a sweetener, with a sweet taste modulating compound of the invention.
- a sweet taste modulating compound of the invention can be added directly to the edible composition comprising a sweetener.
- a sweetener is added simultaneously or sequentially with a sweet taste modulating compound of the invention. If sequentially, the sweetener may be added before or after the sweet taste modulating compound of the invention.
- the edible composition is a food product. In some
- the edible composition is a pharmaceutical composition. In some embodiments, the edible composition is a consumer product. In some
- the edible composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
- the amount of both a sweet taste modulating compound of the present invention and a sweetener used in an edible composition depends upon a variety of factors, including the purpose of the composition and the desired or acceptable perception of sweetness. The amount may depend on the nature of the edible composition, the particular compound added, the sweetener, other compounds present in the composition, the method of preparation (including amount of heat used), and the pH of the edible composition. Those of skill in the art will know how to determine the amounts needed to produce the desired taste(s).
- a sweet taste modulating compound of the invention may be present at any of the concentrations effective for modulating the sweetness of a sweetener listed above.
- the edible compositions are formulated as a concentrate, which is intended for dilution prior to consumption.
- the sweet taste modulating compound of Formula (I), any one of Compounds 1-6, as described herein, or combinations thereof are present at a concentration about 2-fold, about 3-fold, about 4-fold, about 5-fold, about 6-fold, about 7-fold, about 8-fold, about 9-fold, about 10-fold, about 15-fold, about 20-fold, about 25 -fold, about 30-fold, about 35 -fold, about 40-fold, about 45- fold, about 50-fold, about 55 -fold, about 60-fold, about 65 -fold, about 70-fold, about 75-fold, about 80-fold, about 85-fold, about 90-fold, about 95-fold, about 100-fold, about 150-fold, about 200-fold, about 250-fold, about 300-fold, about 350-fold, about 400-fold, about 450-fold, about 500-fold, about 550-fold, about 600-fold, about 650-fold, about 700-fold, about
- the sweet taste modulator of the present invention may be present in a concentrate at a concentration between about 1 to 3000 ppm; 10 to 1000 ppm; 50 to 500 ppm; 50 to 250 ppm; 50 to 100 ppm; 100 to 300 ppm; 100 to 500 ppm; 100 to 1000 ppm; 30 to 3000 ppm; 100 to 3000 ppm; 500 to 1000 ppm; 500 to 3000 ppm; or 1000 to 3000 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of
- Compounds 1-6, or combinations thereof may be present in a concentrate for dilution at a concentration of about 50 to 3000 ppm, 50 to 1000 ppm or 50 to 500 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulating compound of Formula (I), any one of Compounds 1-6, as described herein, or combinations thereof are present at a concentration 2-fold, 3 -fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 15-fold, 20-fold, 25-fold, 30-fold, 35- fold, 40-fold, 45-fold, 50-fold, 55-fold, 60-fold, 65-fold, 70-fold, 75-fold, 80-fold, 85-fold, 90-fold, 95-fold, 100-fold, 150-fold, 200-fold, 250-fold, 300-fold, 350- fold, 400-fold, 450-fold, 500-fold, 550-fold, 600-fold, 650-fold, 700-fold, 750-fold, 800-fold, 850-fold, 900-fold, 950-fold, or 1000-fold above any of the effective concentrations discussed herein.
- the sweet taste modulating compounds may be present in a concentrate - for later dilution - at concentration between 1 ppm and 5000 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention may be present in a concentrate at a concentration between 1 to 3000 ppm; 10 to 1000 ppm; 50 to 500 ppm; 50 to 250 ppm; 50 to 100 ppm; 100 to 300 ppm; 100 to 500 ppm; 100 to 1000 ppm; 30 to 3000 ppm; 100 to 3000 ppm; 500 to 1000 ppm; 500 to 3000 ppm; or 1000 to 3000 ppm.
- a compound of Formula (I) e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof
- the sweet taste modulator of the present invention may be present in a concentrate for dilution at a concentration of 50 to 3000 ppm, 50 to 1000 ppm or 50 to 500 ppm.
- the sweet taste modulator of the present invention e.g., a compound of Formula (I), or any one of
- Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of 1 to 500 ppm; 1 to 250 ppm; 1 to 100 ppm; 1 to 50 ppm; 10 to 500 ppm; 10 to 250 ppm; 10 to 100 ppm; 50 to 500 ppm; 50 to 250 ppm; or 50 to 100 ppm.
- the sweet taste modulator of the present invention may be present in a concentrate for dilution at a concentration of about 50 ppm, about 75 ppm, about 100 ppm, about 150 ppm, about 200 ppm, about 250 ppm, about 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, about 500 ppm, about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, about 800 ppm, about 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1050 ppm, about 1 100 ppm, about 1 150 ppm, about 1200 ppm, about 1250 ppm, about 1300 ppm, about 1350 ppm, about 1400 ppm, about 1450 ppm,
- the sweet taste modulator of the present invention may be present in a concentrate for dilution at a concentration of 50 ppm, 75 ppm, 100 ppm, 150 ppm, 200 ppm, 250 ppm, 300 ppm, 350 ppm, 400 ppm, 450 ppm, 500 ppm, 550 ppm, 600 ppm, 650 ppm, 700 ppm, 750 ppm, 800 ppm, 850 ppm, 900 ppm, 950 ppm, 1000 ppm, 1050 ppm, 1 100 ppm, 1 150 ppm, 1200 ppm, 1250 ppm, 1300 ppm, 1350 ppm, 1400 ppm, 1450 ppm, 1500 ppm, 1550 ppm, 1600 ppm, 1650 ppm, 1700 ppm, 1750
- the edible composition further comprises a sweet taste improving composition.
- one or more or all the compounds of formula (I) to be used according to the invention can also be used in the form of plant extracts.
- the plant extracts are preferably obtained from the corresponding fresh or dried plants or parts of plants.
- the dried plant parts for example fresh or dried roots, root bark, tubers, bulbs, other subterranean or aerial storage organs, spurious fruits, fruits, seeds, bark, wood, pulp, bast, stalks, stems, leaves or blossom (parts)
- a solvent suitable for foodstuffs and indulgence foods at temperatures of 0°C up to the boiling point of the respective solvent or solvent mixture, then filtered and the filtrate is partly or completely concentrated, preferably by distillation, freeze or spray drying.
- the raw extract obtained thus can then be further worked up, for example counter-extracted, purified by distributing, absorption, exclusion, affinity or ion chromatography, distilled, sublimated, purified with adsorbents such as active carbon, bentonite, kieselguhr etc, treated enzymatically (for example with glycosidases to increase the yield of non-sugar-containing molecules), with acid (for example under pressure), with suitable basic solutions, for example of hydroxides, carbonates or hydrogen carbonates of sodium, potassium, calcium, magnesium and zinc, with acidic ion exchangers or with water vapor, mixed with an auxiliary and carrier usually at pressures of 0.01 mbar to 100 bar, preferably 1 mbar to 20 bar and optionally dried (for example spray-dried) and/or taken up in a solvent suitable for foodstuffs and indulgence foods.
- adsorbents such as active carbon, bentonite, kieselguhr etc
- suitable basic solutions for example of hydroxides, carbon
- Solvents suitable for extraction for foodstuffs and indulgence foods include, in particular, water, ethanol, methanol, propylene glycol, glycerin, acetone, dichloromethane, ethyl acetate, diethyl ester, hexane, heptane, triacetin, vegetable oils or fats, supercritical carbon dioxide and mixtures thereof.
- auxiliaries or carriers include maltodextrin, starch, natural or artificial polysaccharides and/or vegetable gums such as modified starches or gum arabic, coloring agents, for example permitted foodstuff dyes, coloring plant extracts, stabilizers, preservatives, antioxidants, viscosity-influencing substances
- the edible compositions may be included in a package.
- the edible composition is packaged in bulk, in which the package contains more of the compositions than would typically be used for a single dish or serving of food or beverage.
- Such bulk packages can be in the form of paper, plastic, or cloth bags or cardboard boxes or drums.
- Such bulk packages may be fitted with plastic or metal spouts to facilitate the dispensing of the edible composition.
- the package may contain an edible composition comprising a sweet taste modulating compound of the present invention and a sweetener.
- the package contains an edible composition comprising a sweet taste modulating compound of the present invention and caloric carbohydrate sweetener.
- the package contains an edible composition comprising a sweet taste modulating compound of the present invention and glucose, fructose, sucrose, or a mixture thereof.
- the package contains an edible composition comprising a sweet taste modulating compound of the present invention and a synthetic sweetener.
- the package contains an edible composition comprising a sweet taste modulating compound of the present invention and a natural high-potency sweetener.
- the edible compositions may be used for medicinal or hygienic purposes, for example, in mouthwash, medicines, pharmaceuticals, cough syrup, throat spray, toothpaste, dental adhesives, tooth whiteners, glues (e.g., on stamps and
- the sweetener composition is in a form of a tabletop sweetener composition comprising at least one sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof, at least one sweetener, at least one bulking agent, and optionally at least one sweet taste improving composition and/or anti-caking agent with improved temporal and/or flavor profile.
- at least one sweet taste modulator according to Formula (I) any one of Compounds 1-6, or combinations thereof
- at least one sweetener at least one bulking agent
- optionally at least one sweet taste improving composition and/or anti-caking agent with improved temporal and/or flavor profile optionally at least one sweet taste improving composition and/or anti-caking agent with improved temporal and/or flavor profile.
- suitable “bulking agents” include, but are not limited to maltodextrin (10 DE, 18 DE, or 5 DE), corn syrup solids (20 or 36 DE), sucrose, fructose, glucose, invert sugar, sorbitol, xylose, ribulose, mannose, xylitol, mannitol, galactitol, erythritol, maltitol, lactitol, isomalt, maltose, tagatose, lactose, inulin, glycerol, propylene glycol, polyols, polydextrose, fructooligosaccharides, cellulose and cellulose derivatives, and mixtures thereof.
- the at least one bulking agent is chosen from, granulated sugar (sucrose) or other caloric sweeteners such as crystalline fructose, other carbohydrates, and sugar alcohols.
- a bulking agent may be used as a sweet taste improving composition.
- anti-caking agent is understood to mean any composition which prevents, reduces, inhibits, or suppresses at least one sweetener molecule from attaching, binding, or contacting to another sweetener molecule.
- anti-caking agent may refer to any composition which assists in content uniformity and uniform dissolution.
- non-limiting examples of anti-caking agents include cream of tartar, calcium silicate, silicon dioxide, microcrystalline cellulose (Avicel, FMC
- the anti-caking agents are present in the tabletop sweetener composition in an amount from about 0.001 to about 3% by weight of the tabletop sweetener composition. In at least one embodiment, the anti-caking agents are present in the tabletop sweetener composition in an amount from 0.001 to 3% by weight of the tabletop sweetener composition.
- Tabletop sweetener compositions may be embodied and packaged in numerous different forms, and may be of any form known in the art.
- the tabletop sweetener compositions may be in the form of powders, granules, packets, tablets, sachets, pellets, cubes, solids, or liquids.
- the invention provides a method of preparing an edible composition.
- the method comprises: (a) providing a sweetener; and (b) adding to the sweetener of (a) a compound of Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof.
- the sweet taste modulator of the invention has been solubilized prior to the addition step (b).
- a solubilizing agent is added to the composition.
- the sweetener of step (a) is provided in a comestibly acceptable carrier.
- method steps (a) and (b) can be performed in any order - i.e., the method may comprise: (a) adding a compound of Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof; and (b) adding a sweetener to the Compound(s) of (a).
- the method comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a solubilizing agent, as discussed herein. In some embodiments, the method further comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a solvent.
- Methods for solubilizing compounds of the present invention include but are not limited to chemical, physical or mechanical means.
- Additives, solubilizing or stabilizing agents may provide chemical means for increasing the concentration of compounds of the present invention in solution.
- Application of mechanical forces resulting in shearing, dispersion or emulsification of compounds of the present invention may also result in an increase in the concentration of compounds of the present invention in solution.
- Changes in temperature, pressure, and/or pH are non-limiting physical means for increasing the solubility of compounds of the present invention and/or maintaining the concentration of the compound in solution.
- the mechanical, physical or chemical means may be used in
- Solubilizing agents include, but are not limited to, glycoprotein- polysaccharides, such as Gum Arabic; homopolymers, such as poly(N-vinyl- pyrrolidone); medium chain mono- and diglycerides, such as Capmul MCM;
- oligosaccharides such as Hp-beta-cyclodextrin, alpha-cyclodextrin, beta- cyclodextrin or gamma-cyclodextrin, and cellulose
- polyglycerol esters such as Caprol PEG 860 ® , Caprol 10G40 ® or Drewpol 10-1-CC ®
- polysorbates such as Tween 20 ® (polysorbate 20), Tween 60 ® (polysorbate 60), and Tween 80 ®
- solubilizing agents include, but are not limited to, GRINDSTED ® ACETEM, alpha-Cyclodextrin, beta-Cyclodextrin, DATEM, Decaglycerol dioleate, Decaglycerol monooleate, Decaglycerol monostearate, Ethoxylated monoglyceride, gamma-Cyclodextrin, Glycerol monoleate, Glycerol monostearate, Glyerol dioleate, Gum Arabic, Hexaglycerol dioleate, Hp-beta- Cyclodextrin, Lecithin, Methyl cellulose, Oleic acid, Poly(N-vinyl-pyrrolidone), Polyoxyethylene (20) sorbitan monooleate, Polyoxyethylene (20) sorbitan monooleate, Polyoxyethylene (20) sorbitan monooleate, Polyoxyethylene (20) sorbitan monooleate, Polyoxyethylene (20)
- the solubilizing agent is alpha-Cyclodextrin. In some embodiments, the solubilizing agent is beta-Cyclodextrin. In some embodiments, the solubilizing agent is gamma-Cyclodextrin. In some embodiments, the solubilizing agent is Gum
- the solubilizing agent is Hp-beta-Cyclodextrin. In some embodiments, the solubilizing agent is Lecithin. In some embodiments, the solubilizing agent is Methyl cellulose. In some embodiments, the solubilizing agent is Poly(N-vinyl-pyrrolidone). In some embodiments, the solubilizing agent is Quillaja saponins. Solubilizing agents may be used at concentrations between 0.001% to 50% to solubilize the compounds of the invention. In some
- concentrations of solubilizing agents in the final product range from about 0.05% to about 2%. In some embodiments, concentrations of solubilizing agents in the final product range from 0.05% to 2%.
- Solvents for dissolving the sweet taste modulator of the invention include, but are not limited to, 1,3-butylene glycol, amyl acetate, benzyl alcohol, butane - 1,3-diol, castor oil, diethyl tartrate, diethylene glycol monoethyl ether, ethyl acetate, ethyl alcohol, glycerin, glycerol, glycerol diacetate, isopropyl alcohol, NEOBEE ® M-5 oil, propylene glycol, and triacetin.
- the solvent is 1,3-butylene glycol.
- the solvent is amyl acetate.
- the solvent is benzyl alcohol. In some embodiments, the solvent is butane- 1,3-diol. In some embodiments, the solvent is castor oil. In some embodiments, the solvent is diethyl tartrate. In some embodiments, the solvent is diethylene glycol monoethyl ether. In some embodiments, the solvent is ethyl acetate. In some embodiments, the solvent is ethyl alcohol. In some embodiments, the solvent is glycerin. In some embodiments, the solvent is glycerol. In some embodiments, the solvent is glycerol diacetate. In some embodiments, the solvent is isopropyl alcohol. In some embodiments, the solvent is propylene glycol. In some embodiments, the solvent is triacetin. Solvents may be used at concentrations between 0.001%> to 50%> to solubilize the compounds of the invention. In some embodiments, solvent concentrations in the final product range from about 0.05 to about 2%.
- the method comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a combination of solubilizing agents, a combination of solvents, or a combination of solubilizing agents and solvents.
- the combination includes polysorbate 80 and Q-NATURALE ® .
- the combination includes propylene glycol and Q-NATURALE ® .
- the combination includes ethanol and Q-NATURALE ® .
- the combination includes triacetin, ethanol, propylene glycol, and polysorbate 80.
- the combination includes NEOBEE ® M-5 oil and Q-NATURALE ® .
- the combination includes NEOBEE ® M-5 oil, lyso-lecithin and Q-NATURALE ® .
- the combination includes
- preserved water comprises one or more of sodium benzoate, potassium sorbate and citric acid.
- preserved water comprises sodium benzoate, potassium sorbate and citric acid.
- combination comprises NEOBEE ® M-5 oil, triacetin and a citrus juice, such as orange juice, lemon juice or grapefruit juice, preferably orange juice.
- solvent concentrations in the final product range from about 0.05 to about 2%.
- the method comprises co-melting a compound of the invention with sugar.
- the compound of the invention and sugar e.g., sucrose
- the sugar-compound solution may then be dried to produce a dry mixture, which may be heated to produce caramel-melts.
- the caramel-melts are dissolved in a solvent, which may then be added to a beverage solution.
- the method results in a clear solution. In some embodiments, the method results in a solution with opacity. In some
- the method does not decrease the sweetness enhancing efficacy of the compound of the invention. In some embodiments, the method does not result in a solution with an off-taste.
- the method of preparing an edible composition of the invention comprises mixing a component or ingredient of the edible composition, such as a sweetener, with a sweet taste modulating compound of the invention.
- a sweet taste modulating compound of the invention can be added directly to the edible composition comprising a sweetener.
- the sweetener is added to the edible composition simultaneously or sequentially with a sweet taste modulating compound of the invention. If sequentially, the sweetener may be added before or after the sweet taste modulating compound of the invention.
- the method includes the addition of the solubilizing agent at any point.
- the solubilizing agent may be added as the first, second, or third component.
- the solubilizing agent may also be added concurrently with any other component.
- the methods of preparing an edible composition further comprise adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- the edible compositions may be a food product, a pharmaceutical composition, or a consumer product.
- composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
- the invention provides a method of enhancing the perception of sweet taste in a subject.
- the method comprises the use of an edible composition of the present invention, where the edible
- composition comprises a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof.
- the edible composition comprises (i) a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof; (ii) a sweetener; and optionally (iii) a solubilizing agent.
- subject refers to a mammal. In preferred embodiments, the subject is human. In some embodiments, a subject is a domestic or laboratory animal, including but not limited to, household pets, such as dogs, cats, pigs, rabbits, rats, mice, gerbils, hamsters, guinea pigs, and ferrets. In some
- a subject is a livestock animal.
- livestock animals include: alpaca, bison, camel, cattle, deer, pigs, horses, llamas, mules, donkeys, sheep, goats, rabbits, reindeer, and yak.
- the method can be used to enhance or potentiate sweet taste in any edible composition, including a foodstuff, food product, pharmaceutical composition or consumer product.
- the edible composition may be in any form.
- the composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
- the edible composition may be utilized by, for example, placement in the oral cavity or by ingestion.
- the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested before an edible composition, such as a foodstuff, a food product, pharmaceutical composition or consumer product, comprising a sweetener, while in other embodiments, the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested after a sweet food stuff, food product, pharmaceutical composition or consumer product.
- the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested concurrently with a sweet food stuff, food product, pharmaceutical composition or consumer product, either as a separate edible composition or by incorporation in the sweet food stuff, food product, pharmaceutical composition or consumer product.
- a sweet taste modulator of the invention can be combined with foodstuffs or food products to enhance or potentiate the sweet taste of a foodstuff or food product.
- a sweet taste modulator of the invention can be used, for example, in a lozenge or gum for use after exposure to a sweet food stuff, food product, pharmaceutical composition or consumer product (e.g. , to enhance or potentiate a sweet aftertaste).
- Method of reducing the amount of a sweetener in an edible composition It may be desirable to reduce the amount of a caloric sweetener in an edible composition to reduce the calorie content of that edible composition. It may also be desirable to decrease the amount of a synthetic sweetener or a non-natural high potency sweetener in an edible composition to decrease an undesirable taste or aftertaste associated with the synthetic sweetener or non-natural high potency sweetener. Accordingly, another aspect of the present invention provides a method of reducing the amount of a sweetener in an edible composition, such as a food product, a pharmaceutical composition or a consumer product.
- An amount of the sweetener in the edible composition may be replaced with a sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof.
- an amount of solubilizing agent may also be added to the edible composition, as described herein.
- replace refers to substituting one compound for another compound in or in the preparation of, for example, an edible composition, such as food product. It includes complete and partial replacements or
- the method comprises: (a) replacing an amount of a sweetener used in preparing an edible composition with an amount of a sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof.
- the sweet taste modulating compound of the invention is added in the form of an edible composition comprising the sweet taste modulator of the invention.
- an amount of solubilizing agent may also be added to the edible composition, as described herein.
- the method of reducing the amount of a sweetener in an edible composition comprises the steps of: (a) ingesting a first edible composition, in which the amount of a sweetener has been reduced; and (b) ingesting a second edible compound, which comprises a sweet taste modulator compound of the present invention.
- the first edible composition is ingested before the second edible composition.
- the first edible composition is ingested after the second edible composition. In some embodiments, the first edible composition is ingested concurrently with the second edible composition. In such methods, an amount of solubilizing agent may also be added along with the sweet taste modulator of the present invention.
- the edible composition is a food product. In some embodiments, the edible composition is a pharmaceutical composition. In some embodiments, the edible composition is a consumer product.
- the sweetener being replaced may be a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener, or combinations thereof. When the sweetener being replaced is a natural caloric sweetener, the sweetener may be sucrose, fructose, glucose, erythritol, high fructose corn/starch syrup, and mixtures thereof. When the sweetener being replaced is a synthetic sweetener, the sweetener may be sucralose, aspartame, potassium acesulfame, and mixtures thereof.
- the method also comprises replacing an amount of a natural caloric sweetener with a synthetic or natural high-potency sweetener and a sweet modulating compound of the present invention, such that any off-taste or after taste associated with the synthetic or natural high-potency sweetener is reduced or eliminated.
- the "sweetener replaced" is the natural caloric sweetener.
- the methods of reducing sugar intake of a subject further comprise the step of identifying a subject in need thereof.
- the skilled worker would be able to identify a subject in need of reducing sugar intake.
- Non- limiting examples of such subjects include subjects that suffer from any one or more of the following disorders: diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia.
- the amount of the sweetener replaced in the edible composition in step (a) is an amount sufficient to maintain or restore the health of a subject.
- the amount of the sweetener replaced in the edible composition may be an amount sufficient to decrease diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia in a subject.
- the amount of the sweetener replaced may be up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99%.
- the amount of the sweet taste modulating compound added in step (b) is effective to enhance the perception of sweet taste in the subject.
- the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99% of the amount of sweetener present in the edible composition. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention. In some embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 25% of the amount of the sweetener present in the edible composition.
- the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 50%> of the amount of the sweetener present in the edible composition. In other embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 75% of the amount of the sweetener present in the edible composition. In yet other embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 99% of the amount of the sweetener present in the edible composition.
- the method of reducing the amount of a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
- a sweet taste improving composition such as a sweet taste improving composition, and/or a sweet taste improving additive.
- Another aspect of the invention provides a method of reducing caloric intake of a subject.
- the method comprises the step of providing an edible composition to the subject, wherein all or a portion of a natural caloric sweetener in the edible composition is replaced with (a) a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof; or (b) one or more synthetic or natural high potency sweeteners and a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof.
- the edible composition may be a food product, a pharmaceutical composition, or a consumer product. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
- the methods of reducing caloric intake of a subject may further comprise the step of identifying a subject in need thereof.
- the skilled worker would be able to identify a subject in need of reducing sugar intake.
- Non-limiting examples of such subjects include subjects that suffer from any one or more of the following disorders: diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia.
- the amount of the natural caloric sweetener replaced in the edible composition is an amount sufficient to maintain or restore the health of a subject.
- the amount of the natural caloric sweetener replaced in the edible composition may be an amount sufficient to result in weight loss in a subject.
- the amount of the natural caloric sweetener replaced in the edible composition may be an amount sufficient to alleviate the effects of, or treat, a disease associated with sugar consumption or excessive weight of the subject (e.g., diabetes).
- the amount of the natural caloric sweetener replaced in the edible composition is up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%,
- the present method results in the subject's daily natural caloric sweetener intake being less than 250 g/day, less than 200 g/day, less than 175 g/day, less than 150 g/day, less than 125 g/day, less than 100 g/day, less than 75 g/day, less than 50 g/day, less than 25 g/day, less than 20 g/day, less than 15 g/day, less than 10 g/day, or less than 25 g/day.
- the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99%.
- these amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention.
- the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 25%. In other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 50%. In other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 75%. In yet other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 99%.
- the method of reducing the amount of a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
- at least one additional additive such as a sweet taste improving composition, and/or a sweet taste improving additive.
- the invention provides methods of enhancing or potentiating the sweet taste in an edible composition.
- the edible composition may be a food product, a pharmaceutical composition, or a consumer product.
- the method comprises: (a) adding an effective amount of a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof, to an edible composition comprising a sweetener such that the perception of sweetness intensity of the sweetener is enhanced.
- the sweetener is either added to the edible composition before the sweet taste modulating compound; concurrently with the sweet taste modulating compound; or after the sweet taste modulating compound.
- the sweetener is naturally or inherently present in the edible composition when the sweet taste modulating compound is added.
- an amount of solubilizing agent may also be added to the edible composition, as described herein.
- the method comprises: (a) ingesting an effective amount of a sweet taste modulating compound according to Formula (I), or any one of
- the edible composition may comprise a sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener, or combinations thereof.
- a sweetener such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener, or combinations thereof.
- the sweetener may be sucrose, fructose, glucose, erythritol, high fructose corn/starch syrup, and mixtures thereof.
- the sweetener is a synthetic sweetener
- the sweetener may be sucralose, aspartame, potassium acesulfame, and mixtures thereof.
- the perception of sweetness intensity of the sweetener is enhanced by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%o, 90%), 95%) or 100%>.
- the perception of sweetness intensity of the sweetener is enhanced beyond 100%), for example, by 125%, 150%, 175%, 200%, 225%, 250%, 275%, 300%, 325%, 350%, 375%, 400%, 425%), 450%), 475%), 500%) or increments in between those recited.
- the perception of sweetness intensity of the sweetener is enhanced by up to 25%. In other embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 50%. In other embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 75%. In other embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 100%.
- the perception of sweetness intensity of the sweetener is enhanced by about 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%, 10-35%, 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25-60%, 25-50%, 25-40%, or 25-30%.
- the perception of sweetness intensity of the sweetener is enhanced by 5-100%, 5- 90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%, 10-35%, 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25-60%, 25-50%, 25-40%, or 25-30%.
- the method of enhancing the sweet taste attributed to a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
- Another aspect of the invention provides a method of enhancing or potentiating activation and/or signaling of a sweet taste receptor.
- the method comprises contacting a sweet taste receptor with a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof, in the presence of a sweetener.
- the method comprises contacting a sweet taste receptor with an edible composition comprising a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof, in the presence of a sweetener.
- the edible composition may be a food product, a pharmaceutical composition, or a consumer product.
- an amount of solubilizing agent may also be present in the edible composition, as described herein.
- the sweet taste receptor is an ex vivo or in vivo receptor present in, for example, an assay.
- the sweet taste receptor also may be an in vivo receptor present in a subject.
- the sweet taste receptor is typically present in the oral cavity or gastrointestinal tract of the subject.
- the sweet receptor is in the oral cavity of a human.
- the sweet receptor is in the oral cavity of a non-human animal, such as an animal model.
- An in vivo sweet responsive assay means an assay where an assessment of increased perception of sweetness can be ascribed.
- Such an assay may be, for example, but not limited to, a human sensory descriptive analysis panel, a human sensory discriminative panel, and/or an expert flavorist assessment.
- Non-human assessments of sweet response include, but not limited to, operant conditioned animal studies of sweetness taste perception and/or lick rate/amount bottle preference tests
- An in vitro sweet responsive assay refers to an assay where an assessment of increased sweet response or interaction can be ascribed.
- An example of such an assay may be, but is not limited to, in vitro receptor binding assays, in vitro receptor cell-based assays, and/or electronic tongue taste analysis.
- enhancement of a sweet taste receptor activation will affect a physiological process or condition.
- physiological processes and conditions affected by the enhancement of sweet taste receptor activation include sweet taste, effects on the gastrointestinal tract, appetite, nutrition, nutrient absorption, satiety, hunger, diabetes, obesity, blood glucose levels, blood glucose regulation, metabolism, diet, and eating disorders.
- compounds of Formula I, compounds 1-6 or combinations thereof can be suitable for masking or reducing an unpleasant taste sensation, in particular a bitter taste sensation of a bitter-tasting substance.
- Compounds of Formula I, compounds 1-6 or combinations thereof can both synergistically enhance the sweet taste sensation of sweeteners like steviol glycosides (for example occurring naturally in Stevia ssp.) and mask or reduce the bitter taste sensation of such steviol glycosides or other bitter tasting sweeteners such as acesulfame-K, saccharin, steviosides, or rebaudiosides.
- Preparations comprising the bitter blocking compounds of the invention can be made in the same or similar manner and concentration as the preparations comprising the sweet taste enhancing preparations of the invention.
- Compound 1 and Compound 4 are prepared by the multi-step sequences described below.
- One of skill in the art would be able to readily adapt the described conditions for the synthesis of any of the compounds of Formula (I).
- Compound 2 is referred to as (S)-2-(3-hydroxy-4- methoxyphenyl)-8-methylchroman-7-ol or (-)-2-(3-hydroxy-4-methoxyphenyl)-8- methylchroman-7-ol.
- Compound 3 is referred to as (R)-2-(3-hydroxy-4- methoxyphenyl)-8-methylchroman-7-ol or (+)-2-(3-hydroxy-4-methoxyphenyl)-8- methylchroman-7-ol.
- reaction mixture was neutralized with ice-cold 10% aq. citric acid.
- the solid formed was filtered, washed with water twice, dried, and then purified with silica-gel chromatography (hexane/ethyl acetate: 100/0 to 50/50 in 15 minutes) to afford the product C (1.7 g, 50%>) as yellow solid.
- LC-MS retention time: 3.09 min, 345 [M+H] + ).
- CHIRALPAK® AS-H 25x0.46 cm purchased from Chiral Technologies, 50% methanol/C0 2 , 100 bar, flow rate of 3 mL/min) with > 99% ee.
- Compound 1 and Compound 2 each occur to different extents in various natural sources which are known in the art. Accordingly, one or both of the Compounds according to the invention can also be used in the form of plant extracts, in particular in the form of plant extracts from one of the plants mentioned in Table 1 below. The references listed in Table 1 are incorporated herein by reference in their entirety. Table 1
- Pancratium Illyricum Casu, L., et al., Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
- Extraction from these natural sources may be done using mixtures of aqueous alcohol with the alcohol content ranging from about 10% to about 99%, or more usually, from about 50 to about 95%. In some embodiments, extraction from these natural sources may be done using mixtures of aqueous alcohol with the alcohol content ranging from 10% to 99%, or more usually, from 50 to 95%.
- alcohols suitable for use include but are not limited to methanol, ethanol, propanol, isopropanol, n-butyl alcohol or mixtures thereof.
- alcohol compositions for use in extractions may be 80:20 or 60:40
- HPLC high performance liquid chromatography
- Compound 2 is isolated from commercial resin extract Dracaena cochinchinensis .
- Compounds 1 and 2 appear as a white powder exhibiting the following properties:
- test compounds used in the following examples may be obtained from the synthetic methods disclosed above.
- the taste test panelists used in the Example 1 were selected using a sensory acuity screening program.
- Candidate taste panelists were recruited, with prescreening and personal interviews, and were assessed and for their ability to detect, recognize and differentiate basic taste attributes or mixtures thereof as part of a standardized acuity test. This included basic tastes of sweet, sour, salty, bitter and umami, as well as having the capacity to focus on specific aspects of sensory character such as ranking the various tastes perceived and identifying the basic tastes presented at threshold levels.
- the aqueous sweetener solutions were prepared by adding sucrose equivalent (SE) quantities of high fructose corn syrup (HFCS) (by weight), to water to achieve the desired concentration.
- SE sucrose equivalent
- HFCS high fructose corn syrup
- the aqueous solutions ranged in pH from pH 2.5-pH 7.
- Compounds of the invention were first prepared as a 500-fold concentrated stock solution in 100% ethanol. These concentrated stocks were then added to the aqueous sweetener solutions to result in a final ethanol concentration of 0.2%.
- the control (positive and negative) samples were also normalized to 0.2% ethanol. This level of ethanol was not seen to contribute any perceived sweetness.
- the 2AFC test used for compound evaluation was a double blinded and randomized test where taste panelists (n >15) evaluate a pair of sweetener solutions at a time - one sample contains aqueous sweetener solution plus compound (i.e. test) while the other contains aqueous sweetener solution at higher concentration without compound (i.e. positive control).
- Each test sample was compared against a positive control. For example, if the test sample contained IX sweetener concentration with compound (e.g. 5brix HFCS with compound), the positive control sample contained a 1. IX sweetener concentration (e.g. 5.5brix HFCS without compound). In this manner, compounds were not assessed simply for an increase in perceived sweetness, but a significant increase in perceived sweetness above the positive control.
- Panelists were instructed not to eat or drink (except water) for at least 1 hour before the test. During the test, panelists were instructed to sip each sample, swirl it around their mouth and then expectorate. After tasting each sample in the pair, panelists were instructed to record the sample that is "sweeter" in taste. Panelists cleansed their palates by rinsing with water, eating a cracker and waiting for an interval of about 5 minutes. All samples were tasted at ambient
- aqueous sweetener solutions were prepared by adding sucrose equivalent quantities of HFCS (by weight), to water to achieve the desired concentration.
- the aqueous solutions ranged in pH from 2.5-pH 7.
- test compounds The intrinsic effect of test compounds on the perception of sweet taste, in an aqueous solution, in humans was evaluated using 2AFC methodology. This test was a double-blinded, randomized study where taste panelists (n >20) evaluate a pair of sweetener solutions at a time- one sample contains aqueous solutions, without sweetener, plus compound (i.e. test) while the other contains aqueous solution containing 1.5% sucrose equivalent (SE), HFCS (i.e. control). Each test sample is compared against the sweetener control to observe if the test is significantly less sweet than the control sample.
- SE sucrose equivalent
- HFCS i.e. control
- Panelists were instructed not to eat or drink (except water) for at least 1 hour before the test. During the test, panelists were instructed to sip each sample, swirl it around their mouth and then expectorate. After tasting each sample in the pair, panelists were instructed to record the sample that is "sweeter" in taste. Panelists cleansed their palates by rinsing with water, eating a cracker and waiting for an interval of about 5 minutes. Each pair was tasted twice. All samples were tasted at ambient temperatures. Data were analyzed using binomial probabilities
- test compound The effect of the test compound on the perception of the sweet taste in a flavored aqueous environment, in the presence of carbohydrate sweeteners, was evaluated using a descriptive analysis methodology with a group of trained panelists, as follows.
- Candidate panelists were recruited, with prescreening and personal interviews, and were assessed for their ability to detect, recognize and differentiate basic taste attributes or mixtures thereof as part of a standardized acuity test. These candidate panelists were also assessed for their innate ability to identify flavors, and to rank on intensity scales. Other senses such as smell and vision were also included as part of the assessment. Candidates also were screened for their ability to use the language to describe and articulate ideas.
- Selected candidates proceeded to training as a group in three phases: (1) Lexicon development, (2) Concept alignment, and (3) Scaling descriptors.
- lexicon development panelists evaluated products appropriate for use in the study to generate and align on terms describing the flavor, taste, aromatic, trigeminal, and temporal attributes.
- concept alignment the panel evaluated the products mentioned above to clarify and confirm the attributes that were generated during lexicon development using reference standards that appropriately define each attribute; these are either physical references (e.g. sucrose solutions) or verbal descriptions (e.g. overall flavor).
- reference standards that appropriately define each attribute; these are either physical references (e.g. sucrose solutions) or verbal descriptions (e.g. overall flavor).
- the panel used in this example was trained to reference sweet attributes in an absolute manner, such that a particular concentration of sweetener is always measured by the panelists at the same point using a 15 cm line scale where each cm represents a 1 % increase in sucrose to cover the range of 0% to 15% sucrose.
- the panel was trained using a hybrid approach between descriptive analysis methods well-known to those skilled in the art. Panel performance was measured at regular intervals, and for data presented, the cohort of 12 panelists demonstrated good performance for reproducibility measured as a panel average of 81%, and defined as the number of attributes with
- the trained panel was then used for a descriptive analysis assessment for Compound 2 and Compound 5 in flavored lemon lime matrix.
- Compound 2 was assessed at a dose of 50 ppm and Compound 5 was assessed at a dose of 20 ppm for sweetness enhancement in high fructose corn syrup (HFCS) sweetened lemon lime matrix.
- HFCS high fructose corn syrup
- the flavored sweetener solutions were prepared by adding sucrose equivalent quantities of HFCS (by weight), to lemon lime matrix to achieve the desired concentration. Compound was first prepared as a 500-fold concentrated stock solution in 100% ethanol. The concentrated stocks were then added to the flavored sweetener solutions to result in a final ethanol concentration of 0.2%. The control (positive and negative) samples were also normalized to 0.2% ethanol. This level of ethanol was not seen to contribute any perceived sweetness
- Sweetness intensities observed for compound-containing solution was significantly different from negative control solutions, as determined by ANOVA.
- the letter "a” indicates significant differences among the samples at 95% confidence level.
- Fold enhancement increase in perceived sweetness was calculated by dividing the DA panel average intensity score observed for a variant sample by that observed for the negative control sample.
- test compound The effect of the test compound on the perception of non- sweet taste attributes (such as bitterness) in a flavored aqueous environment, in the presence of carbohydrate sweeteners, was evaluated using a descriptive analysis methodology with a group of trained panelists, as follows. This occurred as part of DA assessment described previously in Example 3.
- the trained panel was then used for a descriptive analysis assessment for Compound 2 and Compound 5 in lemon lime flavored matrix, sweetened with high fructose corn syrup (HFCS), at a test dose of 50 ppm and 20 ppm, respectively.
- HFCS high fructose corn syrup
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Seasonings (AREA)
Abstract
The present invention provides edible compositions comprising a sweet taste modulator or bitter taste blocker of the present invention, food products comprising such edible compositions and methods of preparing such food products. The present invention also provides methods of reducing the amount of sugar in a food product, methods of reducing the caloric intake in a diet, and methods of enhancing sweet taste or blocking a bitter taste in a food product.
Description
COMPOUNDS, COMPOSITIONS, AND METHODS
FOR MODULATING SWEET TASTE
Cross-Reference to Related Application
[0001] This application claims priority to U.S. Provisional Application
62/045,463, filed September 3, 2014, which the application is incorporated herein by reference in its entirety.
Field of the Invention
[0002] The present invention relates to flavor in edible compositions. Background of the Invention
[0003] There is an increasing demand worldwide to have broader available choices of reduced sugar content in foods and beverages, whether for taste preference, lifestyle reasons or for certain individuals (e.g., diabetic patients) for health-related goals. Accordingly, health benefits associated with the reduction of sugar content in foods and beverages is desirable. The use of non-caloric artificial and natural high-potency sweeteners to reduce the level of sweeteners such as caloric and non-caloric sweeteners in foods is limited due to temporal and/or flavor issues, e.g., slow onset of sweetness, sweetness linger, bitter, metallic or licorice taste. It is, therefore, desirable to provide compounds that may be added to food products, consumer products and pharmaceuticals which allow for the use of reduced amounts of caloric sweeteners (e.g., sugars) while maintaining desirable sweet taste and avoiding the flavor issues associated with sugar substitutes.
Summary of the Invention
[0004] The present disclosure provides compounds that enhance sweet taste, edible compositions comprising such compounds, and methods of preparing such edible compositions. The present disclosure also provides methods of reducing the amount of a sweetener in an edible composition.
The present disclosure further provides a method of enhancing, modulating or potentiating the sweet taste of an edible composition, such as a food, consumer or pharmaceutical product, in a subject. The present disclosure also provides a method of modulating, particularly enhancing or
potentiating the activation of a sweet taste receptor. A further aspect of the present disclosure provides compounds, or mixtures thereof for masking or reducing unpleasant taste sensations, in particular for masking or reducing the bitter taste sensation of a bitter-tastant.
[0005] One aspect of the present disclosure provides compounds for modulating sweet taste (e.g., enhancing sweet taste) of a sweet tastant. In some embodiments, the compound is a flavonoid compound. In some embodiments, the flavonoid is a flavan. In some embodiments, the
flavonoid compound has a molecular weight less than about 1000, 500, or 300 Daltons. In certain embodiments, the flavonoid compound is a
compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, enantiomers thereof, or combinations thereof. In certain embodiments, the flavonoid compound is any one of Compounds 1-6 or combinations thereof, or comestibly or biologically acceptable salts or derivatives thereof. The present disclosure also includes edible
compositions comprising sweet taste modulating compounds such as the compounds of Formula (I). In addition, the present disclosure also includes edible compositions comprising sweet taste modulating compounds such as any one of Compounds 1-6, or combinations thereof.
[0006] Such taste modulators may be combined with any suitable sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener including a synthetic high-potency sweetener, sugar alcohols, rare
sugars, sweetener enhancers or combinations thereof, to provide a composition having enhanced sweetness. In some embodiments, the compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, or enantiomers thereof, or combinations thereof is present in the composition in an amount at or below its inherent sweetness threshold. In other embodiments, any one of
Compounds 1-6 or combinations thereof, or comestibly or biologically acceptable salts or derivatives thereof is present in the composition in an amount at or below its inherent sweetness threshold. In embodiments wherein the compound is present in the composition in an amount at or below its inherent sweetness threshold, the compound does not act as a sweetener. The compositions may further comprise at least one sweet taste improving composition.
[0007] In another aspect, the present disclosure provides a method of enhancing the sweetness of a sweetener comprising combining (i) at least one sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener including a synthetic high-potency sweetener, sugar alcohols, rare sugars, sweetener enhancers or combinations thereof, and (ii) a flavonoid sweet taste modulator of the present invention, such as a compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, or enantiomers thereof, or combinations thereof. In some embodiments, the flavonoid sweet taste modulator of the present invention is any one of Compounds 1-6, or combinations thereof. The method may further comprise combining (iii) at least one sweet taste improving composition. The compounds may be added in an amount at or below their sweetness threshold.
[0008] Other aspects of the present disclosure include edible compositions, such as beverage compositions, concentrates (for use in, e.g., beverage compositions), food products, pharmaceutical preparations and table-top sweeteners comprising the compositions of the present disclosure; methods for preparing an edible composition; methods for reducing the amount of a sweetener in an edible composition; methods for reducing caloric intake; methods of enhancing activation of a sweet taste receptor and methods of synthesizing the sweet taste modulators of the present invention.
[0009] Particular embodiments of the invention are set forth in the following numbered paragraphs:
1. A method of enhancing the sweet taste of a sweetener in an edible
composition, wherein said method comprises adding an effective amount of a compound of Formula (I) any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, to said edible composition, such that the perception of sweetness intensity of said sweetener is enhanced.
2. The method of Paragraph 1 , wherein the method further comprises the step of solubilizing or stabilizing a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
3. The method of Paragraph 2, wherein the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is solubilized by the addition of a solubilizing agent.
4. The method of Paragraph 2, wherein the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is solubilized or maintained in solution by a process, wherein the process includes changes in temperature, pressure and/or time conditions, physical modifications such as reduction of the particle size by homogenization or micronization, modification of crystal form by formation of polymorphs or amorphous forms or where the material to be solubilized is dispersed in one or more carriers, or the use of chemical agents to effect solubilization, such as acids, bases, buffers, co-solvents, surfactants, complexation agents, solubilizers or precipitation inhibitors.
The method of any one of Paragraphs 2-4, wherein the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, a comestibly or biologically acceptable salt thereof, is solubilized by converting the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, into one or more crystalline forms, amorphous forms, one or more alcohol solvate forms, one or more hydrate forms, or mixtures thereof.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 1 , or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 2, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 3, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 4, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 5, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-5, wherein an effective amount of Compound 6, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is added.
The method of any one of Paragraphs 1-11, wherein the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency
sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
The method of Paragraph 12, wherein the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
The method of Paragraph 12, wherein the caloric sweetener is high fructose corn or starch syrup.
The method of Paragraph 12, wherein the caloric sweetener is sucrose. The method of Paragraph 12, wherein the sugar alcohol is a polyol selected from erythritol, sorbitol, mannitol and xylitol.
The method of Paragraph 12, wherein the artificial high-potency sweetener is sucralose or a salt thereof, acesulfame potassium or anther salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
The method of Paragraph 12, wherein the natural high-potency sweetener is a steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, a mogroside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture thereof.
The method of Paragraph 12, wherein the rare sugar is a D-psicose, D- turanose, D-allose, D-tagatose, D-sorbose, L-fructose, L-glucose, D- sorbose, L-fructose, L-talose, L-ribose, L-arabinose or a mixture thereof.
The method of any one of Paragraphs 1-19, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 1 ppm- 100 ppm.
The method of Paragraph 20, wherein said compound of Formula (I) or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 1 ppm-60 ppm.
The method of Paragraph 20, wherein said compound of Formula (I) or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 1 ppm-50 ppm or about 5 ppm-50 ppm.
The method of any one of Paragraphs 1-19, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 30 ppm-3,000 ppm.
The method of any one of Paragraphs 1-19, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm- 1,000 ppm.
The method of any one of Paragraphs 1-19, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm-300 ppm.
The method of any one of Paragraphs 1-19, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 ppm.
The method of any one of Paragraphs 1-26, wherein the edible composition is at a pH of about 2.0 to about 8.5.
The method of Paragraph 27, wherein the edible composition is at a pH of about 2.0 to about 4.0 or about 6.0 to about 8.0.
The method of Paragraph 28, wherein the edible composition is at a pH of about 3.0 or about 7.0.
The method of any one of Paragraphs 1-29, wherein the perception of sweetness intensity of said sweetener is enhanced by about 5-50% in an edible composition at a pH of about 6.5-7.5.
The method of any one of Paragraphs 1-28, wherein the perception of sweetness intensity of said sweetener is enhanced by about 5-50% in an edible composition at a pH of about 2.5-3.5.
The method of any one of Paragraphs 1-29, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-100%.
The method of Paragraph 32, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-60%.
The method of Paragraph 33, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-40%.
The method of Paragraph 34, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-35%.
The method of Paragraph 35, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-25%.
The method of any one of Paragraphs 1-36, wherein the edible composition is a beverage.
The method of Paragraph 37, wherein the beverage is a non-alcoholic beverage.
The method of any one of Paragraphs 1-38, wherein the edible composition further comprises one or more antioxidants, vitamins, glucosamine, dietary fibers, hydration agents, probiotics, prebiotics, phytosterols, omega-3 oils, fatty acids, saponins, natural or synthetic preservatives, minerals, weight management agents, osteoporosis management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, or phytosterols.
The method of any one of Paragraphs 1-39, wherein said edible composition further comprises one or more sweet taste improving additives.
The method of Paragraph 40, wherein said one of more sweet taste improving additives is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
The method of Paragraph 41 , wherein the sweet taste improving additive is a sweet flavor.
The method of Paragraph 41 , wherein the sweet taste improving additive is a polyol.
The method of Paragraph 43, wherein the polyol is erythritol.
The method of Paragraph 44, wherein the ratio of erythritol to the compound of Formula (I), any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a combination thereof, or a comestibly or
biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about 1 : 1 to about 800: 1 by weight.
The method of Paragraph 45, wherein the ratio of erythritol to the compound of Formula (I), any one of Compounds 1-6, or a combination thereof, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about (30-200): 1 or about (50-100): 1 by weight.
The method of Paragraph 41 , wherein the sweet taste improving additive is an amino acid.
The method of Paragraph 47, wherein the amino acid is glycine, alanine, lysine, glutamic acid, taurine, serine or proline.
The method of Paragraph 47 or 48, wherein the amino acid is present in a concentration of about 10 ppm to about 25,000 ppm.
The method of Paragraph 49, wherein the amino acid is present in a concentration of about 100 to about 5,000 ppm.
The method of Paragraph 41 , wherein said sweet taste improving additive is a salt.
The method of Paragraph 51 , wherein said salt is NaCl, KC1 or MgCb. The method of any one of Paragraphs 1-52, wherein the perception of sweetness intensity of said sweetener is enhanced, as measured in an in- vitro assay for a sweet responsive assay.
The method of any one of Paragraphs 1-53, wherein the perception of sweetness intensity of said sweetener is enhanced, as measured in an in- vivo assay for a sweet responsive assay.
The method of any one of Paragraphs 1-54, wherein the compound of Formula (I), or any one of Compounds 1-6, or natural extracts containing the compound of Formula (I), or any one of Compounds 1-3, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, are used to decrease the off-taste in an edible composition.
The method of Paragraph 55, wherein the off-taste is bitter, metallic or astringent.
A composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener.
The composition of Paragraph 57 wherein the compound of Formula (I), or any one of Compounds 1-3, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in one or more natural extracts.
The composition of Paragraph 57 or 58, wherein the composition further comprises a sweetener.
The composition of Paragraph 57-59, wherein the composition further comprises a solubilizing agent.
The composition of any one of Paragraphs 57-60, wherein the sweetener is a caloric sweetener, an artificial sweetener, a natural high- potency sweetener, or combinations thereof.
The composition of Paragraph 61, wherein the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
The composition of Paragraph 62 wherein the caloric sweetener is high fructose corn or starch syrup.
The composition of Paragraph 62 wherein the caloric sweetener is sucrose.
The composition of Paragraph 61, wherein the caloric sweetener is a polyol selected from erythritol, sorbitol, mannitol and xylitol.
The composition of Paragraph 61, wherein the artificial sweetener is sucralose, acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
67. The composition of Paragraph 61 , wherein the natural high-potency sweetener is steviol glycoside, rebaudioside A, rebaudioside B,
rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, Rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture thereof.
68. The composition of any one of Paragraphs 57-67, wherein said
composition comprises Compound 1 , or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
69. The composition of any one of Paragraphs 57-67 wherein said
composition comprises Compound 2, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
70. The composition of any one of Paragraphs 57-67, wherein said
composition comprises Compound 3, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
71. The composition of any one of Paragraphs 57-67, wherein said
composition comprises Compound 4, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
72. The composition of any one of Paragraphs 57-67, wherein said
composition comprises Compound 5, or a comestibly or biologically
acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
73. The composition of any one of Paragraphs 57-67, wherein said
composition comprises Compound 6, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
74. The composition of any one of Paragraphs 57-73, wherein said
compound of Formula (I), any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 0.1 ppm-100 ppm.
75. The composition of Paragraph 74, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 5 ppm-60 ppm.
76. The composition of Paragraph 75, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 10 ppm-50 ppm.
77. The composition of any one of Paragraphs 57-73, wherein said
compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 30 ppm-3,000 ppm.
78. The composition of Paragraph 77, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a
comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm- 1,000 ppm.
79. The composition of Paragraph 78, wherein said compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivatives thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 100 ppm-300 ppm.
80. The composition of any one of Paragraphs 57-74, wherein said
compound of Formula (I), or any one of Compounds 1-6, or a
combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in the edible composition at a concentration of about 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 ppm.
81. The composition of any one of Paragraphs 57-80, wherein the edible composition is at a pH of about 2.0 to about 8.5.
82. The composition of Paragraph 81, wherein the edible composition is at a pH of about 2.0 to about 4.0, about 3.0 to about 7.0, or about 6.0 to about 8.0.
83. The composition of Paragraph 82, wherein the edible composition is at a pH of about 3.0 or about 7.0.
84. The composition of any one of Paragraphs 57-83, wherein the
perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-100%.
85. The composition of Paragraph 84, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-60%.
86. The composition of Paragraph 85, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 5-50%.
87. The composition of Paragraph 85, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-40%.
88. The composition of Paragraph 85, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-35%.
89. The composition of Paragraph 85, wherein the perception of sweetness intensity of said sweetener in the edible composition is enhanced by about 10-25%.
90. The composition of any one of Paragraphs 57-86, wherein the
perception of sweetness intensity of said sweetener is enhanced by about 5- 50% in an edible composition at a pH of about 6.5-7.5.
91. The composition of any one of Paragraphs 57-82, wherein the
perception of sweetness intensity of said sweetener is enhanced by about 5- 40% in an edible composition at a pH of about 2.5-3.5.
92. The composition of any one of Paragraphs 57-91, wherein the edible composition is a beverage.
93. The composition of Paragraph 92, wherein the beverage is a nonalcoholic beverage.
94. The composition of any one of Paragraphs 57-93, wherein the edible composition further comprises one or more antioxidants, vitamins, glucosamine, fibers, hydration agents, probiotics, prebiotics, phytosterols, omega-3 oils, fatty acids, saponins, natural or synthetic preservatives, minerals, weight management agents, osteoporosis management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, or phytosterols.
95. The composition of any one of Paragraphs 57-94, wherein said edible composition further comprises one or more sweet taste improving additives.
96. The composition of Paragraph 95, wherein said sweet taste improving additive is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
97. The composition of Paragraph 96, wherein the sweet taste improving additive is a polyol.
98. The composition of Paragraph 96, wherein the polyol is erythritol.
99. The composition of Paragraph 96, wherein the ratio of erythritol to the compound of Formula (I), or any one of Compounds 1-6, a or combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about 1 : 1 to about 800: 1 by weight.
100. The composition of Paragraph 96, wherein the ratio of erythritol to the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is about (30-200): 1 or about (50-100): 1 by weight.
101. The composition of Paragraph 96, wherein the sweet taste improving additive is an amino acid.
102. The composition of Paragraph 101, wherein the amino acid is glycine, alanine, taurine, serine or proline.
103. The composition of Paragraph 101 or 102, wherein the amino acid is present in a concentration of about 10 ppm to about 25,000 ppm.
104. The composition of Paragraph 101 or 103, wherein the amino acid is present in a concentration of about 100 ppm to about 1000 ppm.
105. The composition of Paragraph 95, wherein said sweet taste improving additive is a salt.
106. The composition of Paragraph 105, wherein said salt is NaCl, KC1 or MgCl2.
107. A method of preparing an edible composition comprising:
(a) providing a comestibly acceptable carrier; and
(b) adding to said comestibly acceptable carrier a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
108. The method of Paragraph 107, wherein the comestibly acceptable carrier comprises a sweetener.
109. The method of Paragraph 107 or 108, wherein the comestibly
acceptable carrier further comprises a solubilizing agent.
110. The method of any one of Paragraphs 107-108, wherein the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
111. The method of Paragraph 110, wherein the caloric sweetener is a
carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose.
112. The method of Paragraph 110, wherein the caloric sweetener is a polyol selected from erythritol, sorbitol, mannitol and xylitol.
113. The method of Paragraph 110, wherein the artificial sweetener is
sucralose or a salt thereof, acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof.
114. The method of Paragraph 110, wherein the natural high-potency
sweetener is steviol glycoside, rebaudioside A, rebaudioside B,
rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture thereof.
115. The method of any one of Paragraphs 107- 114, wherein the method further comprises adding a solubilizing agent.
116. The composition of Paragraph 92 wherein said composition is a
beverage selected from the group consisting of a non-carbonated beverage, carbonated beverage, cola, root beer, fruit flavored beverage, citrus- flavored beverage, fruit juice, fruit-containing beverage, vegetable juice, vegetable containing beverage, tea, coffee, dairy beverage, sports drinks, energy drinks, enhanced and flavored water.
117. The composition of Paragraph 57, wherein the composition is used in food, beverage products, pharmaceutical compositions, nutritional products, functional products, a dietary supplement, over-the-counter medications, or oral care products.
118. A tabletop sweetener composition comprising a sweetener and a sweet taste modulator according to Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
119. The tabletop sweetener composition of Paragraph 118, further
comprising at least one bulking agent, additive, anti-caking agent, functional ingredient or a combination thereof.
120. The tabletop sweetener composition of Paragraph 118, wherein the tabletop sweetener composition is in the form of a liquid.
121. The composition of Paragraph 117, wherein the food or beverage
product is selected from the group consisting of soup, powdered soft drinks, bakery products, chewing gums, confections, cereals, edible gels, jams and jellys, spreads, ketchup, dairy products, frozen dairy products,
gelatins/puddings, and ice-creams.
122. A method of preparing a complex comprising:
(i) heating a mixture comprising solvent, Compound 1, 2, 3, 4, 5, or 6, and at least one maltodextrin or cyclodextrin;
(ii) cooling the mixture; and
(iii) removing the solvent from the mixture to provide a Compound 1, 2, 3, 4, 5, or 6 complex.
123. The method of Paragraph 122, wherein the Compound 1, 2, 3, 4, 5, or 6, and the maltodextrin or cyclodextrin are in a weight ratio from about 1 : 1 to about 1 :20.
124. The method of Paragraph 122, wherein the at least one cyclodextrin is selected from the group consisting of a-cyclodextrin, β-cyclodextrin, γ- cyclodextrin, and derivatives thereof.
125. A delivery system selected from the group consisting of a co- crystallized flavor composition with a sugar or a polyol, an agglomerated flavor composition, a compacted flavor composition, a dried flavor composition, a particle flavor composition, a spheronized flavor
composition, a granular flavor composition or a liquid flavor composition, wherein the flavor composition comprises a compound of Formula (I), or any one of Compounds 1-6 or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
126. A method of reducing the bitter taste of a bitter tastant in an edible
composition, wherein said method comprises adding an effective amount of a compound of Formula (I) or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, to said edible composition, such that the perception of bitter taste of said bitter tastant is reduced.
127. A composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of reducing the bitter taste of a bitter tastant.
128. A composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or
biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener and reducing the bitter taste of a bitter tastant.
129. The composition of Paragraph 128, wherein the composition is a
beverage.
Brief Description of the Drawings
[0010] Figure 1 depicts descriptive analysis assessment of 7 taste attributes for Compound 2 in a lemon-lime matrix sweetened with high fructose corn syrup solution at pH 7. Compound 2 is compared in spider plot format to a control sweetener solution. For Compound 2, in addition to significant increase in perceived sweetness (indicated by ** on the attribute descriptor), other attributes including astringent, licorice and bitter are observed to be significant, for high fructose corn syrup.
[0011] Figure 2 depicts descriptive analysis assessment of 7 taste attributes for Compound 5 in a lemon- lime matrix sweetened with high fructose corn syrup solution at pH 7. Compound 5 is compared in spider plot format to a control sweetener solution. For Compound 5, in addition to significant increase in perceived sweetness (indicated by ** on the attribute descriptor), other attributes including astringent, licorice and bitter are observed to be significant, for high fructose corn syrup.
Detailed Description of the Invention
[0012] In order that the invention described herein may be fully understood, the following detailed description is set forth.
[0013] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as those commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. The materials, methods and examples are illustrative only, and are not intended to be limiting. All publications, patents and other documents mentioned herein are incorporated by reference in their entirety.
[0014] Throughout this specification, the word "comprise" or variations such as "comprises" or "comprising" will be understood to imply the inclusion of a stated integer or groups of integers but not the exclusion of any other integer or group of integers.
[0015] The term "aliphatic" refers to straight chain or branched hydrocarbons that are completely saturated or that contain one or more units of unsaturation. For example, aliphatic groups include substituted or unsubstituted linear or branched alkyl, alkenyl and alkynyl groups. Unless indicated otherwise, the term "aliphatic" encompasses both substituted and unsubstituted hydrocarbons.
[0016] The term "alkoxy" refers to O-alkyl substituent, wherein the alkyl portion may be optionally substituted. Examples of alkoxy substituents include, but are not limited to, methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy. Also explicitly included within the scope of the term "alkoxy" are O-alkenyl or
O-alkynyl groups. In all cases, the alkyl, alkene and alkyne portions may be optionally substituted.
[0017] The term "alkyl" refers to both straight and branched saturated chains containing, for example, 1-3, 1-6, 1-9, or 1-12 carbon atoms. An alkyl group may be optionally substituted.
[0018] The term "alkenyl" refers to both straight and branched saturated chains containing, for example, 2-3, 2-6, 2-9, or 2-12 carbon atoms, and at least one carbon-carbon double bond. An alkenyl group may be optionally substituted.
[0019] The term "alkynyl" refers to both straight and branched saturated chains containing, for example, 2-3, 2-6, 2-9, or 2-12 carbon atoms, and at least one carbon-carbon triple bond. An alkynyl group may be optionally substituted.
[0020] The term "bitter" or "bitter taste" as used herein refers to the perception or gustatory sensation resulting following the detection of a bitter tastant. The following flavor attributes may contribute to bitter taste: astringent, bitter- astringent, metallic, bitter-metallic, as well as off-tastes aftertastes and undesirable tastes including but not limited to freezer-burn and card-board taste or a combination of these. It is noted that, in the art, the term "off-taste" is often synonymous with "bitter taste."
[0021] The term "bitter tastant" refers to a compound that activates or that can be detected by a bitter taste receptor and/or confers the perception of a bitter taste in a subject. A "bitter tastant" also refers to a multiplicity of compounds that combine to activate or be detected by a bitter taste receptor and/or confer the perception of a bitter taste in a subject. Those of skill in the art can readily identify and understand what is meant by a bitter tastant. Bitter tastants may include substances which also possess or primarily possess a sweet taste. Examples of such substances include steviol glycosides and acesulfame potassium.
[0022] The term "combination" refers to a compound of Formula (I), or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, in combination with one or more compounds of Formula (I), or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, or one of Compounds 1-6, or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof, in combination with one or more of Compounds 1-6, or a comestibly or biologically acceptable derivative thereof, or biologically acceptable salt thereof.
[0023] The term "diet" collectively refers to the food products and/or beverages consumed by a subject. A subject's "diet" also includes any consumer products or pharmaceutical compositions the subject ingests.
[0024] The term "flavor modifier" refers to a compound or a mixture of compounds that, when added to an edible composition, such as a food product, changes the individual characteristics of a food flavor (odor and/or taste). Flavor modification effects can include increasing, decreasing, masking, eliminating, reducing, enhancing or changing the perception of relevant sensorial characteristics of flavor in the edible composition. The ability of flavor modifiers to modify flavor may be independent of their aromatic or taste characteristics.
[0025] The term "pharmaceutically active ingredient" refers to a compound in a pharmaceutical composition which is biologically active.
[0026] The term "replace" or "replacing" refers to substituting one compound for another compound in or in the preparation of, for example, an edible composition, such as food product. It includes complete and partial replacements or
substitutions.
[0027] An aliphatic group may contain one or more substituents. Examples of suitable substituents on a saturated or unsaturated carbon of an aliphatic group include, but are not limited to, halogen, -CF3, -R', -OR', -OH, -SH, -SR', protected -OH (such as acyloxy), -N02, -CN, -NH2, -NHR', -N(R')2, -NHCOR',
-NHCONH2, -NHCONHR', -NHCON(R')2, -NRCOR', -NHC02H, -NHC02R', -C02R', -C02H, -COR', -CONH2, -CONHR', -CON(R')2, -S(0)2H, -S(0)2R', -S(0)3H, -S(0)3R', -S(0)2NH2' -S(0)H, -S(0)R', -S(0)2NHR', -S(0)2N(R')2, -NH S(0)2H, or -NHS(0)2R', =0, =S, = NHR', =NN(R')2, =N-OR', = NHCOR', = NHC02R', = NHS02R', =N-CN, or =NR', wherein R' is selected from H, aliphatic, carbocyclyl, heterocyclyl, aryl, aralkyl, heteroaryl, or heteroaralkyl and each R' is optionally substituted with one or more halogen, nitro, cyano, amino, -NH-(unsubstituted aliphatic), -N-(unsubstituted aliphatic)2, carboxy, carbamoyl, hydroxy, -O -(unsubstituted aliphatic), -SH, -S-(unsubstituted aliphatic), CF3, -S(0)2NH2' unsubstituted aliphatic, unsubstituted carbocyclyl, unsubstituted heterocyclyl, unsubstituted aryl, unsubstituted aralkyl, unsubstituted heteroaryl, or unsubstituted heteroaralkyl. Guided by this specification, the selection of suitable substituents is within the knowledge of one skilled in the art.
[0028] As defined herein, the compounds of the invention are intended to include all stereochemical forms of the compound, including geometric isomers (i.e., E, Z) and optical isomers (i.e., R, S, (+), (-)). Single stereochemical isomers as well as enantiomeric mixtures of the present compounds are within the scope of the invention and are specifically contemplated. Unless otherwise stated, formulas depicted herein are also meant to include compounds which differ only in the presence of one or more isotopically enriched atoms. For example, compounds having the present formulas except for the replacement of a hydrogen by a deuterium or tritium, or the replacement of a carbon by a 13C- or 14C-enriched carbon are within the scope of this invention.
[0029] One aspect of present invention provides edible compositions comprising a sweet taste modulator of the present invention, including food products, consumer products, and pharmaceutical compositions comprising said compounds, and methods of preparing a such compositions. The present invention also provides methods of reducing the amount of a sweetener in an edible composition,
methods for reducing caloric intake, methods of enhancing or potentiating sweet taste of a sweetener, methods of blocking a bitter taste, methods of enhancing or potentiating the activity of a sweet taste receptor, and methods of synthesizing sweet taste modulators. The present invention also includes reducing the amount of a sweetener in an edible composition or diet by replacing an amount of sugar or the other sweetener with an amount of one or more compounds or one or more extracts containing compounds of the present invention.
Sweet Taste Modulators
[0030] According to one aspect, the invention provides compounds for modulating sweet taste (e.g., enhancing or potentiating the sweet taste of a sweetener).
[0031] The term "sweet flavor" or "sweet taste" refers to the taste elicited by, for example, sugars. Non-limiting examples of compositions eliciting a sweet flavor include glucose, sucrose, fructose, saccharin, cyclamate, aspartame, acesulfame potassium, sucralose, alitame, and neotame. The amount of sweet flavor or the sweetness of a composition can be determined by, e.g., taste testing.
[0032] As used herein, the term "sweet taste modulators" refers to flavor substances with taste modifying properties. Sweetness enhancers are understood to be a type of "sweet taste modulator" where perception of sweetness is increased in a manner not solely attributable to the inherent sweetness of the sweetness enhancer alone. The term "sweetness enhancer" is understood to include at least compositions capable of enhancing or intensifying the perception of sweet taste of sweetener compositions or sweetened compositions. The term "sweetness enhancer" is synonymous with the terms "sweet taste potentiator," "sweetness potentiator," "sweetness amplifier," and "sweetness intensifier." Generally, the sweet taste modulating compounds provided herein (which serve to enhance the perception of sweetness) may enhance or potentiate the sweet taste of sweeteners without providing any noticeable sweet taste by themselves at acceptable use levels; however, the sweetness enhancers may themselves provide sweet taste at concentrations above a sweetness threshold level. It is noted that the sweetness enhancers may be effective as enhancers even if present at concentrations above
their sweetness threshold level. In such embodiments, there is major contribution of the sweetness enhancer to the sweetness of the composition via enhancement of the inherently sweet taste attributed to a sweetener, where the sweetener is also present in the composition. As used herein, the term "sweetness threshold level" is understood to include at least the concentration at which the sweetness is perceptible as sweet in the edible compositions. The sweetness threshold level varies for different edible compositions (e.g., in different matrices), and may be varied with respect to the individual perceiving the sweetness.
[0033] In all embodiments of the present invention, the sweet taste modulator(s) of the present invention is a different compound from any sweetener. Accordingly, although an ingredient may be characterized as both a sweet taste modulator and a sweetener, in all embodiments of the disclosure, the sweet taste modulator and the sweetener are different ingredients, i.e., the sweet taste modulator and the sweetener are not the same compound.
[0034] Each embodiment of the invention described herein may be taken alone or in combination with one or more other embodiments of the invention.
[0035] The present invention provides flavonoid compounds for modulating or potentiating the sweet taste of a sweetener. The flavonoid compounds of this invention are capable of modulating or potentiating the sweet taste of a sweetener. The flavonoid compound may have a molecular weight less than about 1000, 500, or 300 Daltons. The flavonoid compound may have a molecular weight less than 1000, 500, or 300 Daltons. In some embodiments, the flavonoid is a flavan. In certain embodiments, the flavonoid compound is a compound of Formula (I):
Formula (I);
or a comestibly or biologically acceptable salt or derivative thereof, or an enantiomer thereof,
wherein, as valence and stability permit:
Ri to R6 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H.
In some embodiments of Formula (I),
Ri and R2 are each independently OH or OMe; and
R3-R6 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H.
In some embodiments of Formula (I),
Ri,R2, and R5 are each independently OH or OMe; and
R3,R4, and R6 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H.
In some embodiments of Formula (I),
Ri and R2 are each independently OH or OMe;
R3, R4, and R6 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H; and
R5 is OH.
In some embodiments of Formula (I),
Ri and R2 are each independently OH or OMe
R3 is H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy;
R5 is OH; and
R4 and R6 are Me.
In some embodiments of Formula (I) the Compound is
(S)-2-(3-hydroxy-4-methoxyphenyl)-8-methylchroman-7-ol
Compound 3
(R)-2-(3-hydroxy-4-methoxyphenyl)-8-methylchroman-7-ol
2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-7-ol
Compound 5 (-)-2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-7-ol
Compound 6 (+)-2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-7-ol or a comestibly or biologically acceptable salt or derivative thereof.
[0036] In according to Formula (I) has the
[0038] The terms "comestibly or biologically acceptable derivative" or
"comestibly or biologically acceptable salt" refer to any comestibly or biologically acceptable derivative or salt of a sweet taste modulator of the present invention, which, upon ingestion, is capable of providing (directly or indirectly) a sweet taste modulator or bitter blocker of the present invention, or a polymorph, metabolite, residue or portion thereof, characterized by the ability to enhance the perception of a sweet taste attributed to a sweetener or block the perception of bitter taste attributed to a bitter tastant. A "comestible product" is a product suitable for oral use, such as eating or drinking. Therefore, a comestibly acceptable compound is an edible compound.
[0039] If a comestibly or biologically acceptable salt of a compound of the present invention is used, such salt is preferably derived from inorganic or organic bases. Salts derived from appropriate bases include alkali metal (e.g., sodium and potassium), alkaline earth metal (e.g., magnesium), ammonium and N+(Ci_4 alkyl)4 salts. In some embodiments, the compounds of the present invention are present as sodium or potassium salts.
[0040] Sweet taste modulators synergize with sweeteners to enhance or potentiate the perception of sweet taste due to the sweetener. When sweet taste modulators are used above their sweetness threshold level, they synergize with sweeteners to enhance or potentiate the perception of sweet taste due to the sweetener. In such cases, the overall sweetness of a composition comprising a sweet taste modulator and a sweet compound is higher than the mere addition of inherent sweetness due to each of the sweet taste modulators and a sweet compound. For example, if a sweet taste modulator with a sweetness equivalent to 1% sucrose is added to a 5% sucrose solution, the perceived sweetness of the resulting composition would be greater than that of a 6% sucrose solution -with any perceived sweetness greater than a 6% sucrose solution being attributable to the sweetness enhancing properties of the sweet taste modulators. Such an increase in perceived sweetness may be referred to as synergistic, not additive.
[0041] The terms "sweetness threshold," and "sweetness recognition threshold," are used interchangeably, herein, and refer to the level at which the lowest known concentration of a certain sweet compound is perceivable as sweet by the human sense of taste. This sweetness recognition threshold also encompasses the sweetness detection threshold, referring to the level at which the lowest known concentration of a certain sweet compound is perceivable by the human sense of taste. The sweetness threshold can vary from person to person. The sweetness threshold can also vary from matrix to matrix (e.g. , different sweetness thresholds in water and a carbonated beverage). For example, a sweetness threshold level for sucrose in water could be around 1% or 1.5%. In some embodiments, the sweetness enhancers of Formula (I), any one of Compounds 1-6, or combinations thereof are used at concentrations below their sweetness threshold.
[0042] The terms "effective concentration" and "effective amount" are used interchangeably herein and refer to an amount sufficient to produce a desired property or result. For example, an effective amount of a sweet taste modulator of the present invention is an amount capable of modulating (e.g., enhancing) the perception of sweet taste associated with a sweetener. The term "effective amount" of a sweet taste modulator of the invention also refers to an amount which, when added to an edible composition, enhances the sweet taste of, e.g. , a sugar, thereby allowing for the maintenance of the perception of a desired sweet flavor of the edible composition. The term "effective amount" also refers to the amount of a sweet taste modulator of the present invention capable of modulating (e.g. , enhancing) the perception of a sweet taste associated with either a sweetener in a food product or an inherently sweet food product. The sweet taste modulators of the present invention may impart a sweetness or taste at certain concentrations and no perceptible sweetness or taste at other concentrations. For example, the sweet taste modulator may be present in an amount such that the taste, such as sweetness, of the sweet taste modulator is imperceptible. The compositions discussed herein include an effective amount of the sweet taste modulator. An effective amount of the sweet taste modulator includes an amount sufficient to enhance the perception of sweetness intensity of a sweetener.
[0043] In general, a sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration between about 0.001 ppm and 1000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration between about 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 ppm; 10 to 20 ppm; 10 to 25 ppm; 10 to 30 ppm; 1 to 50 ppm; 5 to 50 ppm; 10 to 50 ppm; 30 to 50 ppm; 1 to 60 ppm; 100 to 300 ppm; 100 to 1000 ppm; or 30 to 3000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a
sweetener when the compound is present at a concentration between about 50 to 100 ppm; 100 to 200 ppm; 200 to 300 ppm; 300 to 400 ppm; 400 to 500 ppm; 500 to 600 ppm; 600 to 700 ppm; 700 to 800 ppm; 800 to 900 ppm; 900 to 1000 ppm; 1000 to 1 100 ppm; 1 100 to 1200 ppm; 1200 to 1300 ppm; 1300 to 1400 ppm; 1400 to 1500 ppm; 1500 to 1600 ppm; 1600 to 1700 ppm; 1700 to 1800 ppm; 1800 to 1900 ppm; 1900 to 2000 ppm; 2000 to 2100 ppm; 2100 to 2200 ppm; 2200 to 2300 ppm; 2300 to 2400 ppm; 2400 to 2500 ppm; 2500 to 2600 ppm; 2600 to 2700 ppm; 2700 to 2800 ppm; 2800 to 2900 ppm, or 2900 to 3000 ppm. In yet other embodiments, the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of about 0.1 to 30 ppm; 1 to 30 ppm; or 1 to 50 ppm. In additional embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of about 0.1 to 5 ppm; 0.1 to 4 ppm; 0.1 to 3 ppm; 0.1 to 2 ppm; 0.1 to 1 ppm; 0.5 to 5 ppm; 0.5 to 4 ppm; 0.5 to 3 ppm; 0.5 to 2 ppm; 0.5 to 1.5 ppm; 0.5 to 1 ppm; 5 to 15 ppm; 6 to 14 ppm; 7 to 13 ppm; 8 to 12 ppm; 9 to 1 1 ppm; 25 to 35 ppm; 26 to 34 ppm; 27 to 33 ppm; 28 to 32 ppm; or 29 to 31 ppm.
[0044] In some embodiments, a sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration between 0.001 ppm and 1000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration between 0.005 to 500 ppm; 0.01 to 100 ppm; 0.05 to 50 ppm; 0.1 to 5 ppm; 0.1 to 10 ppm; 0.1 to 100 ppm; 1 to 10 ppm; 1 to 30 ppm; 1 to 50 ppm; 10 to 20 ppm; 10 to 25 ppm; 10 to 30 ppm; 1 to 50 ppm; 5 to 50 ppm; 10 to 50 ppm; 30 to 50 ppm; 1 to 60 ppm; 100 to 300 ppm; 100 to 1000 ppm; or 30 to 3000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration between 50 to 100
ppm; 100 to 200 ppm; 200 to 300 ppm; 300 to 400 ppm; 400 to 500 ppm; 500 to 600 ppm; 600 to 700 ppm; 700 to 800 ppm; 800 to 900 ppm; 900 to 1000 ppm; 1000 to 1 100 ppm; 1 100 to 1200 ppm; 1200 to 1300 ppm; 1300 to 1400 ppm; 1400 to 1500 ppm; 1500 to 1600 ppm; 1600 to 1700 ppm; 1700 to 1800 ppm; 1800 to 1900 ppm; 1900 to 2000 ppm; 2000 to 2100 ppm; 2100 to 2200 ppm; 2200 to 2300 ppm; 2300 to 2400 ppm; 2400 to 2500 ppm; 2500 to 2600 ppm; 2600 to 2700 ppm; 2700 to 2800 ppm; 2800 to 2900 ppm, or 2900 to 3000 ppm. In yet other embodiments, the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration of 0.1 to 30 ppm; 1 to 30 ppm; or 1 to 50 ppm. In additional embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of 0.1 to 5 ppm; 0.1 to 4 ppm; 0.1 to 3 ppm; 0.1 to 2 ppm; 0.1 to 1 ppm; 0.5 to 5 ppm; 0.5 to 4 ppm; 0.5 to 3 ppm; 0.5 to 2 ppm; 0.5 to 1.5 ppm; 0.5 to 1 ppm; 5 to 15 ppm; 6 to 14 ppm; 7 to 13 ppm; 8 to 12 ppm; 9 to 1 1 ppm; 25 to 35 ppm; 26 to 34 ppm; 27 to 33 ppm; 28 to 32 ppm; or 29 to 31 ppm.
[0045] In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of about 0.1 ppm, about 0.5 ppm, about 1 ppm, about 2 ppm, about 3 ppm, about 4 ppm, about 5 ppm, about 6 ppm, about 7 ppm, about 8 ppm, about 9 ppm, about 10 ppm, about 1 1 ppm, about 12 ppm, about 13 ppm, about 14 ppm, about 15 ppm, about 16 ppm, about 17 ppm, about 18 ppm, about 19 ppm, about 20 ppm, about 21 ppm, about 22 ppm, about 23 ppm, about 24 ppm, about 25 ppm, about 26 ppm, about 27 ppm, about 28 ppm, about 29 ppm, about 30 ppm, about 31 ppm, about 32 ppm, about 33 ppm, about 34 ppm, about 35 ppm, about 36 ppm, about 37 ppm, about 38 ppm, about 39 ppm, about 40 ppm, about 41 ppm, about 42 ppm, about 43 ppm, about 44 ppm, about 45 ppm, about 46 ppm, about 47 ppm, about 48 ppm, about 49 ppm, about 50 ppm, about 51 ppm, about 52 ppm, about 53 ppm, about 54 ppm, about 55 ppm, about 56 ppm, about 57 ppm, about 58 ppm, about 59 ppm, about 60 ppm, about 61 ppm, about 62 ppm,
about 63 ppm, about 64 ppm, about 65 ppm, about 66 ppm, about 67 ppm, about 68 ppm, about 69 ppm, about 70 ppm, about 71 ppm, about 72 ppm, about 73 ppm, about 74 ppm, about 75 ppm, about 76 ppm, about 77 ppm, about 78 ppm, about 79 ppm, about 80 ppm, about 81 ppm, about 82 ppm, about 83 ppm, about 84 ppm, about 85 ppm, about 86 ppm, about 87 ppm, about 88 ppm, about 89 ppm, about 90 ppm, about 91 ppm, about 92 ppm, about 93 ppm, about 94 ppm, about 95 ppm, about 96 ppm, about 97 ppm, about 98 ppm, about 99 ppm, about 100 ppm, about
101 ppm, about 102 ppm, about 103 ppm, about 104 ppm, about 105 ppm, about
106 ppm, about 107 ppm, about 108 ppm, about 109 ppm, about 1 10 ppm, about 1 1 1 ppm, about 1 12 ppm, about 1 13 ppm, about 1 14 ppm, about 1 15 ppm, about
1 16 ppm, about 1 17 ppm, about 1 18 ppm, about 1 19 ppm, about 120 ppm, about
121 ppm, about 122 ppm, about 123 ppm, about 124 ppm, about 125 ppm, about
126 ppm, about 127 ppm, about 128 ppm, about 129 ppm, about 130 ppm, about
131 ppm, about 132 ppm, about 133 ppm, about 134 ppm, about 135 ppm, about 136 ppm, about 137 ppm, about 138 ppm, about 139 ppm, about 140 ppm, about
141 ppm, about 142 ppm, about 143 ppm, about 144 ppm, about 145 ppm, about
146 ppm, about 147 ppm, about 148 ppm, about 149 ppm, or about 150 ppm. In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of about 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 ppm. In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of about 100 ppm, about 200 ppm, about 300 ppm, about 400 ppm, about 500 ppm, about 600 ppm, about 700 ppm, about 800 ppm, about 900 ppm, about 1000 ppm, about 1 100 ppm, about 1200 ppm, about 1300 ppm, about 1400 ppm, about 1500 ppm, about 1600 ppm, about 1700 ppm, about 1800 ppm, about 1900 ppm, about 2000 ppm, about 2100 ppm, about 2200 ppm, about 2300 ppm, about 2400 ppm, about 2500 ppm, about 2600 ppm, about 2700 ppm, about 2800 ppm, about 2900 ppm, or about 3000 ppm. In some embodiments, the compound is present at a concentration of about 0.1 ppm. In some embodiments, the compound is present at
a concentration of about 0.5 ppm. In some embodiments, the compound is present at a concentration of about 1 ppm. In some embodiments, the compound is present at a concentration of about 2 ppm. In some embodiments, the compound is present at a concentration of about 3 ppm. In some embodiments, the compound is present at a concentration of about 4 ppm. In some embodiments, the compound is present at a concentration of about 5 ppm. In some embodiments, the compound is present at a concentration of about 6 ppm. In some embodiments, the compound is present at a concentration of about 7 ppm. In some embodiments, the compound is present at a concentration of about 8 ppm. In some embodiments, the compound is present at a concentration of about 9 ppm. In some embodiments, the compound is present at a concentration of about 10 ppm. In some embodiments, the compound is present at a concentration of about 11 ppm. In some embodiments, the compound is present at a concentration of about 12 ppm. In some embodiments, the compound is present at a concentration of about 13 ppm. In some embodiments, the compound is present at a concentration of about 14 ppm. In some
embodiments, the compound is present at a concentration of about 15 ppm. In some embodiments, the compound is present at a concentration of about 16 ppm. In some embodiments, the compound is present at a concentration of about 17 ppm. In some embodiments, the compound is present at a concentration of about 18 ppm. In some embodiments, the compound is present at a concentration of about 19 ppm. In some embodiments, the compound is present at a concentration of about 20 ppm. In some embodiments, the compound is present at a
concentration of about 21 ppm. In some embodiments, the compound is present at a concentration of about 22 ppm. In some embodiments, the compound is present at a concentration of about 23 ppm. In some embodiments, the compound is present at a concentration of about 24 ppm. In some embodiments, the compound is present at a concentration of about 25 ppm. In some embodiments, the compound is present at a concentration of about 26 ppm. In some embodiments, the compound is present at a concentration of about 27 ppm. In some
embodiments, the compound is present at a concentration of about 28 ppm. In some embodiments, the compound is present at a concentration of about 29 ppm. In some embodiments, the compound is present at a concentration of about 30
ppm. In some embodiments, the compound is present at a concentration of about 31 ppm. In some embodiments, the compound is present at a concentration of about 32 ppm. In some embodiments, the compound is present at a concentration of about 33 ppm. In some embodiments, the compound is present at a
concentration of about 34 ppm. In some embodiments, the compound is present at a concentration of about 35 ppm. In some embodiments, the compound is present at a concentration of about 36 ppm. In some embodiments, the compound is present at a concentration of about 37 ppm. In some embodiments, the compound is present at a concentration of about 38 ppm. In some embodiments, the compound is present at a concentration of about 39 ppm. In some embodiments, the compound is present at a concentration of about 40 ppm. In some
embodiments, the compound is present at a concentration of about 41 ppm. In some embodiments, the compound is present at a concentration of about 42 ppm. In some embodiments, the compound is present at a concentration of about 43 ppm. In some embodiments, the compound is present at a concentration of about 44 ppm. In some embodiments, the compound is present at a concentration of about 45 ppm. In some embodiments, the compound is present at a concentration of about 46 ppm. In some embodiments, the compound is present at a
concentration of about 47 ppm. In some embodiments, the compound is present at a concentration of about 48 ppm. In some embodiments, the compound is present at a concentration of about 49 ppm. In some embodiments, the compound is present at a concentration of about 50 ppm. In some embodiments, the compound is present at a concentration of about 51 ppm. In some embodiments, the compound is present at a concentration of about 52 ppm. In some embodiments, the compound is present at a concentration of about 53 ppm. In some
embodiments, the compound is present at a concentration of about 54 ppm. In some embodiments, the compound is present at a concentration of about 55 ppm. In some embodiments, the compound is present at a concentration of about 56 ppm. In some embodiments, the compound is present at a concentration of about 57 ppm. In some embodiments, the compound is present at a concentration of about 58 ppm. In some embodiments, the compound is present at a concentration of about 59 ppm. In some embodiments, the compound is present at a
concentration of about 60 ppm. In some embodiments, the compound is present at a concentration of about 61 ppm. In some embodiments, the compound is present at a concentration of about 62 ppm. In some embodiments, the compound is present at a concentration of about 63 ppm. In some embodiments, the compound is present at a concentration of about 64 ppm. In some embodiments, the compound is present at a concentration of about 65 ppm. In some embodiments, the compound is present at a concentration of about 66 ppm. In some
embodiments, the compound is present at a concentration of about 67 ppm. In some embodiments, the compound is present at a concentration of about 68 ppm. In some embodiments, the compound is present at a concentration of about 69 ppm. In some embodiments, the compound is present at a concentration of about 70 ppm. In some embodiments, the compound is present at a concentration of about 71 ppm. In some embodiments, the compound is present at a concentration of about 72 ppm. In some embodiments, the compound is present at a
concentration of about 73 ppm. In some embodiments, the compound is present at a concentration of about 74 ppm. In some embodiments, the compound is present at a concentration of about 75 ppm. In some embodiments, the compound is present at a concentration of about 76 ppm. In some embodiments, the compound is present at a concentration of about 77 ppm. In some embodiments, the compound is present at a concentration of about 78 ppm. In some embodiments, the compound is present at a concentration of about 79 ppm. In some
embodiments, the compound is present at a concentration of about 80 ppm. In some embodiments, the compound is present at a concentration of about 81 ppm. In some embodiments, the compound is present at a concentration of about 82 ppm. In some embodiments, the compound is present at a concentration of about 83 ppm. In some embodiments, the compound is present at a concentration of about 84 ppm. In some embodiments, the compound is present at a concentration of about 85 ppm. In some embodiments, the compound is present at a
concentration of about 86 ppm. In some embodiments, the compound is present at a concentration of about 87 ppm. In some embodiments, the compound is present at a concentration of about 88 ppm. In some embodiments, the compound is present at a concentration of about 89 ppm. In some embodiments, the compound
is present at a concentration of about 90 ppm. In some embodiments, the compound is present at a concentration of about 91 ppm. In some embodiments, the compound is present at a concentration of about 92 ppm. In some
embodiments, the compound is present at a concentration of about 93 ppm. In some embodiments, the compound is present at a concentration of about 94 ppm. In some embodiments, the compound is present at a concentration of about 95 ppm. In some embodiments, the compound is present at a concentration of about 96 ppm. In some embodiments, the compound is present at a concentration of about 97 ppm. In some embodiments, the compound is present at a concentration of about 98 ppm. In some embodiments, the compound is present at a
concentration of about 99 ppm. In some embodiments, the compound is present at a concentration of about 100 ppm. In some embodiments, the compound is present at a concentration of about 101 ppm. In some embodiments, the compound is present at a concentration of about 102 ppm. In some embodiments, the compound is present at a concentration of about 103 ppm. In some embodiments, the compound is present at a concentration of about 104 ppm. In some embodiments, the compound is present at a concentration of about 105 ppm. In some
embodiments, the compound is present at a concentration of about 106 ppm. In some embodiments, the compound is present at a concentration of about 107 ppm. In some embodiments, the compound is present at a concentration of about 108 ppm. In some embodiments, the compound is present at a concentration of about 109 ppm. In some embodiments, the compound is present at a concentration of about 110 ppm. In some embodiments, the compound is present at a concentration of about 111 ppm. In some embodiments, the compound is present at a
concentration of about 112 ppm. In some embodiments, the compound is present at a concentration of about 113 ppm. In some embodiments, the compound is present at a concentration of about 114 ppm. In some embodiments, the compound is present at a concentration of about 115 ppm. In some embodiments, the compound is present at a concentration of about 116 ppm. In some embodiments, the compound is present at a concentration of about 117 ppm. In some
embodiments, the compound is present at a concentration of about 118 ppm. In some embodiments, the compound is present at a concentration of about 119 ppm.
In some embodiments, the compound is present at a concentration of about 120 ppm. In some embodiments, the compound is present at a concentration of about 121 ppm. In some embodiments, the compound is present at a concentration of about 122 ppm. In some embodiments, the compound is present at a concentration of about 123 ppm. In some embodiments, the compound is present at a concentration of about 124 ppm. In some embodiments, the compound is present at a concentration of about 125 ppm. In some embodiments, the compound is present at a concentration of about 126 ppm. In some embodiments, the compound is present at a concentration of about 127 ppm. In some embodiments, the compound is present at a concentration of about 128 ppm. In some embodiments, the compound is present at a concentration of about 129 ppm. In some
embodiments, the compound is present at a concentration of about 130 ppm. In some embodiments, the compound is present at a concentration of about 131 ppm. In some embodiments, the compound is present at a concentration of about 132 ppm. In some embodiments, the compound is present at a concentration of about 133 ppm. In some embodiments, the compound is present at a concentration of about 134 ppm. In some embodiments, the compound is present at a concentration of about 135 ppm. In some embodiments, the compound is present at a concentration of about 136 ppm. In some embodiments, the compound is present at a concentration of about 137 ppm. In some embodiments, the compound is present at a concentration of about 138 ppm. In some embodiments, the compound is present at a concentration of about 139 ppm. In some embodiments, the compound is present at a concentration of about 140 ppm. In some embodiments, the compound is present at a concentration of about 141 ppm. In some
embodiments, the compound is present at a concentration of about 142 ppm. In some embodiments, the compound is present at a concentration of about 143 ppm. In some embodiments, the compound is present at a concentration of about 144 ppm. In some embodiments, the compound is present at a concentration of about 145 ppm. In some embodiments, the compound is present at a concentration of about 146 ppm. In some embodiments, the compound is present at a concentration of about 147 ppm. In some embodiments, the compound is present at a concentration of about 148 ppm. In some embodiments, the compound is present
at a concentration of about 149 ppm. In some embodiments, the compound is present at a concentration of about 150 ppm.
[0046] The sweet taste modulator of the present invention (e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may enhance the sweetness of a sweetener when the compound is present at a concentration of 0.1 ppm, 0.5 ppm, 1 ppm, 2 ppm, 3 ppm, 4 ppm, 5 ppm, 6 ppm, 7 ppm, 8 ppm, 9 ppm, 10 ppm, 1 1 ppm, 12 ppm, 13 ppm, 14 ppm, 15 ppm, 16 ppm, 17 ppm, 18 ppm, 19 ppm, 20 ppm, 21 ppm, 22 ppm, 23 ppm, 24 ppm, 25 ppm, 26 ppm, 27 ppm, 28 ppm, 29 ppm, 30 ppm, 31 ppm, 32 ppm, 33 ppm, 34 ppm, 35 ppm, 36 ppm, 37 ppm, 38 ppm, 39 ppm, 40 ppm, 41 ppm, 42 ppm, 43 ppm, 44 ppm, 45 ppm, 46 ppm, 47 ppm, 48 ppm, 49 ppm, or 50 ppm, 51 ppm, 52 ppm, 53 ppm, 54 ppm, 55 ppm, 56 ppm, 57 ppm, 58 ppm, 59 ppm, 60 ppm, 61 ppm, 62 ppm, 63 ppm, 64 ppm, 65 ppm, 66 ppm, 67 ppm, 68 ppm, 69 ppm, 70 ppm, 71 ppm, 72 ppm, 73 ppm, 74 ppm, 75 ppm, 76 ppm, 77 ppm, 78 ppm, 79 ppm, 80 ppm, 81 ppm, 82 ppm, 83 ppm, 84 ppm, 85 ppm, 86 ppm, 87 ppm, 88 ppm, 89 ppm, 90 ppm, 91 ppm, 92 ppm, 93 ppm, 94 ppm, 95 ppm, 96 ppm, 97 ppm, 98 ppm, 99 ppm, 100 ppm, 101 ppm, 102 ppm, 103 ppm, 104 ppm, 105 ppm, 106 ppm, 107 ppm, 108 ppm, 109 ppm, 1 10 ppm, 1 1 1 ppm, 1 12 ppm, 1 13 ppm, 1 14 ppm, 1 15 ppm, 1 16 ppm, 1 17 ppm, 1 18 ppm, 1 19 ppm, 120 ppm, 121 ppm, 122 ppm, 123 ppm, 124 ppm, 125 ppm, 126 ppm, 127 ppm, 128 ppm, 129 ppm, 130 ppm, 131 ppm, 132 ppm, 133 ppm, 134 ppm, 135 ppm, 136 ppm, 137 ppm, 138 ppm, 139 ppm, 140 ppm, 141 ppm, 142 ppm, 143 ppm, 144 ppm, 145 ppm, 146 ppm, 147 ppm, 148 ppm, 149 ppm, or 150 ppm. In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 ppm. In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of 100 ppm, 200 ppm, 300 ppm, 400 ppm, 500 ppm, 600 ppm, 700 ppm, 800 ppm, 900 ppm, 1000 ppm, 1 100 ppm, 1200 ppm, 1300 ppm, 1400 ppm, 1500 ppm, 1600 ppm, 1700 ppm, 1800 ppm, 1900 ppm, 2000
ppm, 2100 ppm, 2200 ppm, 2300 ppm, 2400 ppm, 2500 ppm, 2600 ppm, 2700 ppm, 2800 ppm, 2900 ppm, or 3000 ppm. In some embodiments, the compound present at a concentration of 0.1 ppm. In some embodiments, the compound is present at a concentration of 0.5 ppm. In some embodiments, the compound is present at a concentration of 1 ppm. In some embodiments, the compound is present at a concentration of 2 ppm. In some embodiments, the compound is present at a concentration of 3 ppm. In some embodiments, the compound is present at a concentration of 4 ppm. In some embodiments, the compound is present at a concentration of 5 ppm. In some embodiments, the compound is present at a concentration of 6 ppm. In some embodiments, the compound is present at a concentration of 7 ppm. In some embodiments, the compound is present at a concentration of 8 ppm. In some embodiments, the compound is present at a concentration of 9 ppm. In some embodiments, the compound is present at a concentration of 10 ppm. In some embodiments, the compound is present at a concentration of 11 ppm. In some embodiments, the compound is present at a concentration of 12 ppm. In some embodiments, the compound is present at a concentration of 13 ppm. In some embodiments, the compound is present at a concentration of 14 ppm. In some embodiments, the compound is present at a concentration of 15 ppm. In some embodiments, the compound is present at a concentration of 16 ppm. In some embodiments, the compound is present at a concentration of 17 ppm. In some embodiments, the compound is present at a concentration of 18 ppm. In some embodiments, the compound is present at a concentration of 19 ppm. In some embodiments, the compound is present at a concentration of 20 ppm. In some embodiments, the compound is present at a concentration of 21 ppm. In some embodiments, the compound is present at a concentration of 22 ppm. In some embodiments, the compound is present at a concentration of 23 ppm. In some embodiments, the compound is present at a concentration of 24 ppm. In some embodiments, the compound is present at a concentration of 25 ppm. In some embodiments, the compound is present at a concentration of 26 ppm. In some embodiments, the compound is present at a concentration of 27 ppm. In some embodiments, the compound is present at a concentration of 28 ppm. In some embodiments, the compound is
present at a concentration of 29 ppm. In some embodiments, the compound is present at a concentration of 30 ppm. In some embodiments, the compound is present at a concentration of 31 ppm. In some embodiments, the compound is present at a concentration of 32 ppm. In some embodiments, the compound is present at a concentration of 33 ppm. In some embodiments, the compound is present at a concentration of 34 ppm. In some embodiments, the compound is present at a concentration of 35 ppm. In some embodiments, the compound is present at a concentration of 36 ppm. In some embodiments, the compound is present at a concentration of 37 ppm. In some embodiments, the compound is present at a concentration of 38 ppm. In some embodiments, the compound is present at a concentration of 39 ppm. In some embodiments, the compound is present at a concentration of 40 ppm. In some embodiments, the compound is present at a concentration of 41 ppm. In some embodiments, the compound is present at a concentration of 42 ppm. In some embodiments, the compound is present at a concentration of 43 ppm. In some embodiments, the compound is present at a concentration of 44 ppm. In some embodiments, the compound is present at a concentration of 45 ppm. In some embodiments, the compound is present at a concentration of 46 ppm. In some embodiments, the compound is present at a concentration of 47 ppm. In some embodiments, the compound is present at a concentration of 48 ppm. In some embodiments, the compound is present at a concentration of 49 ppm. In some embodiments, the compound is present at a concentration of 50 ppm. In some embodiments, the compound is present at a concentration of 51 ppm. In some embodiments, the compound is present at a concentration of 52 ppm. In some embodiments, the compound is present at a concentration of 53 ppm. In some embodiments, the compound is present at a concentration of 54 ppm. In some embodiments, the compound is present at a concentration of 55 ppm. In some embodiments, the compound is present at a concentration of 56 ppm. In some embodiments, the compound is present at a concentration of 57 ppm. In some embodiments, the compound is present at a concentration of 58 ppm. In some embodiments, the compound is present at a concentration of 59 ppm. In some embodiments, the compound is present at a concentration of 60 ppm. In some embodiments, the compound is
present at a concentration of 61 ppm. In some embodiments, the compound is present at a concentration of 62 ppm. In some embodiments, the compound is present at a concentration of 63 ppm. In some embodiments, the compound is present at a concentration of 64 ppm. In some embodiments, the compound is present at a concentration of 65 ppm. In some embodiments, the compound is present at a concentration of 66 ppm. In some embodiments, the compound is present at a concentration of 67 ppm. In some embodiments, the compound is present at a concentration of 68 ppm. In some embodiments, the compound is present at a concentration of 69 ppm. In some embodiments, the compound is present at a concentration of 70 ppm. In some embodiments, the compound is present at a concentration of 71 ppm. In some embodiments, the compound is present at a concentration of 72 ppm. In some embodiments, the compound is present at a concentration of 73 ppm. In some embodiments, the compound is present at a concentration of 74 ppm. In some embodiments, the compound is present at a concentration of 75 ppm. In some embodiments, the compound is present at a concentration of 76 ppm. In some embodiments, the compound is present at a concentration of 77 ppm. In some embodiments, the compound is present at a concentration of 78 ppm. In some embodiments, the compound is present at a concentration of 79 ppm. In some embodiments, the compound is present at a concentration of 80 ppm. In some embodiments, the compound is present at a concentration of 81 ppm. In some embodiments, the compound is present at a concentration of 82 ppm. In some embodiments, the compound is present at a concentration of 83 ppm. In some embodiments, the compound is present at a concentration of 84 ppm. In some embodiments, the compound is present at a concentration of 85 ppm. In some embodiments, the compound is present at a concentration of 86 ppm. In some embodiments, the compound is present at a concentration of 87 ppm. In some embodiments, the compound is present at a concentration of 88 ppm. In some embodiments, the compound is present at a concentration of 89 ppm. In some embodiments, the compound is present at a concentration of 90 ppm. In some embodiments, the compound is present at a concentration of 91 ppm. In some embodiments, the compound is present at a concentration of 92 ppm. In some embodiments, the compound is
present at a concentration of 93 ppm. In some embodiments, the compound is present at a concentration of 94 ppm. In some embodiments, the compound is present at a concentration of 95 ppm. In some embodiments, the compound is present at a concentration of 96 ppm. In some embodiments, the compound is present at a concentration of 97 ppm. In some embodiments, the compound is present at a concentration of 98 ppm. In some embodiments, the compound is present at a concentration of 99 ppm. In some embodiments, the compound is present at a concentration of 00 ppm In some embodiments, the compound is present at a concentration of 01 ppm In some embodiments, the compound is present at a concentration of 02 ppm In some embodiments, the compound is present at a concentration of 03 ppm In some embodiments, the compound is present at a concentration of 04 ppm In some embodiments, the compound is present at a concentration of 05 ppm In some embodiments, the compound is present at a concentration of 06 ppm In some embodiments, the compound is present at a concentration of 07 ppm In some embodiments, the compound is present at a concentration of 08 ppm In some embodiments, the compound is present at a concentration of 09 ppm In some embodiments, the compound is present at a concentration of 10 ppm In some embodiments, the compound is present at a concentration of 11 ppm In some embodiments, the compound is present at a concentration of 12 ppm In some embodiments, the compound is present at a concentration of 13 ppm In some embodiments, the compound is present at a concentration of 14 ppm In some embodiments, the compound is present at a concentration of 15 ppm In some embodiments, the compound is present at a concentration of 16 ppm In some embodiments, the compound is present at a concentration of 17 ppm In some embodiments, the compound is present at a concentration of 18 ppm In some embodiments, the compound is present at a concentration of 19 ppm In some embodiments, the compound is present at a concentration of 20 ppm In some embodiments, the compound is present at a concentration of 21 ppm In some embodiments, the compound is present at a concentration of 22 ppm In some embodiments, the compound is present at a concentration of 23 ppm In some embodiments, the compound is present at a concentration of 24 ppm In some embodiments, the compound is
present at a concentration of 125 ppm. In some embodiments, the compound is present at a concentration of 126 ppm. In some embodiments, the compound is present at a concentration of 127 ppm. In some embodiments, the compound is present at a concentration of 128 ppm. In some embodiments, the compound is present at a concentration of 129 ppm. In some embodiments, the compound is present at a concentration of 130 ppm. In some embodiments, the compound is present at a concentration of 131 ppm. In some embodiments, the compound is present at a concentration of 132 ppm. In some embodiments, the compound is present at a concentration of 133 ppm. In some embodiments, the compound is present at a concentration of 134 ppm. In some embodiments, the compound is present at a concentration of 135 ppm. In some embodiments, the compound is present at a concentration of 136 ppm. In some embodiments, the compound is present at a concentration of 137 ppm. In some embodiments, the compound is present at a concentration of 138 ppm. In some embodiments, the compound is present at a concentration of 139 ppm. In some embodiments, the compound is present at a concentration of 140 ppm. In some embodiments, the compound is present at a concentration of 141 ppm. In some embodiments, the compound is present at a concentration of 142 ppm. In some embodiments, the compound is present at a concentration of 143 ppm. In some embodiments, the compound is present at a concentration of 144 ppm. In some embodiments, the compound is present at a concentration of 145 ppm. In some embodiments, the compound is present at a concentration of 146 ppm. In some embodiments, the compound is present at a concentration of 147 ppm. In some embodiments, the compound is present at a concentration of 148 ppm. In some embodiments, the compound is present at a concentration of 149 ppm. In some embodiments, the compound is present at a concentration of 150 ppm.
[0047] In other embodiments, the sweet taste modulator of the present invention (e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of more than about 0.5 ppm, 1 ppm, 5 ppm, 10 ppm, 15 ppm, 20 ppm, 25 ppm, 30 ppm, or 35 ppm, up to, for example, about 35 ppm or 50 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a
compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration of more than 0.5 ppm, 1 ppm, 5 ppm, 10 ppm, 15 ppm, 20 ppm, 25 ppm, 30 ppm, or 35 ppm, up to, for example, 35 ppm or 50 ppm. In some embodiments, the compound is present at a concentration of more than 0.5 ppm. In some embodiments, the compound is present at a concentration of more than 1 ppm. In some embodiments, the compound is present at a concentration of more than 5 ppm. In some embodiments, the compound is present at a concentration of more than 10 ppm. In some embodiments, the compound is present at a concentration of more than 15 ppm. In some embodiments, the compound is present at a concentration of more than 20 ppm. In some embodiments, the compound is present at a concentration of more than 25 ppm. In some
embodiments, the compound is present at a concentration of more than 30 ppm. In some embodiments, the compound is present at a concentration of more than 35 ppm. In some embodiments, the compound is present at a concentration of more than 50 ppm. In additional embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration less than about 50 ppm, 35ppm, 30 ppm, 25 ppm, 20 ppm, 15 ppm, 10 ppm, 5 ppm, 1 ppm, or 0.5 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) enhances the sweetness of a sweetener when the compound is present at a concentration less than 50 ppm, 35ppm, 30 ppm, 25 ppm, 20 ppm, 15 ppm, 10 ppm, 5 ppm, 1 ppm, or 0.5 ppm. In some embodiments, the compound is present at a concentration less than 50 ppm. In some embodiments, the compound is present at a concentration less than 35ppm. In some embodiments, the compound is present at a concentration less than 30 ppm. In some embodiments, the compound is present at a concentration less than 25 ppm. In some embodiments, the compound is present at a
concentration less than 20 ppm. In some embodiments, the compound is present at a concentration less than 15 ppm. In some embodiments, the compound is present at a concentration less than 10 ppm. In some embodiments, the compound is
present at a concentration less than 5 ppm. In some embodiments, the compound is present at a concentration less than 1 ppm. In some embodiments, the compound is present at a concentration less than 0.5 ppm. In yet additional embodiments, the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration less than about 35 ppm, 10 ppm, or 1 ppm. In some embodiments, the sweet taste modulator of the present invention enhances the sweetness of a sweetener when the compound is present at a concentration less than 35 ppm, 10 ppm, or 1 ppm.
[0048] The terms "parts per million" and "ppm" are used in the food industry to refer to a low concentration of a solution. For example, one gram of solute in 1000 ml of solvent has a concentration of 1000 ppm and one thousandth of a gram (0.00 lg) of solute in 1000 ml of solvent has a concentration of one ppm.
Accordingly, a concentration of one milligram per liter (i.e., 1 mg/L) is equal to 1 ppm. A concentration of 1 mg% is 1 mg/lOOmL. Accordingly, a concentration of 1 mg% is equal to 10 ppm.
[0049] The sweet taste modulators of the invention may be combined with known naturally occurring and/or synthetic sweet taste modulators when used in embodiments (e.g. , edible compositions and methods) described herein.
Sweeteners
[0050] In compositions and methods of the invention that comprise a sweetener, the sweetener can be of any type, for example a natural, non-natural, or synthetic sweetener. Non-limiting examples of such sweeteners include caloric
carbohydrate sweeteners, natural carbohydrate sweeteners, non-natural
carbohydrate sweeteners, natural high-potency sweeteners, non-natural high- potency sweeteners, synthetic high potency sweeteners, synthetic carbohydrate sweeteners, sugar alcohols, rare sugars and combinations thereof. In some embodiments, the at least one sweetener is chosen from caloric sweeteners. In another embodiment, the at least one sweetener is chosen from synthetic sweeteners. In another embodiment, the at least one sweetener is chosen from non- natural sweeteners. Non-limiting examples of rare sugars include D-Psicose, D- Turanose, D-allose, D-Tagatose, D-Sorbose, L-fructose, L-glucose, L-fructose, L- talose, L-ribose, L-arabinose.
[0051] In some embodiments, the sweetener is a natural or inherent component of an edible composition. For example, the sweetener may be an inherent component of a food product or of a food stuff, such as fruit or a fruit product (e.g., fruit sauce). Accordingly, the compounds of the present invention may be used in edible compositions to which no sweetener is added.
[0052] The terms "caloric sweeteners" and "caloric carbohydrate sweeteners," are used interchangeably herein, and refer to nutritive sweeteners that provide calories and include all caloric carbohydrate sweeteners, such as sugars and polyols. Non-limiting examples of suitable caloric carbohydrate sweeteners include sucrose, fructose, glucose, erythritol, maltitol, lactitol, sorbitol, mannitol, xylitol, D-tagatose, trehalose, galactose, rhamnose, cyclodextrin (e.g. , - cyclodextrin, β-cyclodextrin, and γ-cyclodextrin), ribulose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, palatinose or isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono- lactone, abequose, galactosamine, xylo-oligosaccharides (xylotriose, xylobiose and the like), gentio-oligoscaccharides (gentiobiose, gentiotriose, gentiotetraose and the like), galacto-oligosaccharides, sorbose, nigero-oligosaccharides,
fructooligosaccharides (kestose, nystose and the like), maltotetraol, maltotriol, malto-oligosaccharides (maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose and the like), lactulose, melibiose, raffinose, rhamnose, ribose, isomerized liquid sugars such as high fructose corn/starch syrup (e.g., HFCS55, HFCS42, or HFCS90), honey, maple syrup, coupling sugars, soybean
oligosaccharides, and glucose syrup. Preferably, the sweetener is a natural sweetener chosen from glucose, fructose, sucrose, and mixtures thereof.
[0053] The term "polyol," as used herein, refers to a molecule that contains more than one hydroxyl group. A polyol may be a diol, triol, or a tetraol, which contain 2, 3, and 4 hydroxyl groups, respectively. A polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively. Additionally, a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of
carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Non-limiting examples of polyols in some embodiments include erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, isomalt, propylene glycol, glycerol (glycerin), threitol, galactitol, palatinose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, and sugar alcohols or any other carbohydrates capable of being reduced which do not adversely affect the taste of the edible composition.
[0054] In some embodiments, the sweetener is a carbohydrate sweetener. In such embodiments, the sweetener is chosen from sucrose, fructose, glucose, erythritol, high fructose corn or starch syrup, and mixtures thereof.
[0055] The terms "synthetic high potency sweetener" and "artificial high potency sweetener" are used interchangeably herein and refer to any composition which is not found in nature and characteristically has a sweetness potency greater than sucrose, fructose, or glucose, yet have fewer or no calories. Non-limiting examples of synthetic sweeteners suitable for embodiments of this invention include sucralose, acesulfame potassium or other salts, aspartame, alitame, saccharin, neohesperidin dihydrochalcone, cyclamate, neotame, advantame, and salts thereof.
[0056] The terms "synthetic sweetener" and "artificial sweetener" are used interchangeably herein and refer to any composition which is not found in nature and characteristically confers a sweet taste, yet have fewer or no calories. In some embodiments, the sweetener is a synthetic sweetener. Preferably, the synthetic sweetener is a synthetic high potency sweetener, such as sucralose, aspartame, potassium acesulfame, and mixtures thereof.
[0057] Other sweeteners suitable for use in embodiments provided herein, for example, include natural sweeteners. The terms "natural high-potency sweetener," "NHPS," "NHPS composition," and "natural high-potency sweetener composition" are used interchangeably, herein, and refer to any sweetener found in nature which may be in raw, extracted, purified, or any other form, singularly or in combination thereof and characteristically have a sweetness potency greater than sucrose, fructose, or glucose, yet have fewer or no calories. Non-limiting examples of
NHPSs suitable for embodiments of this disclosure include steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, glycosylated steviol glycosides, mogrosides, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin and its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid and its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, and cyclocarioside I. In some embodiments, the glycosylated steviol glycoside is 13-[(2-0-P-D-glucopyranosyl- 3-0-(4-0-a-D-glucopyranosyl)-P-D-glucopyranosyl-P-D-glucopyranosyl)oxy] ent- kaur-16-en-19-oic acid-[(4-0-a-D-glucopyranosyl-P-D-glucopyranosyl) ester], 13- [(2-0-P-D-glucopyranosyl-P-D-glucopyranosyl)oxy] e/?t-kaur-16-en-19-oic acid- [(4-0-(4-0-(4-0-a-D-glucopyranosyl)-a-D-glucopyranosyl)-a-D-glucopyranosyl)- β-D-glucopyranosyl ester], 13-[(2-0-P-D-glucopyranosyl-3-0-(4-O-(4-O-(4-O-a- D-glucopyranosyl)-a-D-glucopyranosyl)-a-D-glucopyranosyl)-P-D- glucopyranosyl-P-D-glucopyranosyl)oxy] e/?t-kaur-16-en-19-oic acid β-D- glucopyranosyl ester, or 13-[(2-0-P-D-glucopyranosyl-3-0-(4-O-(4-O-(4-O-a-D- glucopyranosyl)-a-D-glucopyranosyl)-a-D-glucopyranosyl)-P-D-glucopyranosyl- P-D-glucopyranosyl)oxy] e/?t-kaur-16-en-19-oic acid-[(4-O-a-D-glucopyranosyl-P- D-glucopyranosyl) ester]. NHPS also includes modified NHPSs. Modified NHPSs include NHPSs which have been altered naturally. For example, a modified NHPS includes, but is not limited to, NHPSs which have been fermented, contacted with enzyme, or derivatized or substituted on the NHPS. In one embodiment, at least one modified NHPS may be used in combination with at least one NHPS. In another embodiment, at least one modified NHPS may be used without a NHPS. Thus, modified NHPSs may be substituted for a NHPS or may be used in combination with NHPSs for any of the embodiments described herein. For the sake of brevity, however, in the description of embodiments, a modified NHPS is not expressly described as an alternative to an unmodified NHPS, but it
should be understood that modified NHPSs can be substituted for NHPSs in any embodiment disclosed herein.
[0058] In some embodiments, the sweetener may be used individually or in combination with other sweeteners. For example, the sweetener composition may comprise a single caloric sweetener, a single NHPS or a single synthetic sweetener; a single caloric sweetener with a single NHPS; a single caloric sweetener with a single synthetic sweetener; one or more caloric sweetener with a single NHPS; one or more caloric sweetener with a single synthetic sweetener; a single caloric sweetener with one or more NHPS; a single caloric sweetener with one or more synthetic sweeteners; a single NHPS in combination with a single synthetic sweetener; one or more NHPSs in combination with a single synthetic sweetener; a single NHPS in combination with one or more synthetic sweeteners; one or more NHPSs in combination with one or more synthetic sweeteners; or one or more caloric sweetener with one or more NHPS and one or more synthetic sweetener. A plurality of natural and/or synthetic sweeteners may be used as long as the combined effect does not adversely affect the taste of the sweetener composition or orally sweetened composition.
[0059] One of ordinary skill in the art should appreciate that the sweetener composition can be customized to obtain a desired calorie content. For example, a low-caloric or non-caloric synthetic sweetener may be combined with a caloric sweetener and/or other caloric additives to produce a sweetener composition with a preferred calorie content.
[0060] The sweetener is present in the composition in an amount greater than its sweetness threshold level. In some embodiments, the sweetener may be present in an amount ranging from 0.01% to 99.9% by weight, relative to the total weight of the composition. For example, the at least one sweetener may be present in an amount ranging from 2% to 50%, or for example from 4% to 50% by weight, relative to the total weight of the composition. In some embodiments, the at least one sweetener may be present in about 5% to 20% by weight. In further embodiments, the at least one sweetener may be present in about 5% to 15% by weight. In yet further embodiments, the at least one sweetener may be present in about 5%> to 12%) by weight in beverages, for example, in non-alcoholic beverages.
In some embodiments, the at least one sweetener may be present in 5% to 20% by weight. In further embodiments, the at least one sweetener may be present in 5% to 15% by weight. In yet further embodiments, the at least one sweetener may be present in 5% to 12% by weight in beverages, for example, in non-alcoholic beverages.
[0061] In accordance with the disclosure, the sweet taste modulator of the present invention potentiates or enhances the sweetness of the sweetener. The composition comprising the sweetener and the sweet taste modulator of the present invention has more sweetness intensity than a composition comprising the at least one sweetener without the sweet taste modulator.
[0062] As used herein, the term "sweetness intensity" is understood to mean any perceptible sweetness. The composition comprising the sweetener and the sweet taste modulator of the present invention is perceptibly sweeter than a composition comprising the sweetener without the sweet taste modulator. For example, a composition comprising the sweetener and the sweet taste modulator of the present invention may be slightly sweeter, moderately sweeter, or significantly sweeter than a composition comprising the sweetener without the sweet taste modulator. As discussed above, in embodiments where the sweet taste modulators of Formula (I), any one of Compounds 1-6, or combinations thereof are used above their sweetness threshold, the increase in sweetness intensity is synergistic, not additive.
[0063] The sweetness of a composition may be based on (i.e. , relative to) a known sweet standard. Sweet compounds based on such sweet standards include, but are not limited to, for example natural, non-natural, or synthetic sweeteners. Non-limiting examples of such sweeteners include caloric carbohydrate sweeteners, natural carbohydrate sweeteners, non-natural carbohydrate sweeteners, natural high-potency sweeteners, non-natural high-potency sweeteners, synthetic high potency sweeteners, synthetic carbohydrate sweeteners, and combinations thereof. For example, the sweetness of a composition may be based on to a 5% sucrose solution. In such cases, a composition comprising the sweetener and a sweet taste modulator of the present invention may be perceived as having a sweetness equivalent to a 5.5 % sucrose solution. In other embodiments, the composition comprising the sweetener and a sweet taste modulator of the present
invention may be perceived as having a sweetness equivalent to a 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, or 10% sucrose solution. Suitable sweet standards include, but are not limited to, sucrose standards, fructose standards and glucose standards. Each of these standards may be used at concentrations which include, but are not limited to, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, 9.5%, or 10% solution. In some embodiments, the sweetness intensity of the composition comprising the sweetener and a sweet taste modulator of the present invention increases the perceived sweetness based on a sweet standard by greater than 10%>, by greater than 20%, by greater than 30%, by greater than 40%, greater than by 50% or greater than by 60% compared to a composition comprising the sweetener without the sweet taste modulator.
[0064] In some embodiments, the perception of sweetness intensity of the sweetener (i.e., the perception of sweet taste of the sweetener in the edible composition) is enhanced by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100%. In some embodiments, the perception of sweetness intensity of the sweetener is enhanced beyond 100%, for example, by 125%, 150%, 175%, 200%, 225%, 250%, 275%, 300%, 325%, 350%, 375%, 400%, 425%, 450%, 475%, 500% or increments in between those recited. In some embodiments, the perception of sweetness intensity is enhanced by up to 25%. In other embodiments, the perception of sweetness intensity is enhanced by up to 50%). In other embodiments, the perception of sweetness intensity is enhanced by up to 75%). In other embodiments, the sweetness intensity is enhanced by up to 100%). In some embodiments, the perception of sweetness intensity is enhanced by about 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10- 25%. 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25-
60%, 25-50%), 25-40%), or 25-30%). In some embodiments, the perception of sweetness intensity is enhanced by 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%. 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20- 30%, 25-80%, 25-70%, 25-60%, 25-50%, 25-40%, or 25-30%. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention.
[0065] It is contemplated that the combination of at least one sweetness enhancer and at least one sweetener may be carried out in any pH range that does not materially or adversely affect the taste of the sweetener composition or the sweetened composition. A non- limiting example of the pH range may be from about 1.5 to about 9.0. Further examples include a pH range from about 2.0 to about 8.5, from about 2.0 to about 8.0, from about 2.0 to about 7.5, from about 2.0 to about 7.0, from about 2.5 to about 7.0, and from about 3.0 to about 7.0.
Additional examples of pH ranges include from about 2.0 to about 4.0, from about 2.5 to about 3.5, from about 2.5 to about 4.5, from about 3.5 to about 5.5, from about 4.0 to about 5.5, from about 5.0 to about 6.0, from about 6.5 to about 7.5, and from about 6.0 to about 8.0. In some embodiments, the pH is about 3.0 or about 7.0. In some embodiments, the pH is about 1.5, about 1.6, about 1.7, about 1.8, about 1.9, about 2.0, about 2.1, about 2.2, about 2.3, about 2.4, about 2.5, about 2.6, about 2.7, about 2.8, about 2.9, about 3.0, about 3.1, about 3.2, about 3.3, about 3.4, about 3.5, about 3.6, about 3.7, about 3.8, about 3.9, about 4.0, about 4.1, about 4.2, about 4.3, about 4.4, about 4.5, about 4.6, about 4.7, about 4.8, about 4.9, about 5.0, about 5.1, about 5.2, about 5.3, about 5.4, about 5.5, about 5.6, about 5.7, about 5.8, about 5.9, about 6.0, about 6.1, about 6.2, about 6.3, about 6.4, about 6.5, about 6.6, about 6.7, about 6.8, about 6.9, about 7.0, about 7.1, about 7.2, about 7.3, about 7.4, about 7.5, about 7.6, about 7.7, about 7.8, about 7.9, about 8.0, about 8.1, about 8.2, about 8.3, about 8.4, about 8.5, about 8.6, about 8.7, about 8.8, about 8.9, or about 9.0. In some embodiments, the pH range may be from 1.5 to 9.0. Further examples include a pH range from 2.0 to 8.5, from 2.0 to 8.0, from 2.0 to 7.5, from 2.0 to 7.0, from 2.5 to 7.0, and from 3.0 to 7.0. Additional examples of pH ranges include from 2.0 to 4.0, from 2.5 to 3.5, from 2.5 to 4.5, from 3.5 to 5.5, from 4.0 to 5.5, from 5.0 to 6.0, from 6.5 to 7.5,
and from 6.0 to 8.0. In some embodiments, the pH is 3.0 or 7.0. In some embodiments, the pH is 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6.0, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7.0, 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9, 8.0, 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9, or 9.0. The temperature of the composition may, for example, range from about -4 °C to about 90 °C. In some embodiments, the temperature of the composition may, for example, range from -4 °C to 90 °C.
[0066] In some embodiments, the pH is about 1.5. In some embodiments, the pH is about 1.6. In some embodiments, the pH is about 1.7. In some embodiments, the pH is about 1.8. In some embodiments, the pH is about 1.9. In some embodiments, the pH is about 2.0. In some embodiments, the pH is about 2.1. In some embodiments, the pH is about 2.2. In some embodiments, the pH is about 2.3. In some embodiments, the pH is about 2.4. In some embodiments, the pH is about 2.5. In some embodiments, the pH is about 2.6. In some embodiments, the pH is about 2.7. In some embodiments, the pH is about 2.8. In some
embodiments, the pH is about 2.9. In some embodiments, the pH is about 3.0. In some embodiments, the pH is about 3.1. In some embodiments, the pH is about 3.2. In some embodiments, the pH is about 3.3. In some embodiments, the pH is about 3.4. In some embodiments, the pH is about 3.5. In some embodiments, the pH is about 3.6. In some embodiments, the pH is about 3.7. In some
embodiments, the pH is about 3.8. In some embodiments, the pH is about 3.9. In some embodiments, the pH is about 4.0. In some embodiments, the pH is about 4.1. In some embodiments, the pH is about 4.2. In some embodiments, the pH is about 4.3. In some embodiments, the pH is about 4.4. In some embodiments, the pH is about 4.5. In some embodiments, the pH is about 4.6. In some
embodiments, the pH is about 4.7. In some embodiments, the pH is about 4.8. In some embodiments, the pH is about 4.9. In some embodiments, the pH is about 5.0. In some embodiments, the pH is about 5.1. In some embodiments, the pH is about 5.2. In some embodiments, the pH is about 5.3. In some embodiments, the pH is about 5.4. In some embodiments, the pH is about 5.5. In some
embodiments, the pH is about 5.6. In some embodiments, the pH is about 5.7. In
some embodiments, the pH is about 5.8. In some embodiments, the pH is about 5.9. In some embodiments, the pH is about 6.0. In some embodiments, the pH is about 6.1. In some embodiments, the pH is about 6.2. In some embodiments, the pH is about 6.3. In some embodiments, the pH is about 6.4. In some
embodiments, the pH is about 6.5. In some embodiments, the pH is about 6.6. In some embodiments, the pH is about 6.7. In some embodiments, the pH is about 6.8. In some embodiments, the pH is about 6.9. In some embodiments, the pH is about 7.0. In some embodiments, the pH is about 7.1. In some embodiments, the pH is about 7.2. In some embodiments, the pH is about 7.3. In some
embodiments, the pH is about 7.4. In some embodiments, the pH is about 7.5. In some embodiments, the pH is about 7.6. In some embodiments, the pH is about 7.7. In some embodiments, the pH is about 7.8. In some embodiments, the pH is about 7.9. In some embodiments, the pH is about 8.0. In some embodiments, the pH is about 8.1. In some embodiments, the pH is about 8.2. In some
embodiments, the pH is about 8.3. In some embodiments, the pH is about 8.4. In some embodiments, the pH is about 8.5. In some embodiments, the pH is about 8.6. In some embodiments, the pH is about 8.7. In some embodiments, the pH is about 8.8. In some embodiments, the pH is about 8.9. In some embodiments, the pH is about 8.8. In some embodiments, the pH is about 9.0.
[0067] In some embodiments, the pH is 1.5. In some embodiments, the pH is 1.6. In some embodiments, the pH is 1.7. In some embodiments, the pH is 1.8. In some embodiments, the pH is 1.9. In some embodiments, the pH is 2.0. In some embodiments, the pH is 2, .1. In some embodiments, the pH is 2, .2. In some embodiments, the pH is 2, .3. In some embodiments, the pH is 2, .4. In some embodiments, the pH is 2, .5. In some embodiments, the pH is 2, .6. In some embodiments, the pH is 2, .7. In some embodiments, the pH is 2, .8. In some embodiments, the pH is 2, .9. In some embodiments, the pH is 3, .0. In some embodiments, the pH is 3, .1. In some embodiments, the pH is 3, .2. In some embodiments, the pH is 3, .3. In some embodiments, the pH is 3, .4. In some embodiments, the pH is 3, .5. In some embodiments, the pH is 3, .6. In some embodiments, the pH is 3, .7. In some embodiments, the pH is 3, .8. In some embodiments, the pH is 3, .9. In some embodiments, the pH is 4, .0. In some
embodiments, the pH is 4 1. In some embodiments, the pH is 4 2. In some embodiments, the pH is 4 3. In some embodiments, the pH is 4 4. In some embodiments, the pH is 4 5. In some embodiments, the pH is 4 6. In some embodiments, the pH is 4 7. In some embodiments, the pH is 4 8. In some embodiments, the pH is 4 9. In some embodiments, the pH is 5 0. In some embodiments, the pH is 5 1. In some embodiments, the pH is 5 2. In some embodiments, the pH is 5 3. In some embodiments, the pH is 5 4. In some embodiments, the pH is 5 5. In some embodiments, the pH is 5 6. In some embodiments, the pH is 5 7. In some embodiments, the pH is 5 8. In some embodiments, the pH is 5 9. In some embodiments, the pH is 6 0. In some embodiments, the pH is 6 1. In some embodiments, the pH is 6 2. In some embodiments, the pH is 6 3. In some embodiments, the pH is 6 4. In some embodiments, the pH is 6 5. In some embodiments, the pH is 6 6. In some embodiments, the pH is 6 7. In some embodiments, the pH is 6 8. In some embodiments, the pH is 6 9. In some embodiments, the pH is 7 0. In some embodiments, the pH is 7 1. In some embodiments, the pH is 7 2. In some embodiments, the pH is 7 3. In some embodiments, the pH is 7 4. In some embodiments, the pH is 7 5. In some embodiments, the pH is 7 6. In some embodiments, the pH is 7 7. In some embodiments, the pH is 7 8. In some embodiments, the pH is 7 9. In some embodiments, the pH is 8 0. In some embodiments, the pH is 8 1. In some embodiments, the pH is 8 2. In some embodiments, the pH is 8 3. In some embodiments, the pH is 8 4. In some embodiments, the pH is 8 5. In some embodiments, the pH is 8 6. In some embodiments, the pH is 8 7. In some embodiments, the pH is 8 8. In some embodiments, the pH is 8 9. In some embodiments, the pH is 8 8. In some embodiments, the pH is 9 0.
[0068] One of ordinary skill in the art may combine the sweetener(s) and sweet taste modulator(s), in any manner.
Sweet Taste Improving Compositions
[0069] The terms "sweet taste improving composition" and "sweet taste improving additive" are used interchangeably herein and refer to any material that imparts a more sugar-like temporal profile or sugar-like flavor profile or both to a
synthetic sweetener. Suitable sweet taste improving additives useful in
embodiments of this disclosure include amino acids and salts thereof, poly-amino acids and salts thereof, peptides, sugar acids and salts thereof, nucleotides and salts thereof, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic acid salts (e.g., sodium chloride, potassium chloride, magnesium chloride), acid salts (e.g., sodium citrate), bitter compounds, flavorants and flavoring ingredients, astringent compounds, polymers, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, and natural high-potency sweeteners.
[0070] The terms "sugar- like characteristic," "sugar-like taste," "sugar- like sweet," "sugary," and "sugar-like" are used interchangeably, herein, and include any characteristic similar to that of sucrose and include, but are not limited to, maximal response, flavor profile, temporal profile, adaptation behavior, mouth feel, concentration/response function behavior, tastant and flavor/sweet taste interactions, spatial pattern selectivity, and temperature effects. These
characteristics are dimensions in which the taste of sucrose is different from the tastes of sweetness enhanced sweetener compositions. Suitable procedures for determining whether a composition has a more sugar-like taste are well known in the art.
[0071] The compositions of the present invention may also further comprise at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive. For example, the composition of the disclosure may comprise at least one sweet taste improving composition for balancing the temporal and/or flavor profile of the sweetness enhanced sweetener composition. The use of sweet taste improving compositions to improve the temporal and/or flavor profile of sweetener compositions are described in detail in U.S. Patent Application Publication Nos. 2007/012831 1 , 2007/0275147, 2008/0292765, 201 1/016031 1 , and US 201 1/0318464 the disclosures of which are incorporated herein by reference in their entirety.
[0072] Exemplary suitable sweet-taste improving compounds include, but are not limited to, carbohydrates, polyols, amino acids and their corresponding salts, poly- amino acids and their corresponding salts, sugar acids and their corresponding
salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, flavorants and flavoring ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, other sweet taste improving taste additives imparting such sugar-like characteristics, and
combinations thereof. In some embodiments, the sweet-taste improving compound is erythritol. In such embodiments, the ratio of erythritol to any one of Compounds 1-6, or mixtures thereof, is about 1 : 1 to about 800: 1 by weight. In other embodiments, the ratio of erythritol to any one of compounds of Formula (I) or Compounds 1-6, or mixtures thereof, is about (30-200): l or about (50-100): l by weight. In some embodiments, the ratio of erythritol to any one of Compounds 1- 6, or mixtures thereof, is 1 : 1 to 800: 1 by weight. In other embodiments, the ratio of erythritol to any one of Compounds 1-6, or mixtures thereof, is (30-200): 1 or (50-100): 1 by weight.
[0073] Suitable sweet taste improving amino acid additives for use in
embodiments of this disclosure include, but are not limited to, aspartic acid, arginine, glycine, glutamic acid, proline, threonine, theanine, cysteine, cystine, alanine, valine, tyrosine, leucine, isoleucine, asparagine, serine, lysine, histidine, ornithine, methionine, carnitine, aminobutyric acid (α-, β-, or γ-isomers), glutamine, hydroxyproline, taurine, norvaline, sarcosine, and their salt forms such as sodium or potassium salts or acid salts. The sweet taste improving amino acid additives also may be in the D- or L-configuration and in the mono-, di-, or triform of the same or different amino acids. Additionally, the amino acids may be α-, β-, γ-, δ-, and ε-isomers if appropriate. Combinations of the foregoing amino acids and their corresponding salts (e.g. , sodium, potassium, calcium, magnesium salts or other alkali or alkaline earth metal salts thereof, or acid salts) also are suitable sweet taste improving additives in some embodiments. The amino acids may be natural or synthetic. The amino acids also may be modified. Modified amino acids refers to any amino acid wherein at least one atom has been added, removed, substituted, or combinations thereof (e.g., N-alkyl amino acid, N-acyl amino acid, or N-methyl amino acid). Non-limiting examples of modified amino acids include amino acid derivatives such as trimethyl glycine, N-methyl-glycine,
and N-methyl-alanine. As used herein, modified amino acids encompass both modified and unmodified amino acids. As used herein, amino acids also
encompass both peptides and polypeptides (e.g., dipeptides, tripeptides,
tetrapeptides, and pentapeptides) such as glutathione and L-alanyl-L-glutamine. Suitable sweet taste improving polyamino acid additives include poly-L-aspartic acid, poly-L-lysine (e.g., poly-L-a-lysine or poly-L-8-lysine), poly-L-ornithine (e.g., poly-L-a-ornithine or poly-L-8-ornithine), poly-L-arginine, other polymeric forms of amino acids, and salt forms thereof (e.g., calcium, potassium, sodium, or magnesium salts such as L-glutamic acid mono sodium salt). The sweet taste improving poly-amino acid additives also may be in the D- or L-configuration. Additionally, the poly-amino acids may be α-, β-, γ-, δ-, and ε-isomers if appropriate. Combinations of the foregoing poly-amino acids and their
corresponding salts (e.g. , sodium, potassium, calcium, magnesium salts or other alkali or alkaline earth metal salts thereof or acid salts) also are suitable sweet taste improving additives in some embodiments. The poly-amino acids described herein also may comprise co-polymers of different amino acids. The poly-amino acids may be natural or synthetic. The poly-amino acids also may be modified, such that at least one atom has been added, removed, substituted, or combinations thereof (e.g., N-alkyl poly-amino acid or N-acyl poly-amino acid). As used herein, poly- amino acids encompass both modified and unmodified poly-amino acids. For example, modified poly-amino acids include, but are not limited to poly-amino acids of various molecular weights (MW), such as poly-L-a-lysine with a MW of 1,500, MW of 6,000, MW of 25,200, MW of 63,000, MW of 83,000, or MW of 300,000. In some embodiments, the taste improving amino acid additive is glycine, alanine, taurine, serine or proline. In such embodiments, the taste improving amino acid additive is present in a concentration of about 10 ppm to about 25,000 ppm, about 100 ppm to about 1000 ppm, or about 100 to 5000 ppm. In some embodiments, the taste improving amino acid additive is present in a concentration of 10 ppm to 25,000 ppm, 100 ppm to 1000 ppm, or about 100 to 5000 ppm.
[0074] Suitable sweet taste improving sugar acid additives include, for example, but are not limited to aldonic, uronic, aldaric, alginic, gluconic, glucuronic, glucaric, galactaric, galacturonic, and salts thereof (e.g., sodium, potassium,
calcium, magnesium salts or other physiologically acceptable salts), and combinations thereof.
[0075] For example, suitable sweet taste improving nucleotide additives include, but are not limited to, inosine monophosphate ("IMP"), guanosine monophosphate ("GMP"), adenosine monophosphate ("AMP"), cytosine monophosphate ("CMP"), uracil monophosphate ("UMP"), inosine diphosphate, guanosine diphosphate, adenosine diphosphate, cytosine diphosphate, uracil diphosphate, inosine triphosphate, guanosine triphosphate, adenosine triphosphate, cytosine
triphosphate, uracil triphosphate, alkali or alkaline earth metal salts thereof, and combinations thereof. The nucleotides described herein also may comprise nucleotide-related additives, such as nucleosides or nucleic acid bases (e.g. , guanine, cytosine, adenine, thymine, uracil).
[0076] Suitable sweet taste improving organic acid additives include any compound which comprises a -COOH moiety. Suitable sweet taste improving organic acid additives, for example, include but are not limited to C2-C30 carboxylic acids, substituted hydroxyl C2-C30 carboxylic acids, benzoic acid, substituted benzoic acids (e.g., 2,4-dihydroxybenzoic acid), substituted cinnamic acids, hydroxyacids, substituted hydroxybenzoic acids, substituted cyclohexyl carboxylic acids, tannic acid, lactic acid, tartaric acid, citric acid, gluconic acid, glucoheptonic acids, adipic acid, hydroxycitric acid, malic acid, fruitaric acid (a blend of malic, fumaric, and tartaric acids), fumaric acid, maleic acid, succinic acid, chlorogenic acid, salicylic acid, creatine, caffeic acid, bile acids, acetic acid, ascorbic acid, alginic acid, erythorbic acid, polyglutamic acid, glucono delta lactone, and their alkali or alkaline earth metal salt derivatives thereof. In addition, the organic acid additives also may be in either the D- or L-configuration.
[0077] For example, suitable sweet taste improving organic acid additive salts include, but are not limited to, sodium, calcium, potassium, and magnesium salts of all organic acids, such as salts of citric acid, malic acid, tartaric acid, fumaric acid, lactic acid (e.g., sodium lactate), alginic acid (e.g., sodium alginate), ascorbic acid (e.g. , sodium ascorbate), benzoic acid (e.g. , sodium benzoate or potassium benzoate), and adipic acid. The examples of the sweet taste improving organic acid additives described optionally may be substituted with at least one group chosen
from hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, thiol, imine, sulfonyl, sulfenyl, sulfmyl, sulfamyl, carboxalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, anhydride, oximino, hydrazino, carbamyl, phospho, phosphonato, and any other viable functional group provided the substituted organic acid additives function to improve the sweet taste of a synthetic sweetener.
[0078] For example, suitable sweet taste improving inorganic acid additives include but are not limited to phosphoric acid, phosphorous acid, polyphosphoric acid, hydrochloric acid, sulfuric acid, carbonic acid, sodium dihydrogen phosphate, and alkali or alkaline earth metal salts thereof (e.g. , inositol hexaphosphate Mg/Ca).
[0079] Suitable sweet taste improving bitter compound additives, for example, include but are not limited to caffeine, quinine, urea, bitter orange oil, naringin, quassia, and salts thereof.
Edible compositions
[0080] According to one aspect, the invention provides an edible composition comprising a sweet taste modulator of the invention for enhancing or potentiating the sweet taste of a sweetener or for masking or blocking a bitter or unpleasant taste. Thus, such edible compositions may comprise a compound of Formula (I), any one of Compounds 1-6, or combinations thereof. Optionally, the edible composition comprises a (i) sweetener; and (ii) a compound of Formula (I), any one of Compounds 1-6, or combinations thereof.
[0081] The terms "edible composition," "orally ingestible composition" and "sweetenable composition" are used interchangeably, herein, and refer to a composition suitable for consumption, typically via the oral cavity (although consumption may occur via non-oral means such as inhalation). Edible
compositions may be present in any form including, but not limited to, liquids, solids, semi-solids, tablets, lozenges, powders, gels, gums, pastes, slurries, syrups, aerosols and sprays. As used herein, edible compositions include food products, pharmaceutical compositions, and consumer products. The term edible
composition also refers to, for example, dietary and nutritional supplements. As
used herein, edible compositions also include compositions that are placed within the oral cavity but not swallowed, including professional dental products, such as dental treatments, fillings, packing materials, molds and polishes. The term "comestible" refers to similar compositions and is generally used as a synonym to the term "edible."
[0082] The term "food product" refers to any composition comprising one or more processed foodstuffs. Food products include, but are not limited to, confectionaries, bakery products (including, but not limited to, doughs, breads, biscuits, crackers, cakes, pastries, pies, tarts, quiches, and cookies), ice creams (including but not limited to impulse ice cream, take -home ice cream, frozen yogurt, gelato, sorbet, sherbet and soy, oat, bean and rice-based ice cream), dairy products (including, but not limited to, drinking milk, cheese, yogurt, and sour milk drinks), cheeses (including, but not limited to, natural cheeses and processed cheeses), butter, margarine, sweet and savory snacks (including but not limited to fruit snacks, chips/crisps, tortilla/corn chips, popcorn, pretzels, chocolates, and nuts), hot and cold beverages (including, but not limited to, beverages, beverage mixes, concentrates, juices, carbonated beverages, non-carbonated beverages, alcoholic beverages, non-alcoholic beverages, soft drinks, sports drinks, isotonic drinks, coffees, teas, bottled waters, and beverages prepared from botanicals and botanical extracts (including cold beverages that are prepared with botanical or fungi extracts as ingredients, and drinks that are prepared in various ways, such as infusions, decoctions, or other means of extraction or distillation of various plant parts, including, but not limited to leaves, flowers, stems, fruits, roots, rhizomes, stems, bark, volatile oils, or even the whole plant), snack bars (including, but not limited to granola bars, muesli bars, protein bars, breakfast bars, energy bars, and fruit bars), meal replacement products, ready meals (including, but not limited to canned meals, preserved meals, frozen meals, dried meals, chilled meals, dinner mixes, macaroni and cheese, frozen pizza, chilled pizza, and prepared salads), soups (including but not limited to broth-like soups and cream-based soups), broth, gravy, soy sauce, meats and fish (including raw, cooked, and dried meats), deli products (including but not limited to meats and cheeses suitable for slicing or pre- sliced meats and cheeses, e.g. , turkey, chicken, ham, bologna, salami, bierwurst,
capicola, chorizo, corned beef, dutch loaf, Serrano, prosciutto, head cheese, liverwurst, meatloaf (including olive loaf, pepper loaf, pimento loaf, and ham and cheese loaf), mortadella, pastrami, pepperoni, roast beef, roast pork, saucisson, smoked meat, summer sausage, tongue, American cheese, blue cheese, cheddar cheese, Colby cheese, Colby- Jack cheese, gouda, Monterey Jack cheese, muenster cheese mozzarella, parmigiano cheese, pepper jack cheese, provolone, romano cheese, string cheese, spray cheese, and swiss cheese), vegetables (including, but not limited to, raw, pickled, cooked, and dried vegetables, such as french fries), fruits (including raw, cooked, and dried fruits), grains (including, but not limited to, dried cereals and breads), prepared foods (including, but not limited to, dried, canned, or jarred sauces and soups), snack foods, pastas (including, but not limited to, fresh pasta, chilled pasta, frozen pasta, dried pasta, and macaroni), noodles (including, but not limited to, egg noodles, wheat noodles, rice noodles, mung bean noodles, potato noodles, buckwheat noodles, corn noodles, cellophane noodles, chow mein, fettuccini, fusilli, gnocchi, lasagna, linguini, lo mein, macaroni, manicotti, pad thai, penne, ramen, rice vermicelli, rigatoni, soba, spaghetti, spatzle, udon, and ziti), canned foods, frozen foods, dried foods, chilled foods, oils and fats, baby food, spreads, salads, cereals (including, but not limited to, hot and cold cereals), sauces (including, but not limited to, cheese sauces (e.g., for macaroni and cheese) tomato pastes, tomato purees, bouillon cubes, stock cubes, table sauces, bouillabaisse sauces, pasta sauces, cooking sauces, marinades, dry sauces, powder mixes, ketchups, mayonnaises, salad dressings, vinaigrettes, mustards, and dips), jellies, jams, preserves, honey, puddings, recipe mixes, syrups, icings, fillings, infused foods, salt-preserved food, marinated foods and condiments (such as ketchup, mustard and steak sauce). In some embodiments, the food product is animal feed. For example, the food product may be a pet food product, i.e. a food product for consumption by a household pet. In other embodiments, the food product is a livestock food product, i.e. a food product for consumption by livestock.
[0083] The term "foodstuff refers to an unprocessed ingredient or a basic nutrient or flavor containing element used to prepare a food product. Non-limiting
examples of foodstuffs include: fruits, vegetables, meats, fishes, grains, milks, eggs, tubers, sugars, sweeteners, oils, herbs, snacks, sauces, spices and salts.
[0084] The term "processed foodstuff refers to a foodstuff has been subjected to any process which alters its original state (excluding, e.g. , harvesting, slaughtering, and cleaning). Examples of methods of processing foods include, but are not limited to, removal of unwanted outer layers, such as potato peeling or the skinning of peaches; chopping or slicing; mincing or macerating; liquefaction, such as to produce fruit juice; fermentation {e.g. beer); emulsification; cooking, such as boiling, broiling, frying, heating, steaming or grilling; deep frying; baking; mixing; addition of gas such as air entrainment for bread or gasification of soft drinks; proofing; seasoning (with, e.g., herbs, spices, salts); spray drying; pasteurization; packaging {e.g., canning or boxing); extrusion; puffing; blending; and preservation {e.g., adding salt, sugar, potassium lactate or other preservatives).
[0085] The term "consumer product" refers to health and beauty products for the personal use and/or consumption by a subject. Consumer products may be present in any form including, but not limited to, liquids, solids, semi-solids, tablets, capsules, lozenges, strips, powders, gels, gums, pastes, slurries, syrups, aerosols and sprays. Non-limiting examples of consumer products include nutriceuticals, nutritional supplements, lipsticks, lip balms, soaps, shampoos, gums, adhesives {e.g., dental adhesives), toothpastes, oral analgesics, breath fresheners,
mouthwashes, tooth whiteners, and other dentifrices.
[0086] The edible composition may comprise (i) a sweet taste modulator of the invention, or combinations thereof; and (ii) a sweetener. In some embodiments, the sweet taste modulating compound is a flavonoid compound having a molecular weight less than about 1000, 500, or 300 Daltons. In some embodiments, the sweet taste modulating compound is a flavonoid compound having a molecular weight less than 1000, 500, or 300 Daltons. In certain embodiments, the sweet taste modulating compound is a compound of Formula (I), comestibly or biologically acceptable salts or derivatives thereof, enantiomers or diastereomers thereof, or combinations thereof. In other embodiments, the sweet taste modulating compound is a compound of any one of Compounds 1-6, or
combinations thereof, or comestibly or biologically acceptable salts or derivatives thereof.
[0087] In some embodiments, the edible composition naturally or inherently comprises a sweetener. For example, the sweetener may be an inherent component of a food product or of a food stuff, such as fruit or a fruit product (e.g. , fruit sauce). Accordingly, the compounds of the present invention may be added to edible compositions to which no sweetener is added.
[0088] In another embodiments, the edible composition is a sweetened composition comprising (i) a sweet taste modulator of the invention (e.g., a compound of Formula (I), any one of Compounds 1-6, or combinations thereof); and (ii) a sweetener.
[0089] In some embodiments, the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may be used to enhance the sweet taste or perception of any suitable natural or synthetic sweetener, such as any suitable caloric, low-caloric or non-caloric sweetener. The compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may have an inherent sweet taste and, in some embodiments, it is present at or above its sweetness threshold, but is not the primary sweetener in the composition. Rather, the compound of Formula (I), or any one of Compounds 1-6, or combinations thereof serves to enhance the sweet taste of the sweetener. The compound of Formula (I), or any one of Compounds 1-6, or combinations thereof may be present at or below its sweetness threshold. In such cases, the compound serves only to enhance the sweet taste of the sweetener. A person of skill in the art will be able to select the concentration of the sweet taste modulator so that it may impart the perception of enhanced sweetness to a composition comprising a sweetener. For example, a skilled artisan may select a concentration for the sweet taste modulator so that it does not impart any perceptible sweetness to a composition that does not comprise a sweetener. Non-limiting examples of such sweeteners include caloric carbohydrate sweeteners, natural carbohydrate sweeteners, non-natural
carbohydrate sweeteners, natural high-potency sweeteners, non-natural high- potency sweeteners, synthetic high potency sweeteners, synthetic carbohydrate sweeteners, and combinations thereof.
[0090] In some embodiments, the edible composition further comprises functional ingredients. The term "functional ingredient" refers to compound which provide a real or perceived heath benefit to the composition. Functional ingredients include, but are not limited to, saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydration agents, probiotics, prebiotics, weight management agents, osteoporosis
management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, phytosterols, and combinations thereof.
[0091] In some embodiments the edible compositions are beverages. In further embodiments, the beverage can also contain one or more functional ingredients, which provide a real or perceived heath benefit to the composition. Functional ingredients include, but are not limited to, saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydration agents, probiotics, prebiotics, weight management agents, osteoporosis
management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, phytosterols and combinations thereof.
[0092] In certain embodiments, the functional ingredient is at least one saponin. As used herein, the at least one saponin may comprise a single saponin or a plurality of saponins as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one saponin is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0093] Saponins are glycosidic natural plant products comprising an aglycone ring structure and one or more sugar moieties. The combination of the nonpolar aglycone and the water soluble sugar moiety gives saponins surfactant properties, which allow them to form a foam when shaken in an aqueous solution.
[0094] The saponins are grouped together based on several common properties. In particular, saponins are surfactants which display hemolytic activity and form complexes with cholesterol. Although saponins share these properties, they are structurally diverse. The types of aglycone ring structures forming the ring structure in saponins can vary greatly. Non-limiting examples of the types of aglycone ring structures in saponin for use in particular embodiments of the
invention include steroids, triterpenoids, and steroidal alkaloids. Non-limiting examples of specific aglycone ring structures for use in particular embodiments of the invention include soyasapogenol A, soyasapogenol B and soyasopogenol E. The number and type of sugar moieties attached to the aglycone ring structure can also vary greatly. Non-limiting examples of sugar moieties for use in particular embodiments of the invention include glucose, galactose, glucuronic acid, xylose, rhamnose, and methylpentose moieties. Non- limiting examples of specific saponins for use in particular embodiments of the invention include group A acetyl saponin, group B acetyl saponin, and group E acetyl saponin.
[0095] Saponins can be found in a large variety of plants and plant products, and are especially prevalent in plant skins and barks where they form a waxy protective coating. Several common sources of saponins include soybeans, which have approximately 5% saponin content by dry weight, soapwort plants {Saponaria), the root of which was used historically as soap, as well as alfalfa, aloe, asparagus, grapes, chickpeas, yucca, and various other beans and weeds. Saponins may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. A description of conventional extraction techniques can be found in U.S. Pat. Appl. No. 2005/0123662, the disclosure of which is expressly incorporated by reference.
[0096] In certain embodiments, the functional ingredient is at least one antioxidant. As used herein, the at least one antioxidant may comprise a single antioxidant or a plurality of antioxidants as a functional ingredient for the edible compositions {e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one antioxidant is present in the edible composition {e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0097] As used herein "antioxidant" refers to any substance which inhibits, suppresses, or reduces oxidative damage to cells and biomolecules. Without being bound by theory, it is believed that antioxidants inhibit, suppress, or reduce oxidative damage to cells or biomolecules by stabilizing free radicals before they can cause harmful reactions. As such, antioxidants may prevent or postpone the onset of some degenerative diseases.
[0098] Examples of suitable antioxidants for embodiments of this invention include, but are not limited to, vitamins, vitamin cofactors, minerals, hormones, carotenoids, carotenoid terpenoids, non-carotenoid terpenoids, flavonoids, flavonoid polyphenolics (e.g., bioflavonoids), flavonols, flavones, phenols, polyphenols, esters of phenols, esters of polyphenols, nonflavonoid phenolics, isothiocyanates, and combinations thereof. In some embodiments, the antioxidant is vitamin A, vitamin C, vitamin E, ubiquinone, mineral selenium, manganese, melatonin, a-carotene, β-carotene, lycopene, lutein, zeanthin, crypoxanthin, reservatol, eugenol, quercetin, catechin, gossypol, hesperetin, curcumin, ferulic acid, thymol, hydroxytyrosol, tumeric, thyme, olive oil, lipoic acid, glutathinone, gutamine, oxalic acid, tocopherol-derived compounds, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), ethylenediaminetetraacetic acid (EDTA), tert-butylhydroquinone, acetic acid, pectin, tocotrienol, tocopherol, coenzyme Q10, zeaxanthin, astaxanthin, canthaxantin, saponins, limonoids, kaempfedrol, myricetin, isorhamnetin, proanthocyanidins, quercetin, rutin, luteolin, apigenin, tangeritin, hesperetin, naringenin, erodictyol, flavan-3-ols (e.g., anthocyanidins), gallocatechins, epicatechin and its gallate forms, epigallocatechin and its gallate forms (ECGC) theaflavin and its gallate forms, thearubigins, isoflavone
phytoestrogens, genistein, daidzein, glycitein, anythocyanins, cyaniding, delphinidin, malvidin, pelargonidin, peonidin, petunidin, ellagic acid, gallic acid, salicylic acid, rosmarinic acid, cinnamic acid and its derivatives (e.g., ferulic acid), chlorogenic acid, chicoric acid, gallotannins, ellagitannins, anthoxanthins, betacyanins and other plant pigments, silymarin, citric acid, lignan, antinutrients, bilirubin, uric acid, R-a-lipoic acid, N-acetylcysteine, emblicanin, apple extract, apple skin extract (applephenon), rooibos extract red, rooibos extract, green, hawthorn berry extract, red raspberry extract, green coffee antioxidant (GCA), aronia extract 20%, grape seed extract (VinOseed), cocoa extract, hops extract, mangosteen extract, mangosteen hull extract, cranberry extract, pomegranate extract, pomegranate hull extract, pomegranate seed extract, hawthorn berry extract, pomella pomegranate extract, cinnamon bark extract, grape skin extract, bilberry extract, pine bark extract, pycnogenol, elderberry extract, mulberry root extract, wolfberry (goji) extract, blackberry extract, blueberry extract, blueberry
leaf extract, raspberry extract, turmeric extract, citrus bioflavonoids, black currant, ginger, acai powder, green coffee bean extract, green tea extract, and phytic acid, or combinations thereof. In alternate embodiments, the antioxidant is a synthetic antioxidant such as butylated hydroxytolune or butylated hydroxyanisole, for example. Other sources of suitable antioxidants for embodiments of this invention include, but are not limited to, fruits, vegetables, tea, cocoa, chocolate, spices, herbs, rice, organ meats from livestock, yeast, whole grains, or cereal grains.
[0099] Particular antioxidants belong to the class of phytonutrients called polyphenols (also known as "polyphenolics"), which are a group of chemical substances found in plants, characterized by the presence of more than one phenol group per molecule. A variety of health benefits may be derived from
polyphenols, including prevention of cancer, heart disease, and chronic
inflammatory disease and improved mental strength and physical strength, for example. Suitable polyphenols for embodiments of this invention, include catechins, proanthocyanidins, procyanidins, anthocyanins, quercerin, rutin, reservatrol, isoflavones, curcumin, punicalagin, ellagitannin, hesperidin, naringin, citrus flavonoids, chlorogenic acid, other similar materials, and combinations thereof.
[0100] In particular embodiments, the antioxidant is a catechin such as, for example, epigallocatechin gallate (EGCG). Suitable sources of catechins for embodiments of this invention include, but are not limited to, green tea, white tea, black tea, oolong tea, chocolate, cocoa, red wine, grape seed, red grape skin, purple grape skin, red grape juice, purple grape juice, berries, pycnogenol, and red apple peel.
[0101] In some embodiments, the antioxidant is chosen from proanthocyanidins, procyanidins or combinations thereof. Suitable sources of proanthocyanidins and procyanidins for embodiments of this invention include, but are not limited to, red grapes, purple grapes, cocoa, chocolate, grape seeds, red wine, cacao beans, cranberry, apple peel, plum, blueberry, black currants, choke berry, green tea, sorghum, cinnamon, barley, red kidney bean, pinto bean, hops, almonds, hazelnuts, pecans, pistachio, pycnogenol, and colorful berries.
[0102] In particular embodiments, the antioxidant is an anthocyanin. Suitable sources of anthocyanins for embodiments of this invention include, but are not limited to, red berries, blueberries, bilberry, cranberry, raspberry, cherry, pomegranate, strawberry, elderberry, choke berry, red grape skin, purple grape skin, grape seed, red wine, black currant, red currant, cocoa, plum, apple peel, peach, red pear, red cabbage, red onion, red orange, and blackberries.
[0103] In some embodiments, the antioxidant is chosen from quercetin, rutin or combinations thereof. Suitable sources of quercetin and rutin for embodiments of this invention include, but are not limited to, red apples, onions, kale, bog whortleberry, lingonberrys, chokeberry, cranberry, blackberry, blueberry, strawberry, raspberry, black currant, green tea, black tea, plum, apricot, parsley, leek, broccoli, chili pepper, berry wine, and ginkgo.
[0104] In some embodiments, the antioxidant is resveratrol. Suitable sources of resveratrol for embodiments of this invention include, but are not limited to, red grapes, peanuts, cranberry, blueberry, bilberry, mulberry, Japanese Itadori tea, and red wine.
[0105] In particular embodiments, the antioxidant is an isoflavone. Suitable sources of isoflavones for embodiments of this invention include, but are not limited to, soy beans, soy products, legumes, alfalfa spouts, chickpeas, peanuts, and red clover.
[0106] In some embodiments, the antioxidant is curcumin. Suitable sources of curcumin for embodiments of this invention include, but are not limited to, turmeric and mustard.
[0107] In particular embodiments, the antioxidant is chosen from punicalagin, ellagitannin or combinations thereof. Suitable sources of punicalagin and ellagitannin for embodiments of this invention include, but are not limited to, pomegranate, raspberry, strawberry, walnut, and oak-aged red wine.
[0108] In some embodiments, the antioxidant is a citrus flavonoid, such as hesperidin or naringin. Suitable sources of citrus flavonids, such as hesperidin or naringin, for embodiments of this invention include, but are not limited to, oranges, grapefruits, and citrus juices.
[0109] In particular embodiments, the antioxidant is chlorogenic acid. Suitable sources of chlorogenic acid for embodiments of this invention include, but are not limited to, green coffee, yerba mate, red wine, grape seed, red grape skin, purple grape skin, red grape juice, purple grape juice, apple juice, cranberry, pomegranate, blueberry, strawberry, sunflower, Echinacea, pycnogenol, and apple peel.
[0110] In certain embodiments, the functional ingredient is at least one dietary fiber source. As used herein, the at least one dietary fiber source may comprise a single dietary fiber source or a plurality of dietary fiber sources as a functional ingredient for the edible compositions (e.g., beverages) provided herein.
Generally, according to particular embodiments of this invention, the at least one dietary fiber source is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0111] Numerous polymeric carbohydrates having significantly different structures in both composition and linkages fall within the definition of dietary fiber. Such compounds are well known to those skilled in the art, non-limiting examples of which include non-starch polysaccharides, lignin, cellulose, methylcellulose, the hemicelluloses, β-glucans, pectins, gums, mucilage, waxes, inulins, oligosaccharides, fructooligosaccharides, cyclodextrins, chitins, and combinations thereof.
[0112] Polysaccharides are complex carbohydrates composed of
monosaccharides joined by glycosidic linkages. Non-starch polysaccharides are bonded with β-linkages, which humans are unable to digest due to a lack of an enzyme to break the β-linkages. Conversely, digestable starch polysaccharides generally comprise a(l-4) linkages.
[0113] Lignin is a large, highly branched and cross-linked polymer based on oxygenated phenylpropane units. Cellulose is a linear polymer of glucose molecules joined by a β(1-4) linkage, which mammalian amylases are unable to hydrolyze. Methylcellulose is a methyl esther of cellulose that is often used in foodstuffs as a thickener, and emulsifier. It is commercially available (e.g., Citrucel by GlaxoSmithKline, Celevac by Shire Pharmaceuticals). Hemicelluloses are highly branched polymers consisting mainly of glucurono- and 4-0- methylglucuroxylans. β-Glucans are mixed-linkage (1-3), (1-4) β-D-glucose
polymers found primarily in cereals, such as oats and barley. Pectins, such as beta pectin, are a group of polysaccharides composed primarily of D-galacturonic acid, which is methoxylated to variable degrees.
[0114] Gums and mucilages represent a broad array of different branched structures. Guar gum, derived from the ground endosperm of the guar seed, is a galactomannan. Guar gum is commercially available (e.g., Benefiber by Novartis AG). Other gums, such as gum arabic and pectins, have still different structures. Still other gums include xanthan gum, gellan gum, tara gum, psylium seed husk gum, and locust been gum.
[0115] Waxes are esters of ethylene glycol and two fatty acids, generally occurring as a hydrophobic liquid that is insoluble in water.
[0116] Inulins comprise naturally occurring oligosaccharides belonging to a class of carbohydrates known as fructans. They generally are comprised of fructose units joined by β(2-1) glycosidic linkages with a terminal glucose unit.
Oligosaccharides are saccharide polymers containing typically three to six component sugars. They are generally found either O- or N-linked to compatible amino acid side chains in proteins or to lipid molecules. Fructooligosaccharides are oligosaccharides consisting of short chains of fructose molecules.
[0117] Food sources of dietary fiber include, but are not limited to, grains, legumes, fruits, and vegetables. Grains providing dietary fiber include, but are not limited to, oats, rye, barley, wheat,. Legumes providing fiber include, but are not limited to, peas and beans such as soybeans. Fruits and vegetables providing a source of fiber include, but are not limited to, apples, oranges, pears, bananas, berries, tomatoes, green beans, broccoli, cauliflower, carrots, potatoes, celery. Plant foods such as bran, nuts, and seeds (such as flax seeds) are also sources of dietary fiber. Parts of plants providing dietary fiber include, but are not limited to, the stems, roots, leaves, seeds, pulp, and skin.
[0118] Although dietary fiber generally is derived from plant sources, indigestible animal products such as chitins are also classified as dietary fiber. Chitin is a polysaccharide composed of units of acetylglucosamine joined by β(1- 4) linkages, similar to the linkages of cellulose.
[0119] Sources of dietary fiber often are divided into categories of soluble and insoluble fiber based on their solubility in water. Both soluble and insoluble fibers are found in plant foods to varying degrees depending upon the characteristics of the plant. Although insoluble in water, insoluble fiber has passive hydrophilic properties that help increase bulk, soften stools, and shorten transit time of fecal solids through the intestinal tract.
[0120] Unlike insoluble fiber, soluble fiber readily dissolves in water. Soluble fiber undergoes active metabolic processing via fermentation in the colon, increasing the colonic microflora and thereby increasing the mass of fecal solids. Fermentation of fibers by colonic bacteria also yields end-products with significant health benefits. For example, fermentation of the food masses produces gases and short-chain fatty acids. Acids produced during fermentation include butyric, acetic, propionic, and valeric acids that have various beneficial properties such as stabilizing blood glucose levels by acting on pancreatic insulin release and providing liver control by glycogen breakdown. In addition, fiber fermentation may reduce atherosclerosis by lowering cholesterol synthesis by the liver and reducing blood levels of LDL and triglycerides. The acids produced during fermentation lower colonic pH, thereby protecting the colon lining from cancer polyp formation. The lower colonic pH also increases mineral absorption, improves the barrier properties of the colonic mucosal layer, and inhibits inflammatory and adhesion irritants. Fermentation of fibers also may benefit the immune system by stimulating production of T-helper cells, antibodies, leukocytes, splenocytes, cytokinins and lymphocytes.
[0121] In certain embodiments, the functional ingredient is at least one fatty acid.
[0122] As used herein, the at least one fatty acid may be single fatty acid or a plurality of fatty acids as a functional ingredient for the sweetener edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one fatty acid is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0123] As used herein, "fatty acid" refers to any straight chain monocarboxylic acid and includes saturated fatty acids, unsaturated fatty acids, long chain fatty
acids, medium chain fatty acids, short chain fatty acids, fatty acid precursors (including omega-9 fatty acid precursors), and esterified fatty acids. As used herein, "long chain polyunsaturated fatty acid" refers to any polyunsaturated carboxylic acid or organic acid with a long aliphatic tail. As used herein, "omega- 3 fatty acid" refers to any polyunsaturated fatty acid having a first double bond as the third carbon-carbon bond from the terminal methyl end of its carbon chain. In particular embodiments, the omega-3 fatty acid may comprise a long chain omega- 3 fatty acid. As used herein, "omega-6 fatty acid" any polyunsaturated fatty acid having a first double bond as the sixth carbon-carbon bond from the terminal methyl end of its carbon chain.
[0124] Suitable omega-3 fatty acids for use in embodiments of the present invention can be derived from algae, fish, animals, plants, or combinations thereof, for example. Examples of suitable omega-3 fatty acids include, but are not limited to, linolenic acid, alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, stearidonic acid, eicosatetraenoic acid and combinations thereof. In some embodiments, suitable omega-3 fatty acids can be provided in fish oils, (e.g. , menhaden oil, tuna oil, salmon oil, bonito oil, and cod oil), microalgae omega-3 oils or combinations thereof. In particular embodiments, suitable omega-3 fatty acids may be derived from commercially available omega-3 fatty acid oils such as Microalgae DHA oil (from Martek, Columbia, MD), OmegaPure (from Omega Protein, Houston, TX), Marinol C-38 (from Lipid Nutrition, Channahon, IL), Bonito oil and MEG-3 (from Ocean Nutrition, Dartmouth, NS), Evogel (from Symrise, Holzminden, Germany), Marine Oil, from tuna or salmon (from Arista Wilton, CT), OmegaSource 2000, Marine Oil, from menhaden and Marine Oil, from cod (from OmegaSource, RTP, NC).
[0125] Suitable omega-6 fatty acids include, but are not limited to, linoleic acid, gamma-linolenic acid, dihommo-gamma-linolenic acid, arachidonic acid, eicosadienoic acid, docosadienoic acid, adrenic acid, docosapentaenoic acid and combinations thereof.
[0126] Suitable esterified fatty acids for embodiments of the present invention may include, but are not limited to, monoacylgycerols containing omega-3 and/or omega-6 fatty acids, diacylgycerols containing omega-3 and/or omega-6 fatty
acids, or triacylgycerols containing omega-3 and/or omega-6 fatty acids and combinations thereof.
[0127] In certain embodiments, the functional ingredient is at least one vitamin. As used herein, the at least one vitamin may be single vitamin or a plurality of vitamins as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one vitamin is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0128] Vitamins are organic compounds that the human body needs in small quantities for normal functioning. The body uses vitamins without breaking them down, unlike other nutrients such as carbohydrates and proteins. To date, thirteen vitamins have been recognized, and one or more can be used in the functional sweetener and sweetened compositions herein. Suitable vitamins include, vitamin A, vitamin D, vitamin E, vitamin K, vitamin Bl , vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B9, vitamin B12, and vitamin C. Many of vitamins also have alternative chemical names, non-limiting examples of which are provided below.
[0129] Various other compounds have been classified as vitamins by some authorities. These compounds may be termed pseudo-vitamins and include, but are not limited to, compounds such as ubiquinone (coenzyme Q10), pangamic acid, dimethylglycine, taestrile, amygdaline, flavanoids, para-aminobenzoic acid, adenine, adenylic acid, and s-methylmethionine. As used herein, the term vitamin includes pseudo-vitamins.
[0130] In some embodiments, the vitamin is a fat-soluble vitamin chosen from vitamin A, D, E, K and combinations thereof.
[0131] In other embodiments, the vitamin is a water-soluble vitamin chosen from vitamin Bl , vitamin B2, vitamin B3, vitamin B6, vitamin B12, folic acid, biotin, pantothenic acid, vitamin C and combinations thereof.
[0132] In certain embodiments, the functional ingredient is glucosamine.
Generally, according to particular embodiments of this invention, glucosamine is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0133] Glucosamine, also called chitosamine, is an amino sugar that is believed to be an important precursor in the biochemical synthesis of glycosylated proteins and lipids. D-glucosamine occurs naturally in the cartilage in the form of glucosamine-6-phosphate, which is synthesized from fructose-6-phosphate and glutamine. However, glucosamine also is available in other forms, non-limiting examples of which include glucosamine hydrochloride, glucosamine sulfate, N- acetyl-glucosamine, or any other salt forms or combinations thereof. Glucosamine
may be obtained by acid hydrolysis of the shells of lobsters, crabs, shrimps, or prawns using methods well known to those of ordinary skill in the art. In a particular embodiment, glucosamine may be derived from fungal biomass containing chitin, as described in U.S. Patent Publication No. 2006/0172392.
[0134] The edible composition (e.g., beverage) can further comprise chondroitin sulfate.
[0135] In certain embodiments, the functional ingredient is at least one mineral.
[0136] As used herein, the at least one mineral may be single mineral or a plurality of minerals as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one mineral is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0137] Minerals, in accordance with the teachings of this invention, comprise inorganic chemical elements required by living organisms. Minerals are comprised of a broad range of compositions (e.g., elements, simple salts, and complex silicates) and also vary broadly in crystalline structure. They may naturally occur in foods and beverages, may be added as a supplement, or may be consumed or administered separately from foods or beverages.
[0138] Minerals may be categorized as either bulk minerals, which are required in relatively large amounts, or trace minerals, which are required in relatively small amounts. Bulk minerals generally are required in amounts greater than or equal to about 100 mg per day and trace minerals are those that are required in amounts less than about 100 mg per day.
[0139] In particular embodiments of this invention, the mineral is chosen from bulk minerals, trace minerals or combinations thereof. Non-limiting examples of bulk minerals include calcium, chlorine, magnesium, phosphorous, potassium, sodium, and sulfur. Non-limiting examples of trace minerals include chromium, cobalt, copper, fluorine, iron, manganese, molybdenum, selenium, zinc, and iodine. Although iodine generally is classified as a trace mineral, it is required in larger quantities than other trace minerals and often is categorized as a bulk mineral.
[0140] In other particular embodiments of this invention, the mineral is a trace mineral, believed to be necessary for human nutrition, non-limiting examples of
which include bismuth, boron, lithium, nickel, rubidium, silicon, strontium, tellurium, tin, titanium, tungsten, and vanadium.
[0141] The minerals embodied herein may be in any form known to those of ordinary skill in the art. For example, in a particular embodiment the minerals may be in their ionic form, having either a positive or negative charge. In another particular embodiment the minerals may be in their molecular form. For example, sulfur and phosphorous often are found naturally as sulfates, sulfides, and phosphates.
[0142] In certain embodiments, the functional ingredient is at least one preservative. As used herein, the at least one preservative may be single preservative or a plurality of preservatives as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one preservative is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0143] In particular embodiments of this invention, the preservative is chosen from antimicrobials, antioxidants, antienzymatics or combinations thereof. Non- limiting examples of antimicrobials include sulfites, propionates, benzoates, sorbates, nitrates, nitrites, bacteriocins, salts, sugars, acetic acid, dimethyl dicarbonate (DMDC), ethanol, and ozone.
[0144] According to a particular embodiment, the preservative is a sulfite.
Sulfites include, but are not limited to, sulfur dioxide, sodium bisulfite, and potassium hydrogen sulfite.
[0145] According to another particular embodiment, the preservative is a propionate. Propionates include, but are not limited to, propionic acid, calcium propionate, and sodium propionate.
[0146] According to yet another particular embodiment, the preservative is a benzoate. Benzoates include, but are not limited to, sodium benzoate and benzoic acid.
[0147] In another particular embodiment, the preservative is a sorbate. Sorbates include, but are not limited to, potassium sorbate, sodium sorbate, calcium sorbate, and sorbic acid.
[0148] In still another particular embodiment, the preservative is a nitrate and/or a nitrite. Nitrates and nitrites include, but are not limited to, sodium nitrate and sodium nitrite.
[0149] In yet another particular embodiment, the at least one preservative is a bacteriocin, such as, for example, nisin.
[0150] In another particular embodiment, the preservative is ethanol.
[0151] In still another particular embodiment, the preservative is ozone.
[0152] Non-limiting examples of antienzymatics suitable for use as preservatives in particular embodiments of the invention include ascorbic acid, citric acid, and metal chelating agents such as ethylenediaminetetraacetic acid (EDTA).
[0153] In certain embodiments, the functional ingredient is at least one hydration agent. As used herein, the at least one hydration agent may be single hydration agent or a plurality of hydration agents as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one hydration agent is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0154] Hydration products help the body to replace fluids that are lost through excretion. For example, fluid is lost as sweat in order to regulate body
temperature, as urine in order to excrete waste substances, and as water vapor in order to exchange gases in the lungs. Fluid loss can also occur due to a wide range of external causes, non-limiting examples of which include physical activity, exposure to dry air, diarrhea, vomiting, hyperthermia, shock, blood loss, and hypotension. Diseases causing fluid loss include diabetes, cholera, gastroenteritis, shigellosis, and yellow fever. Forms of malnutrition that cause fluid loss include the excessive consumption of alcohol, electrolyte imbalance, fasting, and rapid weight loss.
[0155] In a particular embodiment, the hydration product is a composition that helps the body replace fluids that are lost during exercise. Accordingly, in a particular embodiment, the hydration product is an electrolyte, non-limiting examples of which include sodium, potassium, calcium, magnesium, chloride, phosphate, bicarbonate, and combinations thereof. Suitable electrolytes for use in
particular embodiments of this invention are also described in U.S. Patent No. 5,681,569, the disclosure of which is expressly incorporated herein by reference. In particular embodiments, the electrolytes are obtained from their corresponding water-soluble salts. Non-limiting examples of salts for use in particular
embodiments include chlorides, carbonates, sulfates, acetates, bicarbonates, citrates, phosphates, hydrogen phosphates, tartates, sorbates, citrates, benzoates, or combinations thereof. In other embodiments, the electrolytes are provided by juice, fruit extracts, vegetable extracts, tea, or teas extracts.
[0156] In particular embodiments of this invention, the hydration product is a carbohydrate to supplement energy stores burned by muscles. Suitable
carbohydrates for use in particular embodiments of this invention are described in U.S. Patent Numbers 4,312,856, 4,853,237, 5,681,569, and 6,989,171, the disclosures of which are expressly incorporated herein by reference. Non-limiting examples of suitable carbohydrates include monosaccharides, disaccharides, oligosaccharides, complex polysaccharides or combinations thereof. Non- limiting examples of suitable types of monosaccharides for use in particular embodiments include trioses, tetroses, pentoses, hexoses, heptoses, octoses, and nonoses. Non- limiting examples of specific types of suitable monosaccharides include
glyceraldehyde, dihydroxyacetone, erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose, tagatose, mannoheptulose, sedoheltulose, octolose, and sialose. Non-limiting examples of suitable
disaccharides include sucrose, lactose, and maltose. Non-limiting examples of suitable oligosaccharides include saccharose, maltotriose, and maltodextrin. In other particular embodiments, the carbohydrates are provided by a corn syrup, a beet sugar, a cane sugar, a juice, or a tea.
[0157] In another particular embodiment, the hydration is a flavanol that provides cellular rehydration. Flavanols are a class of natural substances present in plants, and generally comprise a 2-phenylbenzopyrone molecular skeleton attached to one or more chemical moieties. Non- limiting examples of suitable flavanols for use in particular embodiments of this invention include catechin, epicatechin, gallocatechin, epigallocatechin, epicatechin gallate, epigallocatechin 3-gallate,
theaflavin, theaflavin 3-gallate, theaflavin 3'-gallate, theaflavin 3,3' gallate, thearubigin or combinations thereof. Several common sources of flavanols include tea plants, fruits, vegetables, and flowers. In preferred embodiments, the flavanol is extracted from green tea.
[0158] In a particular embodiment, the hydration product is a glycerol solution to enhance exercise endurance. The ingestion of a glycerol containing solution has been shown to provide beneficial physiological effects, such as expanded blood volume, lower heart rate, and lower rectal temperature.
[0159] In certain embodiments, the functional ingredient is chosen from at least one probiotic, prebiotic and combination thereof. As used herein, the at least one probiotic or prebiotic may be single probiotic or prebiotic or a plurality of probiotics or prebiotics as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one probiotic, prebiotic or combination thereof is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0160] Probiotics, in accordance with the teachings of this invention, comprise microorganisms that benefit health when consumed in an effective amount.
Desirably, probiotics beneficially affect the human body's naturally-occurring gastrointestinal microflora and impart health benefits apart from nutrition.
Probiotics may include, without limitation, bacteria, yeasts, and fungi.
[0161] According to particular embodiments, the probiotic is a beneficial microorganisms that beneficially affects the human body's naturally-occurring gastrointestinal microflora and imparts health benefits apart from nutrition.
Examples of probiotics include, but are not limited to, bacteria of the genus Lactobacilli, Bifidobacteria, Streptococci, or combinations thereof, that confer beneficial effects to humans.
[0162] In particular embodiments of the invention, the at least one probiotic is chosen from the genus Lactobacilli. Lactobacilli (i.e., bacteria of the genus Lactobacillus, hereinafter "L.") have been used for several hundred years as a food preservative and for promoting human health. Non-limiting examples of species of Lactobacilli found in the human intestinal tract include L. acidophilus, L. casei, L.
fermentum, L. saliva roes, L. brevis, L. leichmannii, L. plantarum, L. cellobiosus, L. reuteri, L. rhamnosus, L. GG, L. bulgaricus, and L. thermophilus, .
[0163] According to other particular embodiments of this invention, the probiotic is chosen from the genus Bifidobacteria. Bifidobacteria also are known to exert a beneficial influence on human health by producing short chain fatty acids (e.g. , acetic, propionic, and butyric acids), lactic, and formic acids as a result of carbohydrate metabolism. Non-limiting species of Bifidobacteria found in the human gastrointestinal tract include B. angulatum, B. animalis, B. asteroides, B. bifidum, B. bourn, B. breve, B. catenulatum, B. choerinum, B. coryneforme, B. cuniculi, B. dentium, B. gallicum, B. gallinarum, B indicum, B. longum, B.
magnum, B. merycicum, B. minimum, B. pseudocatenulatum, B. pseudolongum, B. psychraerophilum, B. pullorum, B. ruminantium, B. saeculare, B. scardovii, B. simiae, B. subtile, B. thermacidophilum, B. thermophilum, B. urinalis, and B. sp.
[0164] According to other particular embodiments of this invention, the probiotic is chosen from the genus Streptococcus. Streptococcus thermophilus is a gram- positive facultative anaerobe. It is classified as lactic acid bacteria, commonly found in milk and milk products, and is used in the production of yogurt. Other non-limiting probiotic species of this bacteria include Streptococcus salivarus and Streptococcus cremoris.
[0165] Probiotics that may be used in accordance with this invention are well- known to those of skill in the art. Non-limiting examples of foodstuffs comprising probiotics include yogurt, sauerkraut, kefir, kimchi, fermented vegetables, and other foodstuffs containing a microbial element that beneficially affects the host animal by improving the intestinal microbalance.
[0166] Prebiotics, in accordance with the teachings of this invention, are compositions that promote the growth of beneficial bacteria in the intestines.
Prebiotic substances can be consumed by a relevant probiotic, or otherwise assist in keeping the relevant probiotic alive or stimulate its growth. When consumed in an effective amount, prebiotics also beneficially affect the human body's naturally- occurring gastrointestinal microflora and thereby impart health benefits apart from just nutrition. Prebiotic foods enter the colon and serve as substrate for the endogenous bacteria, thereby indirectly providing the host with energy, metabolic
substrates, and essential micronutrients. The body's digestion and absorption of prebiotic foods is dependent upon bacterial metabolic activity, which salvages energy for the host from nutrients that escaped digestion and absorption in the small intestine.
[0167] Prebiotics, in accordance with the embodiments of this invention, include, without limitation, mucopolysaccharides, oligosaccharides, polysaccharides, amino acids, vitamins, nutrient precursors, proteins and combinations thereof.
[0168] According to a particular embodiment of this invention, the prebiotic is chosen from dietary fibers, including, without limitation, polysaccharides and oligosaccharides. These compounds have the ability to increase the number of probiotics, which leads to the benefits conferred by the probiotics. Non- limiting examples of oligosaccharides that are categorized as prebiotics in accordance with particular embodiments of this invention include fructooligosaccharides, inulins, isomalto-oligosaccharides, lactilol, lactosucrose, lactulose, pyrodextrins, soy oligosaccharides, transgalacto-oligosaccharides, and xylo-oligosaccharides.
[0169] According to other particular embodiments of the invention, the prebiotic is an amino acid. Although a number of known prebiotics break down to provide carbohydrates for probiotics, some probiotics also require amino acids for nourishment.
[0170] Prebiotics are found naturally in a variety of foods including, without limitation, bananas, berries, asparagus, garlic, wheat, oats, barley (and other whole grains), flaxseed, tomatoes, Jerusalem artichoke, onions and chicory, greens (e.g., dandelion greens, spinach, collard greens, chard, kale, mustard greens, turnip greens), and legumes (e.g., lentils, kidney beans, chickpeas, navy beans, white beans, black beans).
[0171] In certain embodiments, the functional ingredient is at least one weight management agent. As used herein, the at least one weight management agent may be single weight management agent or a plurality of weight management agents as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one weight management agent is present in the edible composition (e.g. , beverage) in a concentration sufficient to promote health and wellness.
[0172] As used herein, "a weight management agent" includes an appetite suppressant and/or a thermogenesis agent. As used herein, the phrases "appetite suppressant", "appetite satiation compositions", "satiety agents", and "satiety ingredients" are synonymous. The phrase "appetite suppressant" describes macronutrients, herbal extracts, exogenous hormones, anorectics, anorexigenics, pharmaceutical drugs, and combinations thereof, that when delivered in an effective amount, suppress, inhibit, reduce, or otherwise curtail a person's appetite. The phrase "thermogenesis agent" describes macronutrients, herbal extracts, exogenous hormones, anorectics, anorexigenics, pharmaceutical drugs, and combinations thereof, that when delivered in an effective amount, activate or otherwise enhance a person's thermogenesis or metabolism.
[0173] Suitable weight management agents include macronutrient selected from the group consisting of proteins, carbohydrates, dietary fats, and combinations thereof. Consumption of proteins, carbohydrates, and dietary fats stimulates the release of peptides with appetite-suppressing effects. For example, consumption of proteins and dietary fats stimulates the release of the gut hormone cholecytokinin (CCK), while consumption of carbohydrates and dietary fats stimulates release of Glucagon- like peptide 1 (GLP-1).
[0174] Suitable macronutrient weight management agents also include carbohydrates. Carbohydrates generally comprise sugars, starches, cellulose and gums that the body converts into glucose for energy. Carbohydrates often are classified into two categories, digestible carbohydrates (e.g., monosaccharides, disaccharides, and starch) and non-digestible carbohydrates (e.g., dietary fiber). Studies have shown that non-digestible carbohydrates and complex polymeric carbohydrates having reduced absorption and digestibility in the small intestine stimulate physiologic responses that inhibit food intake. Accordingly, the carbohydrates embodied herein desirably comprise non-digestible carbohydrates or carbohydrates with reduced digestibility. Non-limiting examples of such carbohydrates include polydextrose; inulin; monosaccharide-derived polyols such as erythritol, mannitol, xylitol, and sorbitol; disaccharide-derived alcohols such as isomalt, lactitol, and maltitol; and hydrogenated starch hydrolysates.
Carbohydrates are described in more detail herein below.
[0175] In another particular embodiment weight management agent is a dietary fat. Dietary fats are lipids comprising combinations of saturated and unsaturated fatty acids. Polyunsaturated fatty acids have been shown to have a greater satiating power than mono-unsaturated fatty acids. Accordingly, the dietary fats embodied herein desirably comprise poly-unsaturated fatty acids, non-limiting examples of which include triacylglycerols.
[0176] In a particular embodiment, the weight management agents is an herbal extract. Extracts from numerous types of plants have been identified as possessing appetite suppressant properties. Non-limiting examples of plants whose extracts have appetite suppressant properties include plants of the genus Hoodia,
Trichocaulon, Caralluma, Stapelia, Orbea, Asclepias, and Camelia. Other embodiments include extracts derived from Gymnema Sylvestre, Kola Nut, Citrus Auran tium, Yerba Mate, Griffonia Simplicifolia, Guarana, myrrh, guggul Lipid, and black current seed oil.
[0177] The herbal extracts may be prepared from any type of plant material or plant biomass. Non- limiting examples of plant material and biomass include the stems, roots, leaves, dried powder obtained from the plant material, and sap or dried sap. The herbal extracts generally are prepared by extracting sap from the plant and then spray-drying the sap. Alternatively, solvent extraction procedures may be employed. Following the initial extraction, it may be desirable to further fractionate the initial extract (e.g., by column chromatography) in order to obtain an herbal extract with enhanced activity. Such techniques are well known to those of ordinary skill in the art.
[0178] In a particular embodiment, the herbal extract is derived from a plant of the genus Hoodia, species of which include H. alstonii, H. currorii, H. dregei, H. flava, H. gordonii, H.jutatae, H. mossamedensis, H. officinalis, H. parviflorai, H. pedicellata, H. pilifera, H. ruschii, and H. triebneri. Hoodia plants are stem succulents native to southern Africa. A sterol glycoside of Hoodia, known as P57, is believed to be responsible for the appetite-suppressant effect of the Hoodia species.
[0179] In another particular embodiment, the herbal extract is derived from a plant of the genus Caralluma, species of which include C. indica, C.fimbriata, C.
attenuate, C. tuberculata, C. edulis, C. adscendens, C. stalagmifera, C. umbellate, C. penicillata, C. russeliana, C. retrospicens, C. Arabica, and C. lasiantha.
Carralluma plants belong to the same Subfamily as Hoodia, Asclepiadaceae. Caralluma are small, erect and fleshy plants native to India having medicinal properties, such as appetite suppression, that generally are attributed to glycosides belonging to the pregnane group of glycosides, non-limiting examples of which include caratuberside A, caratuberside B, bouceroside I, bouceroside II, bouceroside III, bouceroside IV, bouceroside V, bouceroside VI, bouceroside VII, bouceroside VIII, bouceroside IX, and bouceroside X.
[0180] In another particular embodiment, the at least one herbal extract is derived from a plant of the genus Trichocaulon. Trichocaulon plants are succulents that generally are native to southern Africa, similar to Hoodia, and include the species T. piliferum and T. officinale.
[0181] In another particular embodiment, the herbal extract is derived from a plant of the genus Stapelia or Orbea, species of which include S. gigantean and O. variegate, respectively. Both Stapelia and Orbea plants belong to the same Subfamily as Hoodia, Asclepiadaceae. Not wishing to be bound by any theory, it is believed that the compounds exhibiting appetite suppressant activity are saponins, such as pregnane glycosides, which include stavarosides A, B, C, D, E, F, G, H, I, J, and K.
[0182] In another particular embodiment, the herbal extract is derived from a plant of the genus Asclepias. Asclepias plants also belong to the Asclepiadaceae family of plants. Non- limiting examples of Asclepias plants include A. incarnate, A. curassayica, A. syriaca, and A. tuberose. Not wishing to be bound by any theory, it is believed that the extracts comprise steroidal compounds, such as pregnane glycosides and pregnane aglycone, having appetite suppressant effects.
[0183] In a particular embodiment, the weight management agent is an exogenous hormone having a weight management effect. Non-limiting examples of such hormones include CCK, peptide YY, ghrelin, bombesin and gastrin- releasing peptide (GRP), enterostatin, apolipoprotein A-IV, GLP-1, amylin, somastatin, and leptin.
[0184] In another embodiment, the weight management agent is a
pharmaceutical drug. Non-limiting examples include phentenime, diethylpropion, phendimetrazine, sibutramine, rimonabant, oxyntomodulin, floxetine
hydrochloride, ephedrine, phenethylamine, or other stimulants.
[0185] The at least one weight management agent may be utilized individually or in combination as a functional ingredient for the edible compositions (e.g., beverages) provided in this invention.
[0186] In certain embodiments, the functional ingredient is at least one osteoporosis management agent. As used herein, the at least one osteoporosis management agent may be single osteoporosis management agent or a plurality of osteoporosis management agent as a functional ingredient for the edible
compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one osteoporosis management agent is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0187] Osteoporosis is a skeletal disorder of compromised bone strength, resulting in an increased risk of bone fracture. Generally, osteoporosis is characterized by reduction of the bone mineral density (BMD), disruption of bone micro-architecture, and changes to the amount and variety of non-collagenous proteins in the bone.
[0188] In certain embodiments, the osteoporosis management agent is at least one calcium source. According to a particular embodiment, the calcium source is any compound containing calcium, including salt complexes, solubilized species, and other forms of calcium. Non-limiting examples of calcium sources include amino acid chelated calcium, calcium carbonate, calcium oxide, calcium
hydroxide, calcium sulfate, calcium chloride, calcium phosphate, calcium hydrogen phosphate, calcium dihydrogen phosphate, calcium citrate, calcium malate, calcium citrate malate, calcium gluconate, calcium tartrate, calcium lactate, solubilized species thereof, and combinations thereof.
[0189] According to a particular embodiment, the osteoporosis management agent is a magnesium source. The magnesium source is any compound containing magnesium, including salt complexes, solubilized species, and other forms of
magnesium. Non-limiting examples of magnesium sources include magnesium chloride, magnesium citrate, magnesium gluceptate, magnesium gluconate, magnesium lactate, magnesium hydroxide, magnesium picolate, magnesium sulfate, solubilized species thereof, and mixtures thereof. In another particular embodiment, the magnesium source comprises an amino acid chelated or creatine chelated magnesium.
[0190] In other embodiments, the osteoporosis agent is chosen from vitamins D, C, K, their precursors and/or beta-carotene and combinations thereof.
[0191] Numerous plants and plant extracts also have been identified as being effective in the prevention and treatment of osteoporosis. Not wishing to be bound by any theory, it is believed that the plants and plant extracts stimulates bone morphogenic proteins and/or inhibits bone resorption, thereby stimulating bone regeneration and strength. Non-limiting examples of suitable plants and plant extracts as osteoporosis management agents include species of the genus
Taraxacum and Amelanchier, as disclosed in U.S. Patent Publication No.
2005/0106215, and species of the genus Lindera, Artemisia, Acorus, Carthamus, Carum, Cnidium, Curcuma, Cyperus, Juniperus, Prunus, Iris, Cichorium, Dodonaea, Epimedium, Erigonoum, Soya, Mentha, Ocimum, thymus, Tanacetum, Plantago, Spearmint, Bixa, Vitis, Rosemarinus, Rhus, and Anethum, as disclosed in U.S. Patent Publication No. 2005/0079232.
[0192] In certain embodiments, the functional ingredient is at least one phytoestrogen. As used herein, the at least one phytoestrogen may be single phytoestrogen or a plurality of phytoestrogens as a functional ingredient for the edible compositions {e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one phytoestrogen is present in the edible compositions {e.g. , beverages) in a concentration sufficient to promote health and wellness.
[0193] Phytoestrogens are compounds found in plants which can typically be delivered into human bodies by ingestion of the plants or the plant parts having the phytoestrogens. As used herein, "phytoestrogen" refers to any substance which, when introduced into a body causes an estrogen-like effect of any degree. For
example, a phytoestrogen may bind to estrogen receptors within the body and have a small estrogen-like effect.
[0194] Examples of suitable phytoestrogens for embodiments of this invention include, but are not limited to, isoflavones, stilbenes, lignans, resorcyclic acid lactones, coumestans, coumestrol, equol, and combinations thereof. Sources of suitable phytoestrogens include, but are not limited to, whole grains, cereals, fibers, fruits, vegetables, black cohosh, agave root, black currant, black haw, chasteberries, cramp bark, dong quai root, devil's club root, false unicorn root, ginseng root, groundsel herb, licorice, liferoot herb, motherwort herb, peony root, raspberry leaves, rose family plants, sage leaves, sarsaparilla root, saw palmetto berried, wild yam root, yarrow blossoms, legumes, soybeans, soy products (e.g., miso, soy flour, soymilk, soy nuts, soy protein isolate, tempen, or tofu) chick peas, nuts, lentils, seeds, clover, red clover, dandelion leaves, dandelion roots, fenugreek seeds, green tea, hops, red wine, flaxseed, garlic, onions, linseed, borage, butterfly weed, caraway, chaste tree, vitex, dates, dill, fennel seed, gotu kola, milk thistle, pennyroyal, pomegranates, southernwood, soya flour, tansy, and root of the kudzu vine (pueraria root) and the like, and combinations thereof.
[0195] Isoflavones belong to the group of phytonutrients called polyphenols. In general, polyphenols (also known as "polyphenolics"), are a group of chemical substances found in plants, characterized by the presence of more than one phenol group per molecule.
[0196] Suitable phytoestrogen isoflavones in accordance with embodiments of this invention include genistein, daidzein, glycitein, biochanin A, formononetin, their respective naturally occurring glycosides and glycoside conjugates, matairesinol, secoisolariciresinol, enterolactone, enterodiol, textured vegetable protein, and combinations thereof.
[0197] Suitable sources of isoflavones for embodiments of this invention include, but are not limited to, soy beans, soy products, legumes, alfalfa spouts, chickpeas, peanuts, and red clover.
[0198] In certain embodiments, the functional ingredient is at least one long chain primary aliphatic saturated alcohol. As used herein, the at least one long chain primary aliphatic saturated alcohol may be single long chain primary
aliphatic saturated alcohol or a plurality of long chain primary aliphatic saturated alcohols as a functional ingredient for the edible compositions (e.g., beverages) provided herein. Generally, according to particular embodiments of this invention, the at least one long chain primary aliphatic saturated alcohol is present in the edible composition (e.g., beverage) in a concentration sufficient to promote health and wellness.
[0199] Long-chain primary aliphatic saturated alcohols are a diverse group of organic compounds. The term alcohol refers to the fact these compounds feature a hydroxyl group (-OH) bound to a carbon atom. The term primary refers to the fact that in these compounds the carbon atom which is bound to the hydroxyl group is bound to only one other carbon atom. The term saturated refers to the fact that these compounds feature no carbon to carbon pi bonds. The term aliphatic refers to the fact that the carbon atoms in these compounds are joined together in straight or branched chains rather than in rings. The term long-chain refers to the fact that the number of carbon atoms in these compounds is at least 8 carbons).
[0200] Non-limiting examples of particular long-chain primary aliphatic saturated alcohols for use in particular embodiments of the invention include the 8 carbon atom 1-octanol, the 9 carbon 1-nonanol, the 10 carbon atom 1-decanol, the 12 carbon atom 1-dodecanol, the 14 carbon atom 1-tetradecanol, the 16 carbon atom 1-hexadecanol, the 18 carbon atom 1-octadecanol, the 20 carbon atom 1- eicosanol, the 22 carbon 1-docosanol, the 24 carbon 1-tetracosanol, the 26 carbon 1-hexacosanol, the 27 carbon 1-heptacosanol, the 28 carbon 1-octanosol, the 29 carbon 1-nonacosanol, the 30 carbon 1-triacontanol, the 32 carbon 1- dotriacontanol, and the 34 carbon 1-tetracontanol.
[0201] In a particularly desirable embodiment of the invention, the long-chain primary aliphatic saturated alcohols are policosanol. Policosanol is the term for a mixture of long-chain primary aliphatic saturated alcohols composed primarily of 28 carbon 1-octanosol and 30 carbon 1-triacontanol, as well as other alcohols in lower concentrations such as 22 carbon 1-docosanol, 24 carbon 1-tetracosanol, 26 carbon 1-hexacosanol, 27 carbon 1-heptacosanol, 29 carbon 1-nonacosanol, 32 carbon 1-dotriacontanol, and 34 carbon 1-tetracontanol.
[0202] Long-chain primary aliphatic saturated alcohols are derived from natural fats and oils. They may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. Policosanols can be isolated from a variety of plants and materials including sugar cane (Saccharum officinarium), yams (e.g. Dioscorea opposite), bran from rice (e.g. Oryza sativa), and beeswax. Policosanols may be obtained from these sources by using extraction techniques well known to those of ordinary skill in the art. A description of such extraction techniques can be found in U.S. Pat. Appl. No. 2005/0220868, the disclosure of which is expressly incorporated by reference.
[0203] In certain embodiments, the functional ingredient is at least one phytosterol, phytostanol or combination thereof. Generally, according to particular embodiments of this invention, the at least one phytosterol, phytostanol or combination thereof is present in the edible composition {e.g., beverage) in a concentration sufficient to promote health and wellness.
[0204] As used herein, the phrases "stanol", "plant stanol" and "phytostanol" are synonymous.
[0205] Plant sterols and stanols are present naturally in small quantities in many fruits, vegetables, nuts, seeds, cereals, legumes, vegetable oils, bark of the trees and other plant sources. Although people normally consume plant sterols and stanols every day, the amounts consumed are insufficient to have significant cholesterol-lowering effects or other health benefits. Accordingly, it would be desirable to supplement food and beverages with plant sterols and stanols.
[0206] Sterols are a subgroup of steroids with a hydroxyl group at C-3.
Generally, phytosterols have a double bond within the steroid nucleus, like cholesterol; however, phytosterols also may comprise a substituted sidechain (R) at C-24, such as an ethyl or methyl group, or an additional double bond. The structures of phytosterols are well known to those of skill in the art.
[0207] At least 44 naturally-occurring phytosterols have been discovered, and generally are derived from plants, such as corn, soy, wheat, and wood oils;
however, they also may be produced synthetically to form compositions identical to those in nature or having properties similar to those of naturally-occurring phytosterols. According to particular embodiments of this invention, non-limiting
examples of phytosterols well known to those or ordinary skill in the art include 4- desmethylsterols (e.g., β-sitosterol, campesterol, stigmasterol, brassicasterol, 22- dehydrobrassicasterol, and A5-avenasterol), 4-monomethyl sterols, and 4,4- dimethyl sterols (triterpene alcohols) (e.g. , cycloartenol, 24-methylenecycloartanol, and cyclobranol).
[0208] As used herein, the phrases "stanol", "plant stanol" and "phytostanol" are synonymous. Phytostanols are saturated sterol alcohols present in only trace amounts in nature and also may be synthetically produced, such as by
hydrogenation of phytosterols. According to particular embodiments of this invention, non- limiting examples of phytostanols include β-sitostanol,
campestanol, cycloartanol, and saturated forms of other triterpene alcohols.
[0209] Both phytosterols and phytostanols, as used herein, include the various isomers such as the a and β isomers (e.g., a-sitosterol and β-sitostanol, which comprise one of the most effective phytosterols and phytostanols, respectively, for lowering serum cholesterol in mammals).
[0210] The phytosterols and phytostanols of the present invention also may be in their ester form. Suitable methods for deriving the esters of phytosterols and phytostanols are well known to those of ordinary skill in the art, and are disclosed in U.S. Patent Numbers 6,589,588, 6,635,774, 6,800,317, and U.S. Patent
Publication Number 2003/0045473, the disclosures of which are incorporated herein by reference in their entirety. Non-limiting examples of suitable phytosterol and phytostanol esters include sitosterol acetate, sitosterol oleate, stigmasterol oleate, and their corresponding phytostanol esters. The phytosterols and phytostanols of the present invention also may include their derivatives.
[0211] Generally, the amount of functional ingredient in the edible composition (e.g. , beverage) varies widely depending on the particular edible composition (e.g. , beverage) and the desired functional ingredient. Those of ordinary skill in the art will readily ascertain the appropriate amount of functional ingredient for each beverage.
[0212] In some embodiments, the edible composition further comprises a solubilizing agent, as discussed herein. Compounds - such as sweet taste modulators - have a particular solubility in aqueous solutions. As would be
evident to one of skill in the art, the solubility of a compound depends on a number of factors including, but not limited to, the chemical structure of the compound, the solvent, the pH of the solvent, etc. Solubilizing agents may be used to increase the amount of a compound, such as a sweet taste modulator, that may be dissolved in a particular amount of solvent. In some embodiments, a compound according to Formula (I) or Compounds 1-6, as defined herein, is solubilized by converting the compound into one or more crystalline forms, amorphous forms, one or more alcohol solvate forms, one or more hydrate forms, or mixtures thereof.
[0213] In some embodiments, the edible composition further comprises a surfactant to increase or decrease the effectiveness of the compounds of the present invention as sweet taste modulators. Suitable surfactants include, but are not limited to, non-ionic surfactants (e.g., mono and diglycerides, fatty acid esters, sorbitan esters, propylene glycol esters, and lactylate esters) anionic surfactants (e.g., sulfosuccinates and lecithin) and cationic surfactants (e.g., quaternary ammonium salts).
[0214] The rate of release of the sweet taste modulator of the present invention may be regulated. The release rate of the sweet taste modulator of the present invention can be altered by, for example, varying its solubility in water. Rapid release can be achieved by encapsulating the sweet taste modulator of the present invention with a material with high water solubility. Delayed release of the sweet taste modulator of the present invention can be achieved by encapsulating the sweet taste modulator of the present invention with a material with low water solubility. The sweet taste modulator of the present invention can be
co-encapsulated with carbohydrates or masking tastants such as sweeteners. The rate of release of the sweet taste modulator of the present invention can also be regulated by the degree of encapsulation. In some embodiments, the sweet taste modulator of the present invention is fully encapsulated. In other embodiments, the compounds of the present invention are partially encapsulated. In some embodiments, the rate of release may be regulated so as to release with the sweet taste modulator. In some embodiments, the rate of release may be regulated in a manner that is dependent on the structure of the sweetener and sweet taste modulator.
[0215] The edible compositions of this invention are prepared according to techniques well-known in the art. In general, an edible composition of the invention is prepared by mixing a component or ingredient of the edible composition, such as a sweetener, with a sweet taste modulating compound of the invention. Alternatively, a sweet taste modulating compound of the invention can be added directly to the edible composition comprising a sweetener. In some embodiments, a sweetener is added simultaneously or sequentially with a sweet taste modulating compound of the invention. If sequentially, the sweetener may be added before or after the sweet taste modulating compound of the invention. In some embodiments, the edible composition is a food product. In some
embodiments, the edible composition is a pharmaceutical composition. In some embodiments, the edible composition is a consumer product. In some
embodiments, the edible composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
[0216] The amount of both a sweet taste modulating compound of the present invention and a sweetener used in an edible composition depends upon a variety of factors, including the purpose of the composition and the desired or acceptable perception of sweetness. The amount may depend on the nature of the edible composition, the particular compound added, the sweetener, other compounds present in the composition, the method of preparation (including amount of heat used), and the pH of the edible composition. Those of skill in the art will know how to determine the amounts needed to produce the desired taste(s).
[0217] When the edible compositions are formulated for ingestion via the oral cavity, a sweet taste modulating compound of the invention may be present at any of the concentrations effective for modulating the sweetness of a sweetener listed above.
[0218] In some embodiments, the edible compositions are formulated as a concentrate, which is intended for dilution prior to consumption. Such
concentrates include syrups, frozen concentrates, dry mixes, and food additives. When present in a concentrate, the sweet taste modulating compound of Formula (I), any one of Compounds 1-6, as described herein, or combinations thereof are
present at a concentration about 2-fold, about 3-fold, about 4-fold, about 5-fold, about 6-fold, about 7-fold, about 8-fold, about 9-fold, about 10-fold, about 15-fold, about 20-fold, about 25 -fold, about 30-fold, about 35 -fold, about 40-fold, about 45- fold, about 50-fold, about 55 -fold, about 60-fold, about 65 -fold, about 70-fold, about 75-fold, about 80-fold, about 85-fold, about 90-fold, about 95-fold, about 100-fold, about 150-fold, about 200-fold, about 250-fold, about 300-fold, about 350-fold, about 400-fold, about 450-fold, about 500-fold, about 550-fold, about 600-fold, about 650-fold, about 700-fold, about 750-fold, about 800-fold, about 850-fold, about 900-fold, about 950-fold, or about 1000-fold above any of the effective concentrations discussed herein. Accordingly, the sweet taste
modulating compounds may be present in a concentrate - for later dilution - at concentration between about 1 ppm and 5000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate at a concentration between about 1 to 3000 ppm; 10 to 1000 ppm; 50 to 500 ppm; 50 to 250 ppm; 50 to 100 ppm; 100 to 300 ppm; 100 to 500 ppm; 100 to 1000 ppm; 30 to 3000 ppm; 100 to 3000 ppm; 500 to 1000 ppm; 500 to 3000 ppm; or 1000 to 3000 ppm. In yet other embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of
Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of about 50 to 3000 ppm, 50 to 1000 ppm or 50 to 500 ppm. In additional embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a
concentration of about 1 to 500 ppm; 1 to 250 ppm; 1 to 100 ppm; 1 to 50 ppm; 10 to 500 ppm; 10 to 250 ppm; 10 to 100 ppm; 50 to 500 ppm; 50 to 250 ppm; or 50 to 100 ppm.
[0219] In some embodiments, when present in a concentrate, the sweet taste modulating compound of Formula (I), any one of Compounds 1-6, as described herein, or combinations thereof are present at a concentration 2-fold, 3 -fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, 10-fold, 15-fold, 20-fold, 25-fold, 30-fold, 35- fold, 40-fold, 45-fold, 50-fold, 55-fold, 60-fold, 65-fold, 70-fold, 75-fold, 80-fold,
85-fold, 90-fold, 95-fold, 100-fold, 150-fold, 200-fold, 250-fold, 300-fold, 350- fold, 400-fold, 450-fold, 500-fold, 550-fold, 600-fold, 650-fold, 700-fold, 750-fold, 800-fold, 850-fold, 900-fold, 950-fold, or 1000-fold above any of the effective concentrations discussed herein. The sweet taste modulating compounds may be present in a concentrate - for later dilution - at concentration between 1 ppm and 5000 ppm. In some embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate at a concentration between 1 to 3000 ppm; 10 to 1000 ppm; 50 to 500 ppm; 50 to 250 ppm; 50 to 100 ppm; 100 to 300 ppm; 100 to 500 ppm; 100 to 1000 ppm; 30 to 3000 ppm; 100 to 3000 ppm; 500 to 1000 ppm; 500 to 3000 ppm; or 1000 to 3000 ppm. In yet other
embodiments, the sweet taste modulator of the present invention (e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of 50 to 3000 ppm, 50 to 1000 ppm or 50 to 500 ppm. In additional embodiments, the sweet taste modulator of the present invention (e.g., a compound of Formula (I), or any one of
Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of 1 to 500 ppm; 1 to 250 ppm; 1 to 100 ppm; 1 to 50 ppm; 10 to 500 ppm; 10 to 250 ppm; 10 to 100 ppm; 50 to 500 ppm; 50 to 250 ppm; or 50 to 100 ppm.
[0220] The sweet taste modulator of the present invention (e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of about 50 ppm, about 75 ppm, about 100 ppm, about 150 ppm, about 200 ppm, about 250 ppm, about 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, about 500 ppm, about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, about 800 ppm, about 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1050 ppm, about 1 100 ppm, about 1 150 ppm, about 1200 ppm, about 1250 ppm, about 1300 ppm, about 1350 ppm, about 1400 ppm, about 1450 ppm, about 1500 ppm, about 1550 ppm, about 1600 ppm, about 1650 ppm, about 1700 ppm, about 1750 ppm, about 1800 ppm, about 1850 ppm, about 1900 ppm, about 1950 ppm, about 2000 ppm, about 2050 ppm, about 2100 ppm, about 2150 ppm, about 2200 ppm,
about 2250 ppm, about 2300 ppm, about 2350 ppm, about 2400 ppm, about 2450 ppm, about 2500 ppm, about 2550 ppm, about 2600 ppm, about 2650 ppm, about 2700 ppm, about 2750 ppm, about 2800 ppm, about 2850 ppm, about 2900 ppm, about 2950 ppm, or about 3000 ppm.
[0221] The sweet taste modulator of the present invention (e.g. , a compound of Formula (I), or any one of Compounds 1-6, or combinations thereof) may be present in a concentrate for dilution at a concentration of 50 ppm, 75 ppm, 100 ppm, 150 ppm, 200 ppm, 250 ppm, 300 ppm, 350 ppm, 400 ppm, 450 ppm, 500 ppm, 550 ppm, 600 ppm, 650 ppm, 700 ppm, 750 ppm, 800 ppm, 850 ppm, 900 ppm, 950 ppm, 1000 ppm, 1050 ppm, 1 100 ppm, 1 150 ppm, 1200 ppm, 1250 ppm, 1300 ppm, 1350 ppm, 1400 ppm, 1450 ppm, 1500 ppm, 1550 ppm, 1600 ppm, 1650 ppm, 1700 ppm, 1750 ppm, 1800 ppm, 1850 ppm, 1900 ppm, 1950 ppm, 2000 ppm, 2050 ppm, 2100 ppm, 2150 ppm, 2200 ppm, 2250 ppm, 2300 ppm, 2350 ppm, 2400 ppm, 2450 ppm, 2500 ppm, 2550 ppm, 2600 ppm, 2650 ppm, 2700 ppm, 2750 ppm, 2800 ppm, 2850 ppm, 2900 ppm, 2950 ppm, or 3000 ppm.
[0222] In some embodiments, the edible composition further comprises a sweet taste improving composition.
[0223] As already mentioned, one or more or all the compounds of formula (I) to be used according to the invention can also be used in the form of plant extracts. For this purpose, the plant extracts are preferably obtained from the corresponding fresh or dried plants or parts of plants. The dried plant parts (for example fresh or dried roots, root bark, tubers, bulbs, other subterranean or aerial storage organs, spurious fruits, fruits, seeds, bark, wood, pulp, bast, stalks, stems, leaves or blossom (parts)) preferably in crushed form, are extracted with a solvent suitable for foodstuffs and indulgence foods at temperatures of 0°C up to the boiling point of the respective solvent or solvent mixture, then filtered and the filtrate is partly or completely concentrated, preferably by distillation, freeze or spray drying. The raw extract obtained thus can then be further worked up, for example counter-extracted, purified by distributing, absorption, exclusion, affinity or ion chromatography, distilled, sublimated, purified with adsorbents such as active carbon, bentonite, kieselguhr etc, treated enzymatically (for example with glycosidases to increase the yield of non-sugar-containing molecules), with acid (for example under pressure),
with suitable basic solutions, for example of hydroxides, carbonates or hydrogen carbonates of sodium, potassium, calcium, magnesium and zinc, with acidic ion exchangers or with water vapor, mixed with an auxiliary and carrier usually at pressures of 0.01 mbar to 100 bar, preferably 1 mbar to 20 bar and optionally dried (for example spray-dried) and/or taken up in a solvent suitable for foodstuffs and indulgence foods.
[0224] Solvents suitable for extraction for foodstuffs and indulgence foods include, in particular, water, ethanol, methanol, propylene glycol, glycerin, acetone, dichloromethane, ethyl acetate, diethyl ester, hexane, heptane, triacetin, vegetable oils or fats, supercritical carbon dioxide and mixtures thereof.
[0225] Preferred auxiliaries or carriers include maltodextrin, starch, natural or artificial polysaccharides and/or vegetable gums such as modified starches or gum arabic, coloring agents, for example permitted foodstuff dyes, coloring plant extracts, stabilizers, preservatives, antioxidants, viscosity-influencing substances
[0226] The edible compositions may be included in a package. Optionally, the edible composition is packaged in bulk, in which the package contains more of the compositions than would typically be used for a single dish or serving of food or beverage. Such bulk packages can be in the form of paper, plastic, or cloth bags or cardboard boxes or drums. Such bulk packages may be fitted with plastic or metal spouts to facilitate the dispensing of the edible composition.
[0227] The package may contain an edible composition comprising a sweet taste modulating compound of the present invention and a sweetener. In some embodiments, the package contains an edible composition comprising a sweet taste modulating compound of the present invention and caloric carbohydrate sweetener. In some embodiments, the package contains an edible composition comprising a sweet taste modulating compound of the present invention and glucose, fructose, sucrose, or a mixture thereof. In some embodiments, the package contains an edible composition comprising a sweet taste modulating compound of the present invention and a synthetic sweetener. In some embodiments, the package contains an edible composition comprising a sweet taste modulating compound of the present invention and a natural high-potency sweetener.
[0228] The edible compositions may be used for medicinal or hygienic purposes, for example, in mouthwash, medicines, pharmaceuticals, cough syrup, throat spray, toothpaste, dental adhesives, tooth whiteners, glues (e.g., on stamps and
envelopes), and toxins used in insect and rodent control.
[0229] In some embodiments of the disclosure, the sweetener composition is in a form of a tabletop sweetener composition comprising at least one sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof, at least one sweetener, at least one bulking agent, and optionally at least one sweet taste improving composition and/or anti-caking agent with improved temporal and/or flavor profile.
[0230] For example, suitable "bulking agents" include, but are not limited to maltodextrin (10 DE, 18 DE, or 5 DE), corn syrup solids (20 or 36 DE), sucrose, fructose, glucose, invert sugar, sorbitol, xylose, ribulose, mannose, xylitol, mannitol, galactitol, erythritol, maltitol, lactitol, isomalt, maltose, tagatose, lactose, inulin, glycerol, propylene glycol, polyols, polydextrose, fructooligosaccharides, cellulose and cellulose derivatives, and mixtures thereof. Additionally, the at least one bulking agent is chosen from, granulated sugar (sucrose) or other caloric sweeteners such as crystalline fructose, other carbohydrates, and sugar alcohols. In one embodiment, a bulking agent may be used as a sweet taste improving composition.
[0231] As used herein the phrase "anti-caking agent" is understood to mean any composition which prevents, reduces, inhibits, or suppresses at least one sweetener molecule from attaching, binding, or contacting to another sweetener molecule. Alternatively, "anti-caking agent" may refer to any composition which assists in content uniformity and uniform dissolution. In accordance with some
embodiments, non-limiting examples of anti-caking agents include cream of tartar, calcium silicate, silicon dioxide, microcrystalline cellulose (Avicel, FMC
BioPolymer, Philadelphia, Pa.), and tricalcium phosphate. In at least one embodiment, the anti-caking agents are present in the tabletop sweetener composition in an amount from about 0.001 to about 3% by weight of the tabletop sweetener composition. In at least one embodiment, the anti-caking agents are
present in the tabletop sweetener composition in an amount from 0.001 to 3% by weight of the tabletop sweetener composition.
[0232] Tabletop sweetener compositions may be embodied and packaged in numerous different forms, and may be of any form known in the art. For example, and not by way of limitation, the tabletop sweetener compositions may be in the form of powders, granules, packets, tablets, sachets, pellets, cubes, solids, or liquids.
Method of preparing an edible composition
[0233] According to another aspect, the invention provides a method of preparing an edible composition. The method comprises: (a) providing a sweetener; and (b) adding to the sweetener of (a) a compound of Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof. In some embodiments, the sweet taste modulator of the invention has been solubilized prior to the addition step (b). In other embodiments, a solubilizing agent is added to the composition. In some embodiments, the sweetener of step (a) is provided in a comestibly acceptable carrier. The skilled artisan will appreciate that method steps (a) and (b) can be performed in any order - i.e., the method may comprise: (a) adding a compound of Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof; and (b) adding a sweetener to the Compound(s) of (a).
[0234] In some embodiments, the method comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a solubilizing agent, as discussed herein. In some embodiments, the method further comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a solvent.
[0235] Methods for solubilizing compounds of the present invention include but are not limited to chemical, physical or mechanical means. Additives, solubilizing or stabilizing agents may provide chemical means for increasing the concentration of compounds of the present invention in solution. Application of mechanical forces resulting in shearing, dispersion or emulsification of compounds of the present invention may also result in an increase in the concentration of compounds of the present invention in solution. Changes in temperature, pressure, and/or pH
are non-limiting physical means for increasing the solubility of compounds of the present invention and/or maintaining the concentration of the compound in solution. The mechanical, physical or chemical means may be used in
combination, in the presence or absence of cosolvents, surfactant systems, complexing agents and also including self-assembling nanomicelles,
nanosuspensions, micronization and cocrystallizations. The methods as well as the importance of increasing the solubility of compounds in solution are well known in the art, for example, "Drug solubility: importance and enhancement techniques", ISRN Pharmaceutics, volume 2012, article ID 195727, Ketan T. Savjani, Anuradha K. Gajjar and Jignasa K. Savjani.
[0236] Solubilizing agents include, but are not limited to, glycoprotein- polysaccharides, such as Gum Arabic; homopolymers, such as poly(N-vinyl- pyrrolidone); medium chain mono- and diglycerides, such as Capmul MCM;
oligosaccharides, such as Hp-beta-cyclodextrin, alpha-cyclodextrin, beta- cyclodextrin or gamma-cyclodextrin, and cellulose; polyglycerol esters, such as Caprol PEG 860®, Caprol 10G40® or Drewpol 10-1-CC®; polysorbates, such as Tween 20® (polysorbate 20), Tween 60® (polysorbate 60), and Tween 80®
(polysorbate 80); and saponin/triterpene glycoside, such as quillaja saponin or Q- NATURALE®. For example, solubilizing agents include, but are not limited to, GRINDSTED® ACETEM, alpha-Cyclodextrin, beta-Cyclodextrin, DATEM, Decaglycerol dioleate, Decaglycerol monooleate, Decaglycerol monostearate, Ethoxylated monoglyceride, gamma-Cyclodextrin, Glycerol monoleate, Glycerol monostearate, Glyerol dioleate, Gum Arabic, Hexaglycerol dioleate, Hp-beta- Cyclodextrin, Lecithin, Methyl cellulose, Oleic acid, Poly(N-vinyl-pyrrolidone), Polyoxyethylene (20) sorbitan monooleate, Polyoxyethylene (20) sorbitan monopalmitate, Polyoxyethylene (20) sorbitan monostearate, Polyoxyethylene (20) sorbitan trioleate, Polyoxyethylene (20) sorbitan tristearate, Polysaccharides, polysorbate 20, polysorbate 60, polysorbate 80, Potassium oleate, Propylene glycol monostearate, Propylene glycol monolaurate, Quillaja saponins, Sodium lauryl sulfate, Sodium oleate, Sodium stearoyllactylate, Sorbitan monolaurate, Sorbitan trioleate, Sorbitan tristearate, Sorbitan monooleate, Sorbitan monostearate, Sucrose monoester, and Sucrose monolaurate. In some embodiments, the solubilizing
agent is alpha-Cyclodextrin, beta-Cyclodextrin, gamma-Cyclodextrin, Gum
Arabic, Hp-beta-Cyclodextrin, Lecithin, Methyl cellulose, Poly(N-vinyl- pyrrolidone), or Quillaja saponins (Q-NATURALE®). In some embodiments, the solubilizing agent is alpha-Cyclodextrin. In some embodiments, the solubilizing agent is beta-Cyclodextrin. In some embodiments, the solubilizing agent is gamma-Cyclodextrin. In some embodiments, the solubilizing agent is Gum
Arabic. In some embodiments, the solubilizing agent is Hp-beta-Cyclodextrin. In some embodiments, the solubilizing agent is Lecithin. In some embodiments, the solubilizing agent is Methyl cellulose. In some embodiments, the solubilizing agent is Poly(N-vinyl-pyrrolidone). In some embodiments, the solubilizing agent is Quillaja saponins. Solubilizing agents may be used at concentrations between 0.001% to 50% to solubilize the compounds of the invention. In some
embodiments, concentrations of solubilizing agents in the final product range from about 0.05% to about 2%. In some embodiments, concentrations of solubilizing agents in the final product range from 0.05% to 2%.
[0237] Solvents for dissolving the sweet taste modulator of the invention include, but are not limited to, 1,3-butylene glycol, amyl acetate, benzyl alcohol, butane - 1,3-diol, castor oil, diethyl tartrate, diethylene glycol monoethyl ether, ethyl acetate, ethyl alcohol, glycerin, glycerol, glycerol diacetate, isopropyl alcohol, NEOBEE® M-5 oil, propylene glycol, and triacetin. In some embodiments, the solvent is 1,3-butylene glycol. In some embodiments, the solvent is amyl acetate. In some embodiments, the solvent is benzyl alcohol. In some embodiments, the solvent is butane- 1,3-diol. In some embodiments, the solvent is castor oil. In some embodiments, the solvent is diethyl tartrate. In some embodiments, the solvent is diethylene glycol monoethyl ether. In some embodiments, the solvent is ethyl acetate. In some embodiments, the solvent is ethyl alcohol. In some embodiments, the solvent is glycerin. In some embodiments, the solvent is glycerol. In some embodiments, the solvent is glycerol diacetate. In some embodiments, the solvent is isopropyl alcohol. In some embodiments, the solvent is propylene glycol. In some embodiments, the solvent is triacetin. Solvents may be used at concentrations between 0.001%> to 50%> to solubilize the compounds of
the invention. In some embodiments, solvent concentrations in the final product range from about 0.05 to about 2%.
[0238] In some embodiments, the method comprises adding a compound according to Formula (I) or Compounds 1-6, as defined herein, to a combination of solubilizing agents, a combination of solvents, or a combination of solubilizing agents and solvents. In some embodiments, the combination includes polysorbate 80 and Q-NATURALE®. In some embodiments, the combination includes propylene glycol and Q-NATURALE®. In some embodiments, the combination includes ethanol and Q-NATURALE®. In some embodiments, the combination includes triacetin, ethanol, propylene glycol, and polysorbate 80. In some embodiments, the combination includes NEOBEE® M-5 oil and Q-NATURALE®. In some embodiments, the combination includes NEOBEE® M-5 oil, lyso-lecithin and Q-NATURALE®. In some embodiments, the combination includes
NEOBEE® M-5 oil, lyso-lecithin, preserved water and Q-NATURALE®. In some embodiments, preserved water comprises one or more of sodium benzoate, potassium sorbate and citric acid. Optionally, preserved water comprises sodium benzoate, potassium sorbate and citric acid. In some emboidments, the
combination comprises NEOBEE® M-5 oil, triacetin and a citrus juice, such as orange juice, lemon juice or grapefruit juice, preferably orange juice. In some embodiments, solvent concentrations in the final product range from about 0.05 to about 2%.
[0239] In some embodiments, the method comprises co-melting a compound of the invention with sugar. In such embodiments, the compound of the invention and sugar (e.g., sucrose) are dissolved in a solvent. The sugar-compound solution may then be dried to produce a dry mixture, which may be heated to produce caramel-melts. Optionally, the caramel-melts are dissolved in a solvent, which may then be added to a beverage solution.
[0240] In some embodiments, the method results in a clear solution. In some embodiments, the method results in a solution with opacity. In some
embodiments, the method does not decrease the sweetness enhancing efficacy of the compound of the invention. In some embodiments, the method does not result in a solution with an off-taste.
[0241] In general, the method of preparing an edible composition of the invention comprises mixing a component or ingredient of the edible composition, such as a sweetener, with a sweet taste modulating compound of the invention. Alternatively, a sweet taste modulating compound of the invention can be added directly to the edible composition comprising a sweetener. In some embodiments, the sweetener is added to the edible composition simultaneously or sequentially with a sweet taste modulating compound of the invention. If sequentially, the sweetener may be added before or after the sweet taste modulating compound of the invention. When solubilizing agents are utilized, the method includes the addition of the solubilizing agent at any point. For example, if the composition compromises three components - the sweetener, the sweet taste modulating agent, and the solubilizing compound - the solubilizing compound may be added as the first, second, or third component. The solubilizing agent may also be added concurrently with any other component.
[0242] In some embodiments, the methods of preparing an edible composition further comprise adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
[0243] The edible compositions may be a food product, a pharmaceutical composition, or a consumer product. In some embodiments, the edible
composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
Method of enhancing or potentiating the perception of sweet taste
[0244] According to another aspect, the invention provides a method of enhancing the perception of sweet taste in a subject. The method comprises the use of an edible composition of the present invention, where the edible
composition comprises a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof. Optionally, the edible composition comprises (i) a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof; (ii) a sweetener; and optionally (iii) a solubilizing agent.
[0245] The terms "perception of a sweet taste," "perception of sweetness," "perception of a flavor" and similar terms, refer to the awareness of a subject of a particular taste or flavor.
[0246] The term "subject" refers to a mammal. In preferred embodiments, the subject is human. In some embodiments, a subject is a domestic or laboratory animal, including but not limited to, household pets, such as dogs, cats, pigs, rabbits, rats, mice, gerbils, hamsters, guinea pigs, and ferrets. In some
embodiments, a subject is a livestock animal. Non-limiting examples of livestock animals include: alpaca, bison, camel, cattle, deer, pigs, horses, llamas, mules, donkeys, sheep, goats, rabbits, reindeer, and yak.
[0247] The method can be used to enhance or potentiate sweet taste in any edible composition, including a foodstuff, food product, pharmaceutical composition or consumer product. The edible composition may be in any form. In some embodiments, the composition is in the form of, for example, a gum, lozenge, sauce, condiment, meat matrix, meat slurry, paste, suspension, spread, coating, a liquid, a gel, an emulsion, granules, or seasoning.
[0248] The edible composition may be utilized by, for example, placement in the oral cavity or by ingestion. In some embodiments, the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested before an edible composition, such as a foodstuff, a food product, pharmaceutical composition or consumer product, comprising a sweetener, while in other embodiments, the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested after a sweet food stuff, food product, pharmaceutical composition or consumer product. In other embodiments, the edible composition comprising a sweet taste modulator of the invention is placed in the oral cavity or ingested concurrently with a sweet food stuff, food product, pharmaceutical composition or consumer product, either as a separate edible composition or by incorporation in the sweet food stuff, food product, pharmaceutical composition or consumer product. For example, a sweet taste modulator of the invention can be combined with foodstuffs or food products to enhance or potentiate the sweet taste of a foodstuff or food product.
Alternatively, a sweet taste modulator of the invention can be used, for example, in
a lozenge or gum for use after exposure to a sweet food stuff, food product, pharmaceutical composition or consumer product (e.g. , to enhance or potentiate a sweet aftertaste).
Method of reducing the amount of a sweetener in an edible composition [0249] It may be desirable to reduce the amount of a caloric sweetener in an edible composition to reduce the calorie content of that edible composition. It may also be desirable to decrease the amount of a synthetic sweetener or a non-natural high potency sweetener in an edible composition to decrease an undesirable taste or aftertaste associated with the synthetic sweetener or non-natural high potency sweetener. Accordingly, another aspect of the present invention provides a method of reducing the amount of a sweetener in an edible composition, such as a food product, a pharmaceutical composition or a consumer product. An amount of the sweetener in the edible composition may be replaced with a sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
[0250] The term "replace" or "replacing" refers to substituting one compound for another compound in or in the preparation of, for example, an edible composition, such as food product. It includes complete and partial replacements or
substitutions.
[0251] In some embodiments, the method comprises: (a) replacing an amount of a sweetener used in preparing an edible composition with an amount of a sweet taste modulator according to Formula (I), any one of Compounds 1-6, or combinations thereof. In some embodiments, the sweet taste modulating compound of the invention is added in the form of an edible composition comprising the sweet taste modulator of the invention. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
[0252] In some embodiments, the method of reducing the amount of a sweetener in an edible composition comprises the steps of: (a) ingesting a first edible composition, in which the amount of a sweetener has been reduced; and (b) ingesting a second edible compound, which comprises a sweet taste modulator
compound of the present invention. In some embodiments, the first edible composition is ingested before the second edible composition. In some
embodiments, the first edible composition is ingested after the second edible composition. In some embodiments, the first edible composition is ingested concurrently with the second edible composition. In such methods, an amount of solubilizing agent may also be added along with the sweet taste modulator of the present invention.
[0253] In some embodiments, the edible composition is a food product. In some embodiments, the edible composition is a pharmaceutical composition. In some embodiments, the edible composition is a consumer product. The sweetener being replaced may be a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener, or combinations thereof. When the sweetener being replaced is a natural caloric sweetener, the sweetener may be sucrose, fructose, glucose, erythritol, high fructose corn/starch syrup, and mixtures thereof. When the sweetener being replaced is a synthetic sweetener, the sweetener may be sucralose, aspartame, potassium acesulfame, and mixtures thereof. The method also comprises replacing an amount of a natural caloric sweetener with a synthetic or natural high-potency sweetener and a sweet modulating compound of the present invention, such that any off-taste or after taste associated with the synthetic or natural high-potency sweetener is reduced or eliminated. In such embodiments, the "sweetener replaced" is the natural caloric sweetener.
[0254] In some embodiments, the methods of reducing sugar intake of a subject further comprise the step of identifying a subject in need thereof. The skilled worker would be able to identify a subject in need of reducing sugar intake. Non- limiting examples of such subjects include subjects that suffer from any one or more of the following disorders: diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia.
[0255] In some embodiments, the amount of the sweetener replaced in the edible composition in step (a) is an amount sufficient to maintain or restore the health of a subject. For example, the amount of the sweetener replaced in the edible composition may be an amount sufficient to decrease diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia in a subject. The
amount of the sweetener replaced may be up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99%. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention.
[0256] In some embodiments, the amount of the sweet taste modulating compound added in step (b) is effective to enhance the perception of sweet taste in the subject.
[0257] In some embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99% of the amount of sweetener present in the edible composition. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention. In some embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 25% of the amount of the sweetener present in the edible composition. In other embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 50%> of the amount of the sweetener present in the edible composition. In other embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 75% of the amount of the sweetener present in the edible composition. In yet other embodiments, the amount of the sweet taste modulating compound added in step (b) is sufficient to permit replacement of up to 99% of the amount of the sweetener present in the edible composition.
[0258] In some embodiments, the method of reducing the amount of a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive. Method of reducing caloric intake
[0259] Another aspect of the invention provides a method of reducing caloric intake of a subject. In some embodiments, the method comprises the step of
providing an edible composition to the subject, wherein all or a portion of a natural caloric sweetener in the edible composition is replaced with (a) a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof; or (b) one or more synthetic or natural high potency sweeteners and a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof. The edible composition may be a food product, a pharmaceutical composition, or a consumer product. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
[0260] The methods of reducing caloric intake of a subject may further comprise the step of identifying a subject in need thereof. The skilled worker would be able to identify a subject in need of reducing sugar intake. Non-limiting examples of such subjects include subjects that suffer from any one or more of the following disorders: diabetes, pre-diabetes, insulin resistance, obesity, excessive weight, and hyperglycemia.
[0261] In some embodiments, the amount of the natural caloric sweetener replaced in the edible composition is an amount sufficient to maintain or restore the health of a subject. For example, the amount of the natural caloric sweetener replaced in the edible composition may be an amount sufficient to result in weight loss in a subject. Alternatively, the amount of the natural caloric sweetener replaced in the edible composition may be an amount sufficient to alleviate the effects of, or treat, a disease associated with sugar consumption or excessive weight of the subject (e.g., diabetes). In some embodiments, the amount of the natural caloric sweetener replaced in the edible composition is up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%,
55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99%. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention. In some embodiments, the present method results in the subject's daily natural caloric sweetener intake being less than 250 g/day, less than 200 g/day, less than 175 g/day, less than 150 g/day, less than 125 g/day, less than 100 g/day, less than 75 g/day, less than 50 g/day, less
than 25 g/day, less than 20 g/day, less than 15 g/day, less than 10 g/day, or less than 25 g/day.
[0262] In some embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%, 90%, 95% or 99%. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention. In some embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 25%. In other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 50%. In other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 75%. In yet other embodiments, the amount of sweet taste modulating compound of the invention added to the edible composition is sufficient to permit reduction of a subject's natural caloric sweetener intake by up to 99%.
[0263] In some embodiments, the method of reducing the amount of a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive. Method of enhancing sweet taste of an edible composition
[0264] According to another embodiment, the invention provides methods of enhancing or potentiating the sweet taste in an edible composition. The edible composition may be a food product, a pharmaceutical composition, or a consumer product.
[0265] In one embodiment, the method comprises: (a) adding an effective amount of a sweet taste modulating compound according to Formula (I), or any one of Compounds 1-6, as described herein or combinations thereof, to an edible
composition comprising a sweetener such that the perception of sweetness intensity of the sweetener is enhanced. In some embodiments, the sweetener is either added to the edible composition before the sweet taste modulating compound; concurrently with the sweet taste modulating compound; or after the sweet taste modulating compound. In other embodiments, the sweetener is naturally or inherently present in the edible composition when the sweet taste modulating compound is added. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
[0266] Alternatively, the method comprises: (a) ingesting an effective amount of a sweet taste modulating compound according to Formula (I), or any one of
Compounds 1-6, as described herein, or combinations thereof, before, along with, or after the edible composition such that the perception of sweetness intensity of the sweetener is enhanced. In such methods, an amount of solubilizing agent may also be added to the edible composition, as described herein.
[0267] The edible composition may comprise a sweetener, such as a natural caloric sweetener, a natural high-potency sweetener, a synthetic sweetener, or combinations thereof. When the sweetener is a natural caloric sweetener, the sweetener may be sucrose, fructose, glucose, erythritol, high fructose corn/starch syrup, and mixtures thereof. When the sweetener is a synthetic sweetener, the sweetener may be sucralose, aspartame, potassium acesulfame, and mixtures thereof.
[0268] In some embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70% 75%, 80%, 85%o, 90%), 95%) or 100%>. In some embodiments, the perception of sweetness intensity of the sweetener is enhanced beyond 100%), for example, by 125%, 150%, 175%, 200%, 225%, 250%, 275%, 300%, 325%, 350%, 375%, 400%, 425%), 450%), 475%), 500%) or increments in between those recited. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention. In some embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 25%. In other embodiments, the perception of sweetness intensity of the sweetener is
enhanced by up to 50%. In other embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 75%. In other embodiments, the perception of sweetness intensity of the sweetener is enhanced by up to 100%. In some embodiments, the perception of sweetness intensity of the sweetener is enhanced by about 5-100%, 5-90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%, 10-35%, 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25-60%, 25-50%, 25-40%, or 25-30%. In some embodiments, the perception of sweetness intensity of the sweetener is enhanced by 5-100%, 5- 90%, 5-80%, 5-70%, 5-60%, 5-50%, 5-40%, 5-30%, 10-30%, 10-25%, 10-35%, 20-80%, 20-70%, 20-60%, 20-50%, 20-40%, 20-30%, 25-80%, 25-70%, 25-60%, 25-50%, 25-40%, or 25-30%. These amounts are not meant to be limiting, and increments between the recited percentages are specifically envisioned as part of the invention.
[0269] In some embodiments, the method of enhancing the sweet taste attributed to a sweetener in an edible composition further comprises adding at least one additional additive, such as a sweet taste improving composition, and/or a sweet taste improving additive.
Method of enhancing activation of a sweet taste receptor
[0270] Another aspect of the invention provides a method of enhancing or potentiating activation and/or signaling of a sweet taste receptor. In some embodiments, the method comprises contacting a sweet taste receptor with a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof, in the presence of a sweetener.
[0271] In some embodiments, the method comprises contacting a sweet taste receptor with an edible composition comprising a compound according to Formula (I), or any one of Compounds 1-6, as described herein, or combinations thereof, in the presence of a sweetener. The edible composition may be a food product, a pharmaceutical composition, or a consumer product. In such methods, an amount of solubilizing agent may also be present in the edible composition, as described herein.
[0272] In various embodiments, the sweet taste receptor is an ex vivo or in vivo receptor present in, for example, an assay. The sweet taste receptor also may be an
in vivo receptor present in a subject. In such embodiments, the sweet taste receptor is typically present in the oral cavity or gastrointestinal tract of the subject. In some embodiments, the sweet receptor is in the oral cavity of a human.
Alternatively, the sweet receptor is in the oral cavity of a non-human animal, such as an animal model.
[0273] An in vivo sweet responsive assay means an assay where an assessment of increased perception of sweetness can be ascribed. Such an assay may be, for example, but not limited to, a human sensory descriptive analysis panel, a human sensory discriminative panel, and/or an expert flavorist assessment. Non-human assessments of sweet response include, but not limited to, operant conditioned animal studies of sweetness taste perception and/or lick rate/amount bottle preference tests
[0274] An in vitro sweet responsive assay refers to an assay where an assessment of increased sweet response or interaction can be ascribed. An example of such an assay may be, but is not limited to, in vitro receptor binding assays, in vitro receptor cell-based assays, and/or electronic tongue taste analysis.
[0275] In some embodiments, enhancement of a sweet taste receptor activation will affect a physiological process or condition. Non-limiting examples of physiological processes and conditions affected by the enhancement of sweet taste receptor activation include sweet taste, effects on the gastrointestinal tract, appetite, nutrition, nutrient absorption, satiety, hunger, diabetes, obesity, blood glucose levels, blood glucose regulation, metabolism, diet, and eating disorders.
Methods and Preparations for Blocking or Masking Unpleasant Taste
[0276] In addition to sweetness modulation, compounds of Formula I, compounds 1-6 or combinations thereof, can be suitable for masking or reducing an unpleasant taste sensation, in particular a bitter taste sensation of a bitter-tasting substance. Compounds of Formula I, compounds 1-6 or combinations thereof, can both synergistically enhance the sweet taste sensation of sweeteners like steviol glycosides (for example occurring naturally in Stevia ssp.) and mask or reduce the bitter taste sensation of such steviol glycosides or other bitter tasting sweeteners such as acesulfame-K, saccharin, steviosides, or rebaudiosides. Preparations
comprising the bitter blocking compounds of the invention can be made in the same or similar manner and concentration as the preparations comprising the sweet taste enhancing preparations of the invention.
Preparation of the Compounds of the Invention In one embodiment, Compound 1 and Compound 4 are prepared by the multi-step sequences described below. One of skill in the art would be able to readily adapt the described conditions for the synthesis of any of the compounds of Formula (I).
[0277] Synthesis of racemic Compound 1 and chiral separation of enantiomers
l-(2,4-dihydroxy-3-methylphenyl)ethan-l-one (a) (5.00 g, 29.9 mmol) was dissolved in 50 mL of acetone. Potassium carbonate (4.96 g, 35.9 mmol) was added followed by the addition of chloromethyl methyl ether (2.7 mL). The mixture was stirred at room temperature for 4 hours, and concentrated. Ethyl acetate (200 mL) and water (100 mL) were added. The organic layer was washed with water, brine, dried with Na2S04 and concentrated to afford the crude product (6.3 g), which was used in the next step without further purification. LC-MS (retention time: 2.68 min, 21 1 [M+H]+).
[0279] 2: Preparation of (E)-l-(2-hy droxy-4-(methoxymethoxy)-3- methylphenyl)-3 -(3 -hydroxy-4-methoxyphenyl)prop-2-en- 1 -one (c)
l-(2-hydroxy-4-(methoxymethoxy)-3-methylphenyl)ethan-l-one (b) (from the above experiment, 6.30 g, 30.0 mmol) and 3-hydroxy-4-methoxy-benzaldehyde (4.60 g, 30.0 mmol) were dissolved in 20 mL of EtOH and 10 mL of aq. 50% KOH. The mixture was heated at 60 °C for 1 hour, and then 35 °C for 1 day. The reaction mixture was neutralized with ice-cold 10% aq. citric acid. The solid formed was filtered, washed with water twice and then dried to afford 6.6 g crude product, which was used in the next step without further purification. LC-MS (retention time: 3.18 min, 345 [M+H]+).
[0280] 3 : Preparation of 7-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-8- methylchroman-4-one (d)
(E)- 1 -(2-hydroxy-4-(methoxymethoxy)-3 -methylphenyl)-3 -(3 -hydroxy-4- methoxyphenyl)prop-2-en-l-one (c) (crude 4.30 g) was dissolved in 40 mL of 1.25 M HCl/MeOH. The mixture was heated at 85 °C for 4 hours. The reaction mixture was cooled down and concentrated. The residue was purified with silica gel chromatography (hexane/ethyl acetate: 70/30 for the first 10 minutes, then 50/50) to afford the desired product d (1.5 g, 25% for 3 steps) as a light yellow solid. LC- MS (retention time: 2.42 min, 301 [M+H]+). 1H NMR(CD3OD): 7.63 (d, J= 8.7 Hz, 1H), 6.98-7.04 (m, 3H), 6.56 (d, J= 8.7 Hz, 1H), 5.41 (dd, J= 12.5, 3.2 Hz, 1H), 3.91 (s, 3H), 2.97-3.07 (m, 1H), 2.75-2.82 (m, 1H), 2.11 (s, 3H).
[0281] 4: Preparation of 2-(3-hydroxy-4-methoxyphenyl)-8-methylchroman-7-ol (Compound 1)
7-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-8-methylchroman-4-one (d) (1.0 g, 3.33 mmol) was dissolved in 100 mL of MeOH. 2.0 mL of 1.25 M HCl/MeOH and Pt02 (35 mg, 0.15 mmol) was added into the above solution. The mixture was treated in a Parr hydrogenator at 55 psi for 2.5 hours. LC-MS showed the completion of reaction. 1.0 mL of diisopropylethyl amine (DIPEA) was added. The mixture was concentrated and purified with silica gel chromatography
(hexane/ethyl acetate: 70/30) to afford the desired Compound 1 (670 mg) in a yield of 67%. LC-MS (retention time: 2.61 min, 287 [M+H]+). 1H NMR (DMSO-D6): 8.98 (s, 2H), 6.77-6.92 (m, 3H), 6.67 (d, J= 8.2 Hz, 1H), 6.33 (d, J = 8.2 Hz, 1H), 4.93 (dd, J= 8.2, 2.2 Hz, 1H), 3.76 (s, 3H), 2.41-2.84 (m, 2H), 1.95 (s, 3H), 1.70- 2.10 (m, 2H). 1H NMR (CD3OD): 6.88-6.97 (m, 3H), 6.72 (d, J= 8.1 Hz, 1H),
6.36 (d, J= 8.1 Hz, 1H), 4.90-5.00 (m, 1H), 3.89 (s, 3H), 2.64-2.95 (m, 2H), 2.08 (s, 3H), 1.85-2.20 (m, 2H).
[0282] 1.6 g of racemic sample of Compound 1 was separated by SFC chiral chromatography to provide 826 mg of enantiomer, Compound 3 (retention time: 3.41 min, chiral column: CHIRALPAK AS-H 25x0.46 cm purchased from Chiral Technologies, 50% methanol/C02, 100 bar, flow rate of 3 mL/min) with >99% ee, and 775 mg Compound 2 (retention time: 7.05 min, chiral column: CHIRALPAK IA 25x0.46 cm purchased from Chiral Technologies, 50% methanol/C02, 100 bar, flow rate of 3 mL/min) with > 99% ee. 1H NMR (CD3OD): 6.88-6.97 (m, 3H), 6.72 (d, J= 8.1 Hz, 1H), 6.36 (d, J= 8.1 Hz, 1H), 4.80-5.10 (m, 1H), 3.89 (s, 3H), 2.64-2.95 (m, 2H), 2.08 (s, 3H), 1.85-2.20 (m, 2H). Compound 2 [a]20 D = -45.7 (c = 14.0 mg/mL, CHC13). Compound 2 is referred to as (S)-2-(3-hydroxy-4- methoxyphenyl)-8-methylchroman-7-ol or (-)-2-(3-hydroxy-4-methoxyphenyl)-8- methylchroman-7-ol. Compound 3 is referred to as (R)-2-(3-hydroxy-4- methoxyphenyl)-8-methylchroman-7-ol or (+)-2-(3-hydroxy-4-methoxyphenyl)-8- methylchroman-7-ol.
283] Synthesis of racemic Compound 4 and chiral separation of enantiomers
(S) (R)
[0284] 1 : Preparation of l-(2-hydroxy-4-(methoxymethoxy)-5- methylphenyl)ethan-l-one (B)
l-(2,4-dihydroxy-5-methylphenyl)ethan-l-one (A) (1.77 g, 10.6 mmol) was dissolved in 20 mL of acetone. Potassium carbonate (1.76 g, 12.71 mmol) was added followed by the addition of chloromethyl methyl ether (1 mL). The mixture
was stirred at room temperature for 4 hours, and concentrated. Ethyl acetate (100 mL) and water (50 mL) was added. The organic layer was washed with water, brine, dried with Na2S04 and concentrated. The residue was purified with chromatography (hexane/ethyl acetate: 70/30) to afford compound B (2.0 g, 90%) as white solid. LC-MS (retention time: 2.68 min, 21 1 [M+l]). 1H NMR (DMSO- D6): 12.45 (s, 1H), 7.73 (s, 1H), 6.57 (s, 1H), 5.50 (s, 2H), 3.43 (s, 3H), 2.58 (s, 3H), 2.15 (s, 3H).
[0285] 2: Preparation of (E)-l-(2-hydroxy-4-(methoxymethoxy)-5- methylphenyl)-3 -(3 -hydroxy-4-methoxyphenyl)prop-2-en- 1 -one (C) 1 -(2-hydroxy- 4-(methoxymethoxy)-5-methylphenyl)ethan-l-one (B) (2.0 g, 9.2 mmol) and 3- hydroxy-4-methoxy-benzaldehyde (1.45 g, 9.5 mmol) was in 10 mL of EtOH and 5 mL of aq. 50% KOH. The mixture was heated at 60 °C for 1 hour, and then 35 °C for 1 day. The reaction mixture was neutralized with ice-cold 10% aq. citric acid. The solid formed was filtered, washed with water twice, dried, and then purified with silica-gel chromatography (hexane/ethyl acetate: 100/0 to 50/50 in 15 minutes) to afford the product C (1.7 g, 50%>) as yellow solid. LC-MS (retention time: 3.09 min, 345 [M+H]+).
[0286] 3 : Preparation of 7-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6- methylchroman-4-one (D)
(E)- 1 -(2-hydroxy-4-(methoxymethoxy)-5 -methylphenyl)-3 -(3 -hydroxy-4- methoxyphenyl)prop-2-en-l-one (C) (1.0 g, 3.3 mmol) was dissolved in 10 mL of 1.25 M HCl/MeOH. The mixture was heated at 85 °C for 4 hours. The reaction mixture was cooled down and concentrated. The residue was purified with silica gel chromatography (hexane/ethyl acetate: 100/0 to 50/50 in 5 minutes, then 50/50) to afford the desired product D (450 mg, 45%) as a light yellow solid. LC-MS, (retention time: 2.37 min, 301 [M+H]+).
[0287] 4: Preparation of 2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-7-ol (Compound 4)
7-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-4-one (D) (850 mg, 2.83 mmol) was dissolved in 25 mL of MeOH. 0.5 mL of 1.25 M HCl/MeOH and Pt02 (25 mg, 0.1 1 mmol) was added into the above solution. The mixture was treated in a Parr hydrogenator at 50 psi for 3 hours. LC-MS showed the completion
of reaction. 0.3 mL of diisopropylethyl amine (DIPEA) was added. The mixture was concentrated and purified with silica gel chromatography (hexane/ethyl acetate: 100/0 to 70/30 in 5 minutes, then 70/30) to afford the desired Compound 4 (570 mg) in a yield of 70%. LC-MS (retention time: 2.64 min, 287 [M+H]+). 1H NMR (CD3OD): 6.85-6.95 (m, 3H), 6.76 (s, 1H), 6.28 (s, 1H), 4.80-4.90 (m, 1H), 3.89 (s, 3H), 2.61-2.92 (m, 2H), 2.12 (s, 3H), 1.93-2.10 (m, 2H).
250 mg of racemic sample of Compound 4 was separated by SFC chiral chromatography to provide 115 mg of Compound 6 (retention time: 4.15 min, chiral column: CHIRALPAK® AS-H 25x0.46 cm purchased from Chiral
Technologies, 50%> methanol/C02, 100 bar, flow rate of 3 mL/min) with >99%> ee, and 138 mg Compound 5 (retention time: 9.29 min, chiral column:
CHIRALPAK® AS-H 25x0.46 cm purchased from Chiral Technologies, 50% methanol/C02, 100 bar, flow rate of 3 mL/min) with > 99% ee. 1H NMR
(CD3OD): 6.85-6.96 (m, 3H), 6.77 (s, 1H), 6.28 (s, 1H), 4.80-5.10 (m, 1H), 3.89 (s, 3H), 2.61-2.92 (m, 2H), 2.12 (s, 3H), 1.92-2.16 (m, 2H). Compound 5 [a]20 D = -11.1 (c = 11.2 mg/mL, CHCI3). Based on the observed data described above for compounds 1-6, it is predicted that (-)-2-(3-hydroxy-4-methoxyphenyl)-6- methylchroman-7-ol corresponds to (S)-2-(3 -hydro xy-4-methoxyphenyl)-6- methylchroman-7-ol and (+)-2-(3 -hydroxy-4-methoxyphenyl)-6-methylchroman-7- ol corresponds to (R)-2-(3-hydroxy-4-methoxyphenyl)-6-methylchroman-7-ol.
Extraction of Compounds 1 and 2 from naturally-occurring sources
[0288] Compound 1 and Compound 2 each occur to different extents in various natural sources which are known in the art. Accordingly, one or both of the Compounds according to the invention can also be used in the form of plant extracts, in particular in the form of plant extracts from one of the plants mentioned in Table 1 below. The references listed in Table 1 are incorporated herein by reference in their entirety.
Table 1
Species Reference
Pancratium Illyricum Casu, L., et al., Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.
Bioorganic & medicinal chemistry letters, 2011. 21(23): p. 7041-7044.
Lycoris alhiflora Jitsuno, M, et al., Chemical constituents of Lycoris alhiflora and their cytotoxic activities. Natural product
communications, 201 1. 6(2): p. 1 7-192.
Dracaena cambodiana Luo, Y., et al, Antioxidant phenolic compounds of Dracaena cambodiana.
Molecules, 2010. 15(12): p. 8904-8914.
Dracaena cinnahari Baumer, U. and P. Dietemann,
Identification and differentiation of dragon's blood in works of art using gas chromatography/mass spectrometry.
Analytical and Bioanalytical Chemistry,
2010. 397(3); p. 1363-1376
Dracaena Draco Gonzalez, A.G., et al., Phenolic
Compounds of Dragon 's Blood from
Dracaena draco. Journal of Natural
Products, 2000. 63(9): p. 1297-1299.
Baumer, U. and P. Dietemann,
Identification and differentiation of dragon 's blood in works of art using gas
chromatography/mass spectrometry.
Analytical and Bioanalytical Chemistry, 2010. 397(3): p. 1363-1376
[0289] Extraction from these natural sources may be done using mixtures of aqueous alcohol with the alcohol content ranging from about 10% to about 99%, or more usually, from about 50 to about 95%. In some embodiments, extraction from these natural sources may be done using mixtures of aqueous alcohol with the alcohol content ranging from 10% to 99%, or more usually, from 50 to 95%.
Examples of alcohols suitable for use include but are not limited to methanol, ethanol, propanol, isopropanol, n-butyl alcohol or mixtures thereof. Examples of alcohol compositions for use in extractions may be 80:20 or 60:40
(volume/volume) methanol: water or ethanol: water. An example of purification involves partitioning the crude material between an aqueous alcohol and an organic solvent. The residue obtained by evaporation of the solvent into which the compound of interest is partitioned into is further purified by high performance liquid chromatography (HPLC), typically using reversed-phase support materials such as C-18 Hypersil. Gradients for use in HPLC are known, with an example of a typical gradient being 20% methanol in water, increasing to about 80-85% methanol in water over twenty minutes or 80-85% methanol in water over twenty minutes. Further examples of extraction, isolation and purification of compounds from naturally-occurring sources may be carried out using conventional techniques and procedures known in the art, such as "Natural Products Isolation", in "Methods in Biotechnology", Second Edition, Satyajit D. Sarker, Zahid Latif, Alexander I
Gray (editors), Humana Press, 2006, Totowa, New Jersey. This reference is incorporated herein in its entirety.
[0290] Compound 2 is isolated from commercial resin extract Dracaena cochinchinensis . Compounds 1 and 2 appear as a white powder exhibiting the following properties:
UV max 232 nm, 283 nm 1H NMR (300MHz, MeOD): δ 6.8-7.0 (m, 3H), 6.7 (d, J = 8.4 Hz, 1H), 6.4 (d, J= 8.4 Hz, 1H), 5.1 (m, 1H, partially buried under solvent peaks), 3.9 (s, 3H), 2.6-2.9 (m, 2H), 2.1 (s, 3H), 1.8-2.2 (m, 2H); Mass spectrum (EI): m/z(%)= 286.1(M +, 33); 162.1(19); 137.1(52); 135.0(50); 107.0(20);
77.1(22); Mass spectrum(ESI): m/z(%)= 287.1272(M+H+, 100); 163.0572(49); 137.0596(52). Analysis of the isolated material by chiral supercritical fluid chromatography (SFC) with an AS-H column ((25 x 0.46 cm) and 3 mL/min flow rate of 25% ethanol(DEA)/C02 (100 bar)) gave two chiral isomers with ratio at 80:20.
Examples
[0291] In order that this invention be more fully understood, the following examples are set forth. These examples are for the purpose of illustration only and are not to be construed as limiting the scope of the invention in any way.
[0292] The test compounds used in the following examples may be obtained from the synthetic methods disclosed above.
[0293] The taste test panelists used in the Example 1 were selected using a sensory acuity screening program. Candidate taste panelists were recruited, with prescreening and personal interviews, and were assessed and for their ability to detect, recognize and differentiate basic taste attributes or mixtures thereof as part of a standardized acuity test. This included basic tastes of sweet, sour, salty, bitter and umami, as well as having the capacity to focus on specific aspects of sensory character such as ranking the various tastes perceived and identifying the basic tastes presented at threshold levels.
[0294] Due to the complex nature of taste perception in subjects and the inherently subjective nature of the following experiments, individual taste test
trials may yield different results for a given compound. The data presented in the following Examples is illustrative of the taste testing results observed.
[0295] The taste testing experiments below were conducted with panels of varying size (i.e., panels comprising varying numbers of panelists).
Example 1: 2 Alternative Forced Choice
Effect of test compounds on the perception of sweet taste of high fructose cornsyrup (HFCS) two-alternative forced choice method (2AFC).
[0296] The effect of the test compounds on the perception of the sweet taste of an aqueous solution of sweetener in humans was evaluated using a two-alternative forced choice "sip and spit" method (2AFC).
Preparation of Samples for sensory taste tests
[0297] The aqueous sweetener solutions were prepared by adding sucrose equivalent (SE) quantities of high fructose corn syrup (HFCS) (by weight), to water to achieve the desired concentration. The aqueous solutions ranged in pH from pH 2.5-pH 7. Compounds of the invention were first prepared as a 500-fold concentrated stock solution in 100% ethanol. These concentrated stocks were then added to the aqueous sweetener solutions to result in a final ethanol concentration of 0.2%. The control (positive and negative) samples were also normalized to 0.2% ethanol. This level of ethanol was not seen to contribute any perceived sweetness.
Sensory Methodology: Assessment of sweetness perception using 2AFC method
[0298] The 2AFC test used for compound evaluation was a double blinded and randomized test where taste panelists (n >15) evaluate a pair of sweetener solutions at a time - one sample contains aqueous sweetener solution plus compound (i.e. test) while the other contains aqueous sweetener solution at higher concentration without compound (i.e. positive control). Each test sample was compared against a positive control. For example, if the test sample contained IX sweetener concentration with compound (e.g. 5brix HFCS with compound), the positive control sample contained a 1. IX sweetener concentration (e.g. 5.5brix HFCS without compound). In this manner, compounds were not assessed simply for an
increase in perceived sweetness, but a significant increase in perceived sweetness above the positive control.
[0299] Panelists were instructed not to eat or drink (except water) for at least 1 hour before the test. During the test, panelists were instructed to sip each sample, swirl it around their mouth and then expectorate. After tasting each sample in the pair, panelists were instructed to record the sample that is "sweeter" in taste. Panelists cleansed their palates by rinsing with water, eating a cracker and waiting for an interval of about 5 minutes. All samples were tasted at ambient
temperatures. Data were analyzed using binomial probabilities. The results of the 2 AFC analysis are presented in Table 1 , below.
Table 2. Sensory Data Summary 2AFC assessment of increase in perceived sweetness
Approximate levels of sweetness enhancement in column 5 of Table 2 were calculated as follows: [0300] Approximate levels of sweetness enhancement = Sweetener concentration of positive control surpassed by the test sample, divided by sweetener
concentration for compound-containing sample (e.g.1.3X = 6.5brix HFCS/5brix HFCS). This only indicates that the perceived increase is greater than the positive control, but does not indicate the degree with which the positive control concentration was surpassed.
Example 2: Inherent sweetness
Inherent Sweetness Assessment
Preparation of Samples for sensory taste tests
[0301] The aqueous sweetener solutions were prepared by adding sucrose equivalent quantities of HFCS (by weight), to water to achieve the desired concentration. The aqueous solutions ranged in pH from 2.5-pH 7.
[0302] Compounds were first prepared as a 500-fold concentrated stock solution in 100% ethanol. These concentrated stocks were then added to the aqueous sweetener solutions to result in a final ethanol concentration of 0.2%. The control (positive and negative) samples were also normalized to 0.2% ethanol. This level of ethanol was not seen to contribute any perceived sweetness
Sensory Methodology: Inherent Sweetness Assessment using 2AFC method
[0303] The intrinsic effect of test compounds on the perception of sweet taste, in an aqueous solution, in humans was evaluated using 2AFC methodology. This test was a double-blinded, randomized study where taste panelists (n >20) evaluate a pair of sweetener solutions at a time- one sample contains aqueous solutions, without sweetener, plus compound (i.e. test) while the other contains aqueous solution containing 1.5% sucrose equivalent (SE), HFCS (i.e. control). Each test sample is compared against the sweetener control to observe if the test is significantly less sweet than the control sample.
[0304] Panelists were instructed not to eat or drink (except water) for at least 1 hour before the test. During the test, panelists were instructed to sip each sample, swirl it around their mouth and then expectorate. After tasting each sample in the pair, panelists were instructed to record the sample that is "sweeter" in taste. Panelists cleansed their palates by rinsing with water, eating a cracker and waiting for an interval of about 5 minutes. Each pair was tasted twice. All samples were tasted at ambient temperatures. Data were analyzed using binomial probabilities
[0305] The results of the inherent sweetness analysis are presented in Table 3, below.
Table 3 : Sensory Data: Inherent Sweetness Assessment
For each compound listed in Table 3 : The control sample of 1.5% SE HFCS is significantly sweeter than each of the test samples.
Example 3: Descriptive Analysis
Effect of test compounds on the perception of sweet taste in humans using a trained descriptive analysis
(DA) panel
[0306] The effect of the test compound on the perception of the sweet taste in a flavored aqueous environment, in the presence of carbohydrate sweeteners, was evaluated using a descriptive analysis methodology with a group of trained panelists, as follows.
[0307] Candidate panelists were recruited, with prescreening and personal interviews, and were assessed for their ability to detect, recognize and differentiate basic taste attributes or mixtures thereof as part of a standardized acuity test. These candidate panelists were also assessed for their innate ability to identify flavors, and to rank on intensity scales. Other senses such as smell and vision were also included as part of the assessment. Candidates also were screened for their ability to use the language to describe and articulate ideas.
[0308] Selected candidates proceeded to training as a group in three phases: (1) Lexicon development, (2) Concept alignment, and (3) Scaling descriptors. During lexicon development, panelists evaluated products appropriate for use in the study to generate and align on terms describing the flavor, taste, aromatic, trigeminal, and temporal attributes. During concept alignment, the panel evaluated the products mentioned above to clarify and confirm the attributes that were generated during lexicon development using reference standards that appropriately define
each attribute; these are either physical references (e.g. sucrose solutions) or verbal descriptions (e.g. overall flavor). Product terms and concepts were validated during this portion of the study.
[0309] In the last phase, scaling descriptors, the panel participated in a series of exercises focused on ordering and ranking samples according to relative attribute intensity, measuring attribute intensity using a defined length of line scale.
Whenever possible, different levels or concentration of references were used as anchors to facilitate use of the scale. Panelists were provided with blinded references at this stage to evaluate their understanding and perception of the scale.
[0310] The panel used in this example was trained to reference sweet attributes in an absolute manner, such that a particular concentration of sweetener is always measured by the panelists at the same point using a 15 cm line scale where each cm represents a 1 % increase in sucrose to cover the range of 0% to 15% sucrose. For the rest of the attributes, the panel was trained using a hybrid approach between descriptive analysis methods well-known to those skilled in the art. Panel performance was measured at regular intervals, and for data presented, the cohort of 12 panelists demonstrated good performance for reproducibility measured as a panel average of 81%, and defined as the number of attributes with
reproducibility comparable to group performance (p<0.05), discrimination measured as a panel average of 93%, and defined as the number of attributes significantly different at a 90% confidence level individually (p<0.1), and agreement measured with a cohort average of 72% and defined as the number of attributes that correlate well to the panel consensus (R>0.7).
[0311] The trained panel was then used for a descriptive analysis assessment for Compound 2 and Compound 5 in flavored lemon lime matrix. Compound 2 was assessed at a dose of 50 ppm and Compound 5 was assessed at a dose of 20 ppm for sweetness enhancement in high fructose corn syrup (HFCS) sweetened lemon lime matrix.
[0312] The flavored sweetener solutions were prepared by adding sucrose equivalent quantities of HFCS (by weight), to lemon lime matrix to achieve the desired concentration. Compound was first prepared as a 500-fold concentrated stock solution in 100% ethanol. The concentrated stocks were then added to the
flavored sweetener solutions to result in a final ethanol concentration of 0.2%. The control (positive and negative) samples were also normalized to 0.2% ethanol. This level of ethanol was not seen to contribute any perceived sweetness
[0313] Both control (flavored sweetener solutions without compound) and variant (flavored sweetener solutions with compound) samples were blinded and randomized. Samples were presented in monadic order and panelists were instructed to sip the sample, swirl it in their mouths and expectorate. A total of 7 attributes including sweet, bitter, sour, licorice and thickness were assessed for each sample. For the sweet attribute, panelists made an absolute scoring on a 15 cm line scale where each cm represents a 1% increase in sucrose to cover the range of 0%) to 15%) sucrose. After each sample assessment, panelists performed a standard palate cleansing protocol, and observed an inter-sample interval time (ISI). All samples were evaluated at ambient temperatures.
[0314] Data was collected and exported electronically utilizing FIZZ sensory software. Data analysis was conducted using SENPAQ version 5.0 software that uses tools such as ANOVA, Fisher's LSD, correlation to determine panel performance as well as significant differences between samples and attributes.
Illustrative results of this DA assessment are presented in Tables 4 and 5.
Table 4. DA assessment of sweetness enhancing effects of Compound
2 in lemon lime flavored matrix
contro
Table 5. DA assessment of sweetness enhancing effects of Compound
5 in lemon lime flavored matrix
[0315] Sweetness intensities observed for compound-containing solution (i.e. variant) was significantly different from negative control solutions, as determined by ANOVA. The letter "a" indicates significant differences among the samples at 95% confidence level. Fold enhancement (increase in perceived sweetness) was calculated by dividing the DA panel average intensity score observed for a variant sample by that observed for the negative control sample.
Effect of test compounds on the perception of non-sweet taste attributes in humans using a trained descriptive analysis (DA) panel
[0316] The effect of the test compound on the perception of non- sweet taste attributes (such as bitterness) in a flavored aqueous environment, in the presence of carbohydrate sweeteners, was evaluated using a descriptive analysis methodology with a group of trained panelists, as follows. This occurred as part of DA assessment described previously in Example 3.
[0317] Candidate panelists were recruited, and trained as described previously, in Example 3, above.
[0318] The trained panel was then used for a descriptive analysis assessment for Compound 2 and Compound 5 in lemon lime flavored matrix, sweetened with high fructose corn syrup (HFCS), at a test dose of 50 ppm and 20 ppm, respectively.
[0319] All control and variant samples were prepared as described in Example 3. Both control (flavored sweetener solutions without compound) and variant
(flavored sweetener solutions with compound) samples were blinded and randomized. Samples were presented in monadic order and panelists were instructed to sip the sample, swirl it in their mouths and expectorate. A total of 7 attributes including sweet, bitter, sour, licorice and thickness were assessed for each sample. After each sample assessment, panelists performed a standard palate cleansing protocol, and observed an inter-sample interval time (ISI). All samples were evaluated at ambient temperatures.
[0320] Data was collected and exported electronically utilizing FIZZ sensory software. Data analysis was conducted using SENPAQ version 5.0 software that uses tools such as ANOVA, Fisher's LSD, correlation to determine panel performance as well as significant differences between samples and attributes.
Illustrative results of this DA assessment are presented as sensory Spider Plots in Figures 1 and 2.
Claims
What is claimed:
1. A method of enhancing the sweet taste of a sweetener in an edible composition, wherein said method comprises adding an effective amount of a compound of Formula (I)
Formula (I);
or a comestibly or biologically acceptable salt or derivative thereof, or enantiomer thereof,
wherein, as valence and stability permit:
Ri to Re are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H;
such that the perception of sweetness intensity of said sweetener is enhanced.
A method of reducing the bitter taste of a bitter tastant in an edible composition, wherein said method comprises adding an effective amount of a compound of Formula (I) or a comestibly or biologically acceptable salt or derivative thereof, or an enantiomer thereof, to said edible composition, such that the perception of bitter taste of said bitter tastant is reduced.
The method of claim 1 or 2, wherein, as valence and stability permit:
Ri and R2 are each independently OH or OMe; and
R3-R5 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H.
4. The method of claim 1 or 2, wherein, as valence and stability permit:
Ri,R2, and R5 are each independently OH or OMe; and
R3,R4, and R6 are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H.
5. The method of claim 1 or 2, wherein, as valence and stability permit:
Ri and R2 are each independently OH or OMe;
R3, R4, and Re are each independently H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy, provided that at least one of R4 and R6 is not H; and
R5 is OH.
6. The method of claim 1 or 2, wherein, as valence and stability permit:
Ri and R2 are each independently OH or OMe;
R3 is H, OH, Ci-C6 alkyl, or Ci-C6 alkoxy;
R5 is OH; and
R4 and R6 are Me.
The method of claim 1 or 2, wherein the compound of Formula (I) selected from the roup consisting of:
8. The method of any one of claims 1-7, wherein the method further
comprises the step of solubilizing or stabilizing a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
9. The method of claim 8, wherein the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is solubilized by the addition of a solubilizing agent.
10. The method of claim 8, wherein the compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is solubilized or maintained in solution by a process, wherein the process includes changes in temperature, pressure and/or time conditions, physical modifications such as reduction of the particle size by homogenization or micronization, modification of crystal form by formation of polymorphs or amorphous forms or where the material to be solubilized is dispersed in one or more carriers, or the use of chemical agents to effect solubilization, such as acids, bases, buffers, co- solvents, surfactants, complexation agents, solubilizers or precipitation inhibitors.
11. The method of any one of claims 8-10, wherein the compound of
Formula (I), or any one of Compounds 1-6, or a combination thereof, or enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is solubilized by converting the compound of Formula (I), or any one of
Compounds 1-6, or a combination thereof, or a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, into one or more crystalline forms, amorphous forms, one or more alcohol solvate forms, one or more hydrate forms, or mixtures thereof.
12. The method of any one of claims 1-11, wherein the sweetener is a
caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sug or a combination thereof.
The method of claim 12, wherein:
(a) the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose;
(b) the sugar alcohol is a polyol selected from erythritol, sorbitol, mannitol and xylitol;
(c) the artificial high-potency sweetener is sucralose or a salt thereof,
acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof;
(d) the natural high-potency sweetener is a steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, a mogroside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin,
mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture of any of the foregoing; and
(e) the rare sugar is a D-psicose, D-turanose, D-allose, D-tagatose, D- sorbose, L-fructose, L-glucose, D-sorbose, L-fructose, L-talose, L- ribose, L-arabinose or a mixture of any of the foregoing.
The method of any one of claims 1-13, wherein said edible composition further comprises one or more sweet taste improving additives.
The method of claim 14, wherein said one of more sweet taste improving additives is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
The method of claim 15, wherein the polyol is erythritol.
The method of claim 15, wherein the amino acid is glycine, alanine, lysine, glutamic acid, taurine, serine or proline.
The method of any one of claims 1-17, wherein the compound of Formula (I), or any one of Compounds 1-6, or natural extracts containing the compound of Formula (I), or any one of Compounds 1-3, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, are also used to decrease the off-taste in the edible
composition.
19. The method of claim 18, wherein the off-taste is bitter, metallic or astringent.
20. A composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener or capable of reducing the bitter taste of a bitter tastant.
21. A composition comprising a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, wherein said composition is edible and capable of enhancing the sweet taste of a sweetener and reducing the bitter taste of a bitter tastant.
22. The composition of claim 20 or 21, wherein the compound of Formula (I), or any one of Compounds 1-3, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof, is present in one or more natural extracts.
23. The composition of any one of claims 20-22, wherein the composition further comprises a solubilizing agent.
24. The composition of any one of claims 20-23, wherein the composition further comprises a sweetener.
25. The composition of claim 24, wherein the sweetener is a caloric
sweetener, an artificial sweetener, an artificial high-potency sweetener, a
natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
26. The composition of claim 25, wherein:
(a) the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose;
(b) the sugar alcohol is a polyol selected from erythritol, sorbitol, mannitol and xylitol;
(c) the artificial high-potency sweetener is sucralose or a salt thereof,
acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof;
(d) the natural high-potency sweetener is a steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, a mogroside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture of any of the foregoing; and
(e) the rare sugar is a D-psicose, D-turanose, D-allose, D-tagatose, D- sorbose, L-fructose, L-glucose, D-sorbose, L-fructose, L-talose, L- ribose, L-arabinose or a mixture of any of the foregoing.
27. The composition of any one of claims 20-26, wherein said edible composition further comprises one or more sweet taste improving additives.
28. The composition of claim 27, wherein said sweet taste improving
additive is selected from the group comprising: carbohydrates, polyols, glycosides, amino acids, sugar acids, polyamino acids, nucleotides, salts, organic acids, organic esters, flavoring agents, sweet flavors, alcohols, flavonoids, bitter compounds, proteins, protein hydrolysates, emulsifiers, surfactants and polymers.
29. The composition of claim 28, wherein the polyol is erythritol.
30. The composition of claim 28, wherein the amino acid is glycine,
alanine, taurine, serine or proline.
31. A method of preparing an edible composition comprising:
(a) providing a comestibly acceptable carrier; and
(b) adding to said comestibly acceptable carrier a compound of Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
32. The method of claim 31 , wherein the comestibly acceptable carrier comprises a sweetener.
33. The method of claim 31 or 32, wherein the comestibly acceptable
carrier further comprises a solubilizing agent.
34. The method of any one of claims 31-33, wherein the sweetener is a caloric sweetener, an artificial sweetener, an artificial high-potency sweetener, a natural high-potency sweetener, a sugar alcohol, a rare sugar, or a combination thereof.
35. The method of claim 34, wherein:
(a) the caloric sweetener is a carbohydrate selected from sucrose, high fructose corn or starch syrup, glucose and fructose;
(b) the sugar alcohol is a polyol selected from erythritol, sorbitol, mannitol and xylitol;
(c) the artificial high-potency sweetener is sucralose or a salt thereof,
acesulfame potassium or another salt thereof, aspartame or a salt thereof, alitame or a salt thereof, a sodium or calcium salt of saccharin, neohesperidin dihydrochalcone or a salt thereof, sodium cyclamate or another salt thereof, neotame or a salt thereof, or advantame or a salt thereof;
(d) the natural high-potency sweetener is a steviol glycoside, rebaudioside A, rebaudioside B, rebaudioside C (dulcoside B), rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside I, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside N, rebaudioside O, rebaudioside M, dulcoside A, rubusoside, stevia leaf extract, stevioside, a glycosylated steviol glycoside, a mogroside, mogroside V, isomogroside, mogroside IV, Luo Han Guo fruit extract, siamenoside, monatin or one of its salts (monatin SS, RR, RS, SR), curculin, glycyrrhizic acid or one of its salts, thaumatin, monellin, mabinlin, brazzein, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, baiyunoside, osladin, polypodoside A, pterocaryoside A, pterocaryoside B, mukurozioside, phlomisoside I, periandrin I, abrusoside A, or cyclocarioside I or a mixture thereof; and
(e) the rare sugar is a D-psicose, D-turanose, D-allose, D-tagatose, D- sorbose, L-fructose, L-glucose, D-sorbose, L-fructose, L-talose, L- ribose, L-arabinose or a mixture thereof.
36. The method of any one of claims 31-35, wherein the method further comprises adding a solubilizing agent.
37. A tabletop sweetener composition comprising a sweetener and a sweet taste modulator according to Formula (I), or any one of Compounds 1-6, or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
38. The tabletop sweetener composition of claim 37, further comprising at least one bulking agent, additive, anti-caking agent, functional ingredient or a combination thereof.
39. The tabletop sweetener composition of claim 37, wherein the tabletop sweetener composition is in the form of a liquid.
A method of preparing a complex comprising
(ii) heating a mixture comprising solvent, a compound according to Formula (I) or any one of Compounds 1-6 and at least one maltodextrin or cyclodextrin;
(ii) cooling the mixture; and
(iii) removing the solvent from the mixture to provide the compound according to Formula (I) or any one of Compounds 1-6 complex.
41. The method of claim 40, wherein the compound according to Formula (I) or any one of Compounds 1-6 and the maltodextrin or cyclodextrin are in a weight ratio from about 1 : 1 to about 1 :20.
42. The method of claim 40, wherein the at least one cyclodextrin is selected from the group consisting of a-cyclodextrin, β-cyclodextrin, γ- cyclodextrin, and derivatives thereof.
43. A delivery system selected from the group consisting of a co- crystallized flavor composition with a sugar or a polyol, an agglomerated flavor composition, a compacted flavor composition, a dried flavor composition, a particle flavor composition, a spheronized flavor composition, a granular flavor composition or a liquid flavor composition, wherein the flavor composition comprises a compound of Formula (I), or any one of Compounds 1-6 or a combination thereof, or an enantiomer thereof, a comestibly or biologically acceptable derivative thereof, or a comestibly or biologically acceptable salt thereof.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15838080.8A EP3188728A4 (en) | 2014-09-03 | 2015-09-03 | Compounds, compositions, and methods for modulating sweet taste |
US15/507,468 US20170303574A1 (en) | 2014-09-03 | 2015-09-03 | Compounds, compositions, and methods for modulating sweet taste |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462045463P | 2014-09-03 | 2014-09-03 | |
US62/045,463 | 2014-09-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016036980A1 true WO2016036980A1 (en) | 2016-03-10 |
Family
ID=55440373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/048400 WO2016036980A1 (en) | 2014-09-03 | 2015-09-03 | Compounds, compositions, and methods for modulating sweet taste |
Country Status (3)
Country | Link |
---|---|
US (1) | US20170303574A1 (en) |
EP (1) | EP3188728A4 (en) |
WO (1) | WO2016036980A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017189778A1 (en) * | 2016-04-26 | 2017-11-02 | Chromocell Corporation | Methods, compounds, and compositions, for modulating sweet taste |
WO2018013739A3 (en) * | 2016-07-12 | 2018-03-01 | Chromocell Corporation | Compounds, compositions, and methods for modulating sweet taste |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6217055B1 (en) | 2016-03-31 | 2017-10-25 | サントリーホールディングス株式会社 | Beverages containing catechins and RebD and / or RebM |
US10750764B2 (en) | 2016-03-31 | 2020-08-25 | Suntory Holdings Limited | Stevia-containing beverage |
TW202237834A (en) | 2017-02-03 | 2022-10-01 | 美商克迪科思股份有限公司 | Engineered glycosyltransferases and steviol glycoside glucosylation methods |
BR112020006822B1 (en) | 2017-10-06 | 2023-03-07 | Cargill, Incorporated | METHOD FOR MAKING A COMPOSITION OF YERBA MATE EXTRACT |
CN113727614B (en) | 2019-04-06 | 2024-06-04 | 嘉吉公司 | Sensory modifier |
US20210378264A1 (en) * | 2020-06-05 | 2021-12-09 | Real Peel Inc. | Packaged frozen drink base |
JP7470944B2 (en) | 2020-07-31 | 2024-04-19 | 松谷化学工業株式会社 | Poultry feed and meat |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100292175A1 (en) * | 2009-05-15 | 2010-11-18 | Leibniz-Institut fur Pflanzenbiochemie | Use of hydroxyflavan derivatives for taste modification |
-
2015
- 2015-09-03 WO PCT/US2015/048400 patent/WO2016036980A1/en active Application Filing
- 2015-09-03 US US15/507,468 patent/US20170303574A1/en not_active Abandoned
- 2015-09-03 EP EP15838080.8A patent/EP3188728A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100292175A1 (en) * | 2009-05-15 | 2010-11-18 | Leibniz-Institut fur Pflanzenbiochemie | Use of hydroxyflavan derivatives for taste modification |
Non-Patent Citations (3)
Title |
---|
DATABASE PUBCHEM [o] XP055416251, Database accession no. 128692946 * |
DATABASE PUBCHEM [o] XP055416252, Database accession no. 4710198 * |
See also references of EP3188728A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017189778A1 (en) * | 2016-04-26 | 2017-11-02 | Chromocell Corporation | Methods, compounds, and compositions, for modulating sweet taste |
WO2018013739A3 (en) * | 2016-07-12 | 2018-03-01 | Chromocell Corporation | Compounds, compositions, and methods for modulating sweet taste |
Also Published As
Publication number | Publication date |
---|---|
EP3188728A4 (en) | 2018-02-28 |
EP3188728A1 (en) | 2017-07-12 |
US20170303574A1 (en) | 2017-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3245197B1 (en) | Compositions and methods for modulating sweet taste | |
AU2018202660B2 (en) | Beverages containing rare sugars | |
US20150050410A1 (en) | Compounds, compositions, and methods for modulating sweet taste | |
US10849339B2 (en) | Beverages containing rare sugars | |
EP3019197B1 (en) | Rebaudioside x to provide sweetness enhancement | |
US20200054058A1 (en) | Sweetness and Taste Improvement of Steviol Glycoside and Mogroside Sweeteners with Dihydrochalcones | |
AU2017241771B2 (en) | Sweetness and taste improvement of steviol glycoside or mogroside sweeteners with flavonoids | |
US20170303574A1 (en) | Compounds, compositions, and methods for modulating sweet taste | |
US20190230956A1 (en) | Beverages Containing Rare Sugars | |
KR102628901B1 (en) | Oral sweetener compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15838080 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015838080 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015838080 Country of ref document: EP |